Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,WASHINGTON, D.C. 20549

 

FORM 10-K

 

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year endedFiscal Year Ended December 30, 201731, 2019

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from     to

Commission file number: 000-13470File No. 001-39110

 

NANOMETRICS INCORPORATEDONTO INNOVATION INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

94-2276314

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

1550 Buckeye Drive

Milpitas, California

95035

(Address of principal executive offices)

(Zip

16 Jonspin Road, Wilmington, MA 01887

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (408) 545-6000(978) 253-6200

Securities registered pursuant to Section

SECURITIES REGISTERED PURSUANT TO SECTION 12(b) of the Act:OF THE ACT:

 

Title of each classEach Class

Trading Symbol

Name of each exchangeExchange on which registeredWhich Registered

Common Stock, $0.001 par value per share

 

The NasdaqONTO

New York Stock Market LLC

(Nasdaq Global Select Market)Exchange (NYSE)

Securities registered pursuant to Section

SECURITIES REGISTERED PURSUANT TO SECTION 12(g) of the Act: OF THE ACT:

None

 

Indicate by check mark if the Registrantregistrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes      No .

Indicate by check mark if the Registrantregistrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes      No .

Indicate by check mark whether the Registrantregistrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrantregistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes      No .

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes      No .

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

Indicate by check mark whether the Registrantregistrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”,filer,” “accelerated filer”,filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

Indicate by check mark whether the Registrantregistrant is a shell company (as defined byin Rule 12b-2 of the Act).  Yes      No .

As of June 30, 2017, the last business day of the Registrant’s most recently completed second fiscal quarter, theThe aggregate market value of the common stock of Registrantregistrant’s voting Common Stock held by non-affiliates of the registrant was approximately $811,997,653 based uponon the closing sales price forof the Registrant’s common stock for such date, as quotedCommon Stock on the Nasdaq Global Select Market was approximately $468.3 million. Shares of common stock held by each officer and director and by each person who owned 5% or more of the outstanding common stock have been excluded because such persons may be deemed to be “affiliates” as that term is defined under the rules and regulations of the Exchange Act. This determination of affiliate status is not necessarily a conclusive determination for any other purpose.on June 28, 2019.

The number of shares of the Registrant’s common stockregistrant’s Common Stock outstanding as of February 20, 20186, 2020 was 23,761,304.50,282,160.

DOCUMENTS INCORPORATED BY REFERENCE

The Registrant has incorporated by reference intoItems 10, 11, 12, 13 and 14 of Part III of this Annual Report on Form 10-K portionsincorporate by reference information from the definitive proxy statement for the registrant’s annual meeting of its Proxy Statement for its 2018 Annual Meeting of Stockholdersstockholders scheduled to be filed pursuant to Regulation 14A. The Proxy Statement will be filed within 120 daysheld on May 12, 2020.


Table of Registrant’s fiscal year ended December 30, 2017. Contents

 

1


NANOMETRICS INCORPORATED

FORM 10-K

FOR THE FISCAL YEAR ENDED DECEMBER 30, 2017

TABLE OF CONTENTS

 

PART I

4

ITEM 1.

BUSINESS

4

ITEM 1A.

RISK FACTORS

11

ITEM 1B.

UNRESOLVED STAFF COMMENTS

22

ITEM 2.

PROPERTIES

23

ITEM 3.

LEGAL PROCEEDINGS

23

ITEM 4.

MINE SAFETY DISCLOSURES

23

PART II

24

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

24

ITEM 6.

SELECTED FINANCIAL DATA

27

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

28

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

38

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

39

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

72

ITEM 9A.

CONTROLS AND PROCEDURES

72

ITEM 9B.

OTHER INFORMATION

73

PART III

74

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

74

ITEM 11.

EXECUTIVE COMPENSATION

74

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

74

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

75

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

75

PART IV

76

ITEM 15.

EXHIBITS, FINANCIAL STATEMENT SCHEDULES

76

ITEM 16

FORM 10-K SUMMARY

78

SIGNATURES

79

Item No.

 

Page

PART I

1.

Business

2

1A.

Risk Factors

11

1B.

Unresolved Staff Comments

25

2.

Properties

25

3.

Legal Proceedings

25

4.

Mine Safety Disclosures

25

PART II

5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

26

6.

Selected Financial Data

28

7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

29

7A.

Quantitative and Qualitative Disclosures About Market Risk

38

8.

Financial Statements and Supplementary Data

38

9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

39

9A.

Controls and Procedures

39

9B.

Other Information

40

PART III

10.

Directors, Executive Officers and Corporate Governance

41

11.

Executive Compensation

41

12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

41

13.

Certain Relationships and Related Transactions, and Director Independence

41

14.

Principal Accountant Fees and Services

41

PART IV

15.

Exhibits and Financial Statement Schedule

42

Signatures

 

 

 


Table of Contents

 


CAUTIONARY INFORMATION REGARDING Explanatory Note

On October 25, 2019, Onto Innovation Inc. (the “Company” or “Onto Innovation,” formerly known as Nanometrics Incorporated (“Nanometrics”)) consummated its previously announced merger (the “Merger”) with Rudolph Technologies, Inc. (“Rudolph”). Onto Innovation accounts for the Merger as a reverse acquisition using the acquisition method of accounting in accordance with generally accepted accounting principles, with Rudolph being treated as the acquiring entity for accounting purposes. Because Rudolph is treated as the accounting acquirer in the Merger, the financial statements filed with this annual report on Form 10-K include the financial results of Rudolph for all periods presented and the financial results of the former Nanometrics for the periods on or after October 26, 2019. As used in this report, unless the context suggests otherwise, the terms “we,” “us” or “our” refer to (i) Rudolph and its consolidated subsidiaries for periods through October 25, 2019 and (ii) Onto Innovation and its consolidated subsidiaries for periods on or after October 26, 2019. The terms the “Company” and “Onto Innovation” refer to the combined company following the consummation of the Merger.

FORWARD-LOOKING STATEMENTS

ThisCertain statements in this Annual Report on Form 10-K for the year ended December 30, 2017, or “Form 10-K,” containsof Onto Innovation are forward-looking statements, including those concerning our business operations,momentum and financial performancefuture growth, acceptance of our products and condition as well asservices, our plans, objectives,ability to deliver both products and services consistent with our customers’ demands and expectations and to strengthen our market position, our expectations of the semiconductor market outlook, future revenue, gross profits, research and development and engineering expenses, selling, general and administrative expenses, product introductions, technology development, manufacturing practices, cash requirements, our dependence on certain significant customers and anticipated trends and developments in and management plans for our business operations and financial performancethe markets in which we operate, our anticipated revenue as a result of acquisitions, and condition. Anyour ability to be successful in managing our cost structure and cash expenditures and results of litigation. The statements contained hereinin this Annual Report on Form 10-K that are not purely historical are forward-looking statements within the meaning of historical factsSection 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be deemed to be forward-looking statements. You can identify these statementsidentified by words such as, but not limited to, “anticipate,” “believe,” “could,“continue,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “may,” “could,” “will,” “would,” “forecast,” “project” and otherwords or phrases of similar expressions that are predictions ofmeaning, as they relate to our management or indicateus.

The forward-looking statements contained herein reflect our expectations with respect to future events and future trends. These forward-looking statements are based on current expectations, estimates, forecasts, and projections about our business and the industry in which we operate and management's beliefs and assumptions and are not guarantees of future performance or development and involve known and unknownsubject to certain risks, uncertainties and other factors that areassumptions. Actual results may differ materially from those included in some cases beyond our control. As a result, any or all of oursuch forward-looking statements in this Form 10-K may turn out to be inaccurate. Factors that could materially affect our business operations and financial performance and condition include,for a number of reasons including, but are not limited to, those risksthe following: variations in the level of orders which can be affected by general economic conditions; seasonality and uncertainties described herein under “Item 1A - Risk Factors.”growth rates in the semiconductor manufacturing industry and in the markets served by our customers; the global economic and political climates; difficulties or delays in product functionality or performance; the delivery performance of sole source vendors; the timing of future product releases; failure to respond adequately to either changes in technology or customer preferences; changes in pricing by us or our competitors; our ability to manage growth; changes in management; risk of nonpayment of accounts receivable; changes in budgeted costs; our ability to leverage our resources to improve our position in our core markets, to weather difficult economic environments, to open new market opportunities and to target high-margin markets; the strength/weakness of the back-end and/or front-end semiconductor market segments; the imposition of tariffs or trade restrictions and costs, burdens and restrictions associated with other governmental actions; the ability to successfully integrate the businesses of Rudolph and Nanometrics promptly and effectively and to achieve the anticipated synergies and value-creation contemplated by the Merger within the expected time frame; unanticipated difficulties or expenditures relating to the Merger and integration of the Rudolph and Nanometrics businesses; the response of business partners and retention as a result of the Merger; the diversion of management time in connection with the integration; the effect of litigation related to the Merger; and the “Risk Factors” set forth in Item 1A. You are urged to consider these factorsshould carefully in evaluatingreview the forward-lookingcautionary statements and are cautioned not to place undue reliance“Risk Factors” contained in this Annual Report on the forward-looking statements. The forward-looking statements are based on information available to us as of the filing date of this Form 10-K. Unless required by law, we do not intend to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise. You should however,also review the factorsany additional disclosures and riskscautionary statements and “Risk Factors” we describe in the reports we will fileinclude from time to time in our quarterly reports on Form 10-Q, current reports on Form 8-K and other filings we make with the Securities and Exchange Commission or SEC, after(the “SEC”). The forward-looking statements reflect our position as of the date of this Form 10-K.report and we undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 


1


Table of Contents

PART I

ITEMItem 1.

BUSINESSBusiness.

OverviewGeneral

Onto Innovation is the new entity resulting from the completion on October 25, 2019 of the Merger between Nanometrics Incorporated and its subsidiaries (“Nanometrics”,Rudolph, two long-time leaders in the “Company”, or “we”)semiconductor equipment industry that began operations in 1975 and 1940, respectively. Onto Innovation has been publicly traded since October 2019 (NYSE: ONTO).  

Onto Innovation is a leading providerworldwide leader in the design, development, manufacture and support of process control tools that perform macro defect inspections and metrology, lithography systems, and process control analytical software used by semiconductor wafer and advanced packaging device manufacturers. Our products are also used in a number of other high technology industries including: silicon wafer substrates; light emitting diode (“LED”); vertical-cavity surface-emitting laser (“VCSEL”); micro-electromechanical system (“MEMS”); CMOS image sensor (“CIS”); power device; RF filter; data storage; and certain industrial and scientific applications. We have a combined installed base of over 9,000 systems in the majority of advanced high-performancesemiconductor device production factories worldwide.

We provide process control metrology and yield management solutions used in bare silicon wafer production and wafer processing facilities, often referred to as “front-end” manufacturing and device packaging and test facilities (or “back-end” manufacturing), respectively through a portfolio of standalone systems for macro-defect inspection, systems used primarily in the fabrication of semiconductorspackaging lithography, probe card test and other solid-state devices, including sensors, optoelectronic devices, high-brightness LEDs, discretes,analysis, as well as transparent and data storages components.opaque thin film measurements. Our automated and integrated metrology systems measure critical dimensions, device structures, topography, shape, and various thin film properties, including three-dimensional features and film thickness, as well as optical, electrical and material properties. Our process control solutions are deployed throughoutprimary area of focus is products that provide critical yield-enhancing information, which is used by microelectronic device manufacturers to drive down costs and to decrease the fabrication process, from front-end-of-line substrate manufacturing,time to high-volume production of semiconductorsmarket their devices. All Onto Innovation systems feature sophisticated software and other devices, to advanced three-dimensional wafer-level packaging applications. Our systems enableproduction-worthy automation. In addition, our advanced process control software portfolio includes powerful solutions for device manufacturers, providing improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductorstandalone tools, groups of tools, factory-wide, and other device markets.enterprise-wide suites to enhance productivity and achieve significant cost savings. Onto Innovation’s systems are backed by worldwide customer service and applications support.

We were incorporated in California in 1975,Nanometrics and reincorporated in Delaware in 2006. We have been publicly traded since 1984 (Nasdaq: NANO). We have an extensive installed base of thousands of systems in the majority of advanced semiconductor device production factories worldwide. Our major customers include Samsung Electronics Co. Ltd., SK Hynix Semiconductor, Inc., Micron Technology, Inc., Intel Corporation, Toshiba CorporationRudolph Merger

On October 25, 2019, Nanometrics and Taiwan Semiconductor Manufacturing Company Limited.

Additional information about us is available on our website at http://www.nanometrics.com. The information that can be accessed through our website, however, is not part of this Annual Report. The investor relations section of our website is located at http://www.nanometrics.com/investor.html. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports are available on the investor relations section of our website free of charge as soon as reasonably practicable after we electronically file or furnish such materialsRudolph consummated their previously announced Merger pursuant to the United States Securitiesagreement and Exchange Commission (“SEC”plan of merger, dated as of June 23, 2019 (the “Merger Agreement”). In addition, the reports, by and materials that we file with the SEC are available at the SEC's website (http://www.sec.gov)among Nanometrics, Rudolph and at the SEC's Public Reference Room at 100 F Street, NE, Washington DC 20549. Interested parties may obtain information on the operationPV Equipment Inc.  As a result of the Public Reference RoomMerger, Rudolph became a direct wholly-owned subsidiary of Nanometrics, which was renamed “Onto Innovation Inc.” At the effective time of the Merger, each issued and outstanding share of common stock of Rudolph, par value $0.001 per share (“Rudolph Common Stock”) (other than shares owned by callingRudolph or Nanometrics), was automatically converted into the SEC at 1-800-SEC-0330.right to receive 0.8042 (the “Exchange Ratio”) shares of Onto Innovation common stock, par value $0.001 per share (“Onto Innovation Common Stock”), and cash in lieu of any fractional shares of Onto Innovation Common Stock any former holder of Rudolph Common Stock would otherwise be entitled to receive. Immediately following the effective time of the Merger, each of Nanometrics’ and Rudolph’s stockholders owned approximately 50% of the combined company, Onto Innovation. Pursuant to the Merger Agreement, Onto Innovation accounts for the Merger as a reverse acquisition using the acquisition method of accounting in accordance with generally accepted accounting principles, with Rudolph being treated as the acquiring entity for accounting purposes.  

Industry Background

We participate in the sale, design, manufacture, marketing and support of process control systems for optical critical dimension metrology, thin film metrology, wafer defectinspection, 2D and 3D macro inspection and lithography tools for advanced analytics usedpackaging as well as advanced analytical software for semiconductor manufacturing.manufacturing and certain industrial applications and scientific research. Our principal market is semiconductors.  Semiconductors, primarily packaged as integrated circuits within electronic devices, include consumer electronics, server and enterprise systems, mobile computing (including smart phones and tablets), data storage devices, and embedded automotive and control systems. Integrated circuits are made up of semiconductor material layers integrating millions or billions of transistors and other electronic components, connected through a complex wiring scheme of small copper wires, ultimately packaged into thin form factors to be mounted on circuit boards or other substrates. Our core focus is the measurement and control of the structure, composition, and geometry of the devices from the transistor layer through advanced wafer-level packagingas they are fabricated on silicon wafers to improve device performance and manufacturing yields. Our end customers manufacture many types of integrated circuits for a multitude of applications, each having unique manufacturing challenges. This includes integrated circuits to enable information processing and management (logic integrated circuits), memory storage (NAND, 3D-NAND, NOR,(3D NAND and DRAM), analog devices (e.g., Wi-Fi and 4G5G radio integrated circuits, power devices), MEMS sensor devices (accelerometers, pressure sensors, and microphones), image sensors, thin film headand components for hard disk drives, LEDs, and alternative energy devices such as LEDs, power invertersmanagement.

2


Table of Contents

Current Trends

Advanced Nodes refer to leading edge integrated circuits in which the feature sizes of transistors and solar cells.

other features continue to shrink in specified steps, or nodes measured in nanometers (nm). Demand for our products continues to be driven by our customers'customers’ desire for higher overall chip performance including improvements inwithout increasing the chip size, while improving power efficiency, logic processing capability, data storage volume and manufacturing yield. To achieve these goals, our customers have increased their use of more complex materials and processing methods in their manufacturing flow. The majority of our chip customers manufacture devices in production runs defined by the smallest printed feature and the associated circuit manufacturing methods,primary paths for performance gains are geometric scaling, known as a technology node which are measuredshrinks, or scaling in nanometers ("nm"), or one-billionth of a meter. Current volume production is running from 28nm down to the 10nm nodes across foundry and logic devices, transitioning from 20nm to 1Xnm for DRAM memory (where X is IDM dependent and may be as low as 17nm), and third generation 3D-NAND with up to 64 layers of storage transistors. Our customers continue to develop next generation devices such as 7nm and 5nm devices in logic and foundry, shrink DRAM below the 17nm node, and scale 3D-NAND devices to 96 layers and beyond.three dimensions. In some cases, our customers are implementing new materials and methods in high volume manufacturing, including materials and device architectures to reduce power consumption, and stacked devices. To scale NAND memory devices including 3D-NAND, and advanced interconnect wiring schemes. To shrink features,a new methods, including multiple patterning lithography and extreme ultra-violet lithography (EUV), have3D stacking architecture has been developed.implemented with as many as 128 device layers in production. Additional innovation continues in Data Storage, Power Devices, MEMS, and Image Sensors. We believe the use of these new materials and manufacturing methods has increased demand for our products.products such as the Atlas III+ that is capable of measuring these advanced nodes as certain features shrink to 7nm, 5nm and 3nm.


To shrink features, new methods, including multiple patterning lithography and extreme ultra-violet (“EUV”) lithography, have been developed. The EUV process is driving significantly higher requirements for the silicon wafers that are entering the EUV chamber. Small particles on the backside of the wafer measuring a few micrometers (microns) can distort the images being projected onto the top side. Our BusinessNovusEdge inspection tool has been installed at major silicon wafer manufacturers to detect backside contamination and edge cracking as a final quality control mechanism before wafers are shipped to the semiconductor fabrication manufacturers. The top side of these wafers must also be scanned for any impurities contained in the silicon. This compositional analysis is measured using Onto Innovation’s Fourier Transform Infrared (“FTIR”) systems.  

Advanced Packaging refers to a variety of technologies that enable the miniaturization of electronic products, such as portable consumer devices, including smartphones, watches, and tablets. In electronics manufacturing, integrated circuit packaging is the final stage of semiconductor device fabrication, in which a single circuit made from semiconducting material (a die or chip) is encased in a molded package that provides external connections to a printed circuit board and also prevents physical damage to the chip and corrosion.  Advanced Packaging refers to the conductors and other structures that often connect multiple die, feed them with electric power and create signal paths to and from the PC board, dissipate their heat, and protect them from damage.  Today, the drive to pack more functions into a small space and reduce their power requirements demands that chip packages do much more than ever before to combine multiple chips and functions into a single molded package.

One example of the technology used in Advanced Packaging is the 3D integration of semiconductors and other devices. The technology involves stacking individual die in one integrated package. Through-silicon vias (“TSVs”) are vertical copper interconnects that are embedded from the bottom surface of a die to the top surface, which allows power and communication to be shared among the individually stacked components. The processes required for 3D integration vary from one manufacturer to another and many continue to be optimized for yield and to ensure the functioning of individual stacked chips.

Fan-out wafer level packages are another advanced packaging technology using copper pillars/bumps to vertically connect a wide variety of stacked die and are considered the next disruptive technology for several reasons. First, fan-out wafer level packages significantly reduce the space needed inside an electronic device, such as a smartphone, by combining multiple chips/functions into a single package, often called a System-in-Package (“SIP”). Next, it improves the system’s performance by reducing power and signal conductor lengths, which previously were routed from package to package through a printed circuit (“PC”) board. Using thin redistribution layers (“RDLs”) to “fan out” power and signal connections to the larger contacts on the PC board eliminates the need for a ceramic or laminated substrate, which accounts for 35 percent of the packaging cost.  As a result of the small overall form factor, fan-out wafer level packages provide the functionality needed in high-end mobile and wearable products. We believe the growth of advanced packaging has increased demand for our products such as the Dragonfly G2 System that is capable of inspecting two-dimensional (2D) features to find flaws/defects and detect unwanted residual residue as well as measuring and reporting vertical attributes of 3D pillars and bumps.

Panel Manufacturing. The current process to manufacture advanced packaging involves attaching known good die to a 300mm wafer, used as a temporary carrier when adding components such as RDLs and copper pillars.  SIP packages can often contain side-by-side die, meaning the package can be large and limit the number of packages being placed on a reconstituted wafer. In order to meet the growing demand at reduced average selling prices, manufacturers are looking to scalable technology. Advanced packaging facilities looking to improve cost of ownership and increase productivity are transitioning from round 300mm wafers to large rectangular panels, which can be as large as 600mm x 600mm. This larger size and shape enables companies manufacturing large area packages to efficiently increase the number of devices being

3


Table of Contents

processed at each step as they are no longer limited to operating within the constraints of a round wafer. By responding to market opportunities and addressing the stringent demands of customers’ technical roadmaps, we believe that Onto Innovation is optimally positioned to capitalize on the emerging market of high-volume panel manufacturing.  For example, the JetStep® S lithography system is designed for processing RDLs on both glass and organic laminate panels in the semiconductor Advanced Packaging market. The Firefly™S Series, designed for high resolution inspection, can provide metrology and location information to the JetStep S tool for each die, which greatly improves lithography throughput using Onto Innovation’s exclusive StepFAST™ process.  The Firefly also delivers a combination of defect detection and substrate flexibility in a single platform, reducing capital investment requirements and providing a reliable pathway to transition from wafer to panel-based processes.

Technology

We believe that our expertise in our core technologies of optics and software and our combined investment in research and development will enable us to rapidly develop new technologies and products in order to quickly respond to emerging industry trends and competitive challenges. The breadth of our technology enables us to offer a diverse linecombination of process control products and technologiessolutions. Unique features have been designed into our lithography systems to address the manufacturing requirements of the semiconductor (and other solid-state device) manufacturing industry.meet our customers’ changing process requirements. Our metrology systems measure and characterize the physical dimensions, material composition, optical and electrical characteristics and other critical parameters of solid state devices, from initial wafer substrate manufacturing through final packaging.

We are continually working to strengthen our competitive position by developing innovative technologies and products in our market segment. We have expanded our product offerings to address growing applications within the semiconductor manufacturing and adjacent industries. In pursuit of our goals, we have:

Introduced new products, applications, and upgrades in every core product line and primary market served;

Diversified our product line and strengthened our position with our top customers securing tool of record positions of one or more products in each of the top six customers (as defined by capital expenditures for wafer fab equipment), who combined represent more than 80% of all wafer fab equipment expenditures; and

Continued development of new measurement and inspection technologies provide process control for the majority of wafers processed today in a semiconductor wafer fab. In front-end processes, optical critical dimension (“OCD”) metrology, thin film metrology, wafer stress metrology and macro defect detection and classification technologies allow yield enhancement for critical processes such as photolithography, diffusion, etch, chemical mechanical planarization (“CMP”) and outgoing quality control. Within the final manufacturing (back-end) processes, our 2D/3D advanced fabrication processes.macro defect inspection provides our customers with critical quality assurance and process information. Defects may be created during probing, bumping, dicing, assembly processes (RDLs, TSVs, copper pillars, etc.) or general handling and can have a major impact on device and process quality. Lastly, we turn all of the data gathered into useful knowledge for our customers to make yield-enhancing decisions, which lower their cost of goods sold (“COGS”) and improve their margins.

NanometricsOnto Innovation’s Products

We offer a diverse line of systems to address the broad range of process control requirements of the semiconductor manufacturing industry. In addition, we believe that our product development and engineering expertise and strategic acquisitions will enable us to develop and offer advanced process control solutions that, in the future, should address industry advancement and trends.Metrology

Automated Systems

Metrology Systems.Our automated systems primarily consist of fully automated metrology systems that are employed in semiconductor production environments. The Atlas® III, Atlas II+, and Atlas XP+ representAtlas® family of products represents our line of high-performance metrology systems providing optical critical dimension (“OCD”®),OCD and thin film metrology and wafer stress metrology for transistor and interconnect metrology applications. The thin film and OCD technology in the Atlas is supported by our NanoCD suite of solutions including our NanoDiffract® software, SpectraProbe™ software and NanoGen™ scalable computing engine that enables visualization, modeling, and analysis of complex structures.  The UniFire™ system measures multiple parameters at any given process stepAdditionally, the S3000SX System is used for ultra-thin transparent films metrology in the advanced packaging process flowsemiconductor fabrication applications for critical dimension, overlay, and topography applications and has recently added inspection capabilities for both front-end of line patterned wafer and advanced packaging related applications.nodes.

Integrated Systems

Our integrated metrology (“IM”) systems are installed directly onto wafer processing equipment to provide near real-time measurements for improved process control and maximum throughput. Our IM systems are sold directly to end user customers. The IMPULSE®+ and IMPULSE represent our latest metrology platform for OCD, and thin film metrology, and have been successfully qualified on numerous independent Wafer Fabrication Equipment Suppliers’ platforms. Our NanoCD suite of solutions is sold in conjunction with our IMPULSE systems. Our Trajectory® system provides in-line measurement of layers in thin film thickness and composition in semiconductor applications and is qualified in production with major device makers.


Software

NanoDiffract®NanoDiffract® is a modeling, visualization and analysis software that takes signals from the automated and integrated metrology systems, providing critical dimension, thickness, and optical properties from in linein-line measurements. The software has an intuitive three-dimensional modeling interface to provide visualization of today’s advanced and complex semiconductor devices. There are proprietary fitting algorithms in NanoDiffract that enable very accurate and very fast calculations for signal processing for high fidelity model basedmodel-based measurements.

SpectraProbe™ SpectraProbe is a model-less fitting engine that enables fast time to solution for in-line excursion detection and control. SpectraProbe complements the high-fidelity modeling of NanoDiffract with a simple machine learning interface for rapid recipe deployment. SpectraProbe expands the types of structures that can be used for metrology and control including in-die and on-device areas. Both analysis packages areThe software is supported by the automated and integrated systems, can be deployed in run-time environments and support off-line processing as part of a factory control solution when deployed on NanoCentral and NanoGen, servers.

NanoGen is an enterprise scale computing hardware system that is deployed to run the computing intensive analysis software. NanoGen leverages commercial server chips and networking architecture and is optimized to support the workload of NanoDiffract and SpectraProbe analysis.  NanoCentral

Integrated Metrology Systems. Our integrated metrology (“IM”) systems are installed directly onto wafer processing equipment to provide near real-time measurements for improved process control and maximum throughput. Our IM systems are sold directly to end user customers. The IMPULSE family of products includes the latest technology for OCD, and thin film metrology, and have been successfully qualified on numerous independent Wafer Fabrication Equipment Suppliers’ platforms. Our NanoCD suite of software solutions including NanoDiffract and SpectraProbe, is sold in conjunction with our IMPULSE systems.

Opaque Film Metrology. The MetaPULSE® systems allow customers to simultaneously measure the thickness and other properties of metal or non-metallic opaque film layers in a fab based networkingnon-destructive manner without physically contacting product wafers. PULSE Technology is used in copper or aluminum interconnect processes, as well as various layers in 3D NAND chips and server system providing connectivitythick advanced packaging interconnect applications.  PULSE technology is expanding into new process

4


Table of Contents

applications such as RF filters and compute supportmodules, driven by the need for on-product metrology as feature sizes decrease and pattern densities increase.

Inspection & Yield Management

Silicon Wafer All-surface Inspection/Characterization. All-surface refers to SpectraProbeinspection of the wafer frontside, edge, and connected measurement systems including Atlasbackside as well as the locator notch on the wafer. The AWX and Impulse productsNovusEdge tools utilize optical scattering and imaging technology to inspect these surfaces.  A primary reason for all-surface wafer inspection is to detect and contain any contamination that may spread throughout the wafer fab. For instance, it is critical that the wafer backside be free of defects prior to the EUV lithography process to prevent focus and exposure problems on the wafer frontside.

Materials Characterization

Epitaxial Thickness and Composition. Our materials characterization products include systems that are used to monitor the physical, optical, electrical and material characteristics of discrete electronic industry, opto-electronic, HB-LED (high brightness LEDs), solar PV (solar photovoltaics), compound semiconductor, strained silicon and silicon-on-insulator (“SOI”) devices, including composition, crystal structure, layer thickness, dopant concentration, contamination and electron mobility.

The RPMBlue™ is our Our portfolio of products for materials characterization includes photoluminescence mapping system designed specifically forin the HB-LED market,RPM Blue and is complemented by the RPMBlue-FS, enabling a breadth of researchVertex, and development configurability. We sell Fourier-TransformFourier Transform Infrared (“FTIR”) automated and manual systemsspectroscopy in the QS2200/3300 and QS1200 respectivelyQS Family (QS1200, QS2200, QS4300) systems for substitutesubstrate quality and epitaxial thickness metrology. The NanoSpec

Macro Defect Inspection. Chip manufacturers deploy advanced macro defect inspection throughout the production line to monitor key process steps, gather process-enhancing information and ultimately, lower manufacturing costs. Field-established tools such as the F30, NSX®, and the latest Dragonfly G2 inspection systems are found in wafer fab (front-end) and packaging (back-end) facilities around the world. These high-speed tools incorporate features such as wafer-less recipe creation, tool-to-tool correlation and multiple inspection resolutions. Using Discover® yield management software, the vast amounts of data gathered through automated inspection can be analyzed and classified to determine trends and locate root causes that directly affect yield.

Automated Defect Classification and Pattern Analysis. Automating the defect detection and classification process is best done by a system that can mimic, or even extend, the response of the human eye, but at a much higher speed, with higher resolution and more consistency. Our TrueADC software performs this rapid comparison and classification enabling yield improvement across facilities with consistent results.  

Yield Analysis. Using wafer maps, charts and graphs, the massive amounts of data gathered through automated inspection can be analyzed to determine trends across bumps, die, wafers and lots. Discover Yield and other tools in the Discover suite enable enterprise-wide analysis.  This analysis may determine where a process variation or deviation has occurred, allowing process engineers to make corrections or enhancements to increase yields. Defect data analysis is performed to identify, analyze and locate the source of defects and other manufacturing process excursions. Using either a single wafer map or a composite map created from multiple wafer maps, this analysis enables identification of defect patterns and distribution. When combined with inspection data from strategically placed inspection points, this analysis may pinpoint the source of the defects so corrective action can be taken.

Industrial, Scientific, and Research Markets: 4D Technology. In November of 2018, Nanometrics acquired 4D Technology Corporation, based in Tucson Arizona. The 4D business unit offers a line includingof interferometry systems for the NanoSpec II, supports thin film measurement across alland inspection of high precision surfaces. End markets include high precision optics surfaces and components, aerospace and defense components, automotive and powertrain systems, and unique research and scientific instrumentation that requires the unique high-speed results of the 4D systems.

Lithography

Advanced Packaging Lithography. Our lithography steppers from the JetStep product family, use projection optics to expose circuit patterns from a mask or reticle onto a substrate to expose images with optimal fidelity. The JetStep systems are used principally for package level interconnect and bump layer patterning.  Our JetStepsystems have been specifically designed for these layer applications. The JetStep W Series is designed for wafers and other round substrates while the JetStep S Series is designed for rectangular substrates (panels). Both systems boast a large printable field to maximize throughput while not limiting resolution. High-fidelity optics are able to image the fine features required while at the same time managing the non-flatness that is typical for advanced packaging applications. 

Flat Panel Display Lithography. In addition to semiconductor device applications with the JetStep S and W products, the JetStep G Series is engineered to address the needs of the flat panel display market.  The JetStep G is principally used in both low volume productionGen 4 and research applications.Gen 5 panels for displays used in high resolution, smaller form factor devices, such as smart phones and smart watches.  

Our

5


Table of Contents

Enterprise Software Solutions

Process Control Software. We provide a wide range of advanced process control solutions, all designed to improve factory profitability, including run-to-run control, fault detection, classification and tool automation. Our Advanced Process Control solutions are sold under the Discover™ brand and include Discover Enterprise, Discover Run-to-Run and other solutions.  Discover software can automatically detect or predict tool failure (fault detection) as well as calculate recipe settings for a process that will drive the yielded output to meet and exceed the target, despite variations in the incoming material and minor instabilities within the process equipment.  These process control software solutions enable the factory to increase capacity and yield while decreasing rework and scrap.

Yield Management Software. Semiconductor manufacturers use yield management software to obtain valuable process yield and equipment productivity information. Our Discover Yield, Discover Enterprise, and Discover Patterns software enables fab wide and enterprise wide (multiple factory) yield management based on data analytics from a broad range of sources.  These data sources include wafer fab inspection and metrology systems, can be categorized as follows:tool sensors, tool recipes, electrical tests and the fab environment. The Discover platform utilizes machine learning, advanced analytics, and other analysis and visualization to enable yield management and excursion prevention, and to maximize productivity across the entire semiconductor manufacturing value chain.


6


Table of Contents

Products

 

SystemWAFER AND CHIP MANUFACTURING

Market

Applications

Products

Unpatterned Silicon Wafer

 

Market

Bare wafer edge and backside inspection

NovusEdge™ Wafer System

AWX Series

 

ApplicationsEpitaxial Thickness and Composition / Impurity Detection

QS1200 System

QS2200 System

QS4300 System

RPM Blue & Vertex Systems

AutomatedOCD Metrology

Leading-edge 3D chip manufacturing

Atlas III+ System

IMPULSE+ System

Metal Film Metrology

Opaque metal and semi-transparent film metrology system

MetaPULSE G System

Transparent Film Metrology

Transparent thin film metrology system

Atlas III+ System

IMPULSE+ System

S3000™ System

Macro Defect Inspection

Front-side macro defect inspection system

DragonFly G2 System

F30™ Inspection Module

NSX® Inspection Systems

ADVANCED PACKAGING

Market

Applications

Products

System-in-Package Inspection

2D/3D Advanced Packaging inspection and bump metrology

Dragonfly™G2 System

NSX® Systems

Fan-out Panel Level Packaging

 

 

 

Sub-micron defect panel inspection

Firefly™ Systems

Atlas III, Atlas II+/Atlas XP+

 

Semiconductor2x reduction step and repeat system for advanced packaging lithography on square or rectangular substrates up to Gen 3.5 size

JetStep® X700 System

 

Film Thickness, Film Stress, CDAlignment metrology and lithography optimization

StepFAST Software

UniFireINTEGRATED SOFTWARE SOLUTIONS

Market

Applications

Products

Enterprise / Fabwide

Data

Management

 

Semiconductor

Fabwide yield management system

Film Thickness, Overlay, CD, and Advanced Packaging Applications, InspectionDiscover® Enterprise Software

Discover Yield Software

Discover Defect Software

TrueADC® Enterprise Software

Integrated SystemsTool Centric Analytics

 

 

 

IMPULSE/IMPULSE+Tool-centric yield management system

Discover® Run-to-Run Software

Discover Patterns Software

Semiconductor

Film Thickness, CD

Trajectory

Semiconductor, Solar PV

Film Thickness, Composition

Analysis Software and Computing Systems

 

 

Automatic defect classification software

NanoDiffractDiscover Review Software

Semiconductor

OCD

SpectraProbe

Semiconductor

Excursion Control Film Thickness & OCD

NanoGen/NanoCentral

Semiconductor

Compute Hardware for NanoDiffract & SpectraProbe


Materials Characterization Systems

ECVPro

Compound Semiconductor, Solar PV, HB-LED

Electrical Properties

HL5500

Compound Semiconductor, Solar PV, HB-LED

Electrical Properties

QS1200

Substrate Semiconductor, Solar PV

Substrate Properties, Film Composition and Thickness

QS2200/3300

Substrate Semiconductor

Substrate Properties, Film Composition

NanoSpec® II

Semiconductor

Film Thickness (Tabletop)

RPMBlueTM

HB-LED

Epitaxial Layer Properties

Stratus

Semiconductor

Substrate Properties, Film Composition and Thickness (Tabletop)

See Note 14


7


Table of Contents

Customers

Over 150 microelectronic device manufacturers have purchased Onto Innovation tools and software for installation at multiple sites. We support a diverse customer base in terms of both geographic location and type of device manufactured. Our customers are located in over 20 countries.

In 2019, sales to Taiwan Semiconductor Manufacturing Co. Ltd. and SK Hynix Inc. accounted for 13.4% and 13.1%, respectively, of our consolidated financial statements in Item 8, "Financial Statements and Supplementary Data,"revenue.  In 2018, sales to SK Hynix Inc. accounted for revenues by product type, which information is incorporated by reference here.

Customers

We sell our metrology and inspection systems worldwide to semiconductor manufacturers, and producers of solid state devices. The majority12.2% of our systems are sold to customers located in Asia and the United States.

The following customersrevenue.  No individual end user customer accounted for more than 10% or more of our total net revenues:revenue in 2017.  We do not have purchase contracts with any of our customers that obligate them to continue to purchase our products.

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Samsung Electronics Co. Ltd.

 

 

26%

 

 

***

 

 

 

13%

 

SK Hynix

 

 

13%

 

 

 

15%

 

 

 

11%

 

Micron Technology, Inc.

 

 

12%

 

 

 

20%

 

 

 

16%

 

Intel Corporation

 

 

11%

 

 

 

18%

 

 

***

 

Toshiba Corporation

 

 

11%

 

 

***

 

 

 

10%

 

Taiwan Semiconductor Manufacturing Company Limited

 

***

 

 

 

10%

 

 

 

19%

 

***

The customer accounted for less than 10% of total net revenues during the period.

Sales, Customer Service and MarketingApplication Support

We believe that the capability for direct sales and support is beneficial for developing and maintaining close customer relationships and for rapidly responding to changing customer requirements. We provide local direct sales, service and application support through our worldwide offices located in the United States, South Korea, Japan, Taiwan, China, Singapore and France,Europe, and work with selected dealers and sales representatives on a more limited basis in Asia, in the United States and othervarious countries. Our applications team is composed of technically experienced sales engineers who are knowledgeable in the use of metrology systems generally and the unique features and advantages of our specific products. Supported by our technical applications team, our sales and support teams work closely with our customers to offer cost-effective solutions to complex measurement and process problems.

Net revenues from customers located in the United StatesAs of December 31, 2019, we employed 647 sales and in foreign countries, as a percentage of total net revenues were as follows:

 

 

2017

 

 

2016

 

 

2015

 

United States

 

13%

 

 

14%

 

 

20%

 

China

 

12%

 

 

20%

 

 

9%

 

South Korea

 

36%

 

 

20%

 

 

16%

 

Singapore

 

8%

 

 

17%

 

 

9%

 

Japan

 

16%

 

 

12%

 

 

17%

 

Taiwan

 

8%

 

 

12%

 

 

25%

 

All other countries

 

7%

 

 

5%

 

 

4%

 


See Note 14 of our consolidated financial statements in Item 8, "Financial Statementsmarketing, service and Supplementary Data," for segment and geographical financial information, including revenues and long-lived assets by geographic region, and our consolidated financial statements for net revenue information, which is incorporated by reference here.

Customer Service and Supportapplications support personnel.

We believe that customer service and technical support for our systems are crucial factors that distinguish us from our competitors and are essential to building and maintaining close, long-term relationships with our customers. We generally provide a standard one-year warranty on partsfor our products which range from twelve to fourteen months to cover defects in material and labor for most of our products.workmanship. We provide system support to our customers through factory technical support and globally deployed field service personnel. The factory technical support operations provide customers with telephonic technical support access, direct training programs, operating manuals and other technical support information to enable effective use of our metrology and measurement instruments and systems. We have field service operations based in various locations throughout the United States, South Korea, Taiwan, China, Japan, Singapore, Israel, France, Italy, and Germany.

Service revenues, including sales of replacement parts, represented 17%, 16%, and 22% of total net revenues in 2017, 2016 and 2015, respectively.

Backlog

As of December 30, 2017, and December 31, 2016, our backlog was $34.0 million and $28.5 million, respectively. Backlog includes orders received and booked, both shipped and not yet recognized as revenue, and not shipped, for products, services and upgrades where written customer requests have been received and we expect to ship and/or recognize revenue within 12 months. Orders are subject to cancellation or delay by the customer subject to possible penalties. However, historically, order cancellations have not been significant. Because orders presently in backlog could be cancelled or rescheduled and some orders can be received and shipped within the same quarter, we do not believe that current backlog is an accurate indication of our future revenues or financial performance.

With the adoption of the new revenue guidance, ASC Topic 606, Revenue From Contracts With Customers in the first quarter of fiscal 2018, we expect backlog will be reduced as discussed in Note 2 to the Consolidated Financial Statements in Item 8.

Competition

We offer various products for various semiconductor manufacturing process steps, and several of our products extend across the same process flow. However, for process control of each of these process steps, we have multiple competitors. In every market in which we participate, the global semiconductor equipment industry is intensely competitive, and driven by rapid technological adoption cycles. Our ability to effectively compete depends upon our ability to continually improve our products, applications and services, and our ability to develop new products, applications and services that meet constantly evolving customer requirements.

We believe that our competitive position in each of our markets is based on the ability of our products and services to address customer requirements related to numerous competitive factors. Competitive selections are based on many factors involving technological innovation, productivity, total cost of ownership of the system, including impact on end of line yield, price, product performance and throughput capability, quality, reliability and customer support.

In automated systems for the semiconductor industry, our principal competitors are KLA-Tencor Corporation (“KLA-Tencor”) and Nova Measuring Instruments Ltd. ("Nova") for thin film and critical dimension OCD metrology, and other suppliers for advanced packaging. Our primary competitor in integrated systems is Nova. The opto-electronics and discrete device markets are addressed primarily by our material characterization systems, served by numerous competitors and no single competitor or group of competitors has established a majority position.European locations.

Manufacturing

Our manufacturing operations are in Milpitas California, Tucson Arizona, Wilmington Massachusetts, Bloomington Minnesota, and at various contract manufacturers around the world. It is our strategy to outsource all assemblies that do not contain elements that we believe lead to a direct competitive advantage. The majorityMost of our automated and integrated products are currently manufactured at our Milpitas facility. We also use contract manufacturers in other locations in the United States, China, Israel and Japan.Bloomington facilities. We currently do not expect our manufacturing operations to require additional major investments in capital equipment.


We producemanufacture key partsmodular assemblies and componentsintegrated tools and make reasonable efforts to ensure that any externally purchased parts or raw materials are available from multiple suppliers, but this is not alwaysif possible. Certain components, subassemblies and services necessary for the manufacture of our systems are obtained either from a sole supplier or limited group of suppliers. We also have an established long-term supply agreementagreements with strategic suppliers for the supply of our spectroscopic ellipsometers and interferometerskey assemblies for use in our products. Although we seek to reduce our dependence

We rely on sole anda number of limited source suppliers partialfor certain parts and subassemblies. This reliance creates a potential inability to obtain an adequate supply of required components, and reduced control over pricing and time of delivery of components. An inability to obtain adequate supplies would require us to seek alternative sources of supply or complete lossmight require us to redesign our systems to accommodate different components or subassemblies. To date, we have not experienced any significant delivery delays. However, if we were forced to seek alternative sources of these sourcessupply, manufacture such components or subassemblies internally, or redesign our products, this could disrupt production, delay scheduled deliveriesprevent us from shipping our products to our customers andon a timely basis, which could have a material adverse effect on our revenues and resultsoperations. As of operations.December 31, 2019, we employed 184 manufacturing personnel.

Research and Development

We continue to invest in research and development (“R&D”) to provide our customers with products that add value to their manufacturing processes and that provide a better and differentiated solution than our competitors so that our products stay in the forefront of current and future market demands. Whether it is for an advancement of current technology, yield and manufacturing improvement, enabling new end device technology, or the development of a new application in our core or emerging markets, we are committed to product excellence and longevity.

In our automated

8


Table of Contents

The markets our R&D efforts resulted infor equipment and systems for manufacturing semiconductor devices and for performing OCD metrology, macro-defect inspection, advanced packaging lithography and thin film transparent and opaque process control metrology are characterized by continuous technological development and product innovations. We believe that the successful product launchrapid and ongoing development of the Atlas III product in the marketplace, our flagship product for OCD. The Atlas III product provides enhanced OCD capability with a significantly lower cost of ownership model. In our integrated markets, the IMPULSE system has been further developed for inline lithography track configuration to extend our tool of record position for lithography OCD. The IMPULSE+ system, which incorporates performancenew products and productivity enhancements to the IMPULSE was introduced in 2015existing products is critical to our success. Accordingly, we devote a significant portion of our technical, management and has been qualified across numerous OEM platforms.

Modeling and analysis software including NanoDiffract and systems software has a regular refresh and release cadence.  NanoDiffract 4.0 was released in 2017.  NanoDiffract 4.0 includes improvements in the user interface, compute engine, and analysis leadingfinancial resources to an overall faster time to solution while enabling more complex measurements. SpectraProbe, launched in 2016, is gaining rapid acceptance by our OCD and films metrology customers as it expands the types of structures and applications that can be measured, while reducing time to solution in the factory. SpectraProbe has enabled new process tool monitoring strategies that extend our process control capabilities to process tool and chamber control. The model-less approach reduces the applications time and effort to develop a monitoring recipe, while providing rapid insight into shifting and changing factory conditions.

The Materials Characterization suite of products including the FTIR, Photoluminescence (RPM and Imperia), and NanoSpec families have had significant refresh and customization for customer needs.  The RPM Blue FS, Imperia, and NanoSpec family have all had improvements released in 2017 to improve productivity and measurement performance.

Our research and development expenses for fiscal 2017, 2016 and 2015 were $36.7 million, $31.4 million and $32.7 million, respectively. 

Patents and Intellectual Property

Our success depends in large part on the technical innovation of our products and protecting such innovations through a variety of methods. We actively pursue a program of filing patent applications to seek protection of technologically sensitive features of our metrology and inspection systems.

programs.  As of December 30, 2017,31, 2019, we had 192 patents, including foreign patents, with expiration dates ranging from 2018-2036. employed 376 engineering personnel in research and development.

Intellectual Property

We believe that our success will depend to a great degree upon innovation, technological expertise and our ability to adapt our products to new technology. WhileAs a result, we attempthave a policy of seeking patents on inventions governing new products or technologies as part of our ongoing research, development, and manufacturing activities. As of December 31, 2019, we have been granted, or hold exclusive licenses to, establish our intellectual property rights through484 U.S. and foreign patents. The patents we own, jointly own or exclusively license have expiration dates ranging from 2020 to 2038. We also have 85 pending regular and provisional applications in the U.S. and other countries. Our patents and trademarksapplications principally cover various aspects of metrology, macro-defect detection and protect intellectual property rights through non-disclosure agreements,classification, altered material characterization, lithography techniques and automation.

Our pending patents may never be issued, and even if they are, these patents, our existing patents and the patents we license may not provide sufficiently broad protection to protect our proprietary rights, or they may prove to be unenforceable. To protect our proprietary rights, we also rely on a combination of copyrights, trademarks, trade secret laws, contractual provisions and licenses and non-disclosure agreements. There can be no assurance (i) that any patents issued to or licensed by us will not be challenged, invalidated or circumvented, (ii) that the rights granted thereunder will provide us with a competitive advantage or (iii) that we will be able to fully protect our technology, and competitors may be able to develop similar technology independently. Otherstechnology. Additionally, others may obtain patents and assert them against us. In addition, the laws of certain foreign countries may not protect our intellectual property to the same extent as do the laws of the United States. From time to time, we receive communications from third parties asserting that our metrology systems may contain design features that thesuch third parties claim may infringe upon their proprietary rights.

The laws of some foreign countries do not protect our proprietary rights to the same degree as do the laws of the United States, and many U.S. companies have encountered substantial infringement problems in protecting their proprietary rights against infringement in such countries, some of which are countries in which we have sold and continue to sell products. There is a risk that our means of protecting our proprietary rights may not be adequate. For example, our competitors may independently develop similar technology or duplicate our products. If we fail to adequately protect our intellectual property, it would be easier for our competitors to sell competing products.

Competition

We offer various products for various semiconductor manufacturing process steps, and several of our products extend across the same process flow. However, for process control of each of these process steps, we have multiple established and potential competitors, some of which may have greater financial, research, engineering, manufacturing and marketing resources than we have. We may also face future competition from new market entrants from other overseas and domestic sources. We expect our competitors to continue to improve the design and performance of their current products and processes, and to introduce new products and processes with improved price and performance characteristics. In order to remain competitive, we believe that we will require significant financial resources to offer a broad range of products, and to maintain customer service and support centers worldwide, and to invest in product research and development.  

In every market in which we participate, the global semiconductor equipment industry is intensely competitive, and driven by rapid technological adoption cycles. Our ability to effectively compete depends upon our ability to continually improve our products, applications and services, and our ability to develop new products, applications and services that meet constantly evolving customer requirements.

In automated systems for the semiconductor industry, our principal competitors are KLA Corporation (“KLA”) and Nova Measuring Instruments Ltd. (“Nova”) for thin film and critical dimension OCD metrology. Our principal competitor for advanced packaging inspection is Camtek Ltd. (“Camtek”). While the advanced packaging lithography market is served by various competitors, our primary competitors are Veeco Instruments, Inc. (“Veeco Instruments”) and, to a lesser extent, Nikon Corporation (“Nikon”). Our primary competitor for integrated metrology systems for the semiconductor industry is Nova. The opto-electronics, discrete device and industrial and scientific markets are addressed primarily by our material characterization and 4D business unit systems, served by numerous competitors, of which no single competitor or group of competitors has established a majority position.

We believe that our competitive position in each of our markets is based on the ability of our products and services to address customer requirements related to numerous competitive factors. Competitive selections are based on many factors

9


Table of Contents

involving technological innovation, productivity, total cost of ownership of the system, including impact on end of line yield, price, product performance and throughput capability, quality, reliability and customer support.

Backlog

We schedule production of our systems based upon order backlog and informal customer forecasts. We use the term “backlog” to refer to only those orders to which the customer has been assigned a purchase order number and for which delivery is anticipated within 12 months. Because shipment dates may be changed and customers may cancel or delay orders with little or no penalty, our backlog as of any particular date may not be a reliable indicator of actual sales for any succeeding period. At December 31, 2019, we had a backlog of approximately $71.7 million compared with a backlog of approximately $62.7 million at December 31, 2018.

Employees

At December 30, 2017,31, 2019, we employed 592a total of 1,340 persons worldwide with sales, applications and service support in key geographic areas aligned with our customer locations. None of our employees are represented by a union and we have never experienced a work stoppage as a resultbecause of union actions. We consider our employee relations to be good. Many of our employees have specialized skills that are of value to us. Our future success will depend in large part upon our ability to attract, retain and motivate highly skilled scientific, technical and managerial personnel, who are in great demand in our industry.


Environmental Matters

Our operations are subject to various federal, state and local environmental protection regulations governing the use, storage, handling and disposal of hazardous materials, chemicals, and certain waste products. We believe that compliance with federal, state and local environmental protection regulations will not have a material adverse effect on our capital expenditures, earnings and competitive and financial position.

In the event thatIf we fail to comply with such laws and regulations, we could be liable for damages, penalties and fines. We further discuss the impact of environmental regulation under “Risk Factors- Wethe risk factor, “We are subject to various environmental laws and regulations that could impose substantial costs upon us and may harm our business, operating results and financial condition.” in Item 1A.

Executive OfficersAvailable Information

Our Internet website address is http://www.ontoinnovation.com. The information on our website is not incorporated into this Annual Report. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K (and any amendments to those reports) are made available free of charge, on or through our Internet website, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. All filings we make with the SEC are also available free of charge via EDGAR through the SEC’s website at http://www.sec.gov. In addition, the historic reports and materials that were filed by Nanometrics and Rudolph with the SEC are available at our investor relations website at https://investors.ontoinnovation.com. These filings may also be obtained through the SEC’s website. Documents that are not available through the SEC’s website may also be obtained by submitting an online request to the SEC at http://www.sec.gov.

We also make available, free of charge, through our investor relations website, our corporate governance summary, Code of Business Conduct and Ethics, charters of the Registrant

The namescommittees of our executive officersBoard of Directors, and their ages, titlesother information and biographiesmaterials, including information about how to contact our Board of Directors.

Investors and others should also note that we announce material financial information to our investors using our investor relations website, SEC filings, press releases, public conference calls and webcasts. We use these channels as well as social media to communicate with the public about the Company, our products and services and other matters. It is possible that the information we post on social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in the Company to review the information we post on the social media channels listed on our investor relations website.

10


Table of February 20, 2018, are set forth below:Contents

 

NameItem 1A.

Risk Factors.

Risks Related to Our Business

Our operating results have varied and will likely continue to vary significantly from quarter to quarter in the future, causing volatility in our stock price.

Our quarterly operating results have varied in the past and will likely continue to vary significantly from quarter to quarter in the future, causing volatility in our stock price. Some of the factors that may influence our operating results and subject our stock to extreme price and volume fluctuations include:

 

Age

changes in customer demand for our systems, which is influenced by economic conditions in the semiconductor device industry, demand for products that use semiconductors, market acceptance of our systems and products of our customers and changes in our product offerings;

 

Positionseasonal variations in customer demand;

Dr. Pierre-Yves Lesaicherre

 

54the timing, cancellation or delay of customer orders, shipments and acceptance;

 

President, Chief Executive Officer and Directorthe gain or loss of a key customer or significant changes in the financial condition of one or more key customers;

Greg Swyt

 

57product development costs, including increased research, development, engineering and marketing expenses associated with our introduction of new products and product enhancements; and

 

Vice President, Finance (Principal Financial Officer)

Rollin Kocher

52

Sr. Vice President, Commercial Operations

Kevin Heidrich

47

Sr. Vice President, Strategic Marketingthe levels of our fixed expenses, including research and Business Development

Janet Taylor

60

General Counsel

Dr. Pierre-Yves Lesaicherre joined Nanometrics as President and Chief Executive Officer in November 2017. From January 2012 to February 2017, Dr. Lesaicherre was Chief Executive Officer of Lumileds, an integrated manufacturer of LED components and Automotive Lighting Lamps, where he was responsible for all aspects of the company’s business. Prior to being named Chief Executive Officer, Dr. Lesaicherre also held other management positions at Lumileds from 2006 to 2012. Before Lumileds, Dr. Lesaicherre was Senior Vice President and general manager of the business lines Microcontrollers & Logic at NXP Semiconductors, formerly Philips Semiconductors. He holds an MBA with a focus on international business and strategy from INSEAD, and has MS and Ph.D. degrees in Material Science from the National Polytechnic Institute of Grenoble.

Greg Swyt assumed the role of principal financial officer of Nanometrics in November 2017. Mr. Swyt has served as the Vice President, Finance of Nanometrics from August 2016. Prior to joining Nanometrics, Mr. Swyt was Managing Director, Finance, at Intevac Corporation, a company delivering thin film solutions, from May 2008 to July 2016, where he managed the Global Financial Planning and Analysis Organization, which also included Manufacturing Finance, Government Finance and Regional Finance. Mr. Swyt received a MBA and a BS in Finance from San Jose State University.

Rollin Kocher joined Nanometrics in March 2013 as Vice President of Worldwide Sales and Service. In September 2016, Mr. Kocher was promoted to Senior Vice President, Commercial Operations. Prior to joining Nanometrics, Mr. Kocher held several senior management positions over 17 years at KLA-Tencor, including Global Sales for Films and Scatterometry, Sales for Taiwan, North America and Europe, and Sr. Director of Sales for the Samsung Business Unit. His last position at KLA-Tencor was General Manager of the Samsung Business Unit, and in that capacity, was responsible for Sales, Marketing, Applications, and Service. Mr. Kocher holds a B.S. degree in Electrical Engineering Technology from the University of North Texas.

Kevin Heidrich, Sr. Vice President, Strategic Marketing and Business Development, joined Nanometrics in 2006. Mr. Heidrich has participated in many functions, expanding his scope to include new product development, corporate marketing, product marketing and business development. Mr. Heidrich is now responsible for both corporate strategy and marketing, as Nanometrics expands its overall solution space within process control metrology. Prior to Nanometrics, Mr. Heidrich spent a decade at Intel Corporation in a variety of roles including process research and development at Intel’s Technology Development facility. Mr. Heidrich received B.S. and M.S. degrees from the Colorado School of Mines in Chemical Engineering.

Janet Taylor joined Nanometrics as General Counsel in July 2015. Ms. Taylor served as Senior Vice President, General Counsel and Company Secretary of STATS ChipPAC Ltd., from June 2005 to June 2015, where she was responsible for all legal matters, including corporate governance, intellectual property, litigation and securities compliance. Prior to joining STATS ChipPAC Ltd, Ms. Taylor was engaged in transactional practices at international law firms in New York, Singapore and London. Ms. Taylor was admitted to the Bar in New York in 1990 and in Singapore in 2010. Ms. Taylor holds a J.D. from the Harvard Law School and a B.A. in History from the University of Texas at Austin.


ITEM 1A.

RISK FACTORSdevelopment costs associated with product development, relative to our revenue levels.

In addition to the other information contained in this Annual Report on Form 10-K, we have identified the following risks and uncertainties that may have a material adverse effect on our business, financial condition or results of operations. Investors should carefully consider the risks described below before making an investment decision. The risks described below are not the only ones we face. Additional risks not currently known to us or that we currently believe are immaterial may also impair our business operations. Our business could be harmed by anylight of these risks. The trading price of our common stock could decline due to any of these risks and investors may lose all or part of their investment. This section should be read in conjunction with the Consolidated Financial Statements and Notes thereto, and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in this Annual Report on Form 10-K.

The Global economic conditionsfactors and the cyclical nature of the semiconductor industry, can reduce demand for our products which in turn may cause uswe expect to operate unprofitably and may cause reductions in available cash, and may negatively impact our financial performance.

Global economic conditions, the gradual recovery of the global economy and the cyclical nature of the semiconductor industry have impacted and could impact future customer demand for our products and our financial performance. Demand for our products is largely dependent on our customers' capital spending on semiconductor equipment, which depends, in large part, on consumer spending, required manufacturing capacity, and customer accesscontinue to capital. Economic uncertainty, unemployment, higher interest rates, higher tax rates,experience significant fluctuations in foreign currency exchange rates,quarterly and other economic factors may lead to a decrease in consumer spending and may cause certain customers to cancel existing orders or delay placing orders. If weannual operating results. Moreover, many of our expenses are unable to timely and appropriately adapt to changes resulting from unfavorable economic conditions, it may cause volatility in our operating results, business, and financial condition, and results of operations may be adversely affected.

In addition, demand for our products is highly inelastic which means we have little ability to control product revenues created by customer demand for more capacity. The market for our products is characterized by constant and rapid technological change, price erosion, product obsolescence, evolving standards, short product life cycles and significant volatility in supply and demand. Due to the inelastic nature of demandfixed in the semiconductor industry, we mayshort-term which, together with the need to take actions to reduce costs in the future, which could reduce our ability to significantly investfor continued investment in research and development, at levels we believe are necessary. If we are unablemarketing and customer support, limits our ability to effectively align our cost structure with prevailing market conditions,reduce expenses quickly. As a result, declines in net sales could harm our business financial condition and results of operations may be materially and adversely affected.

We may also experience supplier or customer issues as a result of adverse macroeconomic conditions. If our customers have difficulties in obtaining capital or financing, this could result in lower sales. Customers with liquidity issues could also result in an increase in bad debt expense. These conditions could also affect our key suppliers, which could affect their ability to supply parts and result in delaysthe price of our customer shipments.common stock could substantially decline.

Our largest customers account for a substantial portion of our net revenues,revenue, and our net revenues would materiallyrevenue and cash flows could decline considerably if one or more of these customers were to purchase significantly fewer of our systems.systems or delay or cancel a large order.

Sales to end user customers that individually represent at least five percent of our revenue typically account for, in the aggregate, a considerable amount of our revenue. We operate in the highly concentrated, capital-intensive semiconductor device manufacturing industry. Historically, a significantsubstantial portion of our net revenuesrevenue in each quarter and each year has been derived from sales to relatively few customers, and we expect this trend is expected to continue. In fiscal year 2017, five customers represented 73%If any of our total net revenues. There are only a limited numberkey customers were to purchase significantly fewer of large companies operatingour systems in the semiconductor manufacturing industryfuture, or if they delay or cancel a large order, our revenue and our market is characterized by continued consolidation in the customer base. Accordingly, wecash flows could meaningfully decline. We expect that we will continue to depend on a small number of large customers for a significantsizable portion of our net revenues for the foreseeable future. If our currentrevenue. In addition, as large semiconductor device manufacturers seek to establish closer relationships with their suppliers, we expect that our largecustomer base will become even more concentrated.

Our customers are impaired, or if we aremay be unable to develop similar collaborative relationships with important customers in the future, our net revenues could decline significantly. In addition, because there are a limited number of customers, customers may seek concessions related to price, terms and conditions and intellectual property. Any of these changes could negatively impact our financial performance and results of operations.

We rely on a limited number of outside suppliers and subcontractors to supply certain components and subassemblies, and on a single or a limited group of outside suppliers for certain materialspay us for our products which could resultand services.

Our customers include some companies that may, from time to time, encounter financial difficulties. If a customer’s financial difficulties become severe, the customer may be unwilling or unable to pay our invoices in a potential inability to obtain an adequate supplythe ordinary course of required components due to the suppliers' failure or inability to provide such components in a timely manner, or at all, and reduced control over pricing and timely delivery of components and materials, any ofbusiness, which could adversely affect collections of both our resultsaccounts receivable balance and unbilled services. The bankruptcy of operations.

Our manufacturing activities consist of integrating, assembling and testing components and subassemblies. We rely on a limited number of outside suppliers and subcontractorscustomer with a substantial account balance owed to manufacture certain components and subassemblies. We order one of the most critical components of our technology, the spectroscopic ellipsometer component incorporated into our advanced measurement systems, from external suppliers.


We procure some of our other critical systems' components, subassemblies and services from single suppliers or a limited group of outside suppliers in order to ensure overall quality and timeliness of delivery. Many of these components and subassemblies have significant production lead times. To date, we have been able to obtain adequate supplies of components and subassemblies for our systems in a timely manner. However, disruption or termination of certain of these sourcesus could have a significant adverse impact on our ability to manufacture our systems. In addition, our failure to timely use components in our manufacturing processes due to delays or cancellation of orders may lead to write-downs of inventory. A disruption in supply or inventory window would, in turn, have a material adverse effect on our business, financial condition and results of operations. Our reliance onIn addition, if a sole suppliercustomer declares bankruptcy after paying us certain invoices, a court may determine that we are not properly entitled to that payment and may require repayment of some or a limited groupall of suppliers and our reliance on subcontractors involve several risks, including:

a potential inability to obtain an adequate supply of required components due to the suppliers' failure or inability to provide such components in a timely manner, or at all; and

reduced control over pricing and timely delivery of components.

Although the timeliness, yield and quality of deliveries to date from our subcontractors have been acceptable, manufacture of certain of these components and subassemblies is an extremely complex process, and long lead times are required. Any inability to obtain adequate deliveries or any other circumstance that would require us to seek alternative sources of supply or to manufacture such components internally could delay our ability to ship our products,amount we received, which could damage relationships with current and prospective customers and have a material adverse effect onadversely affect our business, financial condition and results of operations.

SomeVariations in the amount of time it takes for us to sell our systems may cause fluctuations in our operating results, which could cause our stock price to decline.

Variations in the length of our currentsales cycles could cause our revenue and potential competitors have significantly greatercash flows, and consequently, our business, financial condition, operating results and cash flows to fluctuate widely from period to period. This variation could cause our stock price to decline. Our customers generally take a long time to evaluate our inspection and/or film metrology systems and many people are involved in the evaluation process. We expend significant resources than we do,educating and increased competition could impair salesproviding information to

11


Table of Contents

our prospective customers regarding the uses and benefits of our products.

We operate in the highly competitive semiconductor industry and face competition from a number of companies, some of which have greater financial, engineering, manufacturing, research and development, marketing and customer support resources than we do. As a result, our competitors may be able to respond more quickly to new or emerging technologies or market developments by devoting greater resources to the development, promotion and sale of products, which could impair sales of our products. Moreover, there has been merger and acquisition activity among our competitors and potential competitors. These transactions by our competitors and potential competitors may provide them with a competitive advantage over us by enabling them to rapidly expand their product offerings and service capabilities to meet a broader range of customer needs. Many of our customers and potential customerssystems in the semiconductor industry are large companies that require global support and servicefabrication process. The length of time it takes for their metrology systems. Some of our larger or more geographically diverse competitors might be better equippedus to provide this global support and service.make a sale depends upon many factors, including, but not limited to:

the efforts of our sales force;

the complexity of the customer’s fabrication processes;

the internal technical capabilities and sophistication of the customer;

the customer’s budgetary constraints; and

the quality and sophistication of the customer’s current metrology, inspection or lithography equipment.

Because of the high costnumber of switching equipment vendorsfactors influencing the sales process, the period between our initial contact with a customer and the time when we recognize revenue from that customer and receive payment, if ever, varies widely in our markets,length. Our sales cycles, including the time it may be difficulttakes for us to attract customers from our competitors even if our metrology systems are superiorbuild a product to theirs.

We believe that once a semiconductor customer has selected one vendor's metrology system, the customer generally relies upon that system and,specifications after receiving an order to the extent possible, subsequent generationstime we recognize revenue, typically range from three to twenty-four months. Sometimes our sales cycles can be much longer, particularly with customers in Asia. During these cycles, we commit substantial resources to our sales efforts in advance of the same vendor's system, for the life of the application. Once a vendor's metrology system has been installed,receiving any revenue, and we may never receive any revenue from a customer mustdespite our sales efforts. If we do make a sale, our customers often make substantial technical modifications and may experience downtime to switch to another vendor's metrology system. Accordingly, unlesspurchase only one of our systems, offerthe performance or cost advantages that outweighof which they then evaluate for a customer's expense of switching to our systems; it will be difficult for us to achieve significant sales from that customer once it has selected another vendor's system for an application.

Our integrated metrology systems are integrated onto systems sold independently by Wafer Fabrication Equipment Suppliers, and a decrease in sales by these suppliers, or the development of competing systems by these suppliers, could harm our business.

We believe that sales of integrated metrology systems will continue to be an important sourcelengthy period before purchasing any more of our net revenues. Sales of our integrated metrology systems depend upon the ability of a smallsystems. The number of Wafer Fabrication Equipment Suppliersadditional products a customer purchases, if any, depends on many factors, including the customer’s capacity requirements. The period between a customer’s initial purchase and any subsequent purchases can vary from three months to sell semiconductor manufacturing equipment products that are compatible witha year or longer, and variations in the length of this period could cause further fluctuations in our metrology systems as components. If these suppliers, such as Applied Materials, Inc., Ebara Corporation, Lam Research Corporationoperating results and, Tokyo Electron, are unable to sell such products, if they choose to focus their attention on products that do not integratepossibly, in our systems, or if they choose to develop competing systems, our business could suffer.stock price.


We are subject to order and shipment uncertainties. Our profitability will decline if we fail to accurately forecast customer demand when managing inventory.

We typically plan production and inventory levels based on internal forecasts of customer demand, which can be highly unpredictable and can fluctuate substantially, which could lead to excess inventory write-downs and resulting negative impacts on gross margin and net income. We have limited visibility into our customers' inventories, future customer demand and the product mix that our customers will require, which could adversely affect our production forecasts and operating margins. In addition, innovation in our industry could render significant portions of our inventory obsolete. If we overestimate our customers' requirements, we may have excess inventory, which could lead to obsolete inventory and unexpected costs. Conversely, if we underestimate our customers' requirements, we may have inadequate inventory, which could lead to foregone revenue opportunities, loss of potential market share and damage to customer relationships as product deliveries may not be made on a timely basis, disrupting our customers' production schedules. In response to anticipated long lead times to obtain inventory and materials from outside suppliers and foundries, we periodically order materials in advance of customer demand. This advance ordering has in the past and may in the future result in excess inventory levels or unanticipated inventory write-downs if expected orders fail to materialize, or other factors make our products less saleable. In addition, any significant future cancellation or deferral of product orders could adversely affect our revenue and margins, increase inventory write-downs due to obsolete inventory, and adversely affect our operating results and stock price.

IfMost of our revenue has been derived from customers outside of the United States, subjecting us to operational, financial and political risks, such as unexpected changes in regulatory requirements, tariffs, political and economic instability, outbreaks of hostilities, natural disasters, climate change and difficulties in managing foreign sales representatives and foreign branch operations, as well as risks associated with foreign currency fluctuations.

Due to the significant level of our international sales, we are subject to a number of material risks, including:

Compliance with foreign laws. Our business is subject to risks inherent in doing business internationally, including compliance with, inconsistencies among, and unexpected changes in, a wide variety of foreign laws and regulatory environments with which we are not familiar, including, among other issues, with respect to employees, protection of our intellectual property, and a wide variety of operational regulations and trade and export controls under domestic, foreign, and international law.

Unexpected changes in regulatory requirements including tariffs and other market barriers. The semiconductor device industry is a high-visibility industry in many of the European and Asian countries in which we sell our products. Because the governments of these countries have provided extensive financial support to our semiconductor device manufacturing customers in these countries, we believe that our customers could be disproportionately affected by any trade embargoes, excise taxes, tariffs or other restrictions imposed by their governments on trade with United States companies such as ourselves, particularly with respect to the ongoing trade negotiations between the United States and China. As of January

12


Table of Contents

2020, trade delegations from the United States and China reached partial agreement over tariffs on certain products, but if the United States and China do not managecontinue negotiations and reach agreement on a trade policy, tariffs imposed by China may result in lower sales to customers in China as the costs of our supply chain effectively,products become more expensive to such customers. In addition, tariffs imposed by the United States will increase the cost of raw materials that we import from China.  Any restrictions of these types could result in a reduction in our operating results maysales to customers in these countries. In addition, given the relatively fluid regulatory environment in China, there could be adversely affected.

We need to continually evaluate our global supply chainsadditional tax or other regulatory changes in the future. Such actions in the future, as well as other changes in Chinese laws and assess opportunities to reduce costs. We must also enhance quality, speed and flexibility to meet changingregulations, including actions in furtherance of China’s stated policy of reducing its dependence on foreign semiconductor manufacturers, could increase the cost of doing business in China, foster the emergence of Chinese-based competitors, decrease the demand for our customers’ products in China, or reduce the supply of critical materials for our customers’ products, which could have a material adverse effect on our business and product mixresults of operations.

Political and uncertain market conditions. Our success also dependseconomic instability. We are subject to various global risks related to political and economic instabilities in partcountries in which we derive sales. If terrorist activities, armed conflict, civil or military unrest or political instability occurs outside of the U.S., these events may result in reduced demand for our products. There is considerable political instability in Taiwan related to its disputes with China and in South Korea related to its disputes with North Korea. In addition, several Asian countries, particularly Japan, have experienced significant economic instability. An outbreak of hostilities or other political upheaval in China, Taiwan or South Korea, or an economic downturn in Japan or other countries, would likely harm the operations of our customers in these countries. The effect of these types of events on refining our cost structurerevenue and supply chains so thatcash flows could be material because we have flexibilityderive substantial revenue from sales to semiconductor device foundries in Taiwan such as Taiwan Semiconductor Manufacturing Company Ltd., from memory chip manufacturers in South Korea such as Samsung Electronics Co., Ltd., and can maintainfrom semiconductor device manufacturers in Japan such as Toshiba Corporation.

Natural disasters and improve profitability. To improve our margins on a product, we will need to establish high volume supply agreements with our vendors. We cannot be certain that we will be able to timely negotiate vendor supply agreements on improved termsclimate change. Natural disasters, changes in climate and conditions, or at all. Failure to achieve the desired level of cost reductionsgeo-political events could materially adversely affect our financial results. Despiteworldwide operations (or those of our efforts to control costsbusiness partners). The occurrence of one or more natural disasters such as hurricanes, tropical storms, fires, cyclones, earthquakes, tsunamis, flooding, typhoons, volcanic eruptions and increase efficiency in our facilities, changes in demand could still cause us to realize lower operating marginsweather conditions such as major or extended winter storms, droughts and profitability.

If we choose to acquire new and complementary businesses, or products or technologies instead of developing them ourselves, we may be unable to complete these acquisitions or may not be able to successfully integrate an acquired business in a cost-effective and non-disruptive manner.

Our success depends on our ability to continually enhance and broaden our product offerings in response to changing technologies, customer demands and competitive pressures. To achieve this, from time to time we have acquired complementary businesses, products, or technologies instead of developing them ourselves and may choose to do so in the future. If we do identify suitable transactions in the future, we may not be able to complete them on commercially acceptable terms, or at all. We also face intense competition for acquisitions from other acquirers in our industry. These competing acquirers may have significantly greater financial and other resources than us, which may prevent us from successfully pursuing a transaction.

Potential risks associated with acquisitions could include, among other things:

our inability to realize the benefits or cost savings that we expect to realizetornadoes, whether as a result of climate change or otherwise, may disrupt manufacturing or other operations. For example, our Milpitas operations are located near major earthquake fault lines in California. There may also be conflict or uncertainty in the acquisition;

diversioncountries in which we operate, including public health issues (for example, an outbreak of management's attention;a contagious disease such as 2019-Novel Coronavirus (2019-nCoV) as described below, avian influenza, measles or Ebola), safety issues, natural disasters, fire, disruptions of service from utilities, nuclear power plant accidents or general economic or political unrest, including war, civil unrest or terrorist attacks.

our inabilityOur financial and operating performance may be adversely affected by epidemics. Our business and financial and operating performance could be materially and adversely affected by the outbreak of epidemics including but not limited to successfully integrate our businesses with the business2019-Novel Coronavirus (2019-nCoV). As a result of the acquired company;

motivating, recruitingongoing Novel Coronavirus, the operations of our customers in China and retaining executivesTaiwan are expected to experience a slowdown or temporary suspension in production. Our business could be materially and key employees; conforming standards, controls, proceduresadversely affected in the event that the slowdown or suspension continues for a long period of time. During such epidemic outbreak, China and policies, business cultures and compensation structures among our company and the acquired company;

consolidating and streamlining sales, marketing and corporate operations;

potential exposure to unknown liabilities of acquired companies;

loss of key employees and customersTaiwan may adopt certain hygiene measures, including quarantining visitors from places where any of the acquired business;contagious diseases were rampant. Those restrictive measures may adversely affect and

managing tax costs slow down economic development during that period. Any prolonged restrictive measures in order to control the contagious disease or inefficiencies associated with integrating our operations following completion of the acquisitions.

If an acquisition is not successfully completed or integrated into our existing operations,other adverse public health developments in China and Taiwan may have a material adverse effect on our business, financial condition and results of operations.

Difficulties in staffing and managing foreign branch operations. During periods of tension between the governments of the United States and certain other countries, it is often difficult for United States companies such as us to staff and manage operations in such countries. Language and other cultural differences may also inhibit our sales and marketing efforts and create internal communication problems among our U.S. and foreign research and development teams, increasing the difficulty of managing multiple remote locations performing various development, quality assurance, and yield ramp analysis projects.

Currency fluctuations as compared to the U.S. Dollar. A substantial portion of our international sales are denominated in U.S. dollars. As a result, if the dollar rises in value in relation to foreign currencies, our systems will become more expensive to customers outside the United States and less competitive with systems produced by competitors outside the United States. These conditions could negatively impact our international sales. Foreign sales also expose us to collection risk in the event it becomes more expensive for our foreign customers to convert their local currencies into U.S. dollars. Additionally, in the event a larger portion of our revenue becomes denominated in foreign currencies, we would be adversely impacted.


In addition,subject to financea potentially significant exchange rate risk.

13


Table of Contents

FCPA and Other Anti-Corruption Laws. We are subject to the Foreign Corrupt Practices Act of 1977 ("FCPA"), and other laws that prohibit improper payments or offers of payments to foreign governments and their officials and political parties by U.S. persons and issuers as defined by the statute, for the purpose of obtaining or retaining business. Also, similar worldwide anti-bribery laws, such as the U.K. Bribery Act and Chinese anti-corruption laws, generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. Some of our distribution partners are located in parts of the world that have experienced governmental corruption to some degree and, in certain circumstances, strict compliance with anti-bribery laws may conflict with local customs and practices. The policies and procedures we have implemented to discourage these practices by our employees, our existing safeguards and any acquisitionsfuture improvements may prove to be less than effective, and our employees, consultants, sales agents or distributors may engage in conduct for which we might be held responsible. Violations of the FCPA or international anti-corruption laws may result in severe criminal or civil sanctions, and we may be requiredsubject to raise additional funds through public or private equity or debt financings; however:

to obtain such financing we may be forced to obtain financing on terms that are not favorable to us and, in the case of equity or convertible debt financing, the financing may result in dilution to our stockholders; or

such financing may not be available to us at all,other liabilities, which could preventnegatively affect our business, operating results and financial condition. In addition, the U.S. government may seek to hold us liable for successor liability FCPA violations committed by companies in which we invest or that we acquire. We cannot assure you that our internal control policies and procedures will protect us from enteringreckless or completing the acquisition.

Our success depends on the performance of key personnel, includingnegligent acts committed by our senior management and on our ability to identify, hire and retain key management personnel.

We believe our continued ability to recruit, hire, retain and motivate highly-skilled engineering, operations, sales, administrative and managerial personnel is key to our future success. Competition for these employees, is intense, particularly with respect to attracting and retaining qualified technical and senior management personnel. We do not have employment agreements with key members of our technical staff and all of our senior management team. Further, we do not have key person life insurance on any of our executives and these individualsdistributors, partners, consultants or other key employees may leave us. We have experienced turnover in our senior management team in the past. Our business may be harmed if we are unable to recruit, retain and effectively integrate our senior management into our business operations and our ability to implement our strategy could be compromised.agents.

If we deliver systems with defects, our credibility will be harmed revenue from,and the sales and market acceptance of our systems will decrease and we could expend significant capital and resources as a result of such defects.decrease.

Our productssystems are complex and frequently operate in high-performance, challenging environments. Notwithstanding our internal quality specifications, our systems have sometimesoccasionally contained errors, defects and bugs when introduced. If we deliver systems with errors, defectsDefects may be created during probing, bumping, dicing or bugs,general handling, and can have a major impact on device and process quality. When this occurs, our credibility and the market acceptance and sales of our systems wouldcould be harmed. Further, if our systems contain errors, defects or bugs, computer viruses or malicious code as a result of cyber-attacks to our computer networks, we may be required to expend significant capital and resources to alleviate such problems and incur significant costs for product recalls and inventory write-offs.these problems. Defects could also lead to product liability as a result of product liability lawsuits against us or against our customers. We have agreed to indemnify our customers in someunder certain circumstances against liability arising from defects in our systems. Our product liability insurance policy currently provides $2.0 million of aggregate coverage, with an overall umbrella limit of $14.0 million. In the event of a successful product liability claim, we could be obligated to pay damages significantly in excess of our product liability insurance limits.

If we are not successful in developing new and enhanced products for the semiconductor device manufacturing industry, we will lose sales and market share to our competitors.

We operate in an industry that is highly competitive and subject to evolving industry standards, rapid technological changes, rapid changes in consumer demands and the rapid introduction of new, higher performance systems with shorter product life cycles. To be competitive in our demanding market, we must continually design, develop and introduce in a timely manner new lithography, inspection and metrology process control systems that meet the performance and price demands of semiconductor device manufacturers. We must also continue to refine our current systems so that they remain competitive. We expect to continue to make significant investments in our research and development activities. We may experience significantdifficulties or delays in shipping our productsdevelopment efforts with respect to our customers, our businessnew systems, and reputationwe may suffer.

Our products are complex and require technical expertise to design and manufacture properly. Various problems occasionally arise during the manufacturing process that may cause delays and/or impair product quality. Any significant delays stemming from the failure of our products to meet or exceed our internal quality specifications, or for any other reasons, would delay our shipments. Shipment delays could harm our business and reputation in the industry.

Net average selling prices of our products may decrease over time, which could have a material adverse effect on our revenues and profitability.

It is commonnot ultimately be successful in our industry for the average selling price of a given product enhancement efforts to decrease over timeimprove and advance products or in responding effectively to technological change, as production volumes increase, competing products are developed or latest technologies featuring higher performance or lower cost emerge. To combat the negative effects that erosion of average selling prices have had in the pastnot all research and may in the future have on our net revenues, we attempt to actively manage the prices of our existing products and regularly introduce new process technologies and products in the market that exhibit higher performance, that are in demand, or that lower manufacturing cost. Failure to maintain our current prices or to successfully execute on our new product development strategy will cause our net revenues and gross margin to decline, which adversely affect our operating results and stock price.

Third party infringement claims could be costly to defend, and successful infringement claims by third parties couldactivities result in substantial damages, lost product sales and the loss of important intellectual property rights by us.

The semiconductor industry is generally subject to frequent litigation regarding patents and other intellectual property rights. Ourviable commercial success depends, in part, on our ability to avoid infringing or misappropriating patents or other proprietary rights owned by third parties. From time to timeproducts. In addition, we may receive communications from third parties asserting that our metrology systems may contain design features which are claimed to infringe on their proprietary rights. Our new or current products may infringe valid intellectual property rights, but even if our products do not infringe, we may be required to expend significant sums of money to defend against infringement claims, or to actively protect our intellectual property rights through litigation. In the event that a claim is made and there is an adverse result of any intellectual property rights litigation, we could be required to pay substantial damages for


infringement, expend significant resources to develop non-infringing technology, incur material liability for royalty payments or fees to obtain licenses to the technology covered by the litigation, or be subjected to an injunction, which could prevent us from selling our products and materially and adversely affect our net revenues and results of operations. We cannot be sureprovide assurance that we will be successful in any such non-infringing development or that any such license would be available on commercially reasonable terms, if at all. Any claims relating to the infringement of third-party proprietary rights, even if not meritorious, could result in costly litigation, lost sales or damaged customer relationships, and diversion of management's attention and resources.

Our intellectual property may be infringed by third parties despite our efforts to protect it, which could threaten our future success and competitive position and harm our operating results.

Our future success and competitive position depend in part upon our ability to obtain and maintain proprietary technology for our principal product families, and we rely, in part, on patent, trade secret and trademark law to protect that technology. If we fail to adequately protect our intellectual property, it will be easier for our competitors to sell competing products. We own or may license patents relating to our systems, and have filed applications for additional patents. Any of our pending patent applications may be rejected, and we may not in the future be able to develop additional proprietary technology that is patentable. In addition, the patents we own, have been issued or licensed, may not provide us with competitive advantages and may be challenged by third parties. Third parties may also design around these patents.

In addition to patent protection, we rely upon trade secret protection for our confidential and proprietary information and technology. We routinely enter into confidentiality agreements with our employees. However, in the event that these agreements may be breached, we may not have adequate remedies. Our confidential and proprietary information and technology might also be independently developed by or become otherwise known to third parties.

We may be required to initiate litigation to enforce patents issued to or licensed by us, or to determine the scope or validity of a third party's patent or to enforce trade secret, confidentiality or other proprietary rights. Any such litigation, regardless of outcome, could be expensive and time consuming, and could subject us to significant liabilities or require us to re-engineer our product or obtain expensive licenses from third parties, any of which would adversely affect our business and operating results.

Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise obtain or use our products or technology. Our ability to enforce our patents and other intellectual property is limited by our financial resources and is subject to general litigation risks. If we seek to enforce our rights, we may be subject to claims that the intellectual property rights are invalid, are otherwise not enforceable or are licensed to the party against whom we assert a claim. In addition, our assertion of intellectual property rights could result in the other party seeking to assert alleged intellectual property rights of its own against us, which is a frequent occurrence in such litigation.

Our efforts to protect our intellectual property may be less effective in some foreign countries where intellectual property rights are not as well protected as in the United States.

In 2017, 2016, and 2015, 87%, 86% and 80%, respectively, of our total net revenues were derived from sales to customers in foreign countries, including certain countries in Asia, such as Japan, South Korea, China, Singapore and Taiwan. The laws of some foreign countries do not protect our proprietary rights to as great an extent as do the laws of the United States, and many U.S. companies have encountered substantial problems in protecting their proprietary rights against infringement in these countries. If we fail to adequately protect our intellectual property in these countries, it would be easier for our competitors to sell competing products and our business would suffer.

Variations in the amount of time it takes for us to sell our systems may cause volatility in our operating results, which could cause our stock price to decline.

Variations in the length of our sales and product acceptance cycles could cause our revenues to fluctuate widely from period to period. Our customers generally take long periods of time to evaluate our metrology systems. We expend significant resources educating and providing information to our prospective customers regarding the uses and benefits of our systems. The length of time that it takes for us to complete a sale depends upon many factors, including:

the efforts of our sales force and our independent sales representatives;

the complexity of the customer’s metrology needs;

the internal technical capabilities and sophistication of the customer;


the customer’s budgetary constraints; and

the quality and sophistication of the customer’s current processing equipment.

Because of the number of factors influencing the sales process, the period between our initial contact with a customer and the time at which we recognize revenue from that customer, if at all, varies widely. Our sales cycles, including the time it takes for us to build a product to customer specifications after receiving an order, typically range from three to nine months. Occasionally our sales cycles can be much longer, particularly with customers in Asia who may require longer evaluation and acceptance periods. During the sales cycles, we commit substantial resources to our sales efforts in advance of receiving any revenue, and we may never receive any revenue from a customer despite our sales efforts.

If we do complete a sale, customers often purchase only one of our systems and then evaluate its performance for a lengthy period of time before purchasing additional systems. The purchases are generally made through purchase orders rather than through long-term contracts. The number of additional products that a customer purchases, if any, depends on many factors, including a customer’s capacity requirements, and/or shifting to more and advanced manufacturing processes that require more or different products to control. If they change their rate of capacity or have technological change, we cannot compensate for this fluctuation in demand by adjusting the price of our products. The period between a customer’s initial purchase and any subsequent purchases and acceptance is unpredictable and can vary from three months to a year or longer. Variations in the length of this period could cause fluctuations in our operating results, which could adversely affect our stock price.

Relatively small fluctuations in our system sales volume may cause our operating results to vary significantly each quarter.

During any quarter, a significant portion of our revenue is derived from the sale of a relatively small number of systems. Our automated metrology systems can be priced from $800,000 to $2,400,000 per system, and our integrated metrology systems can be priced up to $500,000 per system. Accordingly, a slight change in the number or mix of systems that we sell could cause significant changes in our operating results.

Lack of market acceptance for our products may affect our ability to generate revenue and may harm our business.

We have invested substantial time and resources into the development of new products servicesfor the most opportunistic new markets and technologies. However, we cannot accurately predict the future level of acceptance of our products and services by our customers. As a result, we may not be able to generate anticipated revenue from sales of these products and services, or future new products, services and improvements.

We depend on new products and processes for our success. Consequently, we are subject to risks associated with rapid technological change.

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances enabling such processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. We cannot make assurances if or when the products and solutions where we have focused our research and development expenditures will become commercially successful. If new products have reliability or quality problems, our performance could be impacted by reduced orders, higher manufacturing costs, and delays in acceptance or payment for new products, and additional service and warranty expenses. We might not be able to develop and manufacture new products successfully, or new products that we introduce may fail in the marketplace. Our failure to complete commercialization of these new products in a timely manner could result in unanticipated costs and inventory obsolescence, which would adversely affect our financial results.applications. Any significant delay in releasing new systems could cause our products to become obsolete, adversely affect our reputation, give a competitor a first-to-market advantage or allowcause a competitor to achieve greater market share.

To develop new products and processes, we expect to continue to make significant investments in research and development and to pursue joint development relationships with customers, suppliers or other members of the industry. We must manage product transitions and joint development relationships successfully, as introduction of new products could adversely affect our sale of existing products.


We are subject to risks associated with our competitors’ strategic relationships and their introduction of new products, and we may lack the financial resources or technological capabilities of certain of our competitors needed to capture increased market share.

We expect to face significant competition from multiple current and future competitors. We believe that other companies are developing systems and products that are competitive to our products and are planning to introduce new products, which may affect our ability to sell our existing or future products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.

Some of our competitors have substantially greater financial, resourcesengineering, manufacturing, research and more extensive engineering, manufacturing,development, marketing and customer service and support resources than we do and therefore have the potential to increasingly dominate the semiconductor equipment industry. These competitors may deeply discount products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products.do. As a result, weour competitors may failbe able to continuerespond more quickly to compete successfully worldwide.new or emerging technologies or market developments by devoting greater resources to the development, promotion and sale of products, which could impair sales of our products. Moreover, there has been merger and acquisition activity among our competitors and potential competitors. These transactions by our competitors and potential competitors may provide them with a competitive advantage over us by enabling them to rapidly expand their product offerings and service capabilities to meet a broader range of customer needs. Many of our customers and potential customers in the semiconductor industry are large companies that require global support and service for their metrology systems. Some of our larger or more geographically diverse competitors might be better equipped to provide this global support and service.

In addition, our competitors may provide innovative technology that may have performance advantages over systems we currently offer or may offer in the future. They may be able to develop products comparable or superior to those that we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we currently are developing additional product enhancements that we believe will address future customer requirements, we may fail in a

14


Table of Contents

timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly,

Further, customers that may otherwise desire to purchase our products from us and purchase other products from our competitors may nevertheless purchase competing products from our competitors rather than purchase our products due to a variety of reasons, including to gain favor or volume pricing from our competitors.

If new products developed by us do not gain general market acceptance, we will be unable to generate revenue and recover our research and development costs.

Inspection, lithography and metrology product development is inherently risky because it is difficult to foresee developments in semiconductor device manufacturing technology, coordinate technical personnel, and identify and eliminate system design flaws. Further, our products are complex and often the applications to our customers’ businesses are unique. Any new systems we introduce may not achieve or sustain a significant degree of market acceptance and sales.

We expect to spend a significant amount of time and resources developing new systems and refining our existing systems. In light of the long product development cycles inherent in our industry, these expenditures will be made well in advance of the prospect of deriving revenue from the sale of those systems. Our ability to commercially introduce and successfully market new systems are subject to a wide variety of challenges during the development cycle, including start-up bugs, design defects, and other matters that could delay introduction of these systems. In addition, since our customers are not obligated by long-term contracts to purchase our systems, our anticipated product orders may not materialize, or orders that are placed may be canceled. As a result, if we do not achieve market acceptance of new products, we may be unable to generate sufficient revenue and cash flow to recover our research and development costs and our market share, revenue, operating results or stock price would be negatively impacted.

Even if we are able to develop new products that gain market acceptance, sales of these new products could impair our ability to sell existing products.

Competition from our new systems could have a negative effect on sales of our existing systems and the prices that we could charge for these systems. We may also divert sales and marketing resources from our current systems in order to successfully launch and promote our new or next generation systems. This diversion of resources could have a further negative effect on sales of our current systems and the value of inventory.

Our integrated metrology systems are integrated with systems sold independently by Wafer Fabrication Equipment Suppliers, and a decrease in sales by these suppliers, or the development of competing systems by these suppliers, could harm our business.

We believe that sales of integrated metrology systems will continue to be an important source of our net revenues. Sales of our integrated metrology systems depend upon the ability of a small number of Wafer Fabrication Equipment Suppliers to sell semiconductor manufacturing equipment products that are compatible with our metrology systems as components. If these suppliers, such as Applied Materials, Inc., Ebara Corporation, Lam Research Corporation and Tokyo Electron, are unable to sell such products, if they choose to focus their attention on products that do not integrate our systems, or if they choose to develop competing systems, our business could suffer.

If our relationships with our large customers deteriorate, our product development activities could be adversely affected.

The success of our product development efforts depends on our ability to anticipate market trends and the price, performance and functionality requirements of semiconductor device manufacturers. In order to anticipate these trends and ensure that critical development projects proceed in a coordinated manner, we must continue to collaborate closely with our largest customers. Our relationships with these and other customers provide us with access to valuable information regarding trends in the semiconductor device industry, which enables us to better plan our product development activities. If our current relationships with our large customers are impaired, or if we are unable to develop similar collaborative relationships with important customers in the future, our product development activities could be adversely affected.

15


Table of Contents

We may fail to adequately protect our intellectual property and, therefore, lose our competitive advantage.

Our future success and competitive position depend in part upon our ability to obtain and maintain proprietary technology for our principal product families, and we rely, in part, on patent and trade secret law and confidentiality agreements to protect that technology. If we fail to adequately protect our intellectual property, it will give our competitors a significant advantage. We own or have licensed a number of patents relating to our transparent and opaque thin film metrology, lithography and macro-defect inspection systems, and have filed applications for additional patents.  Any of our pending patent applications may be rejected, and we may be unable to develop additional proprietary technology that is patentable in the future.

In addition, the patents that we do own or that have been issued or licensed to us may not provide us with competitive advantages and may be challenged by third parties. Further, third parties may also design around these patents. In addition to patent protection, we rely upon trade secret protection for our confidential and proprietary information and technology. We routinely enter into confidentiality agreements with our employees and other third parties. Even though these agreements are in place, there can be no assurances that trade secrets and proprietary information will not be disclosed, that others will not independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets, or that we can fully protect our trade secrets and proprietary information. Violations by others of our confidentiality agreements and the loss of employees who have specialized knowledge and expertise could harm our competitive position and cause our sales and operating results to decline as a result of increased competition. Costly and time-consuming litigation might be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection might adversely affect our ability to continue our research or bring products to market.

Protection of our intellectual property rights, or the efforts of third parties to enforce their own intellectual property rights against us, may result in costly and time-consuming litigation, substantial damages, lost product sales and/or the loss of important intellectual property rights.

We may be required to initiate litigation in order to enforce any patents issued to or licensed by us or to determine the scope or validity of a third party’s patent or other proprietary rights. Any litigation, regardless of outcome, could be expensive and time consuming and could subject us to significant liabilities or require us to re-engineer our products or obtain expensive licenses from third parties. There can be no assurance that any patents issued to or licensed by us will not be challenged, invalidated or circumvented, or that the rights granted thereunder will provide us with a competitive advantage.

In addition, our commercial success depends in part on our ability to avoid infringing or misappropriating patents or other proprietary rights owned by third parties. From time to time, we receive communications from third parties asserting that our products or systems infringe, or may infringe, on the proprietary rights of these third parties. These claims of infringement may lead to protracted and costly litigation, which could require us to pay substantial damages or have the sale of our products or systems stopped by an injunction. Infringement claims could also cause product or system delays or require us to redesign our products or systems, and these delays could result in the loss of substantial revenue. We may also be required to obtain a license from the third party or cease activities utilizing the third party’s proprietary rights. We may not be able to enter into such a license or such a license may not be available on commercially reasonable terms. Accordingly, the loss of important intellectual property rights could hinder our ability to sell our systems or to make the sale of these systems more expensive.

Our efforts to protect our intellectual property may be less effective in certain foreign countries where intellectual property rights are not as well protected as in the United States.

The laws of some foreign countries, including China, Japan, South Korea and Taiwan, where we do business, do not protect our proprietary rights to as great an extent as do the laws of the United States, and many U.S. companies have encountered substantial problems in protecting their proprietary rights against infringement abroad. For example, Taiwan is not a signatory of the Patent Cooperation Treaty, which is designed to specify rules and methods for defending intellectual property internationally. The publication of a patent in Taiwan prior to the filing of a patent in Taiwan would invalidate the ability of a company to obtain a patent in Taiwan. Similarly, in contrast to the United States where the contents of patents remain confidential during the patent application process, in Taiwan, the contents of a patent are published upon filing, which provides competitors an advance view of the contents of a patent application prior to the establishment of patent rights. Similarly, China’s protection of intellectual property rights historically has been less stringent and robust compared to other countries such as the United States, and consequently intellectual property rights and confidentiality protections in China may not be as effective as in the United States or other countries.  Monitoring and preventing unauthorized use are also difficult and the measures we take to protect our intellectual property rights may not be adequate.  Accordingly, infringement of our

16


Table of Contents

intellectual property rights poses a serious risk of doing business in China. Consequently, there is a risk that we may be unable to adequately protect our proprietary rights in certain foreign countries. If this occurs, it would be easier for our competitors to develop and sell competing products in these countries.

Some of our current and potential competitors have significantly greater resources than we do, and increased competition could impair sales of our products or cause us to reduce our prices.

The market for semiconductor capital equipment is highly competitive. We face substantial competition from established companies in each of the markets we serve. We principally compete with KLA Corporation, Nova Measuring Instruments, Camtek and Veeco Instruments. We compete to a lesser extent with Nikon. Each of our products also competes with products that use different metrology, inspection or lithography techniques. Some of our competitors have greater financial, engineering, manufacturing and marketing resources, broader product offerings and service capabilities and larger installed customer bases than we do. As a result, these competitors may be able to respond more quickly to new or emerging technologies or market developments by devoting greater resources to the development, promotion and sale of products, which, in turn, could impair sales of our products. Further, there may be significant merger and acquisition activity among our competitors and potential competitors, which, in turn, may provide them with a competitive advantage over us by enabling them to rapidly expand their product offerings and service capabilities to meet a broader range of customer needs.

Many of our customers and potential customers in the semiconductor device manufacturing industry are large companies that require global support and service for their semiconductor capital equipment. We believe that our global support and service infrastructure is sufficient to meet the needs of our customers and potential customers. However, some of our competitors have more extensive infrastructures than we do, which could place us at a disadvantage when competing for the business of global semiconductor device manufacturers. Many of our competitors are investing heavily in the development of new systems that will compete directly with our systems. We have, from time to time, selectively reduced prices on our systems in order to protect our market share, and competitive pressures may necessitate further price reductions. We expect our competitors in each product area to continue to improve the design and performance of their products and to introduce new products with competitive prices and performance characteristics. These product introductions would likely require us to decrease the prices of our systems and increase the level of discounts that we grant our customers. Price reductions or lost sales as a result of these competitive pressures would reduce our total revenue and could adversely impact our financial results.

Because of the high cost of switching equipment vendors in our markets, it is sometimes difficult for us to win new customers from our competitors even if our systems are superior to theirs.

We believe that once a semiconductor device manufacturer has selected one vendor’s capital equipment for a production-line application, the manufacturer generally relies upon that capital equipment and, to the extent possible, subsequent generations of the same vendor’s equipment for the life of the application. Once a vendor’s equipment has been installed in a production line application, a semiconductor device manufacturer must often make substantial technical modifications and may experience production-line downtime in order to switch to another vendor’s equipment. Accordingly, unless our systems offer performance or cost advantages that outweigh a customer’s expense of switching to our systems, it will be difficult for us to achieve significant sales to that manufacturer once it has selected another vendor’s capital equipment for an application.

We must attract and retain experienced senior executives and other key personnel with knowledge of semiconductor device manufacturing and inspection, metrology or lithography equipment and related software to help support our future growth, and competition for such personnel in our industry is high.

Our success depends, to a significant degree, upon the continued contributions of our key executive management, engineering, sales and marketing, customer support, finance and manufacturing personnel. The loss of any of these key personnel through resignations, retirement or other circumstances, each of whom would be extremely difficult to replace, could harm our business and operating results. Although we have employment and noncompetition agreements with key members of our senior management team, these individuals or other key employees may intensify,still leave us, which could have a material adverse effect on our business. We do not have key person life insurance on any of our executives. In addition, to support our future growth, we will need to attract and retain additional qualified employees. Competition for such personnel in our industry is intense, and we may not be successful in attracting and retaining qualified employees.

In order to attract and retain executives and other key employees, the Company must provide a competitive compensation package, including cash and stock-based compensation. If the anticipated value of the Company’s stock-based

17


Table of Contents

incentive awards does not materialize so that they cease to be viewed as valuable, if the Company’s profits decrease, or future competition, operating results, financial condition, and/if the Company’s total compensation package is not viewed as competitive, the Company’s ability to attract, retain and motivate executives and key employees could be weakened.

We obtain some of the components and subassemblies included in our systems from a limited group of suppliers, and the partial or cash flowscomplete loss of one of these suppliers could suffer.cause production delays and a substantial loss of revenue.

We obtain some of the components and subassemblies included in our systems from a limited group of suppliers and do not have long-term contracts with many of our suppliers. Our dependence on limited source suppliers of components and our lack of long-term contracts with many of our suppliers expose us to several risks, including a potential inability to obtain an adequate supply of components, price increases, late deliveries and poor component quality. Disruption or termination of the supply of these components could delay shipments of our systems, damage our customer relationships and reduce our sales. From time to time in the past, we have experienced temporary difficulties in receiving shipments from our suppliers. The lead-time required for shipments of some of our components can be as long as six months. In addition, the lead time required to qualify new suppliers for lasers and certain optics could be as long as a year, and the lead time required to qualify new suppliers of other components could be as long as nine months. If we are unable to adjustaccurately predict our component needs, or if our component supply is disrupted, we may miss market opportunities by not being able to meet the scale of our business in response to rapid changes in demand in the semiconductor equipment industry, our operating results and our ability to compete successfully may be impaired.

The business cycle in the semiconductor equipment industry has historically been characterized by frequent periods of rapid change in demand that challenge our management to adjust spending and resources allocated to operating activities. During periods of growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems and procedures and in training, managing, and appropriately sizing our supply chain, our work force, and other components of our business on a timely basis. Our success will depend, tosystems. Further, a significant extent, onincrease in the abilityprice of one or more of these components or subassemblies could seriously harm our executive officersresults of operations and other members of our senior management to identify and respond to these challenges, our gross margins and earnings may be impaired during periods of demand decline, and we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during periods of demand growth.cash flows.

We manufacture all of our systems at a limited number of facilities, and anyAny prolonged disruption in the operations of thoseour manufacturing facilities could reducehave a material adverse effect on our revenues.revenue.

We produce allthe majority of our systems in our manufacturing facilities located in Milpitas, California.California and Bloomington, Minnesota. We use contract manufacturers in China, Israel, Japan and the United States. Our manufacturing processes are highly complex and require sophisticated and costly equipment and a specially designed facilities.facility. As a result, any prolonged disruption in the operations of our manufacturing facilities, such as those resulting from acts of war, terrorism, political instability, health epidemics, fire, earthquake, flooding or other natural disaster could seriously harm our ability to satisfy our customer order deadlines. If we cannot timely deliver our systems, our results from operations and cash flows could be materially and adversely affected.

We may outsource select manufacturing activities to third-party service providers, which decreases our control over the performance of these functions and may result in lower quality and functionality of our products.

We may outsource product manufacturing to third-party service providers. Outsourcing reduces our control over the performance of the outsourced functions. Dependence on outsourcing may also adversely affect our ability to bring new products to market. If we do not effectively manage our outsourcing strategy or if third party service providers do not perform as anticipated, we may experience operational difficulties, increased costs, manufacturing interruptions or inefficiencies in the operation of our supply chain, any or all of which could delay our delivery of products to our customers, and materially and adversely affect our business, financial condition, and results of operations.


If our network security measures are breached and unauthorized access is obtained to a customer's data, to our data, or to our information technology systems, we may incur significant legal and financial exposure and liabilities.

As part of our business, we store our data and certain data about our customers, vendors and employees in our information technology system.  While our system iswe have security measures in place that are designed with accessto protect this information and prevent data loss and other security breaches, if these measures are breached as a third party gainsresult of third-party action, employee error, malfeasance, break-ins or otherwise, and someone obtains unauthorized access to our customers’, vendors’ or employees’ data, including any data regarding our customers, the security breachwe could expose us to a risk of loss of this information,face loss of business, litigation and possible liability. These security measures mayregulatory investigations or court orders, our reputation could be breached because of cyber-attacks, data breaches, malicious code such as viruses and worms, phishing attempts, employee error, malfeasance or otherwise. Additionally, third parties may attemptseverely damaged, we could be required to fraudulently induce employees or customers into disclosing sensitive information such as user names, passwords or other information to gain access to our customers' data or our data, including our intellectual propertyexpend significant capital and other confidential business information,resources to alleviate the problem, as well as incur significant costs and liabilities, including due to litigation, indemnity obligations, damages for contract breach, penalties for violation of applicable laws or our information technology systems.regulations, and costs for remediation and other incentives offered to customers.

Cyber-attacks and other malicious internet-based activities continue to increase. Because the techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognizedidentified until they are launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. In addition, third parties may attempt to fraudulently induce employees or users to disclose information to gain access to our data or our customers’ data. If any of these events occur, our or our customers’ and vendors’ information could be accessed or disclosed

18


Table of Contents

improperly. Any or all of these issues could negatively affect our ability to attract new customers, cause existing customers to choose to purchase from our competitors, result in reputational damage or subject us to third-party lawsuits, regulatory fines or other action or liability, which could adversely affect our operating results.

The General Data Protection Regulation (GDPR) is a regulation in European Union (EU) law on data protection and privacy for all individuals within the EU and the European Economic Area (EEA). It also addresses the export of personal data outside the EU and EEA areas. We need to put in appropriate technical and organizational measures despiteto implement these data protection principles. The GDPR requirements have been reviewed and are in the process of being implemented. We may also be subject to other data privacy laws in the United States and the other countries in which we operate.

Failure to adjust our orders for parts and subcomponents in an accurate and timely manner in response to changing market conditions or customer acceptance of our products could adversely affect our financial position and results of operations.

Our earnings could be negatively affected and our inventory levels could materially increase if we are unable to predict our inventory needs in an accurate and timely manner and adjust our orders for parts and subcomponents in the event that our needs increase or decrease materially due to unexpected increases or decreases in demand for our products. Any material increase in our inventories could result in an adverse effect on our financial position, while any material decrease in our ability to procure needed inventories could result in an inability to supply customer demand for our products, thus adversely affecting our revenue.

Our ability to fulfill our backlog may have an effect on our long-term ability to procure contracts and fulfill current contracts.

Our ability to fulfill our backlog may be limited by our ability to devote sufficient financial and human capital resources and may be limited by available material supplies. If we do not fulfill our backlog in a timely manner, we may experience delays in product delivery, which would postpone receipt of revenue from those delayed deliveries. Additionally, if we are consistently unable to fulfill our backlog, this may be a disincentive to customers to award large contracts to us in the future until they are comfortable that we can effectively manage our backlog.

If we do not manage our supply chain effectively, our operating results may be adversely affected.

We need to continually evaluate our global supply chains and assess opportunities to reduce costs. We must also enhance quality, speed and flexibility to meet changing demand for our products and product mix and uncertain market conditions. Our success also depends in part on refining our cost structure and supply chains so that we have flexibility and can maintain and improve profitability. Although the current tariff environment has not had a material adverse effect on our costs to date, further deterioration in the tariff environment, or changes in suppliers, may cause our costs to increase, which if we are not able to offset by charging higher sales prices, will cause a decline in our margins. To improve our margins on a product, we will need to establish high volume supply agreements with our vendors. We cannot be certain that we will be able to timely negotiate vendor supply agreements on improved terms and conditions, or at all. Failure to achieve the desired level of cost reductions could adversely affect our financial results. Despite our efforts to create security barrierscontrol costs and increase efficiency in our facilities, changes in demand could still cause us to such threats. Any security breach could resultrealize lower operating margins and profitability.

19


Table of Contents

We may choose to acquire new and complementary businesses, products or technologies instead of developing them ourselves, and we may be unable to complete these acquisitions or may not be able to successfully integrate an acquired business in a losscost-effective and non-disruptive manner.

Our success depends on our ability to continually enhance and broaden our product offerings in response to changing technologies, customer demands and competitive pressures. To this end, we have, from time to time, engaged in the process of confidence byidentifying, analyzing and negotiating possible acquisition transactions, and, from time to time, acquiring one or more businesses, and we expect to continue to do so in the future. We may choose to acquire new and complementary businesses, products, technologies and/or services instead of developing them ourselves. We may, however, face competition for acquisition targets from larger and more established companies with greater financial resources, making it more difficult for us to complete acquisitions. We cannot provide any assurance that we will be successful in consummating future acquisitions on favorable terms or that we will realize the benefits that we anticipate from one or more acquisitions that we consummate. Integrating any business, product, technology or service into our customers, damage our reputation,current operations could be expensive and time-consuming and/or disrupt our ongoing business. Further, there are numerous risks associated with acquisitions and potential acquisitions, including, but not limited to:

diversion of management’s attention from day-to-day operational matters and current products and customers;

lack of synergy or the inability to successfully integrate the new business or to realize expected synergies;

failure to commercialize the new technology or business;

failure to meet the expected performance of the new technology or business;

failure to retain key employees and customer or supplier relationships;

lower-than-expected market opportunities or market acceptance of any new products; and

unexpected reduction of sales of existing products as a result of the introduction of new products.

Our inability to consummate one or more acquisitions on favorable terms, or our failure to realize the intended benefits from one or more acquisitions, could have a material adverse effect on our business, lead to legal liability and negatively impact our future sales.

Ourliquidity, financial position and/or results of operations, could varyincluding as a result of the methods, estimatesour incurrence of indebtedness and judgments we use in applying our accounting policies.

The methods, estimates and judgments we use in applying our accounting policies have a significant impact on our results of operations. See “Note 1. Nature of Business, Basis of Presentation and Significant Accounting Policies” in Part II, Item 8 of our consolidated financial statements. These methods, estimates and judgments are, by their nature, subject to substantial risks, uncertainties and assumptions, and factors may arise over time that leads us to change our methods, estimates and judgments. Changes in these methods, estimates and judgments could significantly affect our results of operations. In particular, our operating results have been affected by changes in our valuation allowance against our deferred tax assets, the calculation of share-based compensationrelated interest expense and byour assumption of unforeseen contingent liabilities. We might need to raise additional funds through public or private equity or debt financings to finance any acquisition. In that event, we could be forced to obtain financing on terms that are not favorable to us and, in the testing and potentialcase of equity financing, that result in dilution to our stockholders. In addition, any impairment of long-lived assets such as goodwill andor other intangible assets. For example, duringassets, amortization of intangible assets, write-down of other assets or charges resulting from the year ended December 31, 2016, we recorded a $27.4 million releasecosts of valuation allowance againstacquisitions and purchase accounting could harm our U.S, certain state and certain foreign deferred tax assets as we determined, based upon an evaluation of all available objectively verifiable evidence, including but not limited to our operations, current earnings and anticipated future earnings that a release is required. The valuation allowance release had a significant impact to our operating results. The process of evaluating the valuation allowance is highly subjective and requires significant judgment, and our results of operations could vary significantly from estimates. To the extent that we believe it is more likely that we will not realize our deferred tax assets, our financial statements will reflect another significant change to our tax provisionbusiness and operating results.

If we cannot effectively manage growth, our business may suffer.

Over the long-term, we intend to grow our business by increasing our sales efforts and completing strategic acquisitions. To effectively manage growth, we must, among other things:

engage, train and manage a larger sales force and additional service personnel;

expand the geographic coverage of our sales force;

expand our information systems;

identify and successfully integrate acquired businesses into our operations; and

administer appropriate financial and administrative control procedures.

Growth of our business will likely place a significant strain on our management, financial, operational, technical, sales and administrative resources. Any failure to effectively manage our growth may cause our business to suffer and our stock price to decline.

Risks Related to Tax Laws, Financial Markets and the Environment

Changes in our effective income tax raterates or tax liabilities could affect our results of operations.results.

WeAs a global company, we are subject to taxation in numerous U.S. statesthe United States and territories. As a result, our effectivevarious other countries. Significant judgment is required to determine and estimate worldwide tax rate is derived from a combination of applicableliabilities. Our future annual and quarterly tax rates in the various places that we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of such places. Our effective tax rate, however, maycould be different than experienced in the past due toaffected by numerous factors, including the passage of the Tax Cuts and Jobs Act, changes in the jurisdictions(1) applicable tax laws; (2) composition of earnings in which our profits are determined to be earned and taxed, increases in expenses not deductible forcountries with differing tax purposes, the results of examinations and auditsrates; or (3) recoverability of our deferred tax filings,assets and liabilities.  In addition, we are subject to regular examination of our inability to secure or sustain acceptable agreements with

20


Table of Contents

income tax authorities, our utilization of net operating losses, changes in available tax credits, changes in accounting for income taxes, and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations and may result in tax obligations in excess of amounts accrued in our financial statements.

The recently passed comprehensive tax reform bill could adversely affect our business and financial condition.

On December 22, 2017, the President signed into law the Tax Cuts and Jobs Act that significantly reformsreturns by the Internal Revenue CodeService and other tax authorities. We regularly assess the likelihood of 1986, as amended,favorable or unfavorable outcomes resulting from these examinations to determine the Code. The Tax Cuts and Jobs Act, among other things, contains significant changes to corporate taxation, including reductionadequacy of our provision for income taxes. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination will not be materially different from the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted earnings (except for certain small businesses), limitation of the deduction of future net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new capital investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits, including the deductibility of executive compensation. Notwithstanding the reductiontreatment reflected in the corporateour historical income tax rate, the overall impact of the Tax Cutsprovisions and Jobs Act is uncertain and our business and financial condition could be adversely affected. The impact of this tax reform on holders of our common stock is also uncertain and could be adverse. We urge our stockholders to consult with their legal and tax advisors with respect to this legislation and the potential tax consequences of investing in or holding our common stock.


We may incur impairments to goodwill or long-lived assets.

We review our long-lived assets, including goodwill and other intangible assets, for impairment annually or more frequently when events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable or it becomes more likely than not that the fair value is reduced below the carrying value of the reporting unit. Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance.

Our recently announced share repurchase program may increase the volatility of our stock and impact our cash position and working capital balances.

In November 2017, our Board of Directors approved a program to repurchase up to $50 million of our common stock. Stock repurchases under the program may be made through open market and privately negotiated transactions, at times and in such amounts as management deems appropriate. Although our share repurchase program is intended to enhance long-term stockholder value, we are unable to ensure the repurchase program’s effectiveness. In addition, the repurchase program could affect the price and increase the volatility of our stock. The program may also diminish our cash reserves that may be needed for business investments, acquisitions of products and technologies or any other purposes.

Our investment portfolio may suffer losses from changes in market interest rates and changes in market conditions,accruals, which could materially and adversely affect our results of operations.

The Organization for Economic Co-operation and Development (“OECD”), released guidance covering various topics, including country-by-country reporting, definitional changes to permanent establishment and Base Erosion and Profit Shifting (“BEPS”), an initiative that aims to standardize and modernize global tax policy. Depending on the final form of guidance adopted by OECD members and legislation ultimately enacted, if any, there may be significant consequences for us due to our international business activities, including, but not limited to, an increase in our tax uncertainty and adverse effects on our provision for income taxes.

Turmoil or fluctuations in the credit markets and the financial services industry may negatively impact our business, results of operations, financial condition and liquidity.

Our investment portfolio primarily comprises corporate debt securities, commercial paper, debt securities issued by U.S. governmental agencies and certificates of deposits. These investments are subject to general credit,or liquidity, and marketour factoring arrangements may expose us to additional risks.

In the past, global credit markets and interest rate risks. Substantially allthe financial services industry have experienced a period of these securities are subject to interest rateunprecedented turmoil and credit risk and will decline in value if interest rates increase or one or moreupheaval characterized by the tightening of the issuers’ credit ratings is reduced. As a result of anymarkets, the weakening of the foregoing, we may experienceglobal economy and an unprecedented level of intervention from the United States and other governments. Adverse economic conditions, such as sustained periods of economic uncertainty or a reductioncrisis in value or loss of liquidity of our investments, whichthe financial markets may have a negativematerial adverse effect on our results of operations, liquidity and financial condition. We follow an established investment policy and set of guidelines to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

Our operating results have varied in the past and probably will continue to vary significantly in the future, which will cause volatility in our stock price.

Our quarterly and annual operating results have varied significantly in the past and are likely to vary in the future, which volatility could cause our stock price to decline. Some of the factors that may influence our operating results and subject our stock to extreme price and volume fluctuations include:

general economic growth or decline in the U.S. or foreign markets;

changes in customer demand for our systems;

the gain or loss of a key customer or significant changes in the financial condition or one or more key customers;

economic conditions in the semiconductor industries;

the timing, cancellation or delay of customer orders and shipments;

the timing of customer acceptance due to delays or failure to meet required specifications;

market acceptance of our products and our customers' products;

if our ability to recoverobtain credit from the higher costs associated with meetingcapital financial markets, or from trade creditors was impaired. In addition, a worsening economy or an economic crisis could also adversely impact our customers' increasing service demands;

competitive pressures on product prices and changes in pricing by our customers or suppliers;

customers’ ability to finance the timingpurchase of new product announcements and product releases bysystems from us or our competitors and oursuppliers’ ability to design, introduceprovide us with product, either of which may negatively impact our business and manufacture new products on a timely and cost-effective basis;

fluctuations in foreign currency exchange rates, particularly the Japanese yen, the Korean won, European euro and the British pound sterling;

the occurrenceresults of trade wars or barriers, or the perception that trade wars or barriers will occur;

the occurrence of tax valuation allowances;


the occurrence of potential impairments of long-lived assets;

the timing of acquisitions of businesses, products or technologies;

the effects of war, natural disasters, acts of terrorism or political unrest;

the loss of key personnel; and

the levels of our fixed expenses, relative to our revenue level.

The foregoing factors are difficult to forecast, and these, as well as other factors, could materially and adversely affect our quarterly and annual operating results. If our operating results in any period fall below the expectations of securities analysts and investors, the market price of our common stock would likely decline.

We are highly dependent on international sales and operations, which exposes us to foreign political and economic risks.

A majority of our sales and operations are outside of the United States. As a result, we are subject to regulatory, geopolitical and other risks associated with doing business in foreign countries. We anticipate that international sales will continue to account for a significant portion of our revenues. International sales and operations carry inherent risks such as:

regulatory limitations imposed by foreign governments;

obstacles to the protection of our intellectual property, political, military and terrorism risks;

foreign currency controls and currency exchange rate fluctuations;

periodic local or international economic downturns;

political instability, natural disasters, acts of war or terrorism in regions where we have operations;

repatriation of cash earned in foreign countries;

longer payment cycles and difficulties in collecting accounts receivable outside of the U.S.;

disruptions or delays in shipments caused by customs brokers or other government agencies;

uncertainty regarding liability under foreign laws;

changes in regulatory requirements (including import and export requirements), tariffs, customs, duties and other trade barriers;

difficulties in staffing and managing foreign operations;

potentially adverse tax consequences resulting from changes in tax laws; and

other challenges caused by distance, language and cultural differences.

If any of these risks materialize and we are unable to manage them, our international sales and operations would suffer.

We are exposed to fluctuations in the foreign currency exchange rates.

As a global concern, we face exposure to adverse movements in foreign currency exchange rates. Our exposure to foreign currency exchange rate fluctuations arise in part from current intercompany accounts in which costs are charged between our U.S. headquarters and foreign subsidiaries. These exposures may change over time as business practices evolve and could have a material adverse impact on our financial results and cash flow.

We are exposed to risks related to our banking arrangements and accounts receivable factoring.

We maintain bank accounts with both domestic and foreign financial institutions, any one of the institutions may prove to not be financially viable. If any of these financial institutions experiences financial difficulties or otherwise are unable to honor our deposit arrangements, we may experience material financial losses due to lack of access to our funds which could have an adverse impact on our operating results, financial condition and cash flows.operations. In addition, we enter into factoring arrangements with certain financial institutions to sell a certain portion of our trade receivables. If we were to stop entering into these factoring arrangements, our operating results, financial condition and cash flows could be adversely impacted by delays or failure to collect the trade receivables.


Anti-takeover provisions in our charter documents and Delaware law could discourage, delay or prevent a change in control of our company and may affect the trading price of our common stock.

The anti-takeover provisions of the Delaware General Corporation Law may discourage, delay or prevent a change in control of our company However, by limiting our ability to engage in a business combination with an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our certificate of incorporation and bylaws may discourage, delay or prevent a change in our management or control over us that stockholders may consider favorable. Our certificate of incorporation and bylaws:

authorize the issuance of “blank check” preferred stock that could be issued by our board of directors to thwart a takeover attempt;

limit who may call special meetings of stockholders; and

prohibit stockholder action by written consent, requiring all actions to be taken at a meeting of the stockholders.

Weentering into these arrangements, we are exposed to various risks relatedadditional risks.  If any of these financial institutions experiences financial difficulties or is otherwise unable to legal proceedings that could result in substantial costs and disruption to normal business operations.

From time to time, and inhonor the future,terms of our factoring arrangements, we may be, involved in legal proceedings or claims that involve breachexperience material financial losses due to the failure of contract, product liability, employment, possible infringement of patents and intellectual property rights of third parties or by third parties. It is difficult to predict the outcome of litigation matters, and there can be no assurance that we will prevail in any litigation. Adverse determinations in such litigation could result in loss of our property rights, subject us to significant liabilities, any ofarrangements, which could significantly and adversely affecthave an adverse impact upon our business,operating results, financial condition and results of operations.

If we are unable to maintain our internal control over financial reporting free of material weaknesses, it could adversely affect our business and results of operations.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management is required to perform evaluations of our internal control over financial reporting and our independent auditors are required to publicly attest to the effectiveness of our internal control over financial reporting.

In our Annual Report on Form 10-K for our fiscal year ended December 31, 2016, management has concluded that, due to a material weakness in internal control surrounding our inventory accounts, our internal control over financial reporting was not effective as of December 31, 2016. In response to the material weakness, we have implemented additional reporting and monitoring controls over additions to or changes to our master records. Also, we have designed an automated methodology for determining and assigning the frequency levels of counting each inventory item. As of December 30, 2017, our management believe our remediation efforts resulted in the elimination of the previously identified material weakness, and has concluded that it has been remediated. While this material weakness has been remediated, we cannot be certain that we will not, in the future, have additional material weaknesses. We will continue to evaluate the effectiveness of our internal controls to ensure that our financial statements continue to be fairly stated in all material respects.cash flows.

We are subject to various environmental laws and regulations that could impose substantial costs upon us and may harm our business, operating results and financial condition.

Some of our operations use substances regulated under various federal, state, local, and international laws governing the environment, including those relating to the storage, use, discharge, disposal, labeling, and human exposure to hazardous and toxic materials. We could incur costs, fines and civil or criminal sanctions, third-party property damage or personal injury claims, or could be required to incur substantial investigation or remediation costs, if we were to violate or become liable under environmental laws. Liability under environmental laws can be joint and several and without regard to comparative fault. Compliance with current or future environmental laws and regulations could restrict our ability to expand our facilities or require us to acquire additional expensive equipment, modify our manufacturing processes, or incur other significant expenses. We may unintentionally violate environmental laws or regulations in the future as a result of human error, equipment failure or other causes.


Compliance with federal securities laws, rulesRisks Related to Our Recently Completed Merger

Combining the businesses of Rudolph and regulations,Nanometrics may be more difficult, costly or time-consuming than expected and we may fail to realize the anticipated benefits of the Merger, which may adversely affect our business results and negatively affect the value of our common stock.

The success of the Merger depends on, among other things, our ability to combine the businesses of Rudolph and Nanometrics in a manner that realizes cost savings and facilitates growth opportunities.

In addition, we must achieve the anticipated growth and cost savings without adversely affecting current revenues and investments in future growth. If we are not able to successfully achieve these objectives, the anticipated benefits of the Merger may not be realized fully, or at all, or may take longer to realize than expected.

21


Table of Contents

An inability to realize the full extent of the anticipated benefits of the Merger, as well as Nasdaq requirements, is becoming increasingly complex,any delays encountered in the integration process, could have an adverse effect upon our revenues, level of expenses and operating results, which may adversely affect the value of our common stock.

In addition, the integration may result in additional and unforeseen expenses, and the significantanticipated benefits of the integration plan may not be realized. Actual growth and cost savings, if achieved, may be lower than what we expect and may take longer to achieve than anticipated. If we are not able to adequately address integration challenges, we may be unable to realize the anticipated benefits of the integration of Rudolph and Nanometrics.

The failure to successfully integrate the businesses and operations of Rudolph and Nanometrics in the expected time frame may adversely affect our future results.

Prior to completion of the Merger, Rudolph and Nanometrics operated independently. There can be no assurances that their businesses can be integrated successfully. It is possible that the integration process could result in the loss of key Rudolph employees or key Nanometrics employees, the loss of customers, the disruption of our ongoing businesses, inconsistencies in standards, controls, procedures and policies, unexpected integration issues, higher than expected integration costs or an overall post-completion integration process that takes longer than originally anticipated. Specifically, the following issues, among others, must be addressed in integrating the operations of Rudolph and Nanometrics in order to realize the anticipated benefits of the Merger so we perform as expected:

combining the companies’ operations and corporate functions;

combining the businesses of Rudolph and Nanometrics and meeting our capital requirements, in a manner that permits us to achieve any cost savings or revenue synergies anticipated to result from the Merger, the failure of which would result in the anticipated benefits of the Merger not being realized in the time frame currently anticipated or at all;

integrating personnel from the two companies;

integrating and unifying the offerings and services available to customers;

harmonizing the companies’ operating practices, employee development and compensation programs, internal controls and other policies, procedures and processes;

maintaining existing agreements with customers, distributors, providers and vendors and avoiding delays in entering into new agreements with prospective customers, distributors, providers and vendors;

addressing possible differences in business backgrounds, corporate cultures and management philosophies;

consolidating the companies’ administrative and information technology infrastructure;

coordinating distribution and marketing efforts; and

coordinating geographically dispersed organizations.

In addition, at times the attention of certain members of management and expenseresources may be focused on the integration of the businesses of the two companies and diverted from day-to-day business operations or other opportunities that may have been beneficial, which may disrupt our business.

We may not be able to retain customers or suppliers, or customers or suppliers may seek to modify contractual obligations with us, which could have an adverse effect on our business and operations. Third parties may terminate or alter existing contracts or relationships with Rudolph or Nanometrics.

As a result of the Merger, we must devotemay experience impacts on relationships with customers and suppliers that may harm our business and results of operations. Certain customers, licensors, business partners or suppliers may seek to terminate or modify contractual obligations whether or not contractual rights were triggered as a result of the Merger. There can be no guarantee that customers and suppliers of Rudolph or Nanometrics will remain with or continue to have a relationship with us or do so on the same or similar contractual terms to those areasthey had with Rudolph or Nanometrics prior to the Merger. If any customers or suppliers seek to terminate or modify contractual obligations or discontinue the relationship with us, then our business and results of operations may be harmed. Furthermore, we do not have long-term arrangements with many of our significant suppliers. If our suppliers were to seek to terminate or modify an arrangement with us, then we may be unable to procure necessary supplies from other suppliers in a timely and efficient manner and on acceptable terms, or at all. Any of the aforementioned disruptions could limit our ability to achieve the anticipated benefits of the Merger.

22


Table of Contents

We may be exposed to increased litigation due to the Merger, which could have an adverse effect on our business and operations.

We may be exposed to increased litigation from stockholders, customers, suppliers, consumers and other third parties due to the combination of Rudolph’s business and Nanometrics’ business. Such litigation may have an adverse impact on our business.

Federal securities laws, rulesbusiness and regulations, as well as Nasdaq rules and regulations, require companies to maintain extensive corporate governance measures, impose comprehensive reporting and disclosure requirements, set strict independence and financial expertise standards for audit and other committee members and impose civil and criminal penalties for companies and their chief executive officers, chief financial officers and directors for securities law violations. These laws, rules and regulations have increased, and in the future, are expected to continue to increase, the scope, complexity and cost of our corporate governance, reporting and disclosure practices, which could harm our results of operations and divert management's attention from businessor may cause disruptions to our operations.

We may be exposedunable to liabilities underretain former Rudolph and Nanometrics personnel successfully.

The success of the FCPA and other anti-corruption laws, and any determination that we violated these laws could have a material adverse effectMerger will depend in part on our business.ability to retain the talents and dedication of the professionals previously separately employed by Rudolph and Nanometrics. It is possible that these employees may decide not to remain with us. If key employees terminate their employment, or if an insufficient number of employees are retained to maintain effective operations, our business activities may be adversely affected and management’s attention may be diverted from successfully integrating Rudolph and Nanometrics to hiring suitable replacements, all of which may cause our business to suffer. In addition, we may not be able to locate suitable replacements for any key employees that leave the Company or offer employment to potential replacements on reasonable terms.

WeRisks Related to the Global Economy and Semiconductor Industry

Cyclicality in the semiconductor device industry has led to substantial decreases in demand for our systems and may, from time to time, continue to do so.

Our operating results are subject to significant variation due to global economic conditions and the Foreign Corrupt Practice Actcyclical nature of 1977 ("FCPA"),the semiconductor device industry. Our business depends upon the capital expenditures of semiconductor device manufacturers, which, in turn, depend upon the current and other lawsanticipated market demand for semiconductors and products using semiconductors. The timing, length and severity of the up-and-down cycles in the semiconductor equipment industry are difficult to predict. In recent years, the industry has experienced significant downturns, generally in connection with declines in economic conditions. This cyclical nature of the industry in which we operate affects our ability to accurately predict future revenue and, thus, future expense levels. When cyclical fluctuations result in lower than expected revenue levels, operating results may be adversely affected, and cost reduction measures may be necessary in order for us to remain competitive and financially sound. During a down cycle, we must be in a position to adjust our cost and expense structure to prevailing market conditions and to continue to motivate and retain our key employees. In addition, during periods of rapid growth, we must be able to increase manufacturing capacity and personnel to meet customer demand. We can provide no assurance that prohibit improper paymentsthese objectives can be met in a timely manner in response to industry cycles. If we fail to respond to industry cycles, our business could be seriously harmed.

In addition, demand for our products is highly inelastic which means we have little ability to control product revenues created by customer demand for more capacity. The market for our products is characterized by constant and rapid technological change, price erosion, product obsolescence, evolving standards, short product life cycles and significant volatility in supply and demand. Due to the inelastic nature of demand in the semiconductor industry, we may need to take actions to reduce costs in the future, which could reduce our ability to significantly invest in research and development at levels we believe are necessary. If we are unable to effectively align our cost structure with prevailing market conditions, our business, financial condition and results of operations may be materially and adversely affected.

We may also experience supplier or offerscustomer issues as a result of paymentsadverse macroeconomic conditions. If our customers have difficulties in obtaining capital or financing, this could result in lower sales. Customers with liquidity issues could also result in an increase in bad debt expense. These conditions could also affect our key suppliers, which could affect their ability to foreign governmentssupply parts and their officials and political parties by U.S. persons and issuers as defined by the statute, for the purpose of obtaining or retaining business. Also, similar worldwide anti-bribery laws, such as the U.K. Bribery Act and Chinese anti-corruption laws, generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. Someresult in delays of our distribution partners are located in partscustomer shipments.

Our future rate of growth is highly dependent on the development and growth of the worldmarket for microelectronic device inspection, lithography and metrology equipment.

We target our products to address the needs of microelectronic device manufacturers for defect inspection, metrology and lithography.  If for any reason the market for microelectronic device inspection, lithography or metrology equipment fails to grow in the long term, we may be unable to maintain current revenue levels in the short term and maintain our historical growth in the long term. Growth in the inspection market is dependent to a large extent upon microelectronic manufacturers replacing manual inspection with automated inspection technology. Growth in the metrology market is dependent to a large extent upon new chip designs and capacity expansion of microelectronic manufacturers. Growth in the lithography market is

23


Table of Contents

dependent on the development of cost-effective packaging with high fine pitch RDLs, ultimately migrating to multi-die, large, form-factor packages. There can be no assurance that have experienced governmental corruptionmanufacturers will undertake these actions at the rate we expect.

Risks Related to some degreeour Stock

Provisions of our charter documents and of Delaware law could discourage potential acquisition proposals and/or delay, deter or prevent a change in control of our company.

Provisions of our certificate of incorporation and by-laws may inhibit changes in control of our company not approved by our Board of Directors. These provisions also limit the circumstances in which a premium can be paid for our common stock and in certain circumstances, strict compliance with anti-bribery lawswhich a proxy contest for control of our board may conflict with local customs and practices. Although we have implemented policies and proceduresbe initiated. These provisions provide for:

a prohibition on stockholder actions through written consent;

a requirement that special meetings of stockholders be called only by our chief executive officer or Board of Directors;

advance notice requirements for stockholder proposals and director nominations by stockholders;

limitations on the ability of stockholders to amend, alter or repeal our by-laws; and

the authority of our board to issue, without stockholder approval, preferred stock with such terms as the board may determine; and

The authority of our board, without stockholder approval, to adopt a stockholder rights plan.

We are also entitled to discourage these practices by our employees, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents or distributors may engage in conduct for which we might be held responsible. Violationsavail ourselves of the FCPA or international anti-corruption lawsprotections of Section 203 of the Delaware General Corporation Law, which could inhibit changes in control of the Company.

Our stock price is volatile.

The market price of our common stock has fluctuated widely. Consequently, the current market price of our common stock may result in severe criminal or civil sanctions,not be indicative of future market prices, and we may be subjectunable to other liabilities, which could negatively affectsustain or increase the value of an investment in our business, operating results and financial condition. common stock. Factors affecting our stock price may include:

variations in operating results from quarter to quarter;

changes in earnings estimates by analysts or our failure to meet analysts’ expectations;

changes in the market price per share of our public company customers;

market conditions in the semiconductor and other industries into which we sell products;

general economic conditions;

political changes, hostilities or natural disasters such as hurricanes and floods;

low trading volume of our common stock; and

the number of firms making a market in our common stock.

In addition, the U.S. government may seek to hold us liable for successor liability FCPA violations committed bystock market has experienced periods of significant price and volume fluctuations. These fluctuations have particularly affected the market prices of the securities of high technology companies in which we invest or that we acquire. We cannot assure you that our internal control policies and procedures will protect us from reckless or negligent acts committed by our employees, distributors, partners, consultants or agents.

Regulations related to conflict minerals could adversely impact our business.

The Dodd-Frank Wall Street Reform and Consumer Protection Act contains provisions to improve transparency and accountability concerning the supply of tin, tantalum, tungsten and gold, known as conflict minerals, originating from the Democratic Republic of Congo, or DRC, and adjoining countries. As a result, in August 2012 the United States Securities and Exchange Commission, or SEC, adopted annual disclosure and reporting requirements for public companies that use conflict minerals mined from the DRC and adjoining countries in their products. We have determined that we use at least one of these conflict mineralslike ours. Any such market fluctuations in the manufacture of our products, although we have not yet determined the source of the minerals that we use. These disclosure requirements require us to use diligent efforts to determine which conflict minerals we use and the source of those conflict minerals, and disclose the results of our findings. There have been and will continue to be costs associated with complying with these disclosure requirements, including those costs incurred in conducting diligent efforts to determine which conflict minerals we use and the sources of conflict minerals used in our products. Further, the implementation of these rulesfuture could adversely affect the sourcing, supplymarket price of our common stock.

There are various risks related to the legal and pricing of materials usedregulatory environments in which we perform our products. As thereoperations and conduct our business that may expose us to risk.

We are faced with various risks that may be only aassociated with our compliance with existing, new, different, inconsistent or conflicting laws, regulations and rules enacted by governments and/or their regulatory agencies in the countries in which we operate as well as rules and policies implemented at our customer sites. These laws, regulations, rules and policies could relate to any of an array of issues including, but not limited number of suppliers offering conflict free minerals, we cannot be sureto, environmental, tax, intellectual property, trade secrets, product liability, contracts, antitrust, employment, securities, import/export and unfair competition. In the event that we willfail to comply with or violate U.S. or foreign laws or regulations or customer policies, we could be ablesubject to obtain necessary conflict free conflict mineralscivil or criminal claims or proceedings that may result in sufficient quantitiesmonetary fines, penalties or at competitive prices. In addition, weother costs against us or our employees, which may face reputational challenges if we determine thatadversely affect our products contain minerals not determinedoperating results, financial condition, customer relations and ability to be conflict free or if we are unable to sufficiently verify the origins for all conflict minerals used inconduct our products through the procedures we implement. If we determine it is necessary to redesign our products to not use conflict minerals, we would incur costs associated with doing so.business.

 

24


Table of Contents

 

ITEMItem 1B.

UNRESOLVED STAFF COMMENTSUnresolved Staff Comments.

None.


ITEMItem 2.

PROPERTIESProperties.

At December 30, 2017,Our principal executive office building is located at 16 Jonspin Road in Wilmington, Massachusetts.  We own our owned or leasedMilpitas and Richardson facilities included those described below:and lease facilities for corporate, engineering, manufacturing, sales and service-related purposes in the United States and six other countries - China, Japan, South Korea, Singapore, Taiwan and France. The following table indicates the location, the general purpose and the square footage of our material facilities. Our leases expire at various times through July 1, 2029.

 

Type

Location

 

Facility Purpose

Approximate

Square

Footage

Wilmington, Massachusetts

Corporate Headquarters, Engineering, Manufacturing and Service

 

 

Use

Owned50,000

 

Milpitas, California

 

135,692Corporate, Engineering, Manufacturing and Service

 

 

Corporate headquarters, manufacturing and corporate housing134,000

LeasedBudd Lake, New Jersey

 

TaiwanCorporate, Engineering and Service

 

 

23,33949,000

Bend, Oregon

Engineering and Service

 

 

Sales and service

Leased19,000

 

Bloomington, Minnesota

Engineering, Manufacturing and Service

98,500

Hillsboro, Oregon

Engineering and Service

20,000

Richardson, Texas

Engineering

21,000

Snoqualmie, Washington

Engineering and Service

20,500

Tucson, Arizona

Engineering, Manufacturing and Service

19,000

Taiwan

Sales and Service

43,500

China

Sales, Service and Engineering

37,500

South Korea

 

21,312Sales and Service

 

 

Sales, service and corporate housing34,000

LeasedJapan

 

United StatesSales and Service

 

 

19,55120,500

Singapore

Sales and Service

 

 

Engineering, sales and service

Leased

Japan

16,628

Sales, service and corporate housing

Leased

China

10,486

Sales and service

Leased

Singapore

4,528

Sales and service

Leased

France

828

Sales and service

Total

232,364

12,000

 

 

We also lease office space for other smaller sales and service offices in several locations throughout the world.

We believe that our existing facilities and capital equipment are suitable for their respective uses and adequate forto meet our current needsrequirements and anticipated growth.

that suitable additional or substitute space is available on commercially reasonable terms if needed.

ITEMItem 3.

The information set forth under Note 9, Commitments10, “Commitments and Contingencies, inContingencies” to the Notes to Consolidated Financial Statements is incorporated herein by reference.

 

 

ITEM 4.

MINE SAFETY DISCLOSURES

N/A.Item 4.Mine Safety Disclosures.

None.

 

 


25


Table of ContentsPART II

 

PART II

ITEMItem 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIESMarket for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information for Common Stock

Our common stock is quoted on the New York Stock Exchange (“NYSE”) under the symbol “ONTO.” Prior to the Merger, Nanometrics’ common stock was quoted on the Nasdaq Global Select Market under the symbol “NANO.“NANO” and Rudolph’s common stock was quoted on the NYSE under the symbol “RTEC.The following table setsSet forth below is a line graph comparing the annual percentage change in the cumulative return to the stockholders of the Company’s common stock with the cumulative return of the NYSE Composite Index, the Nasdaq Composite Index and the industry specific index, PHLX Semiconductor Index, for the fiscal periods indicated,period commencing on December 31, 2014 and ending on December 31, 2019.  Historical data for Onto Innovation in the highline graph for the period commencing on December 31, 2014 and low closing sales prices per shareending on October 25, 2019 reflects the cumulative return to the stockholders of ourNanometrics.

The information contained in the performance graph shall not be deemed to be “soliciting material” or to be “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference into such filing.

The graph assumes that $100 was invested on December 31, 2014 in the Company’s common stock on a quarterly basis as reportedand in each index. No cash dividends have been declared or paid on the Nasdaq Global Select Market.Company’s common stock. Stockholder returns over the indicated period should not be considered indicative of future stockholder returns.

 

 

Fiscal Year 2017

 

High

 

 

Low

 

First quarter

 

$

30.46

 

 

$

24.84

 

Second quarter

 

$

32.20

 

 

$

24.89

 

Third quarter

 

$

28.80

 

 

$

24.64

 

Fourth quarter

 

$

29.14

 

 

$

23.98

 

Fiscal Year 2016

 

High

 

 

Low

 

First quarter

 

$

15.86

 

 

$

12.63

 

Second quarter

 

$

20.62

 

 

$

13.82

 

Third quarter

 

$

22.66

 

 

$

19.65

 

Fourth quarter

 

$

25.83

 

 

$

19.65

 

 

 

12/14

 

 

12/15

 

 

12/16

 

 

12/17

 

 

12/18

 

 

12/19

 

Onto Innovation Inc.

 

 

100.00

 

 

 

90.01

 

 

 

148.99

 

 

 

148.16

 

 

 

162.49

 

 

 

217.24

 

NYSE Composite

 

 

100.00

 

 

 

95.91

 

 

 

107.36

 

 

 

127.46

 

 

 

116.06

 

 

 

145.66

 

NASDAQ Composite

 

 

100.00

 

 

 

106.96

 

 

 

116.45

 

 

 

150.96

 

 

 

146.67

 

 

 

200.49

 

PHLX Semiconductor

 

 

100.00

 

 

 

98.41

 

 

 

137.10

 

 

 

192.69

 

 

 

181.04

 

 

 

295.57

 

 

Stockholders

On26


Table of Contents

As of February 20, 2018,3, 2020, there were approximately 133 holders153 stockholders of record of our common stock. Because brokersstock and the institutions on behalf of stockholders hold many of our shares of common stock, we are unable to estimate the total number of stockholders represented by these record holders.

Dividend Policyapproximately 16,358 beneficial stockholders.

We have never declared or paid anya cash dividendsdividend on our capitalcommon stock. We currently expect to retainThe declaration of any future earnings, if any, for use individends by us is within the operation, expansiondiscretion of our business and repurchase of shares and do not anticipate paying any cash dividends in the foreseeable future.

Issuer Purchases of Equity Securities

On May 29, 2012, our Board of Directors authorizedand will be dependent on our earnings, financial condition and capital requirements as well as any other factors deemed relevant by our Board of Directors.

Following the Merger, we assumed the share repurchase authorization approved on March 14, 2019, by the former Nanometrics Board of Directors.  This share repurchase authorization allows us to purchase up to $20.0$80.0 million worth of shares of our common stockstock. Under the terms of which $4.4 million remainedthis share repurchase authorization, shares may be repurchased through open market or privately negotiated transactions. No shares have been repurchased under this repurchase authorization as of December 31, 2016. On November 15, 20172019.

For further information, see Note 18 in the accompanying Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K.

In addition to our Board of Directors authorized theshare repurchase of up to $50.0 million of ourprogram, we withhold common stock which supersededshares associated with net share settlements to cover tax withholding obligations upon the 2012 repurchase program. This new plan is referred to as the Stock Repurchase Plan. Stock repurchasesvesting of restricted stock unit awards and stock option exercises under the Stock Repurchase Plan may be madeCompany’s equity incentive program. During the three and twelve months ended December 31, 2019, we withheld 51 thousand and 78 thousand shares through open marketnet share settlements, respectively.  For the three and privately negotiated transactions at timestwelve month periods ended December 31, 2019, net share settlements cost $1.8 million and $2.5 million, respectively. Please refer to Note 12 of the Notes to the Consolidated Financial Statements included in such amounts as management deems appropriate. The timing and actual number of shares repurchased is dependentthis Annual Report on a variety of factors including price, corporate and regulatory requirements and other market conditions.

During fiscal year 2017, we repurchased and retired 1,065,848 shares ofForm 10-K for further discussion regarding our common stock at the weighted average price of $25.33 per share under the Stock Repurchase Plan, all of which were purchased in the fourth quarter of fiscal year 2017.equity incentive plan.

The following table summarizes repurchasesprovides details of our common stock purchased during the fourth quarter of fiscal 2017:three month period ended December 31, 2019 (in thousands, except per share data):

Period

 

Total Number

of Shares

Purchased (1)

 

 

Average

Price

Paid per

Share

 

 

Total Number

of Shares

Purchased as

Part of Publicly

Announced

Program

 

 

Maximum

Approximate Dollar Value of

Shares that

May Yet Be

Purchased Under

the Program

 

October 1, 2019 to October 31, 2019

 

 

42

 

 

$

35.56

 

 

 

 

 

$

80,000

 

November 1, 2019 to November 30, 2019

 

 

7

 

 

$

33.44

 

 

 

 

 

$

80,000

 

December 1, 2019 to December 31, 2019

 

 

2

 

 

$

33.54

 

 

 

 

 

$

80,000

 

Three Months Ended December 31, 2019

 

 

51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1  Includes shares withheld through net share settlements.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Total Number of Shares Purchased

 

 

Average Price Paid Per Share

 

 

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs

 

 

Approximate Dollar Value of Shares that May Yet to be Repurchase Under the Plans or Program (in thousands)

 

October 1, 2017, to October 28, 2017

 

 

 

 

 

 

 

 

 

 

$

4,400

 

October 29, 2017, to November 25, 2017

 

 

 

 

 

 

 

 

 

 

$

50,000

 

November 26, 2017, to December 30, 2017

 

 

1,065,848

 

 

$

25.33

 

 

 

1,065,848

 

 

$

23,001

 


The Stock Repurchase Plan was completed in February 2018, with purchases since December 30, 2017 of 896,187 shares of our common stock at the weighted average price of $25.65 for a cost of $23.0 million. No shares were repurchased in fiscal 2016.

 


27



Stock Performance Graph

The following graph presentation compares cumulative five-year stockholder returns on an indexed basis, assuming a $100 initial investment and reinvestmentTable of dividends, of Nanometrics Incorporated, a broad-based equity market index and an industry-specific index. The broad-based equity market index used is the Nasdaq Composite Index and the industry-specific index used is the PHLX Semiconductor Index.Contents

This performance graph shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act of 1933, as amended or the Exchange Act.

 

 

12/12

 

 

12/13

 

 

12/14

 

 

12/15

 

 

12/16

 

 

12/17

 

Nanometrics Incorporated

 

 

100.00

 

 

 

132.11

 

 

 

116.64

 

 

 

104.99

 

 

 

173.79

 

 

 

172.82

 

NASDAQ Composite

 

 

100.00

 

 

 

141.63

 

 

 

162.09

 

 

 

173.33

 

 

 

187.19

 

 

 

242.29

 

PHLX Semiconductor

 

 

100.00

 

 

 

130.15

 

 

 

167.68

 

 

 

156.67

 

 

 

208.23

 

 

 

292.66

 

Recent Sales of Unregistered Securities

None.


 

ITEMItem 6.

SELECTED FINANCIAL DATASelected Financial Data.

The following selected consolidated financial data set forth below is not necessarily indicative of results of future operations and should not be relied upon as an indicator of our future performance. This data should be read in conjunction with our Consolidated Financial Statements and the related Notes thereto appearing elsewhere in this Annual Report on Form 10-K, and Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations”Operations.” The Merger has been accounted for as a reverse acquisition under which Rudolph was considered the accounting acquirer.  As such, the selected financial data below comprises the operating results of Rudolph and its consolidated subsidiaries for periods through October 25, 2019 and Onto Innovation and its consolidated subsidiaries for periods on or after October 26, 2019. The balance sheet data as of December 31, 2019 and 2018 and the statement of operations data for the years ended December 31, 2019, 2018 and 2017 set forth below were derived from our audited Consolidated Financial Statements included elsewhere in this Form 10-K. The balance sheet data as of December 31, 2017, 2016 and 2015, and the statement of operations data for the years ended December 31, 2016 and 2015 were derived from our audited consolidated financial statements not included herein.

 

 

Year Ended December 31,

 

 

 

2019 (1)

 

 

2018 (2)

 

 

2017 (2)

 

 

2016 (2)

 

 

2015 (2)

 

 

 

(In thousands, except per share data)

 

Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

305,896

 

 

$

273,784

 

 

$

255,098

 

 

$

232,780

 

 

$

221,690

 

Cost of revenue

 

 

170,868

 

 

 

125,505

 

 

 

120,503

 

 

 

109,229

 

 

 

102,284

 

Gross profit

 

 

135,028

 

 

 

148,279

 

 

 

134,595

 

 

 

123,551

 

 

 

119,406

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

48,358

 

 

 

39,953

 

 

 

37,694

 

 

 

35,797

 

 

 

32,689

 

Sales and marketing

 

 

28,251

 

 

 

22,010

 

 

 

20,795

 

 

 

18,816

 

 

 

17,047

 

General and administrative

 

 

53,017

 

 

 

33,698

 

 

 

27,878

 

 

 

28,913

 

 

 

34,732

 

Amortization

 

 

10,445

 

 

 

1,534

 

 

 

1,940

 

 

 

2,320

 

 

 

2,145

 

Patent litigation income

 

 

 

 

 

 

 

 

(13,000

)

 

 

(14,643

)

 

 

 

Total operating expenses

 

 

140,071

 

 

 

97,195

 

 

 

75,307

 

 

 

71,203

 

 

 

86,613

 

Operating income (loss)

 

 

(5,043

)

 

 

51,084

 

 

 

59,288

 

 

 

52,348

 

 

 

32,793

 

Interest income (expense), net

 

 

3,666

 

 

 

2,206

 

 

 

971

 

 

 

(2,834

)

 

 

(5,688

)

Other income (expense), net

 

 

780

 

 

 

56

 

 

 

(457

)

 

 

354

 

 

 

(293

)

Income (loss) before provision (benefit) for income

   taxes

 

 

(597

)

 

 

53,346

 

 

 

59,802

 

 

 

49,868

 

 

 

26,812

 

Provision (benefit) for income taxes

 

 

(2,507

)

 

 

8,250

 

 

 

26,893

 

 

 

12,916

 

 

 

8,856

 

Net income

 

$

1,910

 

 

$

45,096

 

 

$

32,909

 

 

$

36,952

 

 

$

17,956

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.06

 

 

$

1.77

 

 

$

1.30

 

 

$

1.48

 

 

$

0.71

 

Diluted

 

$

0.06

 

 

$

1.74

 

 

$

1.27

 

 

$

1.45

 

 

$

0.69

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

29,729

 

 

 

25,470

 

 

 

25,325

 

 

 

25,033

 

 

 

25,258

 

Diluted

 

 

30,007

 

 

 

25,895

 

 

 

25,865

 

 

 

25,566

 

 

 

25,868

 

 

 

December 31,

 

 

 

2019 (1)

 

 

2018

 

 

2017

 

 

2016

 

 

2015

 

Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

130,673

 

 

$

112,388

 

 

$

67,770

 

 

$

37,859

 

 

$

44,554

 

Marketable securities

 

 

189,563

 

 

 

62,684

 

 

 

109,589

 

 

 

87,872

 

 

 

116,924

 

Working capital

 

 

555,921

 

 

 

305,916

 

 

 

279,775

 

 

 

226,668

 

 

 

197,266

 

Total assets

 

 

1,448,580

 

 

 

418,040

 

 

 

385,922

 

 

 

338,699

 

 

 

379,563

 

Convertible senior notes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

57,846

 

Accumulated deficit

 

 

(4,863

)

 

 

(6,773

)

 

 

(51,869

)

 

 

(84,706

)

 

 

(121,658

)

Total stockholders’ equity

 

 

1,264,026

 

 

 

361,888

 

 

 

333,154

 

 

 

293,735

 

 

 

270,678

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)Selected financial data includes the operating results of the former Nanometrics subsequent to the closing of the Merger on October 25, 2019.

(2) Statement of Operations data reflects a reclassification within the categories of operating expenses.  Applications engineering expenses were reclassified from Research and related notes includeddevelopment to Sales and marketing. Sales and marketing expenses were disaggregated from General and administrative expenses.

28


Table of Contents

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

We are a worldwide leader in the design, development, manufacture and support of process control tools that perform macro-defect inspection and metrology, lithography systems, and process control analytical software used by semiconductor and advanced packaging device manufacturers. We deliver comprehensive solutions throughout the semiconductor fabrication process with our families of proprietary products that provide critical yield-enhancing information, enabling microelectronic device manufacturers to drive down costs and time to market of their devices. We provide process and yield management solutions used in both wafer processing facilities, often referred to as “front-end” and device packaging and test facilities, or “back-end” manufacturing, through a portfolio of standalone systems for macro-defect inspection, lithography, probe card test and analysis, and transparent and opaque thin film measurements. All of our systems feature sophisticated software and production-worthy automation. In addition, our advanced process control software portfolio includes powerful solutions for standalone tools, groups of tools, or factory-wide suites to enhance productivity and achieve significant cost savings. Our systems are backed by worldwide customer service and applications support.

Our business is affected by the annual spending patterns of our customers on semiconductor capital equipment. The amount that our customers devote to capital equipment spending depends on a number of factors, including general worldwide economic conditions as well as other economic drivers such as personal computers, mobile devices, data centers, artificial intelligence and automotive sales. Current forecasts by industry analysts for the semiconductor device manufacturing industry project capital equipment spending to increase approximately 5% to 8% for 2020 as compared to 2019. Our revenue and profitability tend to follow the trends of certain segments within the semiconductor market.

Historically, a significant portion of our revenue in each quarter and year has been derived from sales to relatively few customers, and we expect this trend to continue. For the years ended December 31, 2019, 2018 and 2017, aggregate sales to customers that individually represented at least five percent of our revenue accounted for 42.7%, 18.3%, and 27.2% of our revenue, respectively.

Merger

On June 23, 2019, Rudolph and Nanometrics, a provider of advanced process control metrology and software analytics, entered into the Merger Agreement to combine in an all-stock merger of equals transaction. The Merger was completed on October 25, 2019.  As a result of the Merger, Rudolph became a direct wholly-owned subsidiary of Nanometrics, which was renamed “Onto Innovation Inc.” upon the consummation of the Merger. Shares of common stock of Rudolph (NYSE: RTEC) ceased trading on the New York Stock Exchange as of market close on October 25, 2019. Onto Innovation (NYSE: ONTO) shares began trading on the NYSE on October 28, 2019.  At the effective time of the Merger, each issued and outstanding share of Rudolph Common Stock was converted into the right to receive 0.8042 shares of Onto Innovation Common Stock (NYSE: ONTO). Immediately following the effective time of the Merger, each of Nanometrics’ and Rudolph’s stockholders owned approximately 50% of the combined company, Onto Innovation. Pursuant to the Merger Agreement, Onto Innovation accounts for the Merger as a reverse acquisition using the acquisition method of accounting in accordance with generally accepted accounting principles, with Rudolph being treated as the acquiring entity for accounting purposes. As such, the results of operations data below comprise the operating results of Rudolph and its consolidated subsidiaries for periods through October 25, 2019 and Onto Innovation and its consolidated subsidiaries for periods on or after October 26, 2019. See Note 3 to the Consolidated Financial Statements set forth elsewhere in this Annual Report on Form 10-K.10-K for additional information regarding the Merger.

29


Table of Contents

Results of Operations

The following table sets forth, for the periods indicated, our results of operations as percentages of our revenue. Our fiscal yearsresults of operations are reported as one business segment.

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Revenue

 

 

100.0

%

 

 

100.0

%

 

 

100.0

%

Cost of revenue

 

 

55.9

%

 

 

45.8

%

 

 

47.2

%

Gross profit

 

 

44.1

%

 

 

54.2

%

 

 

52.8

%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

15.8

%

 

 

14.6

%

 

 

14.8

%

Sales and marketing

 

 

9.2

%

 

 

8.0

%

 

 

8.1

%

General and administrative

 

 

17.4

%

 

 

12.3

%

 

 

10.9

%

Amortization

 

 

3.4

%

 

 

0.6

%

 

 

0.8

%

Patent litigation income

 

 

%

 

 

%

 

 

(5.1

)%

Total operating expenses

 

 

45.8

%

 

 

35.5

%

 

 

29.5

%

Operating income (loss)

 

 

(1.7

)%

 

 

18.7

%

 

 

23.3

%

Interest income, net

 

 

1.2

%

 

 

0.8

%

 

 

0.4

%

Other income (expense), net

 

 

0.3

%

 

 

%

 

 

(0.2

)%

Income (loss) before provision (benefit) for income taxes

 

 

(0.2

)%

 

 

19.5

%

 

 

23.5

%

Provision (benefit) for income taxes

 

 

(0.8

)%

 

 

3.0

%

 

 

10.6

%

Net income

 

 

0.6

%

 

 

16.5

%

 

 

12.9

%

Results of Operations for 2019, 2018 and 2017 2016, 2015, 2014,

Revenue. Our revenue is derived from the sale of our systems and 2013, as referred to below, refer to our fiscalsoftware, spare parts, and services. Our revenue was $305.9 million, $273.8 million and $255.1 million for the years ended December 30,31, 2019, 2018 and 2017, respectively. This represents an increase of 11.7% from 2018 to 2019 and an increase of 7.3% from 2017 to 2018.  The increase in revenue from 2018 to 2019 was primarily due to the inclusion of revenue from legacy Nanometrics business for the period from October 25, 2019, the effective date of the Merger, through December 31, 2016,2019.  This year-over-year increase in revenue was partially offset by overall spending declines in the semiconductor capital equipment industries. The increase in revenue from 2017 to 2018 was primarily due to an increase in capital spending by front-end memory manufacturers.  

The following table lists, for the periods indicated, the different sources of our revenue in dollars (thousands) and as percentages of our total revenue: 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Systems and software

 

$

255,723

 

 

 

84

%

 

$

234,241

 

 

 

86

%

 

$

216,884

 

 

 

85

%

Parts

 

 

34,892

 

 

 

11

%

 

 

28,658

 

 

 

10

%

 

 

27,143

 

 

 

11

%

Services

 

 

15,281

 

 

 

5

%

 

 

10,885

 

 

 

4

%

 

 

11,071

 

 

 

4

%

Total revenue

 

$

305,896

 

 

 

100

%

 

$

273,784

 

 

 

100

%

 

$

255,098

 

 

 

100

%

Total systems and software revenue increased $21.5 million for the year ended December 26, 2015,31, 2019 as compared to the year ended December 27, 201431, 2018 primarily due to the inclusion of revenue from legacy Nanometrics for the period from the effective date of the Merger.  The year-over-year change in systems revenue was driven by an increase of $29.9 million in process control systems revenue due to inclusion of $56.0 million of revenue from legacy Nanometrics for the period from the effective date of the Merger. This increase was partially offset by decreased demand for our products in both advanced packaging and front-end systems.  Software licensing, support and maintenance revenue decreased $4.0 million, primarily due to a decrease in revenue from our process control and yield management software. The year-over-year increase in parts and services revenue in absolute dollars from 2018 to 2019 was primarily due to the inclusion of $10.3 million of parts and service revenue from legacy Nanometrics for the period from the effective date of the Merger.  Parts and services revenue is generated from part sales, maintenance service contracts, system upgrades, as well as time and material billable service calls.

Total systems and software revenue increased for the year ended December 28, 2013, respectively.31, 2018 as compared to the year ended December 31, 2017 due to increased demand for our products in front-end process control systems. The year-over-year increases in process control systems revenue totaled $12.9 million, primarily due to higher metrology system sales in the 2018 period.  Lithography system revenue increased $0.7 million, primarily due to the shipment of a JetStep G system offset by lower shipments of our JetStep W systems in 2018.  Licensing revenue from software increased $3.7 million primarily due

 

 

 

Fiscal Year

 

 

 

2017(1)

 

 

2016(2)

 

 

2015

 

 

2014(3)

 

 

2013

 

 

 

(in thousands, except per share data)

 

Consolidated Statement of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total net revenues

 

$

258,621

 

 

$

221,129

 

 

$

187,367

 

 

$

166,443

 

 

$

144,307

 

Gross profit

 

$

136,701

 

 

$

114,124

 

 

$

89,667

 

 

$

75,822

 

 

$

62,676

 

Income (loss) from operations

 

$

42,806

 

 

$

29,095

 

 

$

4,973

 

 

$

(11,653

)

 

$

(21,709

)

Net income (loss)

 

$

30,202

 

 

$

44,035

 

 

$

2,905

 

 

$

(31,118

)

 

$

(14,146

)

Basic net income (loss) per share

 

$

1.19

 

 

$

1.79

 

 

$

0.12

 

 

$

(1.30

)

 

$

(0.61

)

Diluted net income (loss) per share

 

$

1.17

 

 

$

1.75

 

 

$

0.12

 

 

$

(1.30

)

 

$

(0.61

)

30


Table of Contents

 

to an increase in revenue from our process control and yield management software. The year-over-year increase in parts and services revenue in absolute dollars from 2017 to 2018 was primarily due to increased spending by our customers on repairs of existing systems.  Parts and services revenue is generated from part sales, maintenance service contracts, system upgrades, as well as time and material billable service calls.

Gross Profit. Our gross profit has been and will continue to be affected by a variety of factors, including  inventory step-up from purchase accounting, manufacturing efficiencies, provision for excess and obsolete inventory, pricing by competitors or suppliers, new product introductions, production volume, customization and reconfiguration of systems, international and domestic sales mix, system and software product mix, and parts and services margins. Our gross profit was $135.0 million, $148.3 million and $134.6 million for the years ended December 31, 2019, 2018 and 2017, respectively.  Our gross profit represented 44.1%, 54.2% and 52.8% for the years ended December 31, 2019, 2018 and 2017, respectively.  The decrease in gross profit as a percentage of revenue from 2018 to 2019 was primarily due to charges to cost of goods sold including a $15.4 million charge for the sale of inventory written-up to fair value upon the Merger and $7.8 million in additional charges related to excess and obsolete inventory.  The increase in gross profit as a percentage of revenue from 2017 to 2018 was primarily due to a change in our systems and software product sales mix and the sale of a lithography system that had previously been partially written down.  

Operating Expenses

Our operating expenses consist of:

(1)

Research and Development. The process control defect inspection and metrology, advanced packaging lithography, and data analysis systems and software market is characterized by continuous technological development and product innovations. We believe that the rapid and ongoing development of new products and enhancements of existing products, including the transition to copper and low-k dielectrics, wafer level packaging, the continuous shrinkage in critical dimensions, and the evolution of ultra-thin gate process control is critical to our success. Accordingly, we devote a significant portion of our technical, management and financial resources to research and development programs. Research and development expenditures consist primarily of salaries and related expenses of employees engaged in research, design and development activities. They also include consulting fees, the cost of related supplies and legal costs to defend our patents. Our net income included a $2.9research and development expenses were $48.4 million, additional tax expense$40.0 million and $37.7 million in 2019, 2018 and 2017, respectively.  The year-over-year dollar increase from 2018 to 2019 was primarily due to increased compensation resulting from the remeasurementinclusion of deferred tax assets relating$7.4 million in research and development expense of legacy Nanometrics resulting from the Merger.  The year-over-year dollar increase from 2017 to the Tax Cuts2018 was primarily due to increased compensation and Jobs Act that was signed into law on December 22, 2017.development initiatives. These costs were partially offset by decreased litigation expenses.  We continue to maintain our commitment to investing in new product development and enhancement to existing products.

(2)

Sales and Marketing. Sales and marketing expenses are primarily comprised of salaries and related costs for sales and marketing personnel, as well as commissions and other non-personnel related expenses.  Our net income included a releasesales and marketing expenses were $28.3 million, $22.0 million and $20.8 million in 2019, 2018 and 2017, respectively.  The year-over-year dollar increase from 2018 to 2019 was primarily due to the inclusion of non-cash valuation allowance$6.9 million in sales and marketing expenses of $27.4 million against a significant portion of our U.S.legacy Nanometrics resulting from the Merger.  The year-over-year increase from 2017 to 2018 was primarily due to compensation costs resulting from headcount and foreign deferred tax assets.salary increases and an increase in sales commissions

(3)

General and Administrative. General and administrative expenses are primarily comprised of salaries and related costs for general administrative personnel, as well as other non-personnel related expenses. Our net loss includedgeneral and administrative expenses were $53.0 million, $33.7 million and $27.9 million in 2019, 2018 and 2017, respectively.  The year-over-year dollar increase from 2018 to 2019 was primarily due to the inclusion of $4.4 million in general and administrative expenses of legacy Nanometrics resulting from the Merger.  In addition, we incurred $14.8 million in merger expenses for bankers fees, legal, accounting, and change in control compensation expenses.  The year-over-year dollar increase from 2017 to 2018 was primarily due to compensation costs resulting from headcount and salary increases.  

Amortization of Identifiable Intangible Assets.  Amortization of identifiable intangible assets was $10.4 million, $1.5 million and $1.9 million in 2019, 2018 and 2017, respectively.  The year-over-year increase in amortization expense from 2018 to 2019 was due additional amortization recorded associated with additional purchased intangible assets recorded as a non-cash valuation allowanceresult of $21.1 million onthe Merger.  The year-over-year decreases in amortization expense from 2017 to 2018 were due to certain U.S. deferred tax assets.intangible assets becoming fully amortized during these periods.

 

 

 

Fiscal Year

 

 

 

2017

 

 

2016

 

 

2015

 

 

2014

 

 

2013

 

 

 

(in thousands)

 

Consolidated Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash, cash equivalents and marketable securities

 

$

117,029

 

 

$

129,961

 

 

$

83,085

 

 

$

83,962

 

 

$

92,862

 

Working capital

 

$

196,019

 

 

$

174,353

 

 

$

132,903

 

 

$

119,797

 

 

$

141,797

 

Total assets

 

$

309,699

 

 

$

287,830

 

 

$

235,540

 

 

$

223,236

 

 

$

262,834

 

Long-term liabilities including current portion of debt

   obligation

 

$

3,221

 

 

$

2,030

 

 

$

3,001

 

 

$

5,497

 

 

$

6,504

 

Total stockholders’ equity

 

$

262,383

 

 

$

243,774

 

 

$

187,328

 

 

$

179,537

 

 

$

207,373

 

31


Table of Contents

 


ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Patent Litigation Income. During the twelve months ended December 31, 2019 and 2018, there was no patent litigation income.  During the twelve months ended December 31, 2017, we recorded income and received cash of $13.0 million from a comprehensive settlement regarding a patent infringement litigation with Camtek.  

OverviewInterest income (expense), net.  In 2019, 2018 and 2017, net interest income was $3.7 million, $2.2 million and $1.0 million, respectively. The increase in net interest income from 2018 to 2019 was due to interest earned on our marketable securities and additional interest income on a higher marketable securities balance following the Merger with Nanometrics.  The increase in net interest income from 2017 to 2018 was due to higher interest earned on our marketable securities.  

You should readIncome taxes. The following table provides details of income tax (dollars in millions):

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Income before income taxes

 

$

(0.6

)

 

$

53.3

 

 

$

59.8

 

Provision (benefit) for income taxes

 

$

(2.5

)

 

$

8.3

 

 

$

26.9

 

Effective tax rate

 

 

419.9

%

 

 

15.5

%

 

 

45.0

%

The income tax provision differs from the federal statutory income tax rate of 21% for 2019 primarily due to a benefit related to the Foreign Derived Intangible Income Deduction (“FDII”) of $2.3 million and tax benefits for research and development credits of $2.1 million, partially offset by non-deductible transaction costs of $1.1 million and Section 162(m) limitation on the deductibility of executive compensation of $0.8 million.

The income tax provision differs from the federal statutory income tax rate of 21% for 2018 primarily due to Foreign Derived Intangible Income Deduction (“FDII”) from Public law No. 115-97, known as the Tax Cuts and Jobs Act (the “Tax Act”) of $2.2 million, tax benefits for research and development credits of $2.3 million, offset by a Section 162(m) limitation on the deductibility of executive compensation of $0.5 million and additional Accounting Standards Codification (“ASC”) 740-10 tax reserves of $0.6 million.

The income tax provision differs from the federal statutory income tax rate of 21% for 2017 primarily due to new regulations resulting from the Tax Act of $9.5 million, offset by tax benefits for research and development credits of $1.6 million, section 199 manufacturing deduction of $1.6 million and excess tax benefits on vesting of restricted stock of $1.6 million.

The Tax Act, which was enacted and signed into law on December 22, 2017, reduced the U.S. federal corporate tax rate from 35% to 21%, effective January 1, 2018. Also, on December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act. SAB 118 provides a measurement period of up to one year from the enactment date to complete the accounting. Any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined. Based on the information available and current interpretation of the rules, we estimated the impact of the reduction in the corporate tax rate and remeasurement of certain deferred tax assets and liabilities. The provisional amount recorded in the fourth quarter of 2017 related to the remeasurement of our deferred tax balance resulted in additional income tax expense of $8.0 million. During the fourth quarter of 2018, we completed the accounting for such revaluation and recorded an additional $0.8 million in tax expense.  The prior year provisional impact and current year finalization of the Tax Act summarized below, which is included as a component of the provision from income taxes is further described in Note 12 in the accompanying Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K (dollars in millions).

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

Re-measurement of U.S. deferred tax assets and liabilities

 

$

 

 

$

 

Transition tax on non-U.S. subsidiaries’ earnings

 

 

 

 

 

0.1

 

Foreign tax credits applied against transition tax

 

 

 

 

 

 

Valuation allowance for unused foreign tax credits

 

 

1.0

 

 

 

0.7

 

     Total impact of the Tax Act on the provision for income taxes

 

$

1.0

 

 

$

0.8

 

Our future effective income tax rate depends on various factors, such as future impacts of the Tax Act, possible further tax legislation, the geographic composition of our pre-tax income, the amount of our pre-tax income as business activities fluctuate, non-deductible expenses incurred in connection with acquisitions and research and development credits as a percentage of aggregate pre-tax income.

32


Table of Contents

Liquidity and Capital Resources

At December 31, 2019, we had $320.2 million of cash, cash equivalents and marketable securities and $555.9 million in working capital.  At December 31, 2018, our cash, cash equivalents and marketable securities totaled $175.1 million, while working capital amounted to $305.9 million.

Net cash and cash equivalents provided by operating activities for the years ended December 31, 2019, 2018 and 2017 totaled $18.1 million, $35.1 million and $64.2 million, respectively.  During the year ended December 31, 2019, cash provided by operating activities was primarily due to net income, adjusted to exclude the effect of non-cash charges, of $53.5 million, a decrease in income taxes of $7.6 million, which were partially offset by a decrease in accounts payable of $12.1 million, a decrease in accrued and other liabilities of $6.7 million, an increase in inventories of $9.3 million, an increase in accounts receivable of $9.7 million and an increase in prepaid expenses and other assets of $5.1 million.

During the year ended December 31, 2018, cash provided by operating activities was primarily due to net income, adjusted to exclude the effect of non-cash charges, of $64.3 million, an increase in accounts payable of $3.5 million, a decrease in income taxes of $1.1 million, a decrease in account receivable of $0.7 million and an increase in accrued and other liabilities of $0.2 million, which were partially offset by an increase in inventories of $31.5 million, and an increase in prepaid expenses and other assets of $3.1 million. The increase in inventories of $31.5 million was primarily due to increased sales projections of our latest products and new product initiatives.

During the year ended December 31, 2017, cash provided by operating activities was primarily due to net income, adjusted to exclude the effect of non-cash charges, of $65.9 million, an increase in accrued and other liabilities of $5.2 million, an increase in accounts payable of $3.2 million and a decrease in account receivable of $0.4 million, which were partially offset by an increase in income taxes of $4.7 million, an increase in inventory of $4.2 million, and an increase in prepaid expenses and other assets of $1.7 million.

Net cash and cash equivalents provided by investing activities for the years ended December 31, 2019 and 2018 was $4.1 million and $33.8 million, respectively.  Net cash and cash equivalents used in investing activities for the year ended December 31, 2017 totaled $32.5 million.  During the year ended December 31, 2019, net cash provided by investing activities included proceeds from maturities and sales of marketable securities of $94.5 million and cash acquired in the Merger of $43.9 million, which were partially offset by purchases of marketable securities of $127.5 million and purchases of property, plant and equipment of $6.8 million.  During the year ended December 31, 2018, net cash provided by investing activities included proceeds from sales of marketable securities of $186.3 million, which was partially offset by purchases of marketable securities of $140.0 million, purchases of property, plant and equipment of $7.5 million and cash advanced on a convertible note receivable of $5.0 million.  During the year ended December 31, 2017, net cash used in investing activities included purchases of marketable securities of $164.7 million, purchases of property, plant and equipment of $10.2 million, and purchase of intangible assets of $1.0 million, which were partially offset by proceeds from sales of marketable securities of $143.3 million.

Net cash used in financing activities was $4.2 million, $23.9 million and $2.6 million in 2019, 2018 and 2017, respectively.  During the year ended December 31, 2019, financing activities used cash to pay taxes related to shares withheld for share based compensation plans of $2.5 million, pay contingent consideration for acquired business of $1.8 million, and purchase shares of our common stock under share repurchase authorizations of $0.7 million. These uses of cash were partially offset by proceeds from sales of shares through employee stock plans of $0.8 million.  During the year ended December 31, 2018, financing activities used cash to purchase shares of our common stock under share repurchase authorizations of $21.1 million, pay taxes related to shares withheld for share based compensation plans of $1.9 million and pay contingent consideration for acquired business of $1.5 million. These uses of cash were partially offset by proceeds from sales of shares through employee stock plans of $0.6 million.  During the year ended December 31, 2017, financing activities included the redemption of stock warrants of $1.0 million, tax payments related to shares withheld for share-based compensation plans of $1.4 million and payment of contingent consideration for acquired businesses of $0.8 million, which were partially offset by proceeds from sales of shares through employee stock plans of $0.6 million.  

From time to time, we evaluate whether to acquire new or complementary businesses, products and/or technologies. We may fund all of or a portion of the price of these investments or acquisitions in cash, stock, or a combination of cash and stock.

On May 31, 2018, we entered into a convertible loan agreement with Simax Precision Technologies Limited (“the borrower”), which allowed them to borrow up to $15.0 million in multiple promissory notes with an interest rate of 4.25% per annum payable on a semi-annual basis.  We expected to be a supplier of lithography modules to Simax, which is used in the manufacture, sale and service of lithography systems. At December 31, 2019, we had $5.0 million in outstanding convertible notes receivable with the borrower.  

33


Table of Contents

During the fourth quarter of 2019, we began negotiations with the borrower to end our relationship as it pertains to this agreement. We determined that it is unlikely that a portion of the convertible note receivable will be collectable, and a reserve in the amount of $2.0 million was recorded during the period ended December 31, 2019.  In addition, we ceased recognizing interest income on these convertible notes receivable as of September 30, 2019. See Note 8 in the accompanying Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K for further information.

Following the Merger, we assumed the share repurchase authorization approved on March 14, 2019, by the former Nanometrics Board of Directors.  This share repurchase authorization allows us to purchase up to $80.0 million worth of shares of our common stock. Under the terms of this share repurchase authorization, shares may be repurchased through open market or privately negotiated transactions. No shares have been repurchased under this repurchase authorization.

For further information regarding our share repurchases, see Note 18 in the accompanying Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K.

We have a credit agreement with a bank that provides for a line of credit that is secured by the marketable securities we have with the bank.  We are permitted to borrow up to 70% of the value of eligible securities held at the time the line of credit is accessed.  As of December 31, 2019, the available line of credit was approximately $91.3 million with an available interest rate of 3.3%.  The credit agreement is available to us until such time that either party terminates the arrangement at its discretion.   To date, we have not utilized the line of credit.

Our future capital requirements will depend on many factors, including the timing and amount of our revenue and our investment decisions, which will affect our ability to generate additional cash. We expect that our existing cash, cash equivalents, marketable securities and availability under our line of credit will be sufficient to meet our anticipated cash requirements for working capital, capital expenditures and other cash needs for the next 12 months following the filing of this Form 10-K. Thereafter, if cash generated from operations and financing activities is insufficient to satisfy our working capital requirements, we may seek additional funding through bank borrowings, sales of securities or other means. There can be no assurance that we will be able to raise any such capital on terms acceptable to us or at all.

Contractual Obligations

The following table summarizes our significant contractual obligations at December 31, 2019, and the effect such obligations are expected to have on our liquidity and cash flows in future periods. This table excludes the liability for unrecognized tax benefits that totaled approximately $10.6 million at December 31, 2019. We are currently unable to provide a reasonably reliable estimate of the amount or periods when cash settlement of this liability may occur (dollars in thousands).

 

 

Payments due by period

 

 

 

Total

 

 

Less than 1

year

 

 

1-3

years

 

 

3-5

years

 

 

More than

5 years

 

Operating lease obligations

 

$

29,152

 

 

$

5,901

 

 

$

12,116

 

 

$

5,856

 

 

$

5,279

 

Open and committed purchase orders

 

 

97,877

 

 

 

93,705

 

 

 

4,172

 

 

 

 

 

 

 

Total

 

$

127,029

 

 

$

99,606

 

 

$

16,288

 

 

$

5,856

 

 

$

5,279

 

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a material effect on our financial condition, results of operations or liquidity and capital resources.

Critical Accounting Policies

Management’s discussion and analysis of our financial condition and results of operations together with “Selectedare based upon our Consolidated Financial Data” and our consolidated financial statements and related notes appearing elsewhereStatements included in this Annual Report on Form 10-K. This discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. The actual results may differ materially from those anticipated10-K, which have been prepared in these forward-looking statements as a result of certain factors, including, but not limited to, those presented under “Risk Factors” in Item 1A and elsewhere in this Annual Report on Form 10-K. Please see “Cautionary Information Regarding Forward-Looking Statements” at the beginning of this Form 10-K for additional information you should consider regarding forward-looking statements.

We are an innovator in the field of metrology systems, inspection systems and advanced analytics for semiconductor manufacturing and other industries. Our systems and solutions are designed to precisely monitor optical critical dimensions, film thickness, and other parameters that are necessary to control the manufacturing process, identify defects, and detect manufacturing equipment anomalies that can affect production yields and device performance.

Principal factors that impact our revenue growth include capital expenditures by manufacturers of semiconductors to increase capacity and to enable their development of new technologies, and our ability to improve market share. The increasing complexity of the manufacturing processes for semiconductors is an important factor in the demand for our innovative metrology systems. Our strategy is to continue to innovate organically as well as to evaluate strategic acquisitions to address business challenges and opportunities.

Our revenues are primarily derived from product sales but are also derived from customer service and system upgrades for the installed base of our products. In 2017, we derived 83% of our total net revenues from product sales and 17% of our total net revenues from services.

Important Themes and Significant Trends

The semiconductor equipment industry is characterized by new manufacturing processes (node) coming to market every two to three years. At every new node, in the semiconductor industry our customers drive the need for metrology as a major component of device manufacturing. These trends include:

Proliferation of Optical Critical Dimension Metrology across Fabrication Processes. Device dimensions must be carefully controlled during each step of processing. These patterned structures are measured at many subsequent production steps including Chemical Mechanical Polishing, Etch, and Thin Film processing, all driving broader OCD adoption. Our proprietary OCD systems can provide the critical process control of these circuit dimensions that is necessary for successful manufacturing of these state-of-the-art devices. Nanometrics OCD technology is broadly adopted across 3D-NAND, DRAM, and logic semiconductor manufacturing processes.

Proliferation of 3D Transistor Architectures. Our end customers continue to improve device density and performance by scaling front-end-of-line transistor architectures. Many of these designs, including FinFET transistors, have buried features and high aspect ratio stacked features that enable improved performance and density. The advanced designs require additional process control to manage the complex shapes and materials properties, driving additional applications of our systems.

Proliferation of High-Density 3D-NAND. Our end customers have migrated to multi (many) layered high aspect ratio 3D-NAND devices. Many stacks of NAND cells are formed in parallel. This 3D-NAND architecture enables cost effective density scaling, removing the burden of density from lithography to deposition and etch processes. These devices require additional process control of deposition stacks, planarization processes, and critical high aspect ratio etch processes. Nanometrics thin films and OCD technologies are adopted across the 3D-NAND process including the periphery CMOS processing, NAND cell formation, and Interconnect of the devices.

Adoption of New Types of Thin Film Materials. The need for ever increasing device circuit speed coupledaccordance with lower power consumption has pushed semiconductor device manufacturers to new materials and processing methods with single atom/sub nanometer control over these processes.

Need for Improved Process Control to Drive Process Efficiencies. Competitive forces influencing semiconductor device manufacturers, such as price-cutting, shorter product life cycles and time to market, place pressure on manufacturers to rapidly achieve production efficiency. Device manufacturers are using our integrated and automated systems, as well as advanced metrology algorithms and analytics throughout the fabrication process to ensure that manufacturing processes scale rapidly, are accurate and can be repeated on a consistent basis.


Critical Accounting Policies

The preparation of our financial statements conforms to accounting principles generally accepted in the United StatesStates. We review the accounting policies we use in reporting our financial results on a regular basis. The preparation of America, whichthese financial statements requires managementus to make estimates and judgments in applying our accounting policies that have an important impact on ouraffect the reported amounts of assets, liabilities, revenue and expenses and related disclosures at the datedisclosure of our financial statements.contingent assets and liabilities. On an ongoing basis, management evaluates itswe evaluate our estimates, including those related to bad debts, inventory valuations,revenue recognition, accounts receivable, inventories, business acquisitions, intangible assets, share-based payments, income taxes and warranty obligations, impairment and income taxes. Management bases itsobligations. We base our estimates and judgments on historical experience and on various other factorsassumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying valuesvalue of assets and liabilities that are not readily apparent from other sources. Actual resultsResults may differ from management’s estimates.these estimates due to actual outcomes being different from those on which we based our assumptions. These estimates and judgments are regularly

34


Table of Contents

reviewed by management on an ongoing basis at the end of each quarter prior to the public release of our financial results. We believe that the application of the following critical accounting policies requiresaffect our more significant judgments and estimates used in the preparation of our Consolidated Financial Statements.

Revenue Recognition. Effective January 1, 2018, we adopted the requirements of Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606).”

Revenue is recognized when control of the promised goods or services are transferred to our customers in an amount that reflects the consideration we expect to be entitled to receive in exchange for those goods or services. We account for a contract when it has approval and commitment from both parties, the rights of the parties and payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

We account for shipping and handling activities as the fulfillment of a promise to transfer goods to the customer and therefore record these activities under the caption “Cost of revenue.” Sales tax and any other taxes collected concurrent with revenue producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense.

Contracts with customers may include multiple performance obligations. For such arrangements, we allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the partprices charged to customers or the expected cost-plus margin.

Revenue from systems is recognized when we transfer control of management. Forthe product to our customer. To indicate transfer of control, we must have a summarypresent right to payment, legal title must have passed to the customer and the customer must have the significant risks and rewards of allownership. We generally transfer control for system sales when the customer or the customer’s agent picks up the system at our facility. Payment for the majority of our accounting policies, including those discussed below, see Note 1 to our consolidated financial statements.

Revenue Recognition - We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred or servicessystems have been rendered, the seller's price is fixed or determinable, and collectability is reasonably assured. We derive revenue from the sale of process control metrology and inspection systems and related upgrades (“product revenue”) as well as spare part sales, billable services and service contracts (together “service revenue”). Upgrades are system software and hardware performance upgrades that extend the features and functionality of a product. Beginning in the first quarter of 2016, we include upgrades in product revenue, which consists of sales of complete, advance process control metrology and inspection systems (the “system(s)”). This change was due to the types of upgrades currently being sold, which are primarily system software and hardware performance upgrades to extend the features and functionality of a product. Previously, upgrades consisted of a group of parts and/or software that change the existing configuration80-90% of the products.

Nanometrics’invoice amount due within 30 days and the remaining amount due upon completion of installation, recalibration and qualification by the customer. We provide an assurance warranty on our systems consistfor a period of hardwaretwelve to fourteen months against defects in material and software components that function together to deliverworkmanship. We provide for the essential functionalityestimated cost of the system. Arrangements for sales of systems often include defined customer-specified acceptance criteria.

For repeat product sales to existing customers, revenue recognition occurswarranties at the time titlerevenue is recognized.

Depending on the terms of the systems arrangement, we may also defer the recognition of a portion of the consideration expected to be received because we have to satisfy a future obligation (e.g., installation, training and risk of loss transferextended warranties). We use an observable price to determine the standalone selling price for separate performance obligations or a cost-plus margin approach when one is not available.

Revenue from software licenses is recognized upfront at the point in time when the software is made available to the customer. Software licenses provide the customer with limited rights to use the software. Revenue from licensing support and maintenance is recognized as the support and maintenance are provided, which usuallyis over the contract period. Payment for software licensing, support and maintenance is generally due in 30 days.

Revenue from parts is recognized when we transfer control of the product, which typically occurs upon shipmentwhen we ship the product from our manufacturing location, if it can be reliably demonstrated thatfacilities to the product has successfully met the defined customer specified acceptance criteria and all other recognition criteria have been met. For initial sales where we have not previously met the defined customer specified acceptance criteria, we recognize product revenues upon the earliercustomer. Payment for parts is generally due in 30 days.

Revenue from services primarily consists of receipt of written customer acceptance or expiration of the contractual acceptance period. In Japan, where contractual terms with the customer specify risk of loss and title transfers upon customer acceptance, we recognize revenue upon receipt of written customer acceptance, provided that all other recognition criteria have been met.

We warrantservice contracts, which provide additional maintenance coverage beyond our assurance warranty on our products, against defects in manufacturing. Upon recognition of product revenue, we record a liability for anticipated warranty costs. On occasion, customers request a warranty period longer than our standard warranty. In those instances, where extended warranty services are separately quoted to the customer, we deferservice labor, consulting and recognize the associated revenue astraining. Revenue from service revenuecontracts is recognized ratably over the term of the service contract. Revenue from service labor, consulting and training is recognized as services are performed. Payment for services is generally due in 30 days.

We includerecord contract liabilities when the portioncustomer has been billed in advance of service contractscompleting our performance obligations. These amounts are recorded as deferred revenue in the Consolidated Balance Sheets.

Business combinations. We account for business combinations under the acquisition method of accounting, which requires us to recognize separately from goodwill the assets acquired, and extended warranty services agreements that are uncompletedthe liabilities assumed at their acquisition date fair values. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the end of any reportingacquisition date as well as contingent consideration, where applicable, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, in deferred revenue.

We also sell software that is considered to be an upgrade to a customer's existing systems. These standalone software sales are not essential to the tangible product's functionality and are accounted for under software revenue recognition rules which require vendor specific objective evidence ("VSOE") of fair value to allocate revenue in a multiple element arrangement. We recognize revenue from standalone software sales when the software is delivered to the customer, provided that all other recognition criteria have been met.

The majority of other upgrades are sold based on published specifications. For simple upgrades that do not require major configuration, revenue is recognized at the time title and risk of loss transfer to the customer, which is usually upon shipment. For complex and extensive upgrades, specific acceptance or prior acceptance for a similar upgrade is required in order to recognize revenue.

We recognize revenue related to spare parts upon shipment. We recognize revenue related to billable services when the services are completed. Service contracts may be purchased by the customer during or after the warranty period and we recognize revenue ratably over the service contract period.


Frequently, we deliver products and various services in a single transaction. Our deliverables consist of tools, installation, upgrades, billable services, spare parts, and service contracts. Our typical multi-element arrangements include a sale of one or multiple tools that include installation and standard warranty. Other arrangements may consist of a sale of tools bundled with service elements or delivery of different types of services. Our tools, upgrades, and spare parts are generally delivered to customers within a period of up to six months from order date. Installation is usually performed soon after delivery of the tool. We defer the portion of revenue associated with installation based on relative selling price and we recognize that revenue upon completion of the installation and receipt of final acceptance. Billable services are billed on a time and materials basis and performed as requested by customers. Under service contract arrangements, services are provided as needed over the fixed arrangement term, and such terms can be up to twelve months. We do not generally grant customers a general right of return or refund and may impose a penalty on orders cancelled priorone year from the acquisition date, we record adjustments to the scheduled shipment date.

We evaluateassets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in our revenue arrangementsconsolidated statements of operations. Accounting for business combinations requires our management to identify deliverablesmake significant estimates and to determine whether these deliverables are separable into multiple units of accounting. We allocateassumptions, especially at the arrangementacquisition date including our estimates for intangible assets, contractual obligations assumed, restructuring liabilities, pre-acquisition contingencies, and contingent consideration, amongwhere applicable. Although we believe the deliverables based on relative selling price. Weassumptions and estimates we have established VSOE for some of our products and services when a substantial majority of selling prices falls within a narrow range when sold separately. For deliverables with no established VSOE, we use best estimate of selling price to determine standalone selling price for such deliverable. We do not use third party evidence to determine standalone selling price since this information is not widely availablemade in the market aspast have been reasonable and appropriate, they are based, in part, on historical experience and information obtained from the management of the acquired companies and are inherently uncertain. Estimates in valuing certain acquired

35


Table of Contents

intangible assets under the income approach include growth in future expected cash flows from product sales, acquired technologies, technology obsolescence rates, estimated cash flows from the projects when completed and discount rates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results.

Excess and Obsolete Inventory. We maintain reserves for our products contain a significant elementexcess and obsolete inventory equal to the difference between the cost of proprietary technologyinventory and the solutions offered differ substantially from our competitors. We have established a process for developing best estimated selling price ("BESP"), which incorporates historical selling prices, the effect of market conditions, gross margin objectives, pricing practices, as well as entity-specific factors. We monitor and evaluate BESP on a regular basis to ensure that changes in circumstances are accounted for in a timely manner.

When certain elements in multiple-element arrangements are not delivered or accepted at the end of a reporting period, the relative selling prices of undelivered elements are deferred until these elements are delivered and/or accepted. If deliverables cannot be accounted for as separate units of accounting, the entire arrangement is accounted for as a single unit of accounting and we defer revenue until all elements are delivered and all revenue recognition requirements are met.

We plan to adopt the new revenue standard, ASC Topic 606, Revenue from Contracts with Customers, in the first quarter of fiscal 2018 by using the modified retrospective method of transition. See “Note 2. Recent Accounting Pronouncements” in Part II, Item 8 of our consolidated financial statements for further discussion on the impact of adopting the new standard.

Allowance for Doubtful Accounts – We maintain allowances for estimated losses resulting from the inability of our customers to make their required payments. We establish credit limits through a process of reviewing the financial history and stability of our customers. Where appropriate and available, we obtain credit rating reports and financial statements of customers when determining or modifying their credit limits. We regularly evaluate the collectability of our trade receivable balances based on a combination of factors such as the length of time the receivables are past due, customary payment practices in the respective geographies and our historical collection experience with customers. We believe that our allowance for doubtful accounts adequately reflects our risk associated with our receivables. If the financial condition of a customer were to deteriorate, resulting in their inability to make payments, we would assess the necessity of recording additional allowances. This would result in additional general and administrative expenses being recorded for the period in which such determination was made

Inventories – Inventories are stated at the lower of cost, which approximates actual cost on a first-in, first-out basis, or net realizable value. We have established inventory reserves when conditions exist that suggest that our inventory may be in excess of anticipated demand or is obsoletevalue based upon our assumptions about future product lifecycles, product demand for our products and market conditions. Once a reserve has been established, it is maintained until the part to which it relates is sold or is otherwise disposed of. Therefore, a sale of reserved inventory has a higher gross profit margin. We regularly evaluate our ability to realize the value of our inventory based on a combination of factors including the following: historical usage rates, forecasted sales of usage, product end-of-life dates, estimated current and future market values and new product introductions. Inventory includes evaluation tools placed at customer sites. For demonstration inventory, we also consider the age of the inventory and potential cost to refurbish the inventory prior to sale. We amortize demonstration inventory over its useful life and the amortization expense is included in total inventory write down on our statements of cash flows. When recorded, our reserves are intended to reduce the carrying value of our inventory to its net realizable value. If actual product lifecycles, product demand for our products deteriorates, orand market conditions are less favorable than those that we project,originally projected by management, additional reservesinventory write-downs may be required, which would adversely affect gross marginrequired.

Long-Lived Assets and net income.


Product Warranties – We sell the majority of our products with a standard twelve-month repair or replacement warranty from the date of acceptance or shipment date. We provide an accrual for estimated future warranty costs based upon the historical relationship of warranty costs to the cost of products sold. The estimated future warranty obligations related to product sales are reported in the period in which the related revenue is recognized. The estimated future warranty obligations are affected by the warranty periods, sales volumes, product failure rates, material usage and labor and replacement costs incurred in correcting a product failure. If actual product failure rates, material usage, labor or replacement costs differ from our estimates, revisions to the estimated warranty obligations would be required. For new product introductions where limited or no historical information exists, we may use warranty information from other previous product introductions to guide us in estimating our warranty accrual. The warranty accrual represents the best estimate of the amount necessary to settle future and existing claims on products sold as of the balance sheet date.Acquired Intangible Assets. We periodically assess the adequacy of our recorded warranty reserve and adjust the amounts in accordance withreview long-lived assets, other than goodwill, for impairment whenever changes in these factors.

Goodwill and Intangible Assets - Intangible assets with finite lives are amortized over their useful lives and are subject to an impairment assessment, as well as an evaluation of the appropriateness of their estimated useful lives, whenever events or changes in circumstances indicate that the carrying amount(s)amount of an asset may not be recoverable. GoodwillAssumptions and indefinite livedestimates used in the determination of impairment losses, such as future cash flows and disposition costs, may affect the carrying value of long-lived assets and the impairment of such long-lived assets, if any, could have a material effect on our consolidated financial statements.  During the year ended December 31, 2019, we recognized a $0.5 million impairment loss on long-lived assets.  No such indicators were noted in 2018 or 2017.

Accounting for Income Taxes. As part of the process of preparing our consolidated financial statements, we are required to estimate our actual current tax exposure together with our temporary differences resulting from differing treatment of items for tax and accounting purposes. These temporary differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheet. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not amortized but tested annuallylikely, we must establish a valuation allowance. Management judgment is required in determining our provision for impairment.income taxes and any valuation allowance recorded against our deferred tax assets. The goodwill impairment assessment involves three tests, Step 0, Step 1need for a valuation allowance is based on our estimates of taxable income by jurisdiction in which we operate and Step 2.the period over which our deferred taxes will be recoverable. In the event that actual results differ from these estimates or we adjust these estimates in future periods, we may need to adjust the valuation allowance, which could materially impact our financial position and results of operations. At December 31, 2019 and 2018, we had recorded valuation allowances of $14.2 million and $3.2 million on certain of our deferred tax assets to reflect the deferred tax assets at the net amount that is more likely than not to be realized.  We evaluated the realizability of the deferred tax assets based on positive earnings as well as the projected earnings in future years and believe it is more likely than not that the substantial majority of our deferred tax asset will be realized in the future years.  We will continue to monitor the realizability of the deferred tax assets and evaluate the valuation allowance.

We recognize liabilities for uncertain tax positions based on a two-step process. The Step 0 test involves performing an initial qualitative assessmentfirst step requires us to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that the asset is impaired and thus whether it is necessaryposition will be sustained on audit, including resolution of any related appeals or litigation processes. The second step requires us to proceed to Step 1 and calculatemeasure the fair valuetax benefit of the reporting unit.tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50% likely of being realized when effectively settled. This measurement step is inherently difficult and requires subjective estimations of such amounts to determine the probability of various possible outcomes. We may proceed directlyreevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues, and new audit activity. Such a change in recognition or measurement could result in the recognition of a tax benefit or an additional charge to the Step 1 test without performingtax provision in the Step 0 test. The Step 1 test involves measuringperiod.

Although we believe the recoverability of goodwill at the reporting unit level by comparing the reporting unit's carrying amount, including goodwill, to the fair value of the reporting unit.

We perform a Step 0 assessment of the goodwill during the fourth quarter of each fiscal year, or whenever events or circumstances occur which indicate that an impairment may have occurred. As part of this assessment, we consider the trading valuemeasurement of our stock, the industry trends, and our sales forecast and products plans to determine if itliabilities for uncertain tax positions is more likely than notreasonable, no assurance can be given that the fair valuefinal outcome of these matters will not be different than what is higher thanreflected in the carrying valueshistorical income tax provisions and accruals. If additional taxes are assessed as a result of an audit or litigation, it could have a material effect on our reporting unit. If,income tax provision and net income in the period or periods for which that determination is made.

Impact of Recent Accounting Pronouncements

Recently Adopted

Effective January 1, 2019, we adopted ASU No. 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.”  This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees.  An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost.  The ASU is effective for the fiscal years beginning after assessingDecember 15, 2018, including interim periods within that fiscal year.  The adoption of ASU No. 2018-07 did not have a material impact on our consolidated financial position, results of operations, and cash flows.  

36


Table of Contents

Effective January 1, 2019, we adopted ASU No. 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.”  The new guidance allows companies to reclassify stranded tax effects resulting from the qualitative factors, we determine that it is not likely that the fair valueTax Act from accumulated other comprehensive income to retained earnings.  The guidance also requires certain new disclosures regardless of a reporting unitcompany’s election.  The standard is less than its carrying value, then performingeffective for annual periods beginning after December 15, 2018 and for interim periods within those annual periods, with earlier adoption permitted.  The adoption of ASU No. 2018-02 did not have a material impact on our consolidated financial position, results of operations, and cash flows.

In January 2017, the two-step impairment test is unnecessary. However, if we conclude otherwise, then we are required to performFinancial Accounting Standards Board (“FASB”) issued ASU No. 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.”  This ASU eliminates Step 1 of2 from the two-step goodwill impairment test.   The Step 1 test requires a comparison of the fair value of our reporting unit to its net book value. If the fair value of the reporting unit is greater than its net book value, then no impairment is deemed to have occurred. If the fair value is less, then the Step 2 must be performed to determine the amount,Accordingly, if any, of actual impairment.

The process of evaluating the potential impairment of goodwill is highly subjective and requires significant judgment. In estimating the fair value of goodwill at the reporting unit level, we make estimates and judgments about future revenues and cash flows for the reporting unit. To determine the fair value, our review process includes the income method and is based on a discounted future cash flow approach that uses estimates including the following for the reporting unit: estimated revenue, market segment growth rates and market share assumptions; estimated costs; and appropriate discount rates based on the particular reporting unit's weighted average cost of capital. Our estimates of market segment growth, our market segment share and costs are based on historical data, various internal estimates and certain external sources, and are based on assumptions that are consistent with the plans and estimates we are using to manage the underlying businesses. Our business consists of both established and emerging technologies and our forecasts for emerging technologies are based upon internal estimates and external sources rather than historical information. We also consider our market capitalization on the dates of our impairment tests in determining the fair value of the respective businesses. As part of this assessment, we consider the trading value of our stock and our implied value, as compared to our net assets, as well as the valuation of our acquired businesses. If the carrying amount of thea reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to the excess, limited to the total amount of goodwill allocated to the reporting unit.  The ASU is effective for the fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years, with earlier adoption permitted.  The adoption of ASU No. 2017-04 in 2019 did not have a material impact on our consolidated financial position, results of operations, and cash flows.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” ASU No. 2016-02 requires that lessees recognize virtually all of their leases on the balance sheet, by recording a right-of-use asset and lease liability. On January 1, 2019, we adopted ASU No. 2016-02 using the modified retrospective method which applies the provisions of the standard at the effective date without adjusting the comparative periods presented.  We also elected the package of practical expedients.

There was not a cumulative-effect adjustment to our beginning retained earnings as determineda result of adopting ASU No. 2016-02. We recognized additional operating lease assets and obligations of $14.4 million as of January 1, 2019. As a result of the Merger, operating lease assets and obligations of $9.7 million were assumed from the former Nanometrics. We elected to not reassess prior conclusions related to the identification, classification and accounting for initial direct costs for leases that commenced prior to January 1, 2019. For additional disclosure and detail, see Note 7 of the Notes to the Consolidated Financial Statements included in this Annual Report on Form 10-K.

Recently Issued

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This standard simplifies the accounting for income taxes by these assessments, goodwill is considered impaired,eliminating certain exceptions to the guidance in Topic 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the Step 2 testrecognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and allocating consolidated income taxes to separate financial statements of entities not subject to income tax. ASU No. 2019-12 is performedeffective for fiscal years beginning after December 15, 2020, with early adoption permitted. Upon adoption, we must apply certain aspects of this standard retrospectively for all periods presented while other aspects are applied on a modified retrospective basis through a cumulative-effect adjustment to measureretained earnings as of the amountbeginning of impairment loss. Asthe fiscal year of adoption. We are currently evaluating the impact of this new standard on our consolidated financial position, results of operations, and cash flows.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.”  This ASU is part of the Step 2 testFASB’s larger disclosure framework project intended to determineimprove the amounteffectiveness of goodwillfinancial statement footnote disclosure.  ASU No. 2018-13 modifies required fair value disclosures related primarily to level 3 investments.  This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods.  The adoption of ASU No. 2018-13 is not expected to have a material effect on our consolidated financial position, results of operations, and cash flows.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting.”  This ASU amends the scope of modification accounting for share-based payment arrangements and provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC 718.  The ASU is effective for the fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years.  The adoption of ASU No. 2017-09 is not expected to have a material effect on our consolidated financial position, results of operations, and cash flows, if any.

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which represents a new credit loss standard that will change the impairment model for most financial assets and certain other financial instruments. Specifically, this guidance will require entities to utilize a new “expected loss” model as it relates to trade receivables, notes receivable and other commitments to extend credit held by a reporting entity. In addition, entities will be required to recognize an allowance for estimated credit losses on

37


Table of Contents

available-for-sale debt securities, regardless of the length of time that a security has been in an unrealized loss position. This guidance will be effective for annual reporting periods beginning after December 15, 2019, including interim periods within those annual reporting periods, with early adoption permitted. We expect that the adoption of this guidance will not have a material impact on our consolidated financial position, results of operations, and cash flows.

Recently issued accounting guidance not discussed above is not applicable or did not have, or is not expected to have, a material impact to the Company.

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk.

Interest Rate and Credit Market Risk

We are exposed to changes in interest rates and market liquidity including our investments in certain available-for-sale securities. Our available-for-sale securities consist of fixed and variable rate income investments, such as municipal notes, municipal bonds and corporate bonds. We continually monitor our exposure to changes in interest rates, market liquidity and credit ratings of issuers for our available-for-sale securities. It is possible that we are at risk if interest rates, market liquidity or credit ratings of issuers change in an unfavorable direction. The magnitude of any we allocategain or loss will be a function of the difference between the fixed or variable rate of the financial instrument and the market rate, and our financial condition and results of operations could be materially affected. Based on a sensitivity analysis performed on our financial investments held as of December 31, 2019, an immediate adverse change of 10% in interest rates (e.g. 3.00% to 3.30%) would result in a decrease of $0.9 million in the fair value of the reporting unit to all of its assetsour available-for-sale debt securities and liabilities as if the reporting unit had been acquired inwould not have a business combination and the fair value of the reporting unit was the price paid to acquire the reporting unit. The excess of the fair value of the reporting unit over the amount assigned to its assets and liabilities is the implied fair value of goodwill. When impairment is deemed to have occurred, we will recognize an impairment charge to reduce the carrying amount of our goodwill to its implied fair value.

Income Tax Assets and Liabilities - We account for income taxes such that deferred tax assets and liabilities are recognized using enacted tax rates for the effect of temporary differences between the book and tax accounting for assets and liabilities. Also, deferred tax assets are reduced by a valuation allowance to the extent we cannot conclude that it is more likely than not that a portion of the deferred tax asset will be realized in the future. We evaluate the deferred tax assetsmaterial impact on a continuous basis throughout the year to determine whether or not a valuation allowance is appropriate. Factors used in this determination include future expected income and the underlying asset or liability which generated the temporary tax difference. Our income tax provision is primarily impacted by federal statutory rates, state and foreign income taxes and changes in our valuation allowance.


Recent Accounting Pronouncements

See Note 2 of our consolidated financial statements for a description of recent accounting pronouncements, including the respective dates of adoption and effects on ourposition, results of operations and financial condition.

Upgrade Revenue and Related Cost

Beginning the first quarter of 2016, we now include revenues associated with upgrade sales under Products Revenues, and the related costs in Cost of Products Revenue. This change was due to the types of upgrades currently being sold, which are primarily system software and hardware performance upgrades to extend the features and functionality of a product. Previously, upgrades consisted of a group of parts and/or software that change the existing configuration of a product. For the twelve months ended December 30, 2017, and December 31, 2016, we included $12.1 million and $11.0 million, respectively of upgrade sales and $2.7 million and $2.4 million, respectively, of costs in Products Revenues and Cost of Products Revenues, respectively. For the twelve months ended December 26, 2015, we included $7.9 million related to upgrade sales, and $3.0 million of costs, in Service Revenues and Costs of Service Revenues, respectively. In our discussion below comparing revenues and gross margin in 2016 to 2015, we compare as if upgrade sales and related costs have been included in Product Revenue and Cost of Revenues in 2015 to give a more meaningful comparison

Results of Operations

Total net revenues

Our net revenues comprised the following (in thousands, except percentages):

 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2017

 

 

2016

 

 

Change

 

Automated systems

 

$

151,401

 

 

$

127,378

 

 

$

24,023

 

 

 

18.9

%

Integrated systems

 

 

42,183

 

 

 

43,846

 

 

 

(1,663

)

 

 

(3.8

)%

Materials characterization systems

 

 

21,293

 

 

 

13,842

 

 

 

7,451

 

 

 

53.8

%

Total product revenue

 

 

214,877

 

 

 

185,066

 

 

 

29,811

 

 

 

16.1

%

Service

 

 

43,744

 

 

 

36,063

 

 

 

7,681

 

 

 

21.3

%

Total net revenues

 

$

258,621

 

 

$

221,129

 

 

$

37,492

 

 

 

17.0

%

 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2016

 

 

2015

 

 

Change

 

Automated systems

 

$

127,378

 

 

$

102,386

 

 

$

24,992

 

 

 

24.4

%

Integrated systems

 

 

43,846

 

 

 

31,579

 

 

 

12,267

 

 

 

38.8

%

Materials characterization systems

 

 

13,842

 

 

 

12,980

 

 

 

862

 

 

 

6.6

%

Total product revenue

 

 

185,066

 

 

 

146,945

 

 

 

38,121

 

 

 

25.9

%

Service

 

 

36,063

 

 

 

40,422

 

 

 

(4,359

)

 

 

(10.8

)%

Total net revenues

 

$

221,129

 

 

$

187,367

 

 

$

33,762

 

 

 

18.0

%

In 2017, total net revenues increased by $37.5 million from 2016. Customer spending trends for 3D-NAND, DRAM and Foundry primarily contributed to our year over year revenue growth. In 2017, the increase in product revenues of approximately $29.8 million was primarily attributable to increased sales of our Automated systems of $24.0 million, primarily comprised of our newest flagship system, the Atlas III. In 2017, we recognized revenues on Atlas III systems into high-volume manufacturing at multiple leading company fabs and regions, across every key device type in the industry. Materials Characterization accounted for $7.5 million of the increase and was partially offset by a slight decrease of $1.7 million in Integrated Systems sales. Service revenue increased by $7.7 million in 2017 principally due to an increase in sales of spare parts and service contracts as a result of our increasing installed base.

In 2016, total net revenues increased by $33.8 million from 2015. During 2016, we included upgrade sales of $11.0 million, in Product Revenues. For the twelve months ended December 26, 2015, Product Revenues do not include $7.9 million related to upgrade sales, which we included in Service Revenues. For the twelve months ended December 31, 2016, had upgrade sales been included in Product Revenue in 2015, Product Revenues would have increased by $30.2 million. The increase was primarily attributable to an industry-wide improvement in 3D NAND-related semiconductor capital spending. Approximately $17.8 million of the increase related to Automated systems sales and $11.7 million of the increase related to our sales of Integrated Systems (principally IMPULSE®), primarily with 3D-NAND-related customers. Materials Characterization also accounted for $0.7 million of the increased systems sales. Service revenue decreased by $4.4 million in 2016. For the twelve months ended December 31, 2016, had upgrade sales been excluded in Service Revenue in 2015, Service Revenue would have increased by $3.5 million principally due to an increase of $3.9 million in sales of spares and services revenue, offset by $0.4 million decline in extended warranty sales.


With a significant portion of the world's semiconductor manufacturing capacity located in Asia, a substantial portion of our revenues continue to be generated in that region. Although sales to customers within individual countries of that region will vary from time to time, we expect that a substantial portion of our revenues will continue to be generated in Asia.

Gross margin

Our gross margin breakdown was as follows:

 

 

Fiscal Year

 

 

 

2017

 

 

2016

 

 

2015

 

Products

 

 

52.9

%

 

 

53.1

%

 

 

46.7

%

Service

 

 

52.4

%

 

 

44.1

%

 

 

51.9

%

The calculation of product gross margin includes cost of products including related upgrades and amortization of intangibles. The gross margin on product revenue remained relatively flat in 2017 compared to 2016. However, the gross margin of our services business improved to 52.4% in 2017 from 44.1% in 2016, reflecting an increase of 8.3 percentage points. The increase in gross margin is due to the increases in margin of service parts, a more favorable product mix and higher utilization of our service personnel.

The gross margin on product revenue increased to 53.1% in 2016 from 46.7% in 2015. In 2015 and prior, sales and related cost for upgrades have been included as part of service revenues. Had upgrade sales and related cost been included in Product Revenue and Cost of Revenues in 2015, Product Gross Margin for 2015 would have been 47.5%. The increase in 2016 of 5.6 percentage points was due to a change in product mix, improved installation and warranty related costs and reduced amortization of intangibles as a result of full amortization of the intangible asset. The gross margin of our services business decreased to 44.1% from 51.9% in 2015, reflecting a decrease of 7.8 percentage points. Had upgrade sales and related cost been excluded from Service Revenues and Cost of Service Revenues, Service Gross Margin for 2015 would have been 49.5%, a decrease of 5.4 percentage points, due to the mix of services provided during the year in comparison to the prior year period, and lower labor utilization of service personnel.

Operating expenses

Our operating expenses comprise the following categories (in thousands, except percentages):

 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2017

 

 

2016

 

 

Change

 

Research and development

 

$

36,716

 

 

$

31,443

 

 

$

5,273

 

 

 

16.8

%

Selling

 

 

30,839

 

 

 

30,181

 

 

 

658

 

 

 

2.2

%

General and administrative

 

 

26,340

 

 

 

23,381

 

 

 

2,959

 

 

 

12.7

%

Amortization of intangible assets

 

 

 

 

 

24

 

 

 

(24

)

 

 

(100.0

)%

Total operating expenses

 

$

93,895

 

 

$

85,029

 

 

$

8,866

 

 

 

10.4

%

 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2016

 

 

2015

 

 

Change

 

Research and development

 

$

31,443

 

 

$

32,701

 

 

$

(1,258

)

 

 

(3.8

)%

Selling

 

 

30,181

 

 

 

28,055

 

 

 

2,126

 

 

 

7.6

%

General and administrative

 

 

23,381

 

 

 

22,444

 

 

 

937

 

 

 

4.2

%

Amortization of intangible assets

 

 

24

 

 

 

114

 

 

 

(90

)

 

 

(78.9

)%

Restructuring charge

 

 

 

 

 

1,380

 

 

 

(1,380

)

 

 

(100.0

)%

Total operating expenses

 

$

85,029

 

 

$

84,694

 

 

$

335

 

 

 

0.4

%

Research and development

Investments in research and development personnel and associated projects are part of our strategy to ensure our products remain competitive and meet customer’s needs. In 2017, research and development costs increased by $5.3 million or 16.8% compared to 2016 primarily due to additional headcount and higher material spending in program related expenses to support our research and development efforts.


Research and development costs decreased by $1.3 million or 3.8% in 2016 compared to 2015 related primarily due to lower spending for material expenses and related costs associated with research and development investments for our next generation systems.

Selling

Selling expenses increased slightly by $0.7 million or 2.2% in fiscal year 2017 compared to fiscal year 2016. The slight increase is due to higher variable compensation, commission expense, and sales related costs, which is consistent with higher revenues in 2017 compared to 2016.

Selling expenses increased by $2.1 million or 7.6% in fiscal year 2016 compared to fiscal year 2015. The increase is due to higher variable compensation, commission expense, and sales related costs, which is consistent with higher revenues in 2016 compared to 2015. In addition, during fiscal year 2016, there was a decrease in utilization of our sales application personnel for installation and warranty effort, which is included in cost of net revenues.

General and administrative

General and administrative expenses increased by $3.0 million or 12.7% in fiscal year 2017 compared to 2016. The increase was primarily due to higher variable compensation costs, recruiting costs associated with our CEO search and higher professional services fees.

General and administrative expenses increased by $0.9 million or 4.2% in fiscal year 2016 compared to 2015. The increase was primarily due to higher variable compensation costs.

Amortization of intangible assets

We recorded no amortization of intangible assets in operating expenses in fiscal 2017 as the related intangible assets became fully amortized in 2016.

Amortization of intangible assets included in operating expenses in fiscal year 2016 decreased slightly compared to 2015, as a result of the reduction in amortization due to intangible assets that became fully amortized in 2016.

Restructuring charge

There were no restructuring charges recorded in 2017 and 2016 fiscal year. We recorded a restructuring charge of $1.4 million in 2015 as a result of our decision to maximize operating effectiveness. This amount includes charges primarily related to employee severance and related costs. As of December 26, 2015, we had completed and settled in full all cash payments related to employee severance.flows.

Other income (expense), net

Our other income (expense), net, consisted of the following items (in thousands, except percentages):

 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2017

 

 

2016

 

 

Change

 

Interest income

 

$

8

 

 

$

35

 

 

$

(27

)

 

 

(77.1

)%

Interest expense

 

 

(92

)

 

 

(285

)

 

 

193

 

 

 

(67.7

)%

Interest expense, net

 

$

(84

)

 

$

(250

)

��

$

166

 

 

 

(66.4

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net gains on investments

 

 

1,311

 

 

 

520

 

 

 

791

 

 

 

152.1

%

Other losses, net

 

 

(735

)

 

 

(230

)

 

 

(505

)

 

 

219.6

%

Other income, net

 

$

576

 

 

$

290

 

 

$

286

 

 

 

98.6

%

Total other income, net

 

$

492

 

 

$

40

 

 

$

452

 

 

 

1130.0

%


 

 

Fiscal Year

 

 

 

 

 

 

 

 

 

 

 

2016

 

 

2015

 

 

Change

 

Interest income

 

$

35

 

 

$

71

 

 

$

(36

)

 

 

(50.7

)%

Interest expense

 

 

(285

)

 

 

(289

)

 

 

4

 

 

 

(1.4

)%

Interest expense, net

 

$

(250

)

 

$

(218

)

 

$

(32

)

 

 

14.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net gains on investments

 

 

520

 

 

 

220

 

 

 

300

 

 

 

136.4

%

Other gains (losses), net

 

 

(230

)

 

 

593

 

 

 

(823

)

 

 

(138.8

)%

Other income, net

 

 

290

 

 

 

813

 

 

 

(523

)

 

 

(64.3

)%

Total other income, net

 

$

40

 

 

$

595

 

 

$

(555

)

 

 

(93.3

)%

Total other income, net increased by $0.5 million in 2017 compared to 2016 period, primarily due to higher net realized investment gains which is in line with the higher cash and cash equivalents balance in fiscal year 2017, partially offset by unfavorable net revaluation of intercompany balances based on foreign currency fluctuations relative to the U.S. dollar, netted against hedging gains and losses.

Total other income, net decreased by $0.6 million in 2016 compared to 2015 period, due to unfavorable impact of fluctuations of foreign currency rates relative to the U.S. dollar, offset in part against the increase of net realized investment gains. In 2015, the impact of fluctuations of foreign currency rates relative to the U.S. dollar was favorable compared to 2016 period.

Provision for (benefit from) income taxes

We recorded an income tax provision of $13.1 million in 2017, an income tax benefit of $14.9 in 2016, and an income tax provision of $2.7 million in 2015. The increase in the provision for 2017 from 2016 was primarily related to the tax effects of the Tax Cuts and Jobs Act of 2017 and increased profitability for the year ended 2017 offset by the release of a valuation allowance against a significant portion of our U.S. deferred tax assets for the year ended 2016. The decrease in the tax provision for 2016 from 2015 was primarily related to the releasing of the same valuation allowance for the year ended 2016.

Our provision for income taxes for 2017 of $13.1 million reflects an effective tax rate of 30.2%. This rate differs from the Federal statutory rate of 35.0% primarily due to foreign income taxed at lower rates, and tax credits generated in the current year, tax benefits associated with the settlement of equity options/awards, and a one-time benefit related to an entity classification change, offset by an additional provision for the tax effects of the Tax Cuts and Job Act of 2017. Our benefit for income taxes for 2016 of $14.9 million reflects an effective tax rate of negative 51.1%. This rate differs from the Federal statutory rate of 35.0% primarily due to the release of a valuation allowance against a significant portion of our U.S. deferred tax assets which represented a $23.9 million benefit, as well as foreign income taxed at lower rates, and tax credits generated in the current year, offset by equity compensation expenses for which no current tax deduction is available. Our provision for income taxes for 2015 of $2.7 million reflects an effective tax rate of 47.8 %. This rate differs from the Federal statutory rate of 35.0% primarily due to losses incurred in foreign jurisdictions where no benefit is currently recorded, as well as equity compensation expenses for which no current tax deduction is available.

We maintain valuation allowances when it is likely that all or a portion of a deferred tax asset will not be realized. Changes in valuation allowances from period to period are included in our income tax provision in the period of change. In determining whether a valuation allowance is warranted, we take into account such factors as prior earnings history, expected future earnings, unsettled circumstances that, if unfavorably resolved, would adversely affect utilization of a deferred tax asset, carry-back and carry-forward periods, and tax strategies that could potentially enhance the likelihood of realization of a deferred tax asset. As such, in 2017, we released a valuation allowance against our Singapore deferred tax assets of $0.3 million. We currently maintain a valuation allowance against our deferred tax assets in California, Germany, and Switzerland.

Liquidity and Capital Resources

Our principal sources of liquidity are cash and cash equivalents, marketable securities and cash flow generated from our operations. Our liquidity is affected by many factors, including those that relate to our specific operations and those that relate to the uncertainties of global and regional economies and the sectors of the semiconductor industry which we operate in. Although our cash requirements will fluctuate based on the timing and extent of these factors, we believe our existing cash, cash equivalents and marketable securities, combined with cash currently projected to be generated from our operations, will be sufficient to meet our liquidity needs through at least the next twelve months.


The following table presents selected financial information and statistics as of and for the years ended December 30, 2017, December 31, 2016 and December 26, 2015 (in millions):

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Cash, cash equivalents and marketable securities

 

$

117.0

 

 

$

130.0

 

 

$

83.1

 

Working capital

 

$

196.0

 

 

$

174.4

 

 

$

132.9

 

Cash provided by (used in) operating activities

 

$

20.6

 

 

$

45.7

 

 

$

1.6

 

Cash provided by (used in) investing activities

 

$

(6.7

)

 

$

(42.1

)

 

$

2.0

 

Cash provided by (used in) financing activities

 

$

(25.6

)

 

$

5.3

 

 

$

0.2

 

During 2017, the $20.6 million cash provided by operating activities was a result of $30.2 million of net income plus $25.3 million net effect of non-cash adjustments to net income, offset by $34.5 million net change in operating assets and liabilities. The change in operating assets and liabilities is generally driven by the timing of our customer payments for account receivable and timing of our vendor payments for accounts payable. We expect that cash provided by operating activities may fluctuate due to several factors, including variations in our operating results, accounts receivable collections performance, inventory and supply chain management, vendor payment initiatives, tax benefits or charges from stock-based compensation, and the timing and amount of compensation and other payments. The $25.1 million decrease in cash from operating activities in fiscal 2017 compared to fiscal 2016 was primarily due to higher inventory levels at the end of the fiscal year and higher accounts receivable balance as a result of the record high revenue level in the fourth quarter of the 2017 fiscal year. Cash used in investing activities of $6.7 million during 2017, consisted primarily of cash used to acquire certain assets and property, plant and equipment of $7.2 million, as sales and maturities of marketable securities were almost entirely offset by purchases of marketable securities. Cash used in financing activities of $25.6 million during 2017 consisted primarily of $27.0 million of common stock repurchases and $4.2 million of cash paid for taxes on net issuance of stock awards, partially offset by proceeds from issuance of common stock from the employee stock purchase program and the exercise of stock options of $5.6 million.

During 2016, cash provided by operating activities was a result of $44.0 million of net income plus the net effect of non-cash adjustments to net income and net change in operating assets and liabilities. The increase in cash from operating activities in fiscal 2016 compared to fiscal 2015 was primarily due to improved working capital, higher revenue levels and higher net income. Cash used in investing activities of $42.1 million during 2016, consisted primarily of $82.9 million net purchases of marketable securities and cash used to acquire $4.0 million of property, plant and equipment, partially offset by cash provided by maturities of marketable securities of $38.8 million and cash received from sales of marketable securities of $6.0 million. Cash provided by financing activities of $5.3 million during 2016 consisted primarily of $8.4 million in proceeds from issuance of common stock from the employee stock purchase program and the exercise of stock options, partially offset by cash paid for taxes on net issuance of stock awards of $1.8 million, $1.0 million of excess tax benefit from equity awards and royalty payments to Zygo of $0.3 million.

During 2015, cash provided by operating activities was a result of $2.9 million of net income, non-cash adjustments to net income of $19.4 million and a decrease in net change in operating assets and liabilities of $20.7 million. Cash from operating activities in fiscal 2015 was a result of improved working capital and an increase in sales. Cash provided by investing activities of $2.0 million during 2015, consisted primarily of cash provided by maturities of marketable securities, net of purchases of $0.4 million, and cash received from sales of marketable securities of $3.4 million, partially offset by cash used to acquire property, plant and equipment of $1.8 million. Cash provided by financing activities of $0.2 million during 2015 consisted primarily of $4.0 million in proceeds from issuance of common stock from the employee stock purchase program and the exercise of stock options, partially offset by cash used to repurchase common stock of $1.7 million, royalty and other payments to Zygo of $0.9 million, and cash paid for taxes on net issuance of stock awards of $1.2 million.

We have evaluated and will continue to evaluate the acquisitions of products, technologies or businesses that are complementary to our business. These activities may result in product and business investments, which may affect our cash position and working capital balances. Some of these activities might require significant cash outlays.

We earn a portion of our operating income outside the United States, which is deemed to be indefinitely reinvested in foreign jurisdictions. As a result, $13.4 million of our cash is held by foreign subsidiaries, a portion of which, would have to be repatriated to the United States. We are currently evaluating whether there is a need to repatriate these funds. We believe our existing balances of cash, cash equivalents and marketable securities will be sufficient to satisfy our working capital needs, capital asset purchases, outstanding commitments and other liquidity requirements associated with our existing operations over the next twelve months.


Should we require more capital in the United States than is generated by our domestic operations, for example to fund significant discretionary activities such as business acquisitions and share repurchases, we could elect to repatriate future earnings from foreign jurisdictions or raise capital in the United States through debt or equity issuances. These alternatives could result in higher effective tax rates, increased interest expense, or dilution of our earnings.

Repurchases of Common Stock

On May 29, 2012, our Board of Directors authorized the repurchase of up to $20.0 million of our common stock, of which $4.4 million remained as of December 31, 2016.

On November 15, 2017 our Board of Directors authorized the repurchase of up to $50.0 million of our common stock, which superseded the 2012 repurchase program. This new plan is referred to as the Stock Repurchase Plan. Stock repurchases under the Stock Repurchase Plan may be made through open market and privately negotiated transactions at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased is dependent on a variety of factors including price, corporate and regulatory requirements and other market conditions.

Shares repurchased and retired in the fourth quarter of fiscal year 2017 under the Stock Repurchase Plan, with the associated cost of repurchase and amount available for repurchase are as follows (in thousands, except number of shares and weighted average price per share):

 

 

Fiscal Year

2017

 

Number of shares of common stock repurchased

 

 

1,065,848

 

Weighted average price per share

 

$

25.33

 

Total cost of repurchase

 

$

26,999

 

Amount available for repurchase at end of period

 

$

23,001

 

The Stock Repurchase Plan was completed in February 2018, with purchases since December 30, 2017 of 896,187 shares of our common stock at the weighted average price of $25.65 for a cost of $23.0 million.

There were no shares repurchased during fiscal year 2016. During fiscal year 2015, we repurchased and retired 111,050 shares of our common stock at the weighted average price of $15.49 per share under a previously approved repurchase plan, all of which were purchased in the first quarter of fiscal year 2015.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements or obligations as of December 30, 2017, and December 31, 2016.

Contractual Obligations

The following table summarizes our contractual cash obligations as of December 30, 2017, and the effect of such obligations.

 

 

 

 

 

 

Payments due by period

 

 

 

Total

 

 

Less than 1 year

 

 

1-3 years

 

 

4-5 years

 

 

More than 5 years

 

Purchase commitments - inventory (1)

 

$

50,654

 

 

$

50,654

 

 

$

 

 

$

 

 

$

 

Other long-term liabilities

 

 

521

 

 

 

1

 

 

 

36

 

 

 

37

 

 

 

447

 

Operating lease obligations

 

 

2,968

 

 

 

1,664

 

 

 

1,248

 

 

 

56

 

 

 

 

Total

 

$

54,143

 

 

$

52,319

 

 

$

1,284

 

 

$

93

 

 

$

447

 

(1)

We maintain certain open inventory purchase agreements with our suppliers to ensure a smooth and continuous supply availability for key components. Our liability under these purchase commitments is generally restricted to a forecasted time-horizon as mutually agreed upon between the parties. This forecasted time-horizon can vary among different suppliers. We estimate our open inventory purchase commitment as of December 30, 2017, was approximately $50.7 million. Actual expenditures will vary based upon the volume of the transactions and length of contractual service provided. In addition, the amounts paid under these arrangements may be less in the event that the arrangements are renegotiated or cancelled.

Excluded from the contractual obligation table above are $4.0 million of future payments related to uncertain tax positions because we cannot reliably estimate the timing of the settlements with the respective tax authorities.


ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Risk

A substantial partportion of our business consistssystems and software sales are denominated in U.S. dollars with the exception of sales madeJapan. As a result, we have relatively little exposure to customers outside the United States: 87%, 86%, and 80%foreign currency exchange risk with respect to these sales. Substantially all of our sales in 2017, 2016, and 2015, respectively; and 22%, 18%, and 22% of net revenues in 2017, 2016, and 2015, respectively, wereJapan are denominated in currencies other thanJapanese yen. From time to time, we may enter into forward exchange contracts to economically hedge a portion, but not all, of the U.S. dollar. Additionally, portionsexisting and anticipated foreign currency denominated transactions expected to occur within 12 months. The change in fair value of our coststhe forward exchange contracts is recognized under the caption “Other (income) expense” in the Consolidated Statements of net revenuesOperations for each reporting period. As of December 31, 2019 and our operating expenses are incurred by our2018, we had seventeen and twenty-seven outstanding forward contracts with a total notional contract value of $38.9 million and $6.7 million, respectively. We do not use derivative financial instruments for trading or speculative purposes.

The Company has branch sales and service offices or subsidiaries in Korea, Japan, China, Taiwan, Singapore and in several countries in Europe. Our international operationssubsidiaries and denominated inbranches operate primarily using local functional currencies.

Our exposure to foreign currency exchange rate fluctuations arises in partarise from intercompany balances in which costs are charged between our U.S. headquarters and that of our foreign subsidiaries. On our consolidated balance sheet theseowned entities. Our intercompany balances are eliminated and thus no consolidated balances are associated with these intercompany balances; however, sincedenominated in U.S. dollars. Since each foreign entity'sentity’s functional currency is generally denominated in its respective local currency, there is exposure to foreign exchange risk onwhen the foreign entity’s intercompany balance is remeasured at a consolidated basis. Intercompany balances are denominated primarilyreporting date, resulting in U.S. dollars and, to a lesser extent, other local currencies.transaction gains or losses. The net intercompany balance, exposed to foreign currency risk, atas of December 30, 2017,31, 2019 was approximately $0.4$24.1 million. A hypothetical change of 10% in the relative value of the USU.S. dollar versus local functional currencies could result in an increase or decrease of approximately $44,000$3.2 million in transaction gains orforeign currency exchange losses / (gains) which would be includedrecorded as non-operating expense under the caption “Other income (expense), net” in our statementConsolidated Statements of operations.Operations.  We cannot accurately predict future exchange rates or the overall impact of future exchange rate fluctuations on our business, results of operations and consolidated financial condition.

To manage the level of exposure to the risk of foreign currency exchange rate fluctuations, we enter into foreign currency forward exchange contracts to protect against a portion of our currency exchange risks associated with existing assets and liabilities. A foreign currency forward exchange contract acts as a hedge by increasing in value when underlying assets decrease in value or underlying liabilities increase in value due to changes in foreign exchange rates. Conversely, a foreign currency forward exchange contract decreases in value when underlying assets increase in value or underlying liabilities decrease in value due to changes in foreign exchange rates. These forward contracts are not designated as accounting hedges, so the unrealized gains and losses are recognized in other income, net, in advance of the actual foreign currency cash flows with the fair value of these forward contracts being recorded as accrued liabilities or other current assets.

Item 8.

Financial Statements and Supplementary Data.

The consolidated financial statements and related information required by this Item are set forth on the pages indicated in Item 15(a) of this Annual Report on Form 10-K.

38


Table of Contents

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A.

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We domaintain disclosure controls and procedures that are designed to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time period specified in SEC rules and forms. These controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, we have recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Management is required to apply judgment in evaluating its controls and procedures.

We performed an evaluation under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to assess the effectiveness of the design and operation of our disclosure controls and procedures under the Exchange Act as of December 31, 2019. Based on that evaluation, our management, including our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were effective as of December 31, 2019 at the reasonable assurance level.

In accordance with the SEC’s published guidance, because the merger with Nanometrics closed in the fourth quarter of the year ended December 31, 2019, and considering it was a reverse merger with Rudolph as the accounting acquirer, we did not use forward contracts for trading purposes. Our forward contracts generally have maturitiessufficient time to fully incorporate Nanometrics into our internal control over financial reporting. Therefore, we excluded Nanometrics from the evaluation of 30 days or less. We enter into foreign currency forward exchange contracts based on estimated future assetdisclosure controls and liability exposures,procedures and the effectiveness of our hedging program depends on our ability to estimate these future asset and liability exposures. Recognized gains and losses with respect to our current hedging activities will ultimately depend on how accurately we are able to match the amount of foreign currency forward exchange contracts with actual underlying asset and liability exposures.

For 2017, 2016 and 2015, foreign currency transactions resulted in a loss of $0.6 million, loss of $0.4 million and a gain of $0.5 million, respectively.

We actively monitor our foreign currency risks, but there is no guarantee that our foreign currency hedging activities will substantially offset the impact of fluctuations in currency exchange rates on our results of operations, cash flows andinternal control over financial position. See “Note 3, Fair Value Measurement and Disclosures” in the Notes to Consolidated Financial Statements for more information regarding our derivatives and hedging activities.

Interest Rate Risk

Our exposure to market risk resulting from changes in interest rates relates primarily to our investment portfolio. At December 30, 2017, and December 31, 2016, we held $82.1 million and $82.9 million, respectively, in marketable securities. The fair value of our marketable securities could be adversely impacted due to a rise in interest rates. A hypothetical immediate and consistent increase in interest rates by 100 basis points from levelsreporting as of December 30, 2017,31, 2019.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the fair valuereliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America. Under the supervision and with the participation of our marketable securities would have declinedmanagement, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by $0.5 million. Securitiesthe Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (“COSO”). Based on our evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2019.

In accordance with longer maturitiesthe SEC’s published guidance, because the merger with Nanometrics closed in the fourth quarter of the year ended December 31, 2019, management excluded Nanometrics from its evaluation of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2019. Nanometrics constituted 26% of total assets as of December 31, 2019 and 22% of revenue for the year then ended.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to a greater interest ratethe risk than thosethat controls may become inadequate because of changes in conditions, or that the degree of compliance with shorter maturitiesthe policies or procedures may be circumvented or deteriorate.

Attestation Report of the Registered Public Accounting Firm

Our consolidated financial statements as of and for the year ended December 31, 2019 have been audited by Ernst & Young LLP, our independent registered public accounting firm, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Ernst & Young LLP has also audited our internal control over financial reporting as of December 30, 2017,31, 2019, as stated in its attestation report included elsewhere in this Annual Report on Form 10-K.

As indicated in the accompanying Management’s Report on Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Nanometrics, which is included in the 2019 consolidated financial statements of the Company and constituted 26% of total assets as of December 31, 2016,2019 and 22% of revenue for the average durationyear then ended. Our audit of our portfolio was less than nine months. We dointernal control over

39


Table of Contents

financial reporting of the Company also did not hold securities for trading purposes.include an evaluation of the internal control over financial reporting of Nanometrics.

Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the Company’s quarter ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Item 9B.

Other Information.

None.

 

 


40


Table of Contents

PART III

Certain information required by Part III is omitted from this Annual Report on Form 10-K because we expect to file a definitive proxy statement within one hundred twenty (120) days after the end of our fiscal year pursuant to Regulation 14A (the “Proxy Statement”) for our Annual Meeting of Stockholders currently scheduled for May 12, 2020, and the information included in the Proxy Statement is incorporated herein by reference.

ITEM 8.Item 10.  

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATADirectors, Executive Officers and Corporate Governance.

The information required by this Item 8with respect to directors and executive officers is included under the headings “Proposal One: Election of Form 10-K is presented hereDirectors,” “Executive Officers” and “Corporate Governance Principles and Practices” in the following order:Proxy Statement, which is incorporated herein by reference. Information regarding compliance with Section 16 of the Exchange Act is incorporated by reference to the information under the heading “Delinquent Section 16(a) Reports” in the Proxy Statement.

Code of Business Conduct and Ethics. We have adopted a code of business conduct and ethics that applies to our principal executive officer, principal financial officer and controller. This code of business conduct and ethics is posted on our internet website address at http://investors.ontoinnovation.com.  We will post on our website any amendment to or waiver from a provision of our code of business conduct and ethics as may be required, and within the time period specified, by applicable SEC rules.

Item 11.

Executive Compensation.

The information required by this Item is included under the headings “Executive Compensation,” “Compensation of Directors,” “Compensation Committee Report on Executive Compensation,” “Stock Ownership/Retention Guidelines for Directors” and “Compensation Committee Interlocks and Insider Participation” in the Proxy Statement, which is incorporated herein by reference.

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this Item is included under the headings “Security Ownership” and “Equity Compensation Plan Information” in the Proxy Statement, which is incorporated herein by reference.

Item 13.

Certain Relationships and Related Transactions, and Director Independence.

The information required by this Item is included under the headings “Related Persons Transactions Policy” and “Board Independence” in the Proxy Statement, which is incorporated herein by reference.

Item 14.

Principal Accounting Fees and Services.

The information required by this Item is included under the heading “Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm” in the Proxy Statement, which is incorporated herein by reference.

41


Table of Contents

PART IV

Item 15.Exhibits and Financial Statement Schedule.

(a)

The following documents are filed as part of this Annual Report on Form 10-K:

1.

Financial Statements

The consolidated financial statements and consolidated financial statement information required by this Item are included on pages F-1 through F-10 of this report. The Reports of Independent Registered Public Accounting Firm appear on pages F-2 through F-5 of this report.

2.

Financial Statement Schedule

See Index to financial statements on page F-1 of this report.

3.

Exhibits

Exhibits are as set forth in the “Exhibit Index”, provided below. Where so indicated, exhibits, which were previously filed, are incorporated by reference.

Exhibit No.

Exhibit Description

Form

File Number

Date of First Filing

Exhibit No./Appendix Reference

2.1

Agreement and Plan of Merger, dated as of June 23, 2019, by and among Nanometrics Incorporated, Rudolph Technologies, Inc. and PV Equipment Inc.

8-K

000-13470

June 24, 2019

2.1

3.1

Amended and Restated Certificate of Incorporation of Onto Innovation Inc.

8-K

001-39110

October 28, 2019

3.2

3.2

Amended and Restated Bylaws of Onto Innovation Inc.

8-K

001-39110

January 27, 2020

3.1

4.1+

Form of Common Stock Certificate

4.2+

Description of Securities

10.1

Nanometrics Incorporated Amended and Restated 2003 Employee Stock Purchase Plan

DEF14A

000-13470

April 4, 2016

Appendix 1

10.1.1

Form of Subscription Agreement Under the Nanometrics Incorporated Amended and Restated 2003 Employee Stock Purchase Plan

S-8

333-40866

June 24, 2019

4.1

10.2*

Nanometrics Incorporated Amended and Restated 2005 Equity Incentive Plan

DEF14A

000-13470

April 4, 2017

Appendix B

10.2.1*

Form of Performance-Based Restricted Stock Unit Agreement

8-K

000-13470

March 24, 2015

99.1

10.2.2*

Nanometrics Incorporated Amended and Restated 2005 Equity Incentive Plan forms of Stock Option and Restricted Stock Unit Agreements

10-K

000-13470

March 13, 2008

10.8

10.3*

Nanometrics Incorporated 2017 Executive Performance Bonus Plan

DEF14A

000-13470

April 4, 2017

Appendix A

10.4*

Rudolph Technologies, Inc. 2009 Stock Plan

DEFR14A

000-27965

May 8, 2009

Appendix A

10.4.1*

Amended form of Employee Restricted Stock Unit Purchase Agreement pursuant to the Rudolph Technologies, Inc. 2009 Stock Plan

10-Q

001-36226

August 3, 2017

10.12

10.5*

Rudolph Technologies, Inc. 2018 Stock Plan

8-K

001-36226

May 16, 2018

10.1

10.5.1*

Form of Employee Performance Stock Unit Purchase Agreement pursuant to the Rudolph Technologies, Inc. 2018 Stock Plan

10-Q

001-36226

August 2, 2018

10.1


42


Table of Contents

 

Exhibit No.

Exhibit Description

Form

File Number

Date of First Filing

Exhibit No./Appendix Reference

10.5.2*

Form of Employee Stock Option Agreement pursuant to the Rudolph Technologies, Inc. 2018 Stock Plan

10-Q

001-36226

August 2, 2018

10.2

10.6*

Compensation Arrangements with Named Executive Officers

8-K

000-13470

March 1, 2018

5.02

10.7*

Form of Indemnification Agreement between the Nanometrics Incorporated and each of its directors and executive officers

8-K

000-13470

February 20, 2013

10.1

10.8*

Form of Indemnity Agreement

8-K

001-36226

June 24, 2019

10.1

10.9*

Form of Indemnification Agreement

8-K

001-39110

November 6, 2019

10.1

10.10*

General Severance Benefits and Change in Control Severance Benefits Agreement between Kevin Heidrich and Nanometrics Incorporated, dated May 19, 2015.

8-K

000-13470

May 22, 2015

10.4

10.11*

General Severance Benefits and Change in Control Severance Benefits Agreement between Janet Taylor and Nanometrics Incorporated, dated August 27, 2015.

10-Q

000-13470

October 30, 2015

10.1

10.12*

General Severance Benefits and Change in Control Severance Benefits Agreement between Rollin Kocher and Nanometrics Incorporated, dated November 10, 2016.

10-K

000-13470

March 3, 2017

10.22

10.13

Independent Contractor Agreement between Nanometrics Incorporated and S. Mark Borowicz, dated January 8, 2018.

10-K

000-13470

February 26, 2018

10.22

10.14*

Employment Agreement between Pierre-Yves Lesaicherre and Nanometrics Incorporated, dated November 27, 2017.

10-K

000-13470

February 26, 2018

10.20

10.15*

Retention Bonus Agreement between Nanometrics Incorporated and Greg Swyt, dated December 18, 2017.

10-K

000-13470

February 26, 2018

10.23

10.16*

Retention Bonus Agreement between Nanometrics and Greg Swyt, dated June 25, 2018.

8-K

000-13470

November 6, 2018

10.1

10.17*

General Severance Benefits and Change in Control Severance Benefits Agreement, dated July 25, 2019, between Nanometrics Incorporated and Greg Swyt.

8-K

000-13470

July 26, 2019

10.1

10.18*

Retention Bonus Agreement, dated September 6, 2019, between Nanometrics Incorporated and Greg Swyt.

8-K

000-13470

September 9, 2019

10.1

10.19*

General Severance Benefits and Change in Control Severance Benefits Agreement between Nanometrics Incorporated and James Barnhart, dated March 12, 2018.

10-Q

000-13470

May 1, 2019

10.1

10.20*

Management Agreement, dated as of July 24, 2000 by and between Rudolph Technologies, Inc. and Steven R. Roth as restated and amended on July 29, 2014.

10-Q

001-36226

August 6, 2014

10.2

10.21*

Employment Agreement, dated as of November 9, 2015, by and between Rudolph Technologies, Inc. and Michael Plisinski.

8-K

001-36226

November 9, 2015

10.1


43


Table of Contents

Exhibit No.

Exhibit Description

Form

File Number

Date of First Filing

Exhibit No./Appendix Reference

10.22*

Executive Change of Control Agreement, dated August 20, 2009, by and between Rudolph Technologies, Inc. and Robert A. Koch.

10-Q

000-27965

November 6, 2009

10.3

10.23

Amendment to Confirmation of Issuer Warrant Transaction, dated July 22, 2011, by and between Rudolph Technologies, Inc. and Credit Suisse International.

8-K

000-27965

July 25, 2011

10.5

10.24

License Agreement, dated June 28, 1995, between the Rudolph Technologies Inc. and Brown University Research Foundation.

S-1

333-86821

September 9, 1999

10.1

21.1+

Subsidiaries.

23.1+

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.

31.1+

Rule 13a-14(a) Certification of Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2+

Rule 13a-14(a) Certification of Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1+

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2+

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

 

 

 

 

101.SCH

Inline XBRL Taxonomy Extension Schema Document

 

 

 

 

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

104

Cover Page Interactive Data File (formatted in inline XBRL and contained in Exhibit 101)

 

 

 

 

*

Management contract, compensatory plan or arrangement.

 

 

 

 

+

Filed herewith.

 

 

 

 

 

 

44


Table of Contents

ONTO INNOVATION INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND

FINANCIAL STATEMENT SCHEDULE

 

 

Page

Consolidated Financial Statements:

 

ReportReports of Independent Registered Public Accounting Firm

40F-2

Consolidated Balance SheetsStatements of Operations for the years ended December 31, 2019, 2018 and 2017

42F-6

Consolidated Statements of Operations

43

Consolidated Statements of Comprehensive Income for the years ended December 31, 2019, 2018 and 2017

44F-7

Consolidated Balance Sheets as of December 31, 2019 and 2018

F-8

Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018 and 2017

F-9

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2019, 2018 and 2017

45F-10

Notes to the Consolidated Financial Statements of Cash Flows

46F-11

Notes to Consolidated Financial Statements

47

Supplementary Data:Statement Schedule:

 

Selected Quarterly Financial Results (Unaudited)Schedule of Valuation and Qualifying Accounts

71F-44

 



F-1


Table of Contents

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and the Board of Directors and Stockholders of Nanometrics IncorporatedOnto Innovation Inc.

 

OpinionsOpinion on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Nanometrics Incorporated and its subsidiariesOnto Innovation Inc., formerly Rudolph Technologies, Inc. (the Company), as of December 30, 201731, 2019 and 2018, the related consolidated statements of operations, comprehensive income, shareholders’ equity and cash flows for each of the three years in the period ended December 31, 2016,2019, and the related notes and financial statement schedule listed in the Index at Item 15(a)(collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 25, 2020 expressed an unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Excess Inventory Reserve

F-2


Table of Contents

Description of the Matter

As described in Note 9 to the consolidated financial statements, the Company had net inventories of $176.1 million as of December 31, 2019, which included materials of $108.5 million, work-in-progress of $42.7 million, and finished goods of $24.9 million. The valuation of certain of the Company’s inventory is subject to risks associated with supply and demand. As described in Note 2 to the consolidated financial statements, the Company maintains reserves for excess and obsolete inventory equal to the difference between the cost of inventory and its estimated net realizable value based upon assumptions about historical and future demand for the Company’s products and market conditions.

Auditing management’s estimate of the excess and obsolete inventory reserve was subjective and required significant judgment as the excess and obsolete inventory reserve is sensitive to changes in the Company’s operations and assumptions used to estimate the reserve including management’s assumptions with regards to product life-cycles, product demand and market conditions, which includes historical usage, expected future usage, on-hand quantities of individual materials, and anticipated engineering design changes or advancements.

How We Addressed the Matter in Our Audit

We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company’s excess and obsolete inventory reserve process, including those over the validity and reasonableness of the data and assumptions used in estimating the excess and obsolete inventory reserve.  

To test the adequacy of the Company’s excess and obsolete inventory reserve, we performed audit procedures that included, among others, assessing methodologies and assumptions used, testing the completeness and accuracy of the underlying data used by management in its analysis including the usage of historical materials, considering potential product obsolescence, observing physical inventory on-hand and inspecting historical gross margins to assess whether any items are being sold at a loss or lower margins that may need to be included in the reserve. We assessed the historical accuracy of management’s estimated excess and obsolete inventory reserve and performed sensitivity analyses to evaluate changes in the estimate that result from changes in the Company’s significant assumptions.

Accounting for Acquisition of Nanometrics Incorporated

Description of the Matter

In October 2019, Rudolph Technologies, Inc. (Rudolph) completed its acquisition of Nanometrics Incorporated (Nanometrics) for net consideration of $890.1 million, including identified intangible assets of $374.9 million, which principally consisted of developed technology, in-process research and development and customer relationships, as disclosed in Note 3 to the consolidated financial statements. The transaction was accounted for as a business combination with Rudolph as the accounting acquirer.

Auditing the fair value of intangible assets was complex due to the sensitivity of the respective fair values to the significant underlying assumptions. The Company engaged a specialist that used an income approach which is based on a discounted cash flow model to measure the intangible assets. The significant assumptions used to estimate the fair value of the intangible assets included discount rates and revenue growth rates. These significant assumptions are forward looking and could be affected by future economic and market conditions. The determination of the accounting acquirer is a subjective determination where management applied judgment in evaluating the relevant criteria to make this determination.

How We Addressed the Matter in Our Audit

We tested the Company’s controls over its accounting for the Nanometrics acquisition. Our tests included controls over the determination of the accounting acquirer and the estimation process supporting the recognition and measurement of the intangible assets, including the significant assumptions used.

To test the estimated fair value of the intangible assets, we performed audit procedures that included, among others, evaluating the Company’s use of the income approach and testing the significant assumptions used in the model, including the completeness and accuracy of the underlying data. We involved our valuation specialists to assist with our evaluation of the methodology used by the Company and significant assumptions included in the fair value estimates. For example, we compared the significant assumptions to current industry, market and economic trends; to the assumptions used to value similar assets in the marketplace; and to the historical results of the acquired business and to other guidelines used by companies within the same industry. To test the determination of the accounting acquirer, we performed audit procedures that included, among others, inspecting the analysis prepared by the Company on this topic and evaluating the accuracy of the information and the judgments made by management considering historical information, the merger agreement and other relevant information relating to the terms of the merger and the prospective plans of the Company after the merger.

/s/ Ernst & Young LLP

We have served as the Company’s auditor since 2008.

Iselin, New Jersey

February 25, 2020

F-3


Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and the Board of Directors of Onto Innovation Inc.

Opinion on Internal Control Over Financial Reporting

We have audited Onto Innovation Inc.’s (formerly Rudolph Technologies, Inc.) internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Onto Innovation Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on the COSO criteria.

As indicated in the accompanying Management’s Report on Internal Control Over Financial Reporting, management’s assessment of and conclusion on the effectiveness of internal control over financial reporting did not include the internal controls of Nanometrics Incorporated, which is included in the 2019 consolidated financial statements of the Company and constituted 26% of total assets as of December 31, 2019 and 22% of revenue for the year then ended. Our audit of internal control over financial reporting of the Company also did not include an evaluation of the internal control over financial reporting of Nanometrics Incorporated.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 30, 2017, including31, 2019, and the related notes and financial statement schedule listed in the index appearing under itemIndex at Item 15(a)(2) (collectively referred to as the “consolidated financial statements”).  We also have audited the Company's internal control over financial reporting as of December 30, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  

In and our report dated February 25, 2020 expressed an unqualified opinion the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 30, 2017 and December 31, 2016, and the results of its operations and its cash flows for each of the three years in the period ended December 30, 2017 in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 30, 2017, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.thereon.

 

Basis for OpinionsOpinion

 

The Company'sCompany’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report of Management on Internal Control overOver Financial Reporting appearing under Item 9A.Reporting. Our responsibility is to express opinionsan opinion on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits.audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB")PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our auditsaudit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the auditsaudit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

 

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audits also includedrisk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audits provideaudit provides a reasonable basis for our opinions.opinion.

 

Definition and Limitations of Internal Control overOver Financial Reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i)(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 


F-4


Table of Contents

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/PricewaterhouseCoopers Ernst & Young LLP

San Jose, California

February 26, 2018

 

We have served as the Company’s auditor since 2010.Iselin, New Jersey


NANOMETRICS INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands except share and per share amounts)

 

 

December 30, 2017

 

 

December 31, 2016

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

34,899

 

 

$

47,062

 

Marketable securities

 

 

82,130

 

 

 

82,899

 

Accounts receivable, net of allowances of $126 and $73, respectively

 

 

62,457

 

 

 

39,457

 

Inventories

 

 

52,860

 

 

 

38,837

 

Inventories-delivered systems

 

 

1,534

 

 

 

2,457

 

Prepaid expenses and other

 

 

6,234

 

 

 

5,667

 

Total current assets

 

 

240,114

 

 

 

216,379

 

Property, plant and equipment, net

 

 

44,810

 

 

 

44,226

 

Goodwill

 

 

10,232

 

 

 

8,940

 

Intangible assets, net

 

 

2,206

 

 

 

412

 

Deferred income tax assets

 

 

11,924

 

 

 

17,399

 

Other assets

 

 

413

 

 

 

474

 

Total assets

 

$

309,699

 

 

$

287,830

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

13,857

 

 

$

11,342

 

Accrued payroll and related expenses

 

 

12,901

 

 

 

12,656

 

Deferred revenue

 

 

7,408

 

 

 

9,168

 

Other current liabilities

 

 

7,249

 

 

 

8,047

 

Income taxes payable

 

 

2,680

 

 

 

813

 

Total current liabilities

 

 

44,095

 

 

 

42,026

 

Deferred revenue

 

 

1,661

 

 

 

816

 

Income taxes payable

 

 

860

 

 

 

841

 

Deferred tax liability

 

 

179

 

 

 

20

 

Other long-term liabilities

 

 

521

 

 

 

353

 

Total liabilities

 

 

47,316

 

 

 

44,056

 

Commitments and contingencies (Note 9)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value; 3,000,000 shares authorized;

   no shares issued or outstanding

 

 

 

 

 

 

Common stock, $0.001 par value, 47,000,000 shares authorized: 24,628,722

   and 25,070,889, respectively, issued and outstanding

 

 

26

 

 

 

25

 

Additional paid-in capital

 

 

255,368

 

 

 

271,969

 

Retained earnings (deficit)

 

 

9,113

 

 

 

(22,174

)

Accumulated other comprehensive income (loss)

 

 

(2,124

)

 

 

(6,046

)

Total stockholders’ equity

 

 

262,383

 

 

 

243,774

 

Total liabilities and stockholders’ equity

 

$

309,699

 

 

$

287,830

 

See Notes to Consolidated Financial StatementsFebruary 25, 2020

 

 


NANOMETRICS INCORPORATEDF-5


Table of Contents

ONTO INNOVATION INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)data)

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

214,877

 

 

$

185,066

 

 

$

146,945

 

Service

 

 

43,744

 

 

 

36,063

 

 

 

40,422

 

Total net revenues

 

 

258,621

 

 

 

221,129

 

 

 

187,367

 

Costs of net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of products

 

 

100,910

 

 

 

85,391

 

 

 

76,224

 

Cost of service

 

 

20,804

 

 

 

20,160

 

 

 

19,450

 

Amortization of intangible assets

 

 

206

 

 

 

1,454

 

 

 

2,026

 

Total costs of net revenues

 

 

121,920

 

 

 

107,005

 

 

 

97,700

 

Gross profit

 

 

136,701

 

 

 

114,124

 

 

 

89,667

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

36,716

 

 

 

31,443

 

 

 

32,701

 

Selling

 

 

30,839

 

 

 

30,181

 

 

 

28,055

 

General and administrative

 

 

26,340

 

 

 

23,381

 

 

 

22,444

 

Amortization of intangible assets

 

 

 

 

 

24

 

 

 

114

 

Restructuring charge

 

 

 

 

 

 

 

 

1,380

 

Total operating expenses

 

 

93,895

 

 

 

85,029

 

 

 

84,694

 

Income from operations

 

 

42,806

 

 

 

29,095

 

 

 

4,973

 

Other (income) expense:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

8

 

 

 

35

 

 

 

71

 

Interest expense

 

 

(92

)

 

 

(285

)

 

 

(289

)

Other income, net

 

 

576

 

 

 

290

 

 

 

813

 

Total other income, net

 

 

492

 

 

 

40

 

 

 

595

 

Income before income taxes

 

 

43,298

 

 

 

29,135

 

 

 

5,568

 

Provision for (benefit from) income taxes

 

 

13,096

 

 

 

(14,900

)

 

 

2,663

 

Net income

 

$

30,202

 

 

$

44,035

 

 

$

2,905

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.19

 

 

$

1.79

 

 

$

0.12

 

Diluted

 

$

1.17

 

 

$

1.75

 

 

$

0.12

 

Weighted average shares used in per share calculation:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

25,334

 

 

 

24,655

 

 

 

24,059

 

Diluted

 

 

25,919

 

 

 

25,153

 

 

 

24,375

 

 

 

Year Ended December 31

 

 

 

2019

 

 

2018

 

 

2017

 

Revenue

 

$

305,896

 

 

$

273,784

 

 

$

255,098

 

Cost of revenue

 

 

170,868

 

 

 

125,505

 

 

 

120,503

 

Gross profit

 

 

135,028

 

 

 

148,279

 

 

 

134,595

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

48,358

 

 

 

39,953

 

 

 

37,694

 

Sales and marketing

 

 

28,251

 

 

 

22,010

 

 

 

20,795

 

General and administrative

 

 

53,017

 

 

 

33,698

 

 

 

27,878

 

Amortization

 

 

10,445

 

 

 

1,534

 

 

 

1,940

 

Patent litigation income

 

 

 

 

 

 

 

 

(13,000

)

Total operating expenses

 

 

140,071

 

 

 

97,195

 

 

 

75,307

 

Operating income (loss)

 

 

(5,043

)

 

 

51,084

 

 

 

59,288

 

Interest income, net

 

 

3,666

 

 

 

2,206

 

 

 

971

 

Other income (expense), net

 

 

780

 

 

 

56

 

 

 

(457

)

Income (loss) before provision (benefit) for income taxes

 

 

(597

)

 

 

53,346

 

 

 

59,802

 

Provision (benefit) for income taxes

 

 

(2,507

)

 

 

8,250

 

 

 

26,893

 

Net income

 

$

1,910

 

 

$

45,096

 

 

$

32,909

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.06

 

 

$

1.77

 

 

$

1.30

 

Diluted

 

$

0.06

 

 

$

1.74

 

 

$

1.27

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

29,729

 

 

 

25,470

 

 

 

25,325

 

Diluted

 

 

30,007

 

 

 

25,895

 

 

 

25,865

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See Notes to Consolidated Financial StatementsThe accompanying notes are an integral part of these consolidated financial statements.

 

 


NANOMETRICS INCORPORATEDF-6


Table of Contents

ONTO INNOVATION INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

 

 

 

Year Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Net income

 

$

30,202

 

 

$

44,035

 

 

$

2,905

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Change in foreign currency translation adjustment

 

 

4,170

 

 

 

(869

)

 

 

(2,344

)

Employee benefit plan adjustment

 

 

(160

)

 

 

(17

)

 

 

(76

)

Net change on unrealized (losses) gains on available-for-sale investments

 

 

(88

)

 

 

42

 

 

 

(13

)

Other comprehensive income (loss)

 

 

3,922

 

 

 

(844

)

 

 

(2,433

)

Comprehensive income

 

$

34,124

 

 

$

43,191

 

 

$

472

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Net income

 

$

1,910

 

 

$

45,096

 

 

$

32,909

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Change in net unrealized gains (losses) on investments

 

 

(44

)

 

 

136

 

 

 

(89

)

Change in currency translation adjustments

 

 

709

 

 

 

(194

)

 

 

1,663

 

Total comprehensive income

 

$

2,575

 

 

$

45,038

 

 

$

34,483

 

 

See Notes to Consolidated Financial StatementsThe accompanying notes are an integral part of these consolidated financial statements.

 

 


NANOMETRICS INCORPORATEDF-7


Table of Contents

ONTO INNOVATION INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITYBALANCE SHEETS

(In thousands, except per share amounts)data)

 

 

 

Common Stock

 

 

Additional

Paid-In

 

 

Accumulated

 

 

Accumulated

Other

Comprehensive

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income

 

 

Equity

 

Balance as of December 27, 2014

 

 

23,813,729

 

 

 

24

 

 

 

251,396

 

 

 

(69,114

)

 

 

(2,769

)

 

 

179,537

 

Net income

 

 

 

 

 

 

 

 

 

 

 

2,905

 

 

 

 

 

 

 

2,905

 

Employee benefit plan adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(76

)

 

 

(76

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,344

)

 

 

(2,344

)

Unrealized loss on investments, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(13

)

 

 

(13

)

Issuance of common stock under stock-based

   compensation plans

 

 

521,607

 

 

 

 

 

 

2,792

 

 

 

 

 

 

 

 

 

2,792

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

6,248

 

 

 

 

 

 

 

 

 

6,248

 

Repurchases and retirement of common stock under

   share repurchase plans

 

 

(111,050

)

 

 

 

 

 

(1,721

)

 

 

 

 

 

 

 

 

(1,721

)

Balance as of December 26, 2015

 

 

24,224,286

 

 

 

24

 

 

 

258,715

 

 

 

(66,209

)

 

 

(5,202

)

 

 

187,328

 

Net income

 

 

 

 

 

 

 

 

 

 

 

44,035

 

 

 

 

 

 

 

44,035

 

Employee benefit plan adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(17

)

 

 

(17

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(869

)

 

 

(869

)

Unrealized gain on investments, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

42

 

 

 

42

 

Issuance of common stock under stock-based

   compensation plans

 

 

846,603

 

 

 

1

 

 

 

6,624

 

 

 

 

 

 

 

 

 

6,625

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

7,666

 

 

 

 

 

 

 

 

 

7,666

 

Excess tax benefit related to stock options

 

 

-

 

 

 

 

 

 

(1,036

)

 

 

 

 

 

 

 

 

(1,036

)

Balance as of December 31, 2016

 

 

25,070,889

 

 

 

25

 

 

 

271,969

 

 

 

(22,174

)

 

 

(6,046

)

 

 

243,774

 

Net income

 

 

 

 

 

 

 

 

 

 

 

30,202

 

 

 

 

 

 

 

30,202

 

Adjustment due to adoption of ASU 2016-09 Improvements to Employee Share-Based

Payment Accounting

 

 

 

 

 

 

 

 

 

 

139

 

 

 

1,085

 

 

 

 

 

 

 

1,224

 

Employee benefit plan adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(160

)

 

 

(160

)

Foreign currency translation adjustments

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

4,170

 

 

 

4,170

 

Unrealized loss on investments, net of tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(88

)

 

 

(88

)

Issuance of common stock under stock-based

   compensation plans

 

 

623,681

 

 

 

1

 

 

 

1,440

 

 

 

 

 

 

 

 

 

1,441

 

Stock-based compensation expense

 

 

 

 

 

 

 

 

8,819

 

 

 

 

 

 

 

 

 

8,819

 

Repurchases and retirement of common stock under

   share repurchase plans

 

 

(1,065,848

)

 

 

 

 

 

(26,999

)

 

 

 

 

 

 

 

 

(26,999

)

Balance as of December 30, 2017

 

 

24,628,722

 

 

$

26

 

 

$

255,368

 

 

$

9,113

 

 

$

(2,124

)

 

$

262,383

 

 

 

December 31,

2019

 

 

December 31,

2018

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

130,673

 

 

$

112,388

 

Marketable securities

 

 

189,563

 

 

 

62,684

 

Accounts receivable, less allowance of $1,247 in 2019 and $691 in 2018

 

 

123,656

 

 

 

64,194

 

Inventories

 

 

176,134

 

 

 

96,820

 

Prepaid expenses and other current assets

 

 

21,638

 

 

 

14,821

 

Total current assets

 

 

641,664

 

 

 

350,907

 

Property, plant and equipment, net

 

 

98,420

 

 

 

18,874

 

Goodwill

 

 

307,148

 

 

 

22,495

 

Identifiable intangible assets, net

 

 

371,953

 

 

 

7,448

 

Deferred income taxes

 

 

1,456

 

 

 

12,810

 

Other assets

 

 

27,939

 

 

 

5,506

 

Total assets

 

$

1,448,580

 

 

$

418,040

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

27,738

 

 

$

16,981

 

Accrued liabilities

 

 

26,204

 

 

 

13,700

 

Deferred revenue

 

 

12,629

 

 

 

6,767

 

Other current liabilities

 

 

19,172

 

 

 

7,543

 

Total current liabilities

 

 

85,743

 

 

 

44,991

 

Deferred and other tax liabilities

 

 

67,040

 

 

 

 

Other non-current liabilities

 

 

31,771

 

 

 

11,161

 

Total liabilities

 

 

184,554

 

 

 

56,152

 

Commitments and contingencies (Note 10)

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 3,000 and 4,021 shares authorized, 0 shares

  issued and outstanding at December 31, 2019 and 2018, respectively.

 

 

 

 

 

 

Common stock, $0.001 par value, 97,000 and 80,420 shares authorized, 50,184

  and 24,855 issued and outstanding at December 31, 2019 and 2018,

  respectively.

 

 

50

 

 

 

31

 

Additional paid-in capital

 

 

1,269,437

 

 

 

369,893

 

Accumulated other comprehensive loss

 

 

(598

)

 

 

(1,263

)

Accumulated deficit

 

 

(4,863

)

 

 

(6,773

)

Total stockholders’ equity

 

 

1,264,026

 

 

 

361,888

 

Total liabilities and stockholders’ equity

 

$

1,448,580

 

 

$

418,040

 

 

See Notes to Consolidated Financial StatementsThe accompanying notes are an integral part of these consolidated financial statements.

 


NANOMETRICS INCORPORATED

F-8


Table of Contents

ONTO INNOVATION INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

30,202

 

 

$

44,035

 

 

$

2,905

 

Reconciliation of net income to net cash provided

   by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

6,920

 

 

 

8,295

 

 

 

9,075

 

Stock-based compensation

 

 

8,819

 

 

 

7,666

 

 

 

6,248

 

Excess tax benefit from equity awards

 

 

 

 

 

1,036

 

 

 

 

Disposal of fixed assets

 

 

631

 

 

 

478

 

 

 

1,121

 

Inventory write-down

 

 

2,020

 

 

 

2,110

 

 

 

2,645

 

Deferred income taxes

 

 

6,858

 

 

 

(16,783

)

 

 

345

 

Changes in fair value of contingent payments to Zygo Corporation

 

 

 

 

 

(1,175

)

 

 

(56

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(19,523

)

 

 

(2,707

)

 

 

(12,610

)

Inventories

 

 

(18,037

)

 

 

4,526

 

 

 

(16,431

)

Inventories-delivered systems

 

 

923

 

 

 

399

 

 

 

(943

)

Prepaid expenses and other

 

 

(230

)

 

 

905

 

 

 

3,271

 

Accounts payable, accrued and other liabilities

 

 

1,049

 

 

 

2,462

 

 

 

4,167

 

Deferred revenue

 

 

(915

)

 

 

(3,634

)

 

 

1,006

 

Income taxes payable

 

 

1,886

 

 

 

(1,928

)

 

 

828

 

Net cash provided by operating activities

 

 

20,603

 

 

 

45,685

 

 

 

1,571

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Payment for acquisition of certain assets

 

 

(2,000

)

 

 

 

 

 

 

Sales of marketable securities

 

 

53,030

 

 

 

5,955

 

 

 

3,383

 

Maturities of marketable securities

 

 

77,250

 

 

 

38,775

 

 

 

41,863

 

Purchases of marketable securities

 

 

(129,766

)

 

 

(82,864

)

 

 

(41,449

)

Purchases of property, plant and equipment

 

 

(5,204

)

 

 

(3,999

)

 

 

(1,846

)

Net cash (used in) provided by investing activities

 

 

(6,690

)

 

 

(42,133

)

 

 

1,951

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Payments to Zygo Corporation related to acquisition

 

 

 

 

 

(315

)

 

 

(851

)

Proceeds from sale of shares under employee stock option

   plans and purchase plan

 

 

5,576

 

 

 

8,447

 

 

 

3,974

 

Excess tax benefit from equity awards

 

 

 

 

 

(1,036

)

 

 

 

Taxes paid on net issuance of stock awards

 

 

(4,135

)

 

 

(1,822

)

 

 

(1,182

)

Repurchases of common stock under share repurchase plans

 

 

(26,999

)

 

 

-

 

 

 

(1,721

)

Net cash (used in) provided by financing activities

 

 

(25,558

)

 

 

5,274

 

 

 

220

 

Effect of exchange rate changes on cash and cash equivalents

 

 

(518

)

 

 

82

 

 

 

(264

)

Net (decrease) increase in cash and cash equivalents

 

 

(12,163

)

 

 

8,908

 

 

 

3,478

 

Cash and cash equivalents, beginning of period

 

 

47,062

 

 

 

38,154

 

 

 

34,676

 

Cash and cash equivalents, end of period

 

$

34,899

 

 

$

47,062

 

 

$

38,154

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid (refund) for income taxes, net

 

$

3,040

 

 

$

3,767

 

 

$

(826

)

Supplemental disclosure of non-cash investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Transfer of inventory to property, plant and equipment, net

 

$

2,451

 

 

$

2,345

 

 

$

1,469

 

Property, plant and equipment included in accounts payable

 

$

957

 

 

$

683

 

 

$

36

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

1,910

 

 

$

45,096

 

 

$

32,909

 

Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation

 

 

5,965

 

 

 

4,848

 

 

 

3,990

 

Amortization of intangibles

 

 

10,445

 

 

 

1,534

 

 

 

1,940

 

Share-based compensation

 

 

10,585

 

 

 

6,062

 

 

 

5,670

 

Acquired inventory step-up amortization

 

 

15,370

 

 

 

 

 

 

 

Provision for doubtful accounts and inventory valuation

 

 

11,202

 

 

 

3,335

 

 

 

3,608

 

Deferred income taxes

 

 

(4,116

)

 

 

2,163

 

 

 

17,207

 

Other, net

 

 

2,098

 

 

 

1,265

 

 

 

590

 

Change in operating assets and liabilities net of assets acquired and liabilities assumed in merger:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(9,721

)

 

 

706

 

 

 

430

 

Income taxes

 

 

7,648

 

 

 

1,056

 

 

 

(4,727

)

Inventories

 

 

(9,338

)

 

 

(31,545

)

 

 

(4,218

)

Prepaid expenses and other assets

 

 

(5,079

)

 

 

(3,101

)

 

 

(1,686

)

Accounts payable

 

 

(12,138

)

 

 

3,512

 

 

 

3,198

 

Accrued and other liabilities

 

 

(6,685

)

 

 

163

 

 

 

5,260

 

Net cash and cash equivalents provided by operating activities

 

 

18,146

 

 

 

35,094

 

 

 

64,171

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of marketable securities

 

 

(127,462

)

 

 

(140,018

)

 

 

(164,661

)

Proceeds from sales of marketable securities

 

 

94,486

 

 

 

186,332

 

 

 

143,349

 

Purchases of property, plant and equipment

 

 

(6,802

)

 

 

(7,542

)

 

 

(10,210

)

Cash acquired from merger

 

 

43,882

 

 

 

 

 

 

 

Cash advance on convertible note receivable

 

 

 

 

 

(5,000

)

 

 

 

Purchase of intangible assets

 

 

 

 

 

 

 

 

(1,000

)

Net cash and cash equivalents provided by (used in) investing activities

 

 

4,104

 

 

 

33,772

 

 

 

(32,522

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Redemption of stock warrants

 

 

 

 

 

 

 

 

(1,025

)

Purchases of common stock

 

 

(744

)

 

 

(21,069

)

 

 

 

Tax payments related to shares withheld for share-based compensation plans

 

 

(2,540

)

 

 

(1,921

)

 

 

(1,358

)

Payment of contingent consideration for acquired business

 

 

(1,758

)

 

 

(1,543

)

 

 

(792

)

Issuance of shares through share-based compensation plans

 

 

844

 

 

 

624

 

 

 

623

 

Net cash and cash equivalents used in financing activities

 

 

(4,198

)

 

 

(23,909

)

 

 

(2,552

)

Effect of exchange rate changes on cash and cash equivalents

 

 

233

 

 

 

(339

)

 

 

814

 

Net increase in cash and cash equivalents

 

 

18,285

 

 

 

44,618

 

 

 

29,911

 

Cash and cash equivalents at beginning of year

 

 

112,388

 

 

 

67,770

 

 

 

37,859

 

Cash and cash equivalents at end of year

 

$

130,673

 

 

$

112,388

 

 

$

67,770

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes paid (received), net

 

$

(3,848

)

 

$

4,301

 

 

$

14,605

 

Litigation settlement received

 

$

 

 

$

 

 

$

13,000

 

See Notes to Consolidated Financial Statements

The accompanying notes are an integral part of these consolidated financial statements.

 

F-9


NANOMETRICS INCORPORATED


Table of ContentsNOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

Note 1. NatureONTO INNOVATION INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the years ended December 31, 2019, 2018 and 2017

(In thousands)

 

 

Common Stock

 

 

Additional Paid-in

 

 

Accumulated

Other

Comprehensive

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Deficit

 

 

Total

 

Balance at December 31, 2016

 

 

25,033

 

 

$

31

 

 

$

381,189

 

 

$

(2,779

)

 

$

(84,706

)

 

$

293,735

 

Issuance of shares through share-based

   compensation plans, net

 

 

348

 

 

 

1

 

 

 

623

 

 

 

 

 

 

 

 

 

624

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,909

 

 

 

32,909

 

Share-based compensation

 

 

 

 

 

 

 

 

5,670

 

 

 

 

 

 

 

 

 

5,670

 

Cumulative effect of a change in accounting

    for share-based compensation

 

 

 

 

 

 

 

 

72

 

 

 

 

 

 

(72

)

 

 

 

Share-based compensation plan

    withholdings

 

 

(47

)

 

 

 

 

 

(1,358

)

 

 

 

 

 

 

 

 

(1,358

)

Redemption of stock warrants

 

 

82

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency translation

 

 

 

 

 

 

 

 

 

 

 

1,663

 

 

 

 

 

 

1,663

 

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

(89

)

 

 

 

 

 

(89

)

Balance at December 31, 2017

 

 

25,416

 

 

 

32

 

 

 

386,196

 

 

 

(1,205

)

 

 

(51,869

)

 

 

333,154

 

Issuance of shares through share-based

   compensation plans, net

 

 

358

 

 

 

 

 

 

624

 

 

 

 

 

 

 

 

 

624

 

Repurchase of common stock

 

 

(853

)

 

 

(1

)

 

 

(21,068

)

 

 

 

 

 

 

 

 

(21,069

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45,096

 

 

 

45,096

 

Share-based compensation

 

 

 

 

 

 

 

 

6,062

 

 

 

 

 

 

 

 

 

6,062

 

Share-based compensation plan

    withholdings

 

 

(66

)

 

 

 

 

 

(1,921

)

 

 

 

 

 

 

 

 

(1,921

)

Currency translation

 

 

 

 

 

 

 

 

 

 

 

(194

)

 

 

 

 

 

(194

)

Unrealized gain on investments

 

 

 

 

 

 

 

 

 

 

 

136

 

 

 

 

 

 

136

 

Balance at December 31, 2018

 

 

24,855

 

 

 

31

 

 

 

369,893

 

 

 

(1,263

)

 

 

(6,773

)

 

 

361,888

 

Effect of merger

 

 

25,060

 

 

 

19

 

 

 

890,112

 

 

 

 

 

 

 

 

 

890,131

 

Issuance of shares through share-based

   compensation plans, net

 

 

377

 

 

 

 

 

 

2,131

 

 

 

 

 

 

 

 

 

2,131

 

Repurchase of common stock

 

 

(30

)

 

 

 

 

 

(744

)

 

 

 

 

 

 

 

 

(744

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,910

 

 

 

1,910

 

Share-based compensation

 

 

 

 

 

 

 

 

10,585

 

 

 

 

 

 

 

 

 

10,585

 

Share-based compensation plan

    withholdings

 

 

(78

)

 

 

 

 

 

(2,540

)

 

 

 

 

 

 

 

 

(2,540

)

Currency translation

 

 

 

 

 

 

 

 

 

 

 

709

 

 

 

 

 

 

709

 

Unrealized loss on investments

 

 

 

 

 

 

 

 

 

 

 

(44

)

 

 

 

 

 

(44

)

Balance at December 31, 2019

 

 

50,184

 

 

$

50

 

 

$

1,269,437

 

 

$

(598

)

 

$

(4,863

)

 

$

1,264,026

 

The accompanying notes are an integral part of Business, these consolidated financial statements

F-10


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

1.

Organization and Nature of Operations:

Onto Innovation Inc. (“Onto Innovation” or the “Company”) is a worldwide leader in the design, development, manufacture and support of process control tools that perform macro-defect inspections and metrology, lithography systems, and process control analytical software used by semiconductor and advanced packaging device manufacturers. The Company’s products are also used in a number of other high technology industries including: silicon wafer substrates; light emitting diode (“LED”); vertical-cavity surface-emitting laser (“VCSEL”); micro-electromechanical system (“MEMS”); CMOS image sensor (“CIS”); power device; RF filter; data storage; and certain industrial and scientific applications.  The Company provides process and yield management solutions used in bare silicon wafer production and wafer processing facilities, often referred to as “front-end” manufacturing and device packaging and test facilities, (or “back-end” manufacturing), respectively through a portfolio of standalone systems for macro-defect inspection, packaging lithography, probe card test and analysis, as well as transparent and opaque thin film measurements. Our automated and integrated metrology systems measure critical dimensions, device structures, topography, shape, and various thin film properties, including three-dimensional features and film thickness, as well as optical, electrical and material properties. Our primary area of focus are products that provide critical yield-enhancing information, which is used by microelectronic device manufacturers to drive down costs and to decrease the time to market of their devices. All of Onto Innovation’s systems feature sophisticated software and production-worthy automation. In addition, the Company’s advanced process control software portfolio includes powerful solutions for standalone tools, groups of tools, factory-wide, and enterprise-wide suites to enhance productivity and achieve significant cost savings. Onto Innovation’s systems are backed by worldwide customer service and applications support. The Company has branch sales and service offices or subsidiaries in Korea, Japan, China, Taiwan, Singapore and in several countries in Europe. The Company operates in a single reportable segment and is a provider of process characterization equipment and software for wafer fabs and advanced packaging facilities.

Basis of PresentationPresentation. As further discussed in Note 3 of Notes to the Consolidated Financial Statements, Rudolph Technologies, Inc. (“Rudolph”) and Significant Accounting Policies

Description of Business Nanometrics Incorporated (“Nanometrics” or) completed a merger effective October 25, 2019 (the “Merger”).  Upon consummation of the “Company”Merger, the combined company was renamed Onto Innovation.  The Merger was accounted for as a reverse acquisition where Rudolph was the accounting acquirer and Nanometrics was the legal acquirer in accordance with Accounting Standards Codification (“ASC”) Topic 805, “Business Combinations” (“ASC 805”).  Accordingly, Rudolph’s historical results of operations replaced the Nanometrics historical results of operations for all periods prior to the merger.  Specifically, the accompanying Consolidated Financial Statements for all periods prior to the Merger are those of Rudolph and its wholly-owned subsidiaries design, manufacture, market, sellfor the period after the Merger, also include Nanometrics.  The Consolidated Financial Statements reflect the assets and support optical critical dimension ("OCD"), thin filmliabilities of Rudolph at historical cost basis and overlay dimension metrologythe assets and inspection systems used primarilyliabilities of Nanometrics are reflected at fair value under the acquisition method.  While Rudolph applied the acquisition method of accounting to Nanometrics, the legal capital in the manufacturingcurrent and prior periods has been retroactively adjusted to reflect the legal capital of semiconductors, solar photovoltaics (“solar PV”)Nanometrics.  Accordingly, earnings per share has been retroactively restated for periods prior to the merger date.

Reclassifications. In conjunction with the Merger, the Company assessed the need to realign its financial statement presentation and high-brightness LEDs (“HB-LED”),certain income statement classifications were adjusted with prior periods reclassified to conform with current period presentation. The changes made were as well as by customers in the silicon wafer and data storage industries. Nanometrics' metrology systems precisely measure a wide rangefollows:

Amounts related to sales and marketing are now presented on a separate line on the Consolidated Statements of Operations and were previously reported under the caption “Selling, general and administrative.”

Amounts related to applications engineering are now presented under the caption, “Sales and marketing” on the Consolidated Statements of Operations and were previously reported under the caption “Research and development.”

Certain line items on the prior period Consolidated Balance Sheet were combined to conform to current period presentation. For additional information on the Company’s balance sheet details, see Note 9 of Notes to the Consolidated Financial Statements.

F-11


Table of film types deposited on substrates during manufacturing to control manufacturing processes and increase production yields in the fabrication of integrated circuits. The Company’s OCD technology is a patented critical dimension measurement technology that is used to precisely determine the dimensions on the semiconductor wafer that directly control the resulting performance of the integrated circuit devices. The thin film metrology systems use a broad spectrum of wavelengths, high-sensitivity optics, proprietary software, and patented technology to measure the thickness and uniformity of films deposited on silicon and other substrates as well as their chemical composition. The overlay metrology systems are used to measure the overlay accuracy of successive layers of semiconductor patterns on wafers in the photolithography process. Nanometrics' inspection systems are used to find defects on patterned and unpatterned wafers at nearly every stage of the semiconductor production flow. The corporate headquarters of Nanometrics is located in Milpitas, California.Contents

Basis of Presentation

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

2.

Summary of Significant Accounting Policies:

Consolidation. The consolidated financial statements include Nanometrics Incorporatedreflect the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminatedeliminated.

Revenue Recognition. Revenue is recognized when control of the promised goods or services are transferred to the Company’s customers in consolidation.

Fiscal Yearan amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. The Company utilizesaccounts for a 52/53 week fiscal year endingcontract when it has approval and commitment from both parties, the rights of the parties and payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

The Company has elected to account for shipping and handling activities as the fulfillment of a promise to transfer goods to the customer and therefore records these activities under the caption “Cost of revenue.” Sales tax and any other taxes collected concurrent with revenue producing activities are excluded from revenue. Incidental items that are immaterial in the context of the contract are recognized as expense. These accounting policy elections are consistent with the manner in which the Company has historically recorded these items.

Contracts with customers may include multiple performance obligations. For such arrangements, the Company allocates revenue to each performance obligation based on its relative standalone selling price. The Company generally determines standalone selling prices based on the last Saturdayprices charged to customers or the expected cost-plus margin.

Systems and Software Revenue

Revenue from systems is recognized when the Company transfers control of the calendar year. For eachproduct to the customer. To indicate transfer of fiscal years ended Decembercontrol, the Company must have a present right to payment, legal title must have passed to the customer and the customer must have the significant risks and rewards of ownership. The Company generally transfers control for system sales when the customer or the customer’s agent picks up the system at the Company’s facility. Payment for the majority of the Company’s systems have 80-90% of the invoice amount due within 30 2017, December 31, 2016,days and December 26, 2015, the remaining amount due upon completion of installation, recalibration and qualification by the customer. The Company provides an assurance warranty on its systems for a period presented consistedof twelve to fourteen months against defects in material and workmanship. The Company provides for the estimated cost of product warranties at the time revenue is recognized.

Depending on the terms of the systems arrangement, the Company may also defer the recognition of a 52-weekportion of the consideration expected to be received because the Company has to satisfy a future obligation (e.g., installation, training and extended warranties). The Company uses an observable price to determine the standalone selling price for separate performance obligations or a cost-plus margin approach when one is not available.

Revenue from software licenses provides the customer with a right to use the software as it exists when made available to the customer. Revenue from software licenses are recognized upfront at the point in time when the software is made available to the customer. Revenue from licensing support and maintenance is recognized as the support and maintenance are provided, which is over the contract period. Payment for software licensing, support and maintenance is generally due in 30 days.

Parts Revenue

Revenue from parts is recognized when the Company transfers control of the product, which typically occurs when the Company ships the product from its facilities to the customer. Payment for parts is generally due in 30 days.

Services Revenue

Revenue from services primarily consists of service contracts, which provide additional maintenance coverage beyond the Company’s assurance warranty on its products, service labor, consulting and training. Revenue from service contracts is recognized ratably over the term of the service contract. Revenue from service labor, consulting and training is recognized as services are performed. Payment for services is generally due in 30 days. Revenue from installation services is recognized at a point in time when installation is complete.


F-12


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Practical Expedients

The Company generally expenses sales commissions when incurred because the amortization period is one year 53-weekor less. These costs are recorded within selling, general and administrative expenses.

The Company does not adjust the amount of consideration for the effects of a significant financing component as the payment terms are generally one year or less.

The Company does not disclose the value of remaining performance obligations for contracts with an original expected length of one year or less and 52-week year, respectively.contracts for which the Company recognizes revenue in the amount to which it has the right to invoice.

Upgrade Revenue and Related Cost - BeginningFor additional information on the first quarterCompany’s revenue recognition, see Note 11 of 2016, revenues associated with upgrade sales are now includedNotes to the Consolidated Financial Statements.

BusinessCombinations.  We account for business combinations under Products Revenues,the acquisition method of accounting, which requires us to recognize separately from goodwill the assets acquired, and the related costs in Cost of Products Revenue. This change was dueliabilities assumed at their acquisition date fair values. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the typesassets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of upgrades currently being sold, whichthe measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are primarily system softwarerecognized in our consolidated statements of operations. Accounting for business combinations requires our management to make significant estimates and hardware performance upgrades to extendassumptions, especially at the featuresacquisition date including our estimates for intangible assets, contractual obligations assumed, restructuring liabilities, pre-acquisition contingencies, and functionality of a product. Previously upgrades consisted of a group of parts and/or software that changecontingent consideration, where applicable. Although we believe the existing configuration of a product. For the twelve months ended December 30, 2017,assumptions and December 31, 2016, $12.1 million and $11.0 million, respectively, of upgrade sales and $2.7 million and $2.4 million of costs, respectively, are included in Products Revenues and Cost of Products Revenues. For the year ended December 26, 2015, $7.9 million related to upgrade sales, and $3.0 million of costs, are included in Service Revenues and Costs of Service Revenues, respectively,estimates we have made in the accompanying Condensedpast have been reasonable and appropriate, they are based, in part, on historical experience and information obtained from the management of the acquired companies and are inherently uncertain. Estimates in valuing certain acquired intangible assets under the income approach include growth in future expected cash flows from product sales, acquired technologies, technology obsolescence rates, estimated cash flows from the projects when completed and discount rates. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results.

For additional information on the Company’s business combinations, see Note 3 of Notes to the Consolidated Statement of Operations.Financial Statements.

Use of EstimatesEstimates.  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities atas of the date of the financial statements and the reported amounts of revenuesrevenue and expenses during the reportedreporting period. Significant estimates made by management include the allowances for doubtful accounts and convertible notes receivable, excess and obsolete inventory, fair value of assets acquired and liabilities assumed in a business combination, recoverability and useful lives of property, plant and equipment and identifiable intangible assets, recoverability of goodwill, recoverability of deferred tax assets, liabilities for product warranty, contingencies, including litigation reserves and share-based payments and liabilities for tax uncertainties. Actual results could differ materially from those estimates. Estimates are used for, but not limited to, revenue recognition, the provision for doubtful accounts, the provision for excess, obsolete, or slow-moving inventories, valuation of intangible and long-lived assets, warranty accruals, income taxes, valuation of stock-based compensation, and contingencies.

Foreign Currency Translation – The assets and liabilities of foreign subsidiaries are translated from their respective local functional currencies at exchange rates in effect at the balance sheet date and income and expense accounts are translated at average exchange rates during the reporting period. Resulting translation adjustments are reflected in “Accumulated other comprehensive income,” a component of stockholders’ equity. Foreign currency transaction gains and losses, as well as remeasurement of assets and liabilities denominated in a currency other than the functional currency are reflected in “Other income (expense)” in the consolidated statements of operations in the period incurred, and consists of a $0.6 million loss, a $0.4 million loss and a $0.5 million gain for the years ended December 30, 2017, December 31, 2016, and December 26, 2015, respectively.

Revenue Recognition –  The Company derives revenue from the sale of process control metrology and inspection systems and related upgrades (“product revenue”) as well as spare part sales, billable service and service contracts (together “service revenue”). Upgrades are system software and hardware performance upgrades that extend the features and functionality of a product. As discussed above, commencing in the first quarter of 2016, upgrades are included in product revenue, which consists of sales of complete, advanced process control metrology and inspection systems (the “system(s)”). Nanometrics’ systems consist of hardware and software components that function together to deliver the essential functionality of the system. Arrangements for sales of systems and upgrades often include defined customer-specified acceptance criteria.

47


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

In summary, the Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the seller's price is fixed or determinable, and collectability is reasonably assured.

For repeat product sales to existing customers, revenue recognition occurs at the time title and risk of loss transfer to the customer, which usually occurs upon shipment from the Company's manufacturing location, if it can be reliably demonstrated that the product has successfully met the defined customer specified acceptance criteria and all other recognition criteria have been met. For initial sales where the product has not previously met the defined customer specified acceptance criteria, product revenues are recognized upon the earlier of receipt of written customer acceptance or expiration of the contractual acceptance period. In Japan, where contractual terms with the customer specify risk of loss and title transfers upon customer acceptance, revenue is recognized upon receipt of written customer acceptance, provided that all other recognition criteria have been met.

The Company warrants its products against defects in manufacturing. Upon recognition of product revenue, a liability is recorded for anticipated warranty costs. On occasion, customers request a warranty period longer than the Company's standard warranty. In those instances, where extended warranty services are separately quoted to the customer, the associated revenue is deferred and recognized as service revenue ratably over the term of the extended warranty period. The portion of service contracts and extended warranty services agreements that are uncompleted at the end of any reporting period are included in deferred revenue.

As part of its customer services, the Company sells software that is considered to be an upgrade to a customer's existing systems. These standalone software sales are not essential to the tangible product's functionality and are accounted for under software revenue recognition rules which require vendor specific objective evidence (“VSOE”) of fair value to allocate revenue in a multiple element arrangement. Revenue from software sales is recognized when the software is delivered to the customer, provided that all other recognition criteria have been met.

The majority of other upgrades are sold based on published specifications. For simple upgrades that do not require major configuration, revenue is recognized at the time title and risk of loss transfer to the customer, which is usually upon shipment. For complex and extensive upgrades, specific acceptance or prior acceptance for a similar upgrade is required in order to recognize revenue.

Revenue related to spare parts is recognized upon shipment. Revenue related to billable services is recognized as the services are performed. Service contracts may be purchased by the customer during or after the warranty period and revenue is recognized ratably over the service contract period.

Frequently, the Company delivers products and various services in a single transaction. The Company's deliverables consist of tools, installation, upgrades, billable services, spare parts, and service contracts. The Company's typical multi-element arrangements include a sale of one or multiple tools that include installation and standard warranty. Other arrangements consist of a sale of tools bundled with service elements or delivery of different types of services. The Company's tools, upgrades, and spare parts are generally delivered to customers within a period of up to six months from order date. Installation is usually performed soon after delivery of the tool. The portion of revenue associated with installation is deferred based on relative selling price and that revenue is recognized upon completion of the installation and receipt of final acceptance. Billable services are billed on a time and materials basis and performed as requested by customers. Under service contract arrangements, services are provided as needed over the fixed arrangement term, which terms can be up to twelve months. The Company does not grant its customers a general right of return or any refund terms and imposes a penalty on orders cancelled prior to the scheduled shipment date.

The Company regularly evaluates its revenue arrangements to identify deliverables and to determine whether these deliverables are separable into multiple units of accounting. The Company allocates the arrangement consideration among the deliverables based on relative selling prices. The Company has established VSOE for some of its products and services when a substantial majority of selling prices falls within a narrow range when sold separately. For deliverables with no established VSOE, the Company uses best estimate of selling price to determine standalone selling price for such deliverable. The Company does not use third party evidence to determine standalone selling price since this information is not widely available in the market as the Company's products contain a significant element of proprietary technology and the solutions offered differ substantially from competitors. The Company has established a process for developing estimated selling prices, which incorporates historical selling prices, the effect of market conditions, gross margin objectives, pricing practices, as well as entity-specific factors. The Company monitors and evaluates estimated selling price on a regular basis to ensure that changes in circumstances are accounted for in a timely manner.

48


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

When certain elements in multiple-element arrangements are not delivered or accepted at the end of a reporting period, the relative selling prices of undelivered elements are deferred until these elements are delivered and/or accepted. If deliverables cannot be accounted for as separate units of accounting, the entire arrangement is accounted for as a single unit of accounting and revenue is deferred until all elements are delivered and all revenue recognition requirements are met.

Cash and Cash EquivalentsEquivalents. Cash and Marketable Securities – The Company considers allcash equivalents include cash and highly liquid investmentsdebt instruments with original maturities of three months or less when purchased,purchased.

MarketableSecurities. The Company determined that all of its investment securities are to be cash equivalents. Marketableclassified as available-for-sale. Available-for-sale debt securities are classified as “available-for-sale” and are reportedcarried at fair value, with the unrealized gains and losses reported in stockholders'stockholders’ equity as a component ofunder the caption “Accumulated other comprehensive income. The cost ofloss.” Realized gains and losses and, interest and dividends on available-for-sale securities sold is based on the specific identification method. The Company classifies its investmentsare included in interest income and other, net. Available-for-sale securities are classified as current based on the natureassets regardless of the investment and their availabilitymaturity date if they are available for use in current operations. The Company reviews its investment portfolio quarterlyto identify and evaluate investments that have indications of possible impairment. Factors considered in

F-13


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, credit quality and the Company’s ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. When a decline in fair value is determined to be other-than-temporary, unrealized losses on available-for-sale securities are charged against earnings. The specific identification method is used to determine if any securities may be other-than-temporarily impaired due to increased credit risk, changes in industry or sector of a certain instrument or ratings downgrades.

Fair Value of Financial Instruments – Financial instruments include cash and cash equivalents, accounts receivable and accounts payable. Cash equivalents are stated at fair market value based on quoted market prices. The carrying values of accounts receivable and accounts payable approximate their fair values because of the short-term maturity of these financial instruments.

Derivatives – The Company enters into foreign currency forward exchange contracts to protect against currency exchange risks associated with existing assets and liabilities. A foreign currency forward exchange contract acts as a hedge by increasing in value when underlying assets decrease in value or underlying liabilities increase in value due to changes in foreign exchange rates. Conversely, a foreign currency forward exchange contract decreases in value when underlying assets increase in value or underlying liabilities decrease in value due to changes in foreign exchange rates. These forward contracts are not designated as accounting hedges, so the unrealized gains and losses are recognized in other income, net, in advanceon marketable securities.

For additional information on the Company’s marketable securities, see Note 5 of Notes to the actual foreign currency cash flows with the fair value of these forward contracts being recorded as accrued liabilities or other current assets. Consolidated Financial Statements.

AllowanceforDoubtfulAccounts.  The Company does not use forward contracts for trading purposes.

Allowance for Doubtful Accounts – The Company maintains allowances for estimated losses resulting from the inability of its customers to make required payments. Credit limits are established through a process of reviewing the financial history and stability of its customers. Where appropriate and available, the Company obtains credit rating reports and financial statements of customers when determining or modifying their credit limits. The Company regularly evaluates the collectability of its tradeaccounts receivable balances based on a combination of factors such asfactors. Where the Company is aware of circumstances that may impair a specific customer’s ability to meet its financial obligation, the Company records a specific allowance against amounts due, thereby reducing the net recognized receivable to the amount management reasonably believes will be collected. For all other customers, the Company recognizes allowances for doubtful accounts based on the length of time the receivables are past due, customary payment practices inoutstanding, industry and geographic concentrations, the respective geographiescurrent business environment and historical collection experience with customers. The Company believes that its allowance for doubtful accounts adequately reflects the risk associated with its receivables. If the financial conditions of a customer were to deteriorate, resulting in their inability to make payments, the Company may need to record additional allowances, which would result in additional general and administrative expenses being recorded for the period in which such determination was made.experience.

Inventories.  Inventories are stated at the lower of cost which approximates actual costor net realizable value.  Net realizable value is the estimated selling prices in the ordinary course of business, less predictable costs of completion, disposal and transportation.  Cost is generally determined on a first-in, first-out basis, or net realizable value.and includes material, labor and manufacturing overhead costs. The Company is exposedreviews and sets standard costs as needed, but at a minimum, on an annual basis, at current manufacturing costs in order to a number of economic and industry factors that could result in portions of inventory becoming either obsolete or in excess of anticipated usage, or saleable only for amounts that are less than their carrying amounts. These factors include, but are not limited to, technological changes in the market, the Company’s ability to meet changing customer requirements, competitive pressures in products and prices, and the availability of key components from suppliers. approximate actual costs.

The Company has establishedevaluates inventories for excess quantities and obsolescence. The Company establishes inventory reserves when conditions exist that suggest that inventory may be in excess of anticipated demand or is obsolete based upon assumptions about historical and future demand for the Company’s products and market conditions. In addition, inventories are evaluated for potential obsolescence due to the effect of known and anticipated engineering design changes. Once a reserve has been established, it is maintained until the partitem to which it relates is soldscrapped or is otherwise disposed of.sold. The Company regularly evaluates its ability to realize the value of inventory based on a combination of factors including the following: historical usage rates, forecasted sales of usage, product end-of-life dates, estimated current and future market values and new product introductions. For demonstration inventory, the Company also considers the age of the inventory and potential cost to refurbish the inventory prior to sale. Demonstration inventory is amortized over its useful life and the amortization expense is included in total inventory write down on the statements of cash flows. When recorded, reserves are intended to reduce the carrying value of the Company’s inventory to its net realizable value. If actual demand for the Company’s products deteriorates, or market conditions are less favorable than those that the Company projects, additional reserves may be required.Charges to Cost of revenue for excess and obsolete inventories totaled $10,841 in 2019.  Included in this amount is a charge of $5,945 recorded in the fourth quarter related to excess inventory from a deemphasized product line and the rationalization of service inventory after the Merger.   In 2018 and 2017, the Company recorded charges of $3,042 and $3,833, respectively.

Inventories – delivered systems – The Company reflects the cost of systems that were invoiced upon shipment but deferred for revenue recognition purposes separate from its inventory held for sale as “Inventories – delivered systems.”

49


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Property, Plant and EquipmentEquipment.Property, plant and equipment are stated at cost. Depreciation and amortization is computed using the straight–line method over the following estimated useful lives of the assets:

Building and Improvements

5-40 years

Machineryproperty, plant and equipment

3-10 years

Furniture and fixtures

3-10 years

Software

3-7 years

Goodwill and Intangible Assets – Goodwill is initially recorded when the purchase price paid for an acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Intangible assets with finite lives are amortized over their respective useful lives on a straight-line basis and are also evaluated annually for impairment or whenever events or circumstances occur which indicate that those assets might be impaired. Goodwill and indefinite lived assets are not amortized but tested annually for impairment. The Company’s impairment review process is completed during the fourth quarter of each year or whenever events, or circumstances occur which indicate that an impairment may have occurred. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, the Company determines that it is not likely that the fair value of a reporting unit is less than its carrying value, then performing the two-step impairment test is unnecessary. However, if the Company concludes otherwise, then it is required to perform the first step of the two-step goodwill impairment test. The first step requires a comparison of the fair value of Nanometrics’ reporting unit to its net book value. If the fair value of the reporting unit is greater than its carrying value, then no impairment is deemed to have occurred. If the fair value is less, then the second step must be performed to determine the amount, if any, of actual impairment. Amortization of intangible assets with finite lives is computed using the straight-line method over the following estimated useful lives of the assets:assets, which are five to twenty-two years for buildings, three to ten years for machinery and equipment, three to ten years for furniture and fixtures, three years for computer equipment, and three to seven years for software. Leasehold improvements are amortized using the straight-line method over the lesser of the lease term or the estimated useful life of the related asset. Repairs and maintenance costs are expensed as incurred and major renewals and betterments are capitalized.

 

Developed technology


5-10 years

Customer relationships

2-10 years

Brand name

5-10 years

Patented technology

7-10 years

Trademark

5 years

 

F-14


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Impairment of Long-Lived Assets – The Company evaluates its long-livedAssets.  Long-lived assets, such as property, plant, and equipment, and identifiable acquired intangible assets with definite useful lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When the sumRecoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future net cash flows expected to result frombe generated by the useasset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset and its eventual disposition is less than its carrying amount, impairment may exist. To determine the amount of impairment, the Company comparesexceeds the fair value of the asset, which is generally based on discounted cash flows. For the year ended December 31, 2019, there was an impairment to an item in property, plant and equipment of $507, which was recorded in general and administrative expenses in the Consolidated Statements of Operations.  There were 0 impairments of long-lived assets for the years ended December 31, 2018 and 2017.  

Goodwill and Intangible Assets.Intangible assets with finite useful lives are amortized using the straight-line method over their estimated useful lives. Goodwill and indefinite lived assets are tested for impairment on an annual basis or when an event or changes in circumstances indicate that its carrying value.value may not be recoverable. Goodwill impairment is tested at the reporting unit level, which is defined as an operating segment or one level below the operating segment.  The Company has 1 operating segment. NaN goodwill impairment occurred in 2019, 2018, or 2017. Goodwill is reviewed for impairment using either a qualitative assessment or a quantitative goodwill impairment test. If the Company chooses to perform a qualitative assessment and determine the fair value more likely than not exceeds the carrying value, no further evaluation is necessary. When the Company performs the quantitative goodwill impairment test, it compares fair value to carrying value, which includes goodwill. If fair value exceeds carrying value, the goodwill is not considered impaired. If the carrying value ofis higher than the asset exceeds its fair value, the difference would be recognized as an impairment loss equalloss.

For additional information on the Company’s goodwill and purchased intangible assets, see Note 6 of Notes to the difference is recognized. See Note 7, "Goodwill and Intangible Assets" for further details.Consolidated Financial Statements.

Income Tax Assets and Liabilities – The Company accounts for income taxes such that deferred tax assets and liabilities must be recognized using enacted tax rates for the effectConcentration of temporary differences between the book and tax accounting for assets and liabilities. Also, deferred tax assets are reduced by a valuation allowance to the extent that management cannot conclude that it is more likely than not that a portion of the deferred tax asset will be realized in the future. The Company evaluates the deferred tax assets on a continuous basis throughout the year to determine whether or not a valuation allowance is appropriate. Factors used in this determination include future expected income and the underlying asset or liabilityCredit Risk. Financial instruments, which generated the temporary tax difference. The income tax provision is primarily impacted by federal statutory rates, state and foreign income taxes and changes in the valuation allowance.

Product Warranties – The Company sells the majority of its products with a twelve-month repair or replacement warranty from the date of acceptance, which generally represents the date of shipment. The Company provides an accrual for estimated future warranty costs based upon the historical relationship of warranty costs to the cost of products sold. The estimated future warranty obligations related to product sales are reported in the period in which the related revenue is recognized. The estimated future warranty obligations are affected by the warranty periods, sales volumes, product failure rates, material usage and labor and replacement costs incurred in correcting a product failure. If actual product failure rates, material usage, labor or replacement costs differ from the Company’s estimates, revisions to the estimated warranty obligations would be required. For new product introductions where limited or no historical information exists,potentially subject the Company may use warranty information from other previous product introductions to guide it in estimating the warranty accrual. The warranty accrual represents the best estimate of the amount necessary to settle future and existing claims on products sold as of the balance sheet date. The Company periodically assesses the adequacy of its recorded warranty reserve and adjusts the amounts in accordance with changes in these factors.

50


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Shipping and Handling Costs – Shipping and handling costs are included as a component of cost of net revenues.

Advertising Costs – The Company expenses advertising costs as incurred. Advertising costs were $0.2 million in 2017, $0.2 million in 2016, and $0.3 million in 2015.

Defined Employee Benefit Plans – The Company maintains a defined benefit pension plan in Taiwan for which current service costs are charged to operations as they accrue based on services rendered by employees during the year. Pension benefit obligations are determined by using management’s actuarial assumptions, including discount rates, assumed asset rates of return, compensation increases and employee turnover rates.

Net Income Per Share - Basic net income per share excludes dilution and is computed by dividing net income by the number of weighted average common shares outstanding for the period. Diluted net income per share reflects the potential dilution from outstanding dilutive stock options (using the treasury stock method), restricted stock units subject to vesting and shares issuable under the employee stock purchase plan. In applying the treasury stock method 0.6 million, 0.5 million and 0.3 million stock option shares for fiscal year 2017, 2016 and 2015, respectively, were included in the calculation of diluted shares.  

Certain Significant Risks and Uncertainties – Financial instruments that potentially subject us to a concentrationconcentrations of credit risk, consist primarily of cash, cash equivalents, marketable securities, and accounts receivable. The Company'sreceivable, cash and cash equivalents are primarily invested in deposit accounts and money market accounts with large financial institutions. At times, these deposits and securities may exceed federally insured limits; however, the Company has not experienced any losses on such accounts.marketable securities. The Company investsperforms ongoing credit evaluations of its customers and generally does not require collateral for sales on credit. The Company maintains allowances for potential credit losses. The Company maintains cash not required for use in operations in highand cash equivalents and marketable securities with higher credit quality securities based onissuers and monitors the Company's investment policy.amount of credit exposure to any one issuer. The Company's investment policy provides guidelines and limits regarding credit quality, investment concentration, investment type, and maturity that the Company believes will provide liquidity while reducing risk of loss of capital. Investments are of a short-term nature and include investments in commercial paper, corporate debt securities, asset-backed securities, U.S. Treasury, U.S. Government, and U.S. Agency debt.

The Company sells its products primarily to end users in the United States, Asia and Europe and, generally, does not require its customers to provide collateral or other security to support accounts receivable. Management performs ongoing credit evaluations of its customers’ financial condition and maintains an allowance for estimated potential bad debt losses. The Company’s customer base is highly concentrated and historically, a relatively small number of customers have accounted for a significant portion of its revenues. Aggregate revenue from the Company's top five largest customers in 2017, 2016 and 2015 consisted of 73%, 73% and 69%, respectively, of its total net revenues. The Company participates in a dynamic high technology industry and believes that changes in any of the following areas could have a material adverse effect on its future financial position, results of operations or cash flows: advances and trends in new technologies and industry standards; competitive pressures in the form of new products or price reductions on current products; changes in product mix; changes in the overall demand for products offered; changes in third-party manufacturers; changes in key suppliers; changes in certain strategic relationships or customer relationships; litigation or claims against the Company based on intellectual property, patent, product, regulatory or other factors; fluctuations in foreign currency exchange rates; risk associated with changes in domestic and international economic and/or political regulations; availability of necessary components or sub-assemblies; disruption of manufacturing facilities; and its ability to attract and retain employees necessary to support its growth.

Certain components and sub-assemblies used in the Company’s products are purchased from a sole supplier or a limited group of suppliers. In particular, theThe Company currently purchases its spectroscopic ellipsometer and robotics used in its advanced measurement systems from a sole supplier or a limited group of suppliers located in the United States. Any shortage or interruption in the supply of any of the components or sub-assemblies used in its products or its inability to procure these

F-15


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

components or sub-assemblies from alternate sources on acceptable terms could have a material adverse effect on its business, financial condition and results of operations.

Note 2. Recent Accounting Pronouncements

Accounting Standards Adopted

In March 2016, the FASB issued an accounting standard update that simplifies several aspects of the accounting for share-based payment award transactions, including income tax consequences, classification of awards as equity or liability, and classification on the statement of cash flows. The new standard requires adoption of certain amendments relevant to the Company to be applied using a modified retrospective transition method by means of cumulative effect adjustment to retained earnings as of the beginning of the fiscal year 2017.

51


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The new standard permits entities to make an accounting policy election related to how forfeitures will impact the recognition of compensation cost for stock-based compensation. The Company has elected to account for forfeitures as they occur and adopted this change on a modified retrospective basis. The cumulative effect of this change resulted in a $0.1 million increase to accumulated deficit as of January 1, 2017.

Furthermore, the standard requires excess tax benefits and tax deficiencies to be recorded in the income statement when the awards vest or are settled rather than paid-in capital. The Company recorded the cumulative effect of this change as a $1.2 million reduction to accumulated deficit in the first quarter of fiscal 2017 to reflect the recognition of excess tax benefits in prior years, with a corresponding adjustment to deferred tax assets and long-term tax liabilities. The Company adopted the guidance related to the recognition of excess tax benefits and deficiencies as income tax expense or benefit on a modified retrospective basis. In addition, the Company elected to report cash flows related to excess tax benefits on a prospective basis. The presentation requirements for cash flows related to employee taxes paid for withheld shares had no impact to the Company’s statement of cash flows since such cash flows have historically been presented as a financing activity. 

In July 2015, the FASB issued an accounting standard update which simplifies the measurement of inventory by requiring inventory to be measured at the lower of cost and net realizable value. The new standard applies only to inventories for which cost is determined by methods other than last-in-first-out and the retail inventory method. Effective in the first quarter of fiscal 2017, the Company adopted this guidance. The adoption of this guidance did not have a significant impact on the Company’s consolidated financial condition and results of operation.

Accounting Standards Not Yet Adopted

In January 2017, the Financial Accounting Standards Board (the "FASB") issued an accounting standard update which simplifies the subsequent measurement of goodwill and removes step 2 from the goodwill impairment test. Instead, an entity should record an impairment charge based on excess of a reporting unit’s carrying amount over its fair value. The standard is effective for public companies for fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial condition and results of operations.

In October 2016, the FASB issued an accounting standard update which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. This standard will be effective for annual reporting periods beginning after December 15, 2017, including interim reporting period within those annual periods. Early adoption is permitted. This standard update is required to be adopted using the modified retrospective approach, with a cumulative catch-up adjustment to retained earnings in the period of adoption. The Company is currently evaluating the impact of adopting this standard on its consolidated financial condition and results of operations.

In August 2016, the FASB issued an accounting standard which addresses eight specific cash flow classification issues. This update is effective for public companies for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years. Early adoption is permitted, including in an interim period. If early adopted in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period, and all the amendments must be adopted in the same period. The standard is to be applied through a retrospective transition method to each period presented. If it is impracticable to apply retrospectively for some of the issues, the amendments for those issues would be applied prospectively as of the earliest date practicable. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated statement of cash flows.

In June 2016, the FASB issued an accounting standard which requires measurement and timely recognition of expected credit losses for financial assets. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The standard is to be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. The Company is currently evaluating the effect of this update on its consolidated financial condition and results of operations.

52


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

In February 2016, the FASB issued an accounting standard update which requires lessees to record a right-of-use asset and a corresponding lease liability on the balance sheet (with the exception of short-term leases). For lessees, leases will continue to be classified as either operating or financing in the income statement. The standard is effective for public companies for annual reporting periods beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. This standard is required to be applied with a modified retrospective transition approach. Warranties. The Company generally does not finance purchases of equipment or other capital, but does lease some equipment and facilities. The Company is currently evaluating the impact of this standardprovides a warranty on its consolidated financial statementsproducts for a period of twelve to fourteen months against defects in material and related disclosures but anticipates most its existing operating lease commitments will be recognized as operating lease liabilities and right-of-use assets.

In May 2014, the FASB issued an accounting standard update which requires an entity to recognize the amount of revenue to which it expects to be entitled to for transferring promised goods or services to customers. The updated standard replaces most existing revenue recognition guidance in U.S. GAAP when it becomes effective and permits the use of either the retrospective or cumulative effect transition method (“modified retrospective” method). In August 2015, the FASB deferred for one year the effective date of the new revenue standard, with early adoption permitted but not earlier than the original effective date. Consequently, the new standard will be effective for the Company on December 31, 2017 and the Company has determined it will not adopt early.

Based on the Company’s assessment, the Company will adopt the new guidance in the first quarter of fiscal 2018 by using the modified retrospective method of transition. While the Company is concluding its assessment of the impact of the new standard, the Company believes that the timing of revenue recognition for certain systems and performance obligations, will generally occur earlier than under current revenue recognition guidance. Under current U.S. GAAP, revenue for certain systems or performance obligations is delayed until formal customer sign-off has occurred and/or contractual obligations have been met, whereas under the new standard, revenue should be recorded when transfer of control has occurred, which is normally upon shipment. While the Company expects revenue related to these arrangements to remain unchanged in total, the nature of when control transfers may change the timing of revenue recognition. Nanometrics expects the full-year positive impact to the opening balance of retained earnings related to the adoption of the new standard to be in the range of $0.7 million to $1.2 million. This amount reflects the margin related to revenue deferred as of December 30, 2017, that will not be reported as revenue in fiscal 2018. The amount of this revenue is estimated to be between $1.5 million and $2.5 million. This amount will also be reflected as a reduction to the beginning backlog of the first quarter of fiscal 2018. This amount is comprised of goods shipped in fiscal 2017 but deferred due to either lack of customer acceptance or failure of the customer to meet certain contractual commitments. Under the new standard, the Company has determined that transfer of control occurs at the time of shipment for these items and that the deferral of revenue associated with the unbilled amount is no longer appropriate per the new standard. Additionally, the Company believes the adoption of the new standard will not result in a different set of performance obligations, when compared to current GAAP. The Company further believes that required changes to its current business processes and IT systems, to comply with the new standard, will be minor in nature. Other aspects of the standard, including the capitalization of costs related to the acquisition and/or fulfillment of the Company’s contracts are still being evaluated, but the Company believes impacts are immaterial. The Company is concluding its evaluation of the impact of the new standard on the Company’s contracts with customers and will continue to monitor industry activities and other guidance provided by the accounting profession and regulators and adjust its approach and implementation plans as required.

Note 3. Fair Value Measurements and Disclosures

The Company determines the fair values of its financial instruments based on the fair value hierarchy established in FASB Accounting Standards Codification ("ASC") 820, Fair Value Measurement, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into the following three levels that may be used to measure fair value:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.

Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Such unobservable inputs include an estimated discount rate used in the Company's discounted present value analysis of future cash flows, which reflects the Company's estimate of debt with similar terms in the current credit markets. As there is currently minimal activity in such markets, the actual rate could be materially different.

53


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability.

The following tables present the Company’s assets and liabilities measured at estimated fair value on a recurring basis, excluding accrued interest components, categorized in accordance with the fair value hierarchy (in thousands), as of the following dates:

 

 

December 30, 2017

 

 

December 31, 2016

 

 

 

Fair Value Measurements

Using Input Types

 

 

 

 

 

 

Fair Value Measurements

Using Input Types

 

 

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

256

 

 

$

 

 

$

 

 

$

256

 

 

$

959

 

 

$

 

 

$

 

 

$

959

 

Commercial paper

   and corporate debt

   securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,499

 

 

 

 

 

 

2,499

 

Total cash equivalents

 

$

256

 

 

$

 

 

$

 

 

$

256

 

 

$

959

 

 

$

2,499

 

 

$

 

 

$

3,458

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury,

   U.S. Government

   and U.S. Government

   agency debt securities

 

 

 

 

 

1,495

 

 

 

 

 

 

1,495

 

 

 

 

 

 

17,072

 

 

 

 

 

 

17,072

 

Certificate of deposits

 

 

 

 

 

14,497

 

 

 

 

 

 

14,497

 

 

 

 

 

 

23,019

 

 

 

 

 

 

23,019

 

Commercial paper

 

 

 

 

 

7,949

 

 

 

 

 

 

7,949

 

 

 

 

 

 

22,402

 

 

 

 

 

 

22,402

 

Municipal securities and

   corporate debt securities

 

 

 

 

 

47,968

 

 

 

 

 

 

47,968

 

 

 

 

 

 

14,943

 

 

 

 

 

 

14,943

 

Asset backed securities

 

 

 

 

 

10,221

 

 

 

 

 

 

10,221

 

 

 

 

 

 

5,463

 

 

 

 

 

 

5,463

 

Total marketable securities

 

$

 

 

$

82,130

 

 

$

 

 

$

82,130

 

 

$

 

 

$

82,899

 

 

$

 

 

$

82,899

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total(1)

 

$

256

 

 

$

82,130

 

 

$

 

 

$

82,386

 

 

$

959

 

 

$

85,398

 

 

$

 

 

$

86,357

 

(1)

Excludes $34.6 million and $43.6 million held in operating accounts as of December 30, 2017, and December 31, 2016, respectively.

The fair values of the marketable securities that are classified as Level 1 in the table above were derived from quoted market prices for identical assets or liabilities in active markets that the Company has the ability to access. The fair value of marketable securities that are classified as Level 2 in the table above were derived from non-binding market consensus prices that were corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques with all significant inputs derived from or corroborated by observable market data. There were no transfers of instruments between Level 1, Level 2 and Level 3 during the financial periods presented. 

Derivatives

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies. These derivatives are carried at fair value with changes recorded in other income, net in the consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by re-measurement of the underlying assets and liabilities. The derivatives have maturities of approximately 30 days.

The settlement result of forward foreign currency contracts included in the fiscal year ended December 30, 2017 and December 31, 2016, was a gain of $1.4 million and a loss of $1.7 million, respectively, and these balances are included in other income, net, in the consolidated statements of operations.

54


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following table summarizes the Company’s outstanding derivative instruments on a gross basis:

 

 

As of December 30, 2017

 

 

As of December 31, 2016

 

 

 

Notional Amount

 

 

Fair Value

 

 

Notional Amount

 

 

Fair Value

 

 

 

(in millions)

 

 

Asset

 

 

Liability

 

 

(in millions)

 

 

Asset

 

 

Liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Undesignated Hedges:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forward Foreign Currency Contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchase

 

$

27.5

 

 

 

 

 

$

0.1

 

 

$

12.6

 

 

 

 

 

 

 

Sell

 

$

16.8

 

 

 

0.1

 

 

 

 

 

$

1.3

 

 

 

 

 

 

 

Note 4. Cash and Investments

The following table presents cash, cash equivalents, and available-for-sale investments as of the following dates (in thousands):

 

 

December 30, 2017

 

 

 

Amortized Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Market

Value

 

Cash

 

$

34,643

 

 

$

 

 

$

 

 

$

34,643

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

256

 

 

 

 

 

 

 

 

 

256

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government agency securities

 

 

1,500

 

 

 

 

 

 

(5

)

 

 

1,495

 

Certificates of deposits

 

 

14,498

 

 

 

 

 

 

(1

)

 

 

14,497

 

Commercial paper

 

 

7,952

 

 

 

 

 

 

(3

)

 

 

7,949

 

Corporate debt securities

 

 

48,073

 

 

 

 

 

 

(105

)

 

 

47,968

 

Asset-backed securities

 

 

10,240

 

 

 

 

 

 

(19

)

 

 

10,221

 

Total cash, cash equivalents, and marketable

   securities

 

$

117,162

 

 

$

 

 

$

(133

)

 

$

117,029

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

 

Amortized Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Market

Value

 

Cash

 

$

43,604

 

 

$

 

 

$

 

 

$

43,604

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

959

 

 

 

 

 

 

 

 

 

959

 

Commercial paper and corporate debt securities

 

 

2,499

 

 

 

 

 

 

 

 

 

2,499

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

5,667

 

 

 

 

 

 

 

 

 

5,667

 

U.S. Government agency securities

 

 

11,412

 

 

 

 

 

 

(7

)

 

 

11,405

 

Certificates of deposits

 

 

23,000

 

 

 

19

 

 

 

 

 

 

23,019

 

Commercial paper

 

 

22,402

 

 

 

 

 

 

 

 

 

22,402

 

Corporate debt securities

 

 

14,194

 

 

 

 

 

 

(6

)

 

 

14,188

 

Municipal securities

 

 

756

 

 

 

 

 

 

(1

)

 

 

755

 

Asset-backed securities

 

 

5,466

 

 

 

 

 

 

(3

)

 

 

5,463

 

Total cash, cash equivalents, and marketable

   securities

 

$

129,959

 

 

$

19

 

 

$

(17

)

 

$

129,961

 

55


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Available-for-sale marketable securities, readily convertible to cash, with maturity dates of 90 days or less are classified as cash equivalents, while those with maturity dates greater than 90 days are classified as marketable securities within short-term assets. All marketable securities as of December 30, 2017, and December 31, 2016, were available-for-sale and reported at fair value based on the estimated or quoted market prices as of the balance sheet date. Gross realized gains and losses on sale of securities are recorded in other income, net, in the Company’s statement of operations. Net realized gains and losses for fiscal 2017, 2016, and 2015 was $1.3 million, $0.5 million and $0.2 million, respectively.

Unrealized gains or losses, net of tax effect, are recorded in accumulated other comprehensive income (loss) within stockholders' equity. Both the gross unrealized gains and gross unrealized losses for the fiscal years ended December 30, 2017, and December 31, 2016 were insignificant and no marketable securities had other than temporary impairment. All marketable securities as of December 30, 2017, and December 31, 2016, had maturity dates of less than two years.

Note 5. Accounts Receivable

The Company maintains arrangements under which eligible accounts receivable in Japan are sold without recourse to unrelated third-party financial institutions. These receivables were not included in the consolidated balance sheets as the criteria for sale treatment had been met. After a transfer of financial assets, an entity stops recognizing the financial assets when control has been surrendered. The agreement met the criteria of a true sale of these assets since the acquiring party retained the title to these receivables and had assumed the risk that the receivables will be collectible. The Company pays administrative fees as well as interest ranging from 0.61% to 1.68% based on the anticipated length of time between the date the sale is consummated and the expected collection date of the receivables sold. The Company sold $18.6 million and $31.5 million of receivables during fiscal years ended December 30, 2017, and December 31, 2016, respectively. There were no material gains or losses on the sale of such receivables. There were no amounts due from such third party financial institutions at December 30, 2017, and December 31, 2016.

56


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 6. Financial Statement Components

The following tables provide details of selected financial statement components as of the following dates (in thousands):

 

 

At

 

 

 

December 30, 2017

 

 

December 31, 2016

 

Inventories:

 

 

 

 

 

 

 

 

Raw materials and sub-assemblies

 

$

32,187

 

 

$

23,506

 

Work in process

 

 

13,498

 

 

 

10,347

 

Finished goods

 

 

7,175

 

 

 

4,984

 

Inventories

 

 

52,860

 

 

 

38,837

 

Inventories-delivered systems

 

 

1,534

 

 

 

2,457

 

Total inventories

 

$

54,394

 

 

$

41,294

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net:(1)

 

 

 

 

 

 

 

 

Land

 

$

15,573

 

 

$

15,568

 

Building and improvements

 

 

20,880

 

 

 

20,532

 

Machinery and equipment

 

 

36,380

 

 

 

35,659

 

Furniture and fixtures

 

 

2,420

 

 

 

2,282

 

Software

 

 

9,558

 

 

 

9,756

 

Capital in progress

 

 

4,418

 

 

 

2,748

 

Total property, plant and equipment, gross

 

 

89,229

 

 

 

86,545

 

Accumulated depreciation and amortization

 

 

(44,419

)

 

 

(42,319

)

Total property, plant and equipment, net

 

$

44,810

 

 

$

44,226

 

(1) Total depreciation and amortization expense for the years ended December 30, 2017, December 31, 2016 and December 26, 2015 was $6.7 million, $6.8 million, and $6.9 million, respectively.

 

Other Current Liabilities:

 

 

 

 

 

 

 

 

Accrued warranty

 

$

4,863

 

 

$

3,838

 

Accrued taxes

 

 

813

 

 

 

706

 

Customer deposits

 

 

 

 

 

581

 

Accrued professional services

 

 

534

 

 

 

424

 

Accrued royalties

 

 

 

 

 

1,233

 

Other

 

 

1,039

 

 

 

1,265

 

Total other current liabilities

 

$

7,249

 

 

$

8,047

 

Components of Accumulated Other Comprehensive Income (Loss)

 

 

 

 

 

 

Foreign

Currency

Translations

 

 

Defined

Benefit

Pension Plans

 

 

Unrealized

Income (Loss)

on Investment

 

 

Accumulated

Other

Comprehensive

Income

 

Balance as of December 26, 2015

 

$

(4,948

)

 

$

(210

)

 

$

(44

)

 

$

(5,202

)

Current period change

 

 

(869

)

 

 

(17

)

 

 

42

 

 

 

(844

)

Balance as of December 31, 2016

 

 

(5,817

)

 

 

(227

)

 

 

(2

)

 

 

(6,046

)

Current period change

 

 

4,170

 

 

 

(160

)

 

 

(88

)

 

 

3,922

 

Balance as of December 30, 2017

 

$

(1,647

)

 

$

(387

)

 

$

(90

)

 

$

(2,124

)

The items above, except for unrealized income (loss) on investment, did not impact the Company’s income tax provision. The amounts reclassified from each component of accumulated other comprehensive income into income statement line items were insignificant.

57


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Note 7. Goodwill and Intangible Assets

The following table summarizes the activity in the Company’s goodwill during the years ended December 30, 2017 and December 31, 2016, respectively (in thousands):

 

 

Amounts

 

Balance as of December 26, 2015

 

$

9,415

 

Foreign currency movements

 

 

(475

)

Balance as of December 31, 2016

 

 

8,940

 

Foreign currency movements

 

 

1,292

 

Balance as of December 30, 2017

 

$

10,232

 

There were no business acquisitions made by the Company during fiscal years 2017, 2016 and 2015.

Goodwill Impairment and Long-lived Asset Impairment

The Company’s impairment review process is completed during the fourth quarter of each year, or whenever events or circumstances occur that indicate that an impairment may have occurred. The goodwill impairment assessment involves three tests, Step 0, Step 1 and Step 2. The Company performs a Step 0 test, which involves an initial qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the two-step impairment test is necessary. Otherwise, no further testing is necessary.

The Company completed its annual goodwill impairment assessment during the fourth quarter of 2017 by first performing a Step 0 qualitative assessment. As part of this assessment, the Company considered the trading value of the Company's stock, the industry trends, and the Company's sales forecast and products plans. The Company concluded that it was more likely than not that the fair value was more than the carrying values of the Company's reporting unit and therefore did not proceed to the Step 1 goodwill impairment test.

The process of evaluating the potential impairment of long-lived assets is highly subjective and requires significant judgment. In estimating the fair value of these assets, the Company made estimates and judgments about future revenues and cash flows. The Company’s forecasts were based on assumptions that are consistent with the plans and estimates the Company is using to manage its business. Changes in these estimates could change the Company’s conclusion regarding impairment of the long-lived assets and potentially result in future impairment charges for all or a portion of their balance at December 30, 2017. The Company did not record any impairment charges related to goodwill in fiscal year 2017.

The Company assesses if there have been triggers that may require it to evaluate the reasonableness of the remaining estimated useful lives of its intangible assets. No such triggers were identified during fiscal year 2017.

Finite-lived intangible assets are recorded at cost, less accumulated amortization. Finite-lived intangible assets as of December 30, 2017, and December 31, 2016 consisted of the following (in thousands):

 

 

December 30, 2017

 

 

 

Adjusted cost

 

 

Accumulated

amortization

 

 

Net carrying

amount

 

Developed technology

 

$

18,887

 

 

$

(16,681

)

 

$

2,206

 

Customer relationships

 

 

9,438

 

 

 

(9,438

)

 

 

 

Brand names

 

 

1,927

 

 

 

(1,927

)

 

 

 

Patented technology

 

 

2,252

 

 

 

(2,252

)

 

 

 

Trademark

 

 

80

 

 

 

(80

)

 

 

 

Total

 

$

32,584

 

 

$

(30,378

)

 

$

2,206

 

58


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

 

 

December 31, 2016

 

 

 

Adjusted cost

 

 

Accumulated

amortization

 

 

Net carrying

amount

 

Developed technology

 

$

15,726

 

 

$

(15,380

)

 

$

346

 

Customer relationships

 

 

9,322

 

 

 

(9,322

)

 

 

 

Brand names

 

 

1,927

 

 

 

(1,927

)

 

 

 

Patented technology

 

 

2,252

 

 

 

(2,186

)

 

 

66

 

Trademark

 

 

80

 

 

 

(80

)

 

 

 

Total

 

$

29,307

 

 

$

(28,895

)

 

$

412

 

The amortization of finite-lived intangibles is computed using the straight-line method. Estimated lives of finite-lived intangibles range from two to ten years. Total amortization expense for the fiscal years ended December 30, 2017, December 31, 2016 and December 26, 2015, was $0.2 million, $1.5 million and $2.1 million, respectively.

There were no impairment charges related to intangible assets recorded during the year ended December 30, 2017.

The estimated future amortization expense of finite intangible assets as of December 30, 2017, is as follows (in thousands):

Fiscal Years

 

Amounts

 

2018

 

 

283

 

2019

 

 

352

 

2020

 

 

286

 

2021

 

 

286

 

2022

 

 

286

 

Thereafter

 

 

713

 

Total future amortization expense

 

 

2,206

 

Note 8. Warranties

Product Warranty – The Company sells the majority of its products with a 12 months repair or replacement warranty from the date of acceptance or shipment date.workmanship. The Company provides an accrual for estimated future warranty costs based upon the historical relationship of warranty costs to theestimated cost of products sold. The estimated future warranty obligations related to product sales are recorded inwarranties at the period in which the relatedtime revenue is recognized. The estimated future warranty obligations are affected by the warranty periods, sales volumes, product failure rates, material usage and labor and replacement costs incurred in correcting a product failure. If actual product failure rates, material usage, labor or replacement costs were to differ from the Company’s estimates, revisions to the estimated warranty obligations would be required. For new product introductions where limited or no historical information exists, the Company may use warranty information from other previous product introductions to guide it in estimating its warranty accrual. The warranty accrual represents the best estimate of the amount necessary to settle future and existing claims on products sold as of the balance sheet date. The Company periodically assesses the adequacy of its reportedrecorded warranty reserve and adjusts suchthe amounts in accordance with changes in these factors.

ComponentsIncome Taxes. The Company accounts for income taxes using the asset and liability approach for deferred taxes which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or tax returns. A valuation allowance is recorded to reduce a deferred tax asset to that portion which more likely than not will be realized.

For additional information on the Company’s income taxes, see Note 14 of Notes to the Consolidated Financial Statements.

Translation of Foreign Currencies.The Company has branch operations or wholly-owned subsidiaries in the United States, Europe, Japan, China, Taiwan, Singapore and South Korea. Its international subsidiaries and branches operate primarily through the use of local functional currencies.  A substantial portion of the warranty accrual, which wereCompany’s international systems sales are denominated in U.S. dollars with the exception of Japan.  Consequently, we have relatively little exposure to foreign currency exchange risk with respect to these sales.

Assets and liabilities are translated at exchange rates in effect at the balance sheet date, and income and expense accounts and cash flow items are translated at average monthly exchange rates during the period. Net exchange gains or losses resulting from the translation of foreign financial statements and the effect of exchange rates on intercompany transactions of a long-term investment nature are recorded directly as a separate component of stockholders’ equity under the caption, “Accumulated other comprehensive loss.” Any foreign currency gains or losses related to transactions are included in operating results. The Company had accumulated exchange losses resulting from the accompanying consolidated balance sheetstranslation of foreign operation financial statements of $564 and $1,273 as of December 31, 2019 and 2018, respectively.

Share-based Compensation. The Company measures the cost of employee services received in exchange for the award of equity instruments based on the fair value of the award at the date of grant. Compensation expense is recognized using the straight-line attribution method to recognize share-based compensation over the service period of the award, with adjustments recorded for forfeitures as they occur.

For additional information on the Company’s share-based compensation plans, see Note 12 of Notes to the Consolidated Financial Statements.

Research and Development Costs.  Expenditures for research and development are expensed as incurred.

Fair Value of Financial Instruments. The carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their short maturities.  The estimated fair value of these obligations is based, primarily, on a market approach, comparing the Company’s interest rates to those rates the Company believes it would reasonably receive upon re-entry into the market.  Judgment is required to estimate the fair value using available market information and appropriate valuation methods.

For additional information on the Company’s fair value of financial instruments, see Note 4 of Notes to the Consolidated Financial Statements.

F-16


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Derivative Instruments and Hedging Activities. The Company, when it considers it to be appropriate, enters into forward contracts to hedge the economic exposures arising from foreign currency denominated transactions. At December 31, 2019 and 2018, these contracts included the future sale of Japanese Yen to purchase U.S. dollars. The foreign currency forward contracts were entered into by the Company’s Japanese subsidiary to hedge a portion of certain intercompany obligations. Post-merger with Nanometrics, the Company enters into forward contracts for several other currencies including the Korean Won, Taiwanese dollar and Chinese Yuan Renminbi. The forward contracts are not designated as hedges for accounting purposes and therefore, the change in fair value is recorded in general and administrative expenses in the Consolidated Statements of Operations.  The Company records its forward contracts at fair value in either prepaid expenses and other current assets or other current liabilities in the Consolidated Balance Sheets.

The dollar equivalent of the U.S. dollar forward contracts and related fair values as of December 31, 2019 and 2018 were as follows (in thousands)follows:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Notional amount

 

 

38,887

 

 

 

6,746

 

Fair value of asset (liability)

 

 

120

 

 

 

(32

)

During the years ended December 31, 2019 and 2017, the Company recorded gains of $ $343 and $105 on maturities of forward contracts, respectively.  During the year ended December 31, 2018, the Company recognized a loss of $81 on maturities of forward contracts.  The aggregate notional amounts of matured contracts were $58,522, $8,465 and $9,582 for 2019, 2018 and 2017, respectively.

Contingencies and Litigation.  The Company is subject to the possibility of losses from various contingencies, including certain legal proceedings, lawsuits and other claims. The Company accrues for a loss contingency when it concludes that the likelihood of a loss is probable and the amount of the loss can be reasonably estimated. If the Company concludes that loss contingencies that could be material to any one of its financial statements are not probable, but are reasonably possible, or are probable, but cannot be estimated, then the Company discloses the nature of the loss contingencies, together with an estimate of the range of possible loss or a statement that such loss is not reasonably estimable. The Company expenses as incurred the costs of defending legal claims against the Company. The Company does not recognize gain contingencies until realized. See Note 10 of the Notes to the Consolidated Financial Statements, “Commitments and Contingencies” for a detailed description.

Recent Accounting Pronouncements.

Recently Adopted

Effective January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) No. 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.”  This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees.  An entity should apply the requirements of Topic 718 to nonemployee awards except for specific guidance on inputs to an option pricing model and the attribution of cost.  The ASU is effective for the fiscal years beginning after December 15, 2018, including interim periods within that fiscal year.  The adoption of ASU No. 2018-07 did not have a material impact on the Company’s consolidated financial position, results of operations, and cash flows.  

Effective January 1, 2019, the Company adopted ASU No. 2018-02, “Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.”  The new guidance allows companies to reclassify stranded tax effects resulting from the Tax Cuts and Jobs Act (the “Tax Act”) from accumulated other comprehensive income to retained earnings.  The guidance also requires certain new disclosures regardless of a company’s election.  The standard is effective for annual periods beginning after December 15, 2018 and for interim periods within those annual periods, with earlier adoption permitted.  The adoption of ASU No. 2018-02 did not have a material impact on the Company’s consolidated financial position, results of operations, and cash flows.

In January 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.”  This ASU eliminates Step 2 from the goodwill impairment test.   Accordingly, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss

F-17


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

will be recognized in an amount equal to the excess, limited to the total amount of goodwill allocated to the reporting unit.  The ASU is effective for the fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years, with earlier adoption permitted.  The adoption of ASU No. 2017-04 during 2019 did not have a material impact on the Company’s consolidated financial position, results of operations, and cash flows.

In February 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” ASU No. 2016-02 requires that lessees recognize virtually all of their leases on the balance sheet, by recording a right-of-use asset and lease liability. On January 1, 2019, the Company adopted ASU No. 2016-02 using the modified retrospective method which applies the provisions of the standard at the effective date without adjusting the comparative periods presented.  The Company also elected the package of practical expedients.

There was not a cumulative-effect adjustment to the Company’s beginning retained earnings as a result of adopting ASU No. 2016-02. The Company has recognized additional operating lease assets and obligations of $14,426 as of January 1, 2019. As a result of the Merger, operating lease assets and obligations of $9,658 were assumed from the former Nanometrics. The Company elected to not reassess prior conclusions related to the identification, classification and accounting for initial direct costs for leases that commenced prior to January 1, 2019. For additional disclosure and detail, see Note 7 of the Notes to the Consolidated Financial Statements, “Leasing Arrangements.”

Recently Issued

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Topic 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The new guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and allocating consolidated income taxes to separate financial statements of entities not subject to income tax. ASU No. 2019-12 is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. Upon adoption, the Company must apply certain aspects of this standard retrospectively for all periods presented while other aspects are applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The Company is currently evaluating the impact of this new standard on its consolidated financial position, results of operations, and cash flows.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.”  This ASU is part of the FASB’s larger disclosure framework project intended to improve the effectiveness of financial statement footnote disclosure.  ASU No. 2018-13 modifies required fair value disclosures related primarily to level 3 investments.  This ASU is effective for annual periods beginning after December 15, 2019 and interim periods within those annual periods.  The adoption of ASU No. 2018-13 is not expected to have a material effect on the Company’s consolidated financial position, results of operations, and cash flows.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting.”  This ASU amends the scope of modification accounting for share-based payment arrangements and provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under Accounting Standards Codification (“ASC”) 718.  The ASU is effective for the fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years.  The adoption of ASU No. 2017-09 is not expected to have a material effect on the Company’s consolidated financial position, results of operations, and cash flows, if any.


F-18


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which represents a new credit loss standard that will change the impairment model for most financial assets and certain other financial instruments. Specifically, this guidance will require entities to utilize a new “expected loss” model as it relates to trade receivables, notes receivable and other commitments to extend credit held by a reporting entity. In addition, entities will be required to recognize an allowance for estimated credit losses on available-for-sale debt securities, regardless of the length of time that a security has been in an unrealized loss position. This guidance will be effective for annual reporting periods beginning after December 15, 2019, including interim periods within those annual reporting periods, with early adoption permitted. The Company expects that the adoption of this guidance will not have a material impact on its consolidated financial position, results of operations, and cash flows.

Recently issued accounting guidance not discussed above is not applicable or did not have, or is not expected to have, a material impact to the Company.

3.

Business Combination:

Pursuant to the Agreement and Plan of Merger dated as of June 23, 2019 (the “Merger Agreement”), among Rudolph Technologies, Inc. (“Rudolph”), Nanometrics Incorporated, (“Nanometrics”) and PV Equipment Inc., a wholly-owned subsidiary of Nanometrics, (“Merger Sub”) Merger Sub merged with and into Rudolph, with Rudolph continuing as a wholly-owned subsidiary of Onto Innovation (formerly Nanometrics) and the surviving corporation of the merger (the “Merger”). The Merger was effective on October 25, 2019 (the “Effective Time”). At the Effective Time, each share of Rudolph common stock, par value $0.001 per share, issued and outstanding immediately prior to the Effective Time (other than shares owned by Rudolph or Nanometrics) was converted into the right to receive 0.8042 (the “Exchange Ratio”) shares of common stock, par value $0.001 per share, of Onto Innovation common stock, par value $0.001 per share, and cash in lieu of any fractional shares of Onto Innovation common stock any former holder of Rudolph common stock would otherwise be entitled to receive. Immediately following the Effective Time of the Merger, Rudolph’s and Nanometrics’ common stockholders each owned approximately 50% of the outstanding common stock of the combined company on a fully diluted basis.

The Merger creates a company that is an end-to-end metrology, inspection, process control software, and lithography equipment provider for the semiconductor industry and other advanced markets with a global support organization whose technology development teams, and product portfolio creates unique end-to-end solutions across the entire semiconductor fabrication process. The company will be able to provide improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductor and other advanced markets.

The combined company accounts for the Merger as a reverse acquisition, using the acquisition method of accounting in accordance with generally accepted accounting principles, with Rudolph being treated as the acquiring entity for accounting purposes. In identifying Rudolph as the accounting acquiring entity, Rudolph and Nanometrics reviewed the accounting guidance as provided in ASC 805, which takes into account the type of consideration, the structure of the merger and the other transactions contemplated by the merger agreement, relative outstanding share ownership, the composition of the combined company board of directors, designation of certain senior management positions of the combined company, mainly the Chief Executive Officer and the Chief Financial Officer, relative voting rights, relative size as measured by assets, revenue or earnings as well as other metrics an investor would use for evaluating the respective company’s current and future financial performance, which of the combining entities initiated the combination and where the combined company’s headquarters will be located.

The acquisition method of accounting is based on ASC 805, and uses the fair value concepts defined in ASC Topic 820, “Fair Value Measurement” (“ASC 820”). The purchase price allocation described herein is preliminary and is based on the information that was available to make estimates of the fair value and may change as further information becomes available and additional analysis are completed. While the Company believes that such information provides a reasonable basis for estimating the fair values, more evidence and information may be obtained during the measurement period that results in changes to the estimated fair value amounts. The measurement period ends on the earlier of one year after the Effective Time or the date information about the facts and circumstances that existed at the Effective Time becomes available. Such adjustments, if necessary, will be recognized during the period in which that amounts are determined. These

F-19


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

adjustments may include: (1) changes in the fair value of certain intangible assets acquired; and (2) changes in deferred tax assets and liabilities related to the fair value estimates.

At the Effective Time of the Merger, Nanometrics changed its name to Onto Innovation Inc., and its shares began trading on the New York Stock Exchange (the “NYSE”) on October 28, 2019 (NYSE: ONTO). At the close of trading on October 25, 2019, Rudolph common stock ceased being listed on the NYSE. The accompanying consolidated financial statements for all periods presented are those of Rudolph with those of Nanometrics included only from the Effective Time through year-end.

The acquisition was nontaxable to the Company and certain of the assets acquired, including goodwill, will not be deductible for tax purposes. The acquired assets and liabilities of Nanometrics were recorded at their respective fair values including an amount for goodwill, which represents the purchase price paid in excess of the fair value of the net tangible and intangible assets acquired and liabilities assumed, and is attributable primarily to expected synergies, economies of scale and the assembled workforce of Nanometrics.

ASC 805 requires, among other things, that assets acquired, and liabilities assumed, be recognized at their fair values as of the Effective Time. In addition, ASC 805 requires that the consideration transferred be measured at the Effective Time of the Merger at the then-current market price. The market price of the shares of Rudolph common stock at the Effective Time was $28.50, which was based on the closing price of shares of Rudolph common stock on the NYSE on Friday, October 25, 2019, the last day of trading prior to the Effective Time.

ASC 820 defines the term “fair value” and sets forth the valuation requirements for any asset or liability measured at fair value, expands related disclosure requirements and specifies a hierarchy of valuation techniques based on the nature of the inputs used to develop the fair value measurements. Fair value is defined in ASC 829 as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.” This is an exit price concept for the valuation of the asset or liability. In addition, market participants are assumed to be buyers and sellers in the principal (or most advantageous) market for the asset or liability. Fair value measurements for an asset assume the highest and best use by these market participants, As a result of these standards, the Company may be required to record the fair value of assets which are not intended to be used or sold and/or to value assets at fair values that do not reflect the Company’s intended use for those assets. Many of these fair value measurements can be highly subjective, and it is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts.

The aggregate purchase price of $890,131 consisted of 25,060 shares of common stock valued at $884,801 and the fair value of assumed Nanometrics equity awards of $5,330.  Under ASC 805, acquisition-related transaction costs (e.g., advisory, legal, investment banking and other professional fees) are not included as a component of consideration transferred but are accounted for as expenses in the periods in which such costs are incurred. Total transaction costs incurred by the Company were $9,907 during the year ended December 31, 2019 and are included in general and administrative expense in the Consolidated Statements of Operations.


F-20


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

The following table summarizes the preliminary allocation of the total purchase consideration to the initial estimated fair values of the assets acquired and liabilities assumed as of October 25, 2019:

Cash and cash equivalents

$43,882

Marketable securities

94,389

Account receivables

49,917

Inventories

98,478

Prepaid expenses and other current assets

7,734

Property, plant and equipment

77,451

Operating lease right-of-use assets

9,658

Identifiable intangible assets

374,900

Deferred income taxes

1,352

Other assets

850

   Total assets acquired

758,611

Accounts payable

(23,361)

Payroll and related expenses

(20,290)

Deferred revenue

(5,931)

Other current liabilities

(10,739)

Income taxes payable

(2,699)

Other non-current liabilities

(90,113)

   Net assets acquired

605,478

Goodwill

284,653

Total purchase consideration

$890,131

The fair value of accounts receivable, net, consisted of gross contractual accounts receivable reduced by approximately $200 for receivables not expected to be collected as of the acquisition date. The inventory acquired consisted primarily of work in process, for which fair value was measured based on determining its net realizable value as such value represents an exit price in an orderly transaction between market participants, and raw materials. Factors that required judgment in determining the net realizable value for the inventory included determining estimated selling prices, cost to complete, costs to dispose, operating profit, and discount rates, among others. The Company recorded a $26,486 step-up of inventory to its fair value as of the Merger date based on the preliminary valuation.

The preliminary allocation of the intangible assets subject to amortization is as follows:

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

Balance as of beginning of period

 

$

3,838

 

 

$

4,504

 

Accruals for warranties issued during period

 

 

5,247

 

 

 

4,509

 

Settlements during the period

 

 

(4,222

)

 

 

(5,175

)

Balance as of end of period

 

$

4,863

 

 

$

3,838

 

 

Estimated

Fair Value

 

Weighted Average

Useful Life (years)

Developed technology

$260,500

 

6.6

In-process research and development

46,600

 

indefinite

Customer relationships

53,000

 

13.1

Backlog

6,700

 

1.1

Trademarks and trade names

8,100

 

7.5

Total intangible assets

$374,900

 

 

Acquired intangible assets reported above are being amortized using the straight-line method over their estimated useful lives, which approximates the pattern of how the economic life is expected to be used. This includes amounts allocated to customer relationships because of anticipated high customer retention rates that are common in the semiconductor capital equipment industry.

Developed technology relates to Nanometrics’ product family and was valued using the multi-period excess earnings method under the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by the developed technology less charges representing the contribution of other assets to those cash flows. The

F-21


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

average estimated useful life of developed technologies was determined to be 6.6 years and was based on the technology cycle related to each developed technology, as well as the cash flows over the respective forecast period.

The fair value of the in-process research and development (“IPRD”) was determined using the multi-period excess earnings method under the income approach. Such method reflects the present value of the projected cash flows that are expected to be generated by the IPRD, less costs to complete the development and charges representing the contribution of other assets to those cash flows.

Customer relationships represent the fair value of future projected revenue that will be derived from sales of products to new and existing customers and was valued using the distributor method under the income approach. This method reflects the present value of projected distributor margins to be derived from sales to existing customers less charges representing the contribution of other assets to those cash flows. The estimated useful life of the customer relationships was determined to be 13.1 years and was based on historical customer turnover rates.

Order backlog represents the fair value of future projected revenue that will be derived from outstanding orders from customers that have not yet been shipped and was valued using the multi-period excess earnings method under the income approach, which reflects the present value of such outstanding orders less charges representing the contribution of other assets to those cash flows. The estimated useful life of the order backlog was determined to be 1.1 years and was based on historical order fulfilment rates.

Trademarks and trade names relate to the “Nanometrics” trademarks and trade names and were fair valued by applying the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue under the trademarks and trade names. The estimated useful life of the trademarks and trade names was determined to be 7.5 years and was based on the expected life of the trademarks and trade names and the cash flows anticipated over the forecast period.

Factors that required a judgment in determining the fair value for the acquired intangible assets included estimating future cash flows, revenue and gross margin assumptions, technology lives, future operating expenses, and discount rates, among others.

The Company has determined that the estimated useful life of the acquired in-process research and development is currently indeterminate; thus, it has been categorized as indefinite and will be reviewed annually for impairment, along with the Company’s other long-lived assets with indefinite lives, unless its estimated useful life is known.

The Company believes the amounts of purchased intangible assets recorded above represent the fair values of and approximate the amounts a market participant would pay for such assets as of the Effective Time.

The results of operations of Nanometrics are reported in the Company’s consolidated financial statements from the Effective Time and include $66,261 of total net sales and an operating loss of $7,065 for the year ended December 31, 2019.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information summarizes the combined results of operations of Rudolph and Nanometrics, on a pro forma basis, as if the companies had combined at the beginning of fiscal year 2018. The pro forma financial information is presented for informational purposes only and may not necessarily reflect the actual results of operations that would have been achieved if the Merger had taken place on January 1, 2018, nor are they necessarily reflective of future results of operations. The pro forma information for all periods presented also includes adjustments to amortization charges for acquired intangible assets, depreciation charges for stepped-up fair value of acquired fixed assets, related tax effects and other adjustments.


F-22


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

The reported financial information for the year ended December 31, 2019 includes the results of Rudolph for the year then-ended and the results of Nanometrics from the Effective Time through December 31, 2019. The reported financial information for the year ended December 31, 2018 is the historical results of Rudolph:

 

Year Ended December 31,

 

 

2019

 

 

2018

 

 

Reported

 

 

Pro Forma

 

 

Reported

 

 

Pro Forma

 

Net revenue

$

305,896

 

 

$

525,455

 

 

$

273,784

 

 

$

598,307

 

Net income attributable to Onto Innovation

 

1,910

 

 

 

901

 

 

 

45,096

 

 

 

36,246

 

The pro forma results have been adjusted to eliminate $37,900 of merger-related costs incurred by Rudolph and Nanometrics that would have been incurred in 2017 had the Merger occurred on January 1, 2018.

4.

Fair Value Measurements:

The Company applies a three-level valuation hierarchy for fair value measurements. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the asset or liability. Level 3 inputs are unobservable inputs based on management’s assumptions used to measure assets and liabilities at fair value. A financial asset’s or liability’s fair value measurement classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.


F-23


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

The following tables provide the assets and liabilities carried at fair value measured on a recurring basis at December 31, 2019 and December 31, 2018: 

 

 

Fair Value Measurements Using

 

 

 

Carrying

Value

 

 

Quoted Prices in

Active Markets

for Identical

Assets (Level 1)

 

 

Significant

Other

Observable

Inputs (Level 2)

 

 

Significant

Unobservable

Inputs (Level 3)

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

81,108

 

 

$

 

 

$

81,108

 

 

$

 

Asset-backed securities

 

 

10,779

 

 

 

 

 

 

10,779

 

 

 

 

Certificates of deposit

 

 

30,507

 

 

 

 

 

 

30,507

 

 

 

 

Commercial paper

 

 

30,708

 

 

 

 

 

 

30,708

 

 

 

 

Corporate bonds

 

 

36,461

 

 

 

 

 

 

36,461

 

 

 

 

Foreign currency forward contracts

 

 

120

 

 

 

 

 

 

120

 

 

 

 

Total assets

 

$

189,683

 

 

$

 

 

$

189,683

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration - acquisitions

 

$

569

 

 

$

 

 

$

 

 

$

569

 

Total liabilities

 

$

569

 

 

$

 

 

$

 

 

$

569

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale debt securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

62,684

 

 

$

 

 

$

62,684

 

 

$

 

Total assets

 

$

62,684

 

 

$

 

 

$

62,684

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration - acquisitions

 

$

2,060

 

 

$

 

 

$

 

 

$

2,060

 

Foreign currency forward contracts

 

 

32

 

 

 

 

 

 

32

 

 

 

 

Total liabilities

 

$

2,092

 

 

$

 

 

$

32

 

 

$

2,060

 

 The Company’s available-for-sale debt securities classified as Level 2 are valued using observable inputs to quoted market prices, benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency.  The foreign currency forward contracts are primarily measured based on the foreign currency spot and forward rates quoted by the banks or foreign currency dealers.  Investment prices are obtained from third party pricing providers, which model prices utilizing the above observable inputs, for each asset class.

Level 3 liabilities consisted of contingent consideration related to an acquisition for which the Company uses a discounted cash flow model to value these liabilities.  The Level 3 assumptions used in the discounted cash flow model for the contingent consideration included projected revenue, timing of cash flows and estimates of discount rates of 0.0% and 9.2% for the years ended December 31, 2019 and 2018, respectively.  A significant decrease in the projected revenue or increase in discount rates could result in a significantly lower fair value measurement for the contingent consideration.

F-24


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

This table presents a reconciliation of all liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the year ended December 31, 2019:

 

 

Fair Value

Measurements

Using

Significant

Unobservable

Inputs (Level 3)

 

Balance at December 31, 2018

 

$

2,060

 

Total loss due to remeasurement included in general and

   administrative expense

 

 

267

 

Additions

 

 

 

Payments

 

 

(1,758

)

Transfer into (out of) Level 3

 

 

 

Balance at December 31, 2019

 

$

569

 

See Note 5 for additional discussion regarding the fair value of the Company’s marketable securities.

Fair Value of Other Financial Instruments

The carrying value of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximates fair value because of the short-term maturity of these instruments. The estimated fair value of these obligations is based, primarily, on a market approach, comparing the Company’s interest rates to those rates the Company believes it would reasonably receive upon re-entry into the market. Judgment is required to estimate the fair value using available market information and appropriate valuation methods.

The carrying amount of the convertible notes receivable approximates fair value based on current interest rates for instruments with similar characteristics. Convertible notes receivable are initially recognized at fair value. The Company does not subsequently adjust the fair value of these convertible notes receivable unless it is determined that the convertible note receivable is impaired. The Company considers the issuer’s financial condition, payment history, and other relevant factors when assessing the collectability of the convertible note and to reserve the portion of such convertible note for which collection does not appear likely.

5.

Marketable Securities:

The Company has evaluated its investment policies and determined that all of its marketable securities, which are comprised of debt securities, are to be classified as available-for-sale.  The Company’s available-for-sale debt securities are carried at fair value, with the unrealized gains and losses reported in Stockholders’ equity under the caption “Accumulated other comprehensive loss.”  Realized gains and losses on available-for-sale securities are included in “Other income (expense)” on the Consolidated Statements of Operations. The Company records other-than-temporary impairment charges for its available-for-sale debt securities when it intends to sell the securities, it is more-likely-than not that it will be required to sell the securities before a recovery, or when it does not expect to recover the entire amortized cost basis of the securities.  The cost of securities sold is based on the specific identification method.

The Company has determined that the gross unrealized losses on its marketable securities at December 31, 2019 and 2018 are temporary in nature. The Company reviews its investment portfolio to identify and evaluate marketable securities that have indications of possible impairment. Factors considered in determining whether a loss is other-than-temporary include the length of time and extent to which fair value has been less than the cost basis, credit quality and the Company’s ability and intent to hold the securities for a period of time sufficient to allow for any anticipated recovery in market value.

F-25


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

At December 31, 2019 and 2018, marketable securities are categorized as follows:

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding Gains

 

 

Gross

Unrealized

Holding Losses

 

 

Fair

Value

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

80,926

 

 

$

188

 

 

$

6

 

 

$

81,108

 

Asset-backed securities

 

 

10,767

 

 

 

12

 

 

 

 

 

 

10,779

 

Certificates of deposit

 

 

30,500

 

 

 

7

 

 

 

 

 

 

30,507

 

Commercial paper

 

 

30,707

 

 

 

1

 

 

 

 

 

 

30,708

 

Corporate bonds

 

 

36,409

 

 

 

52

 

 

 

 

 

 

36,461

 

Total marketable securities

 

$

189,309

 

 

$

260

 

 

$

6

 

 

$

189,563

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

62,681

 

 

$

43

 

 

$

40

 

 

$

62,684

 

Total marketable securities

 

$

62,681

 

 

$

43

 

 

$

40

 

 

$

62,684

 

The amortized cost and estimated fair value of marketable securities classified by the maturity date listed on the security, regardless of the Consolidated Balance Sheet classification, is as follows at December 31, 2019 and 2018:

 

 

December 31, 2019

 

 

December 31, 2018

 

 

 

Amortized

Cost

 

 

Fair

Value

 

 

Amortized

Cost

 

 

Fair

Value

 

Due within one year

 

$

152,649

 

 

$

152,852

 

 

$

47,767

 

 

$

47,732

 

Due after one through five years

 

 

36,660

 

 

 

36,711

 

 

 

14,914

 

 

 

14,952

 

Due after five through ten years

 

 

 

 

 

 

 

 

 

 

 

 

Due after ten years

 

 

 

 

 

 

 

 

 

 

 

 

Total marketable securities

 

$

189,309

 

 

$

189,563

 

 

$

62,681

 

 

$

62,684

 

The following table summarizes the estimated fair value and gross unrealized holding losses of marketable securities, aggregated by investment instrument and period of time in an unrealized loss position, at December 31, 2019 and 2018.

 

 

In Unrealized Loss Position

For Less Than 12 Months

 

 

In Unrealized Loss Position

For Greater Than 12 Months

 

 

 

Fair

Value

 

 

Gross

Unrealized

Losses

 

 

Fair

Value

 

 

Gross

Unrealized

Losses

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

14,166

 

 

$

6

 

 

$

 

 

$

 

Total marketable securities

 

$

14,166

 

 

$

6

 

 

$

 

 

$

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal notes and bonds

 

$

27,952

 

 

$

30

 

 

$

4,671

 

 

$

10

 

Total marketable securities

 

$

27,952

 

 

$

30

 

 

$

4,671

 

 

$

10

 

See Note 4 for additional discussion regarding the fair value of the Company’s marketable securities.


F-26


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

6.

Goodwill and Purchased Intangible Assets:

Goodwill

The changes in the carrying amount of goodwill are as follows:

Balance at December 31, 2017, net of accumulated impairment charge of $192,872

 

$

22,495

 

Goodwill acquired during the period

 

 

 

Balance at December 31, 2018

 

 

22,495

 

Goodwill acquired during the period (Note 3)

 

 

284,653

 

Balance at December 31, 2019

 

$

307,148

 

 

 

 

 

 

Purchased Intangible Assets

Purchased intangible assets as of December 31, 2019 and 2018 are as follows:

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

Finite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

$

326,726

 

 

$

67,861

 

 

$

258,865

 

Customer and distributor relationships

 

 

69,261

 

 

 

11,078

 

 

 

58,183

 

Trademarks and trade names

 

 

12,461

 

 

 

4,156

 

 

 

8,305

 

Total finite-lived intangible assets

 

 

408,448

 

 

 

83,095

 

 

 

325,353

 

In-process research and development

 

 

46,600

 

 

 

 

 

 

46,600

 

Total identifiable intangible assets

 

$

455,048

 

 

$

83,095

 

 

$

371,953

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2018

 

 

 

 

 

 

 

 

 

 

 

 

Finite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

$

66,177

 

 

$

59,692

 

 

$

6,485

 

Customer and distributor relationships

 

 

9,560

 

 

 

9,082

 

 

 

478

 

Trademarks and trade names

 

 

4,361

 

 

 

3,876

 

 

 

485

 

Total identifiable intangible assets

 

$

80,098

 

 

$

72,650

 

 

$

7,448

 

Intangible asset amortization expense amounted to $10,445, $1,534 and $1,940 for the years ended December 31, 2019, 2018 and 2017, respectively. Assuming no change in the gross carrying value of identifiable intangible assets and estimated lives, estimated amortization expenses are $53,741 for 2020, $48,009 for 2021, $47,610 for 2022, $47,135 for 2023, and $41,450 for 2024.

7.

Leasing Arrangements:

The Company leases space for its corporate headquarters, manufacturing, sales and service operations, vehicles and information technology equipment under operating leases. All of the Company’s leases are operating leases.  The Company elected not to apply Accounting Standard Codification Topic 842 (“ASC 842”) to arrangements with lease terms of less than 12 months.  Operating lease right-of-use assets and obligations are reflected within the captions “Operating lease right-of-use assets,” “Current operating lease obligations,” and “Non-current operating lease obligations,” respectively, on the Consolidated Balance Sheets.

Operating lease costs were $4,124 during the twelve months ended December 31, 2019.  These costs are primarily related to long-term operating leases, but also include immaterial amounts for short-term leases less than 12 months.  Operating lease costs are recognized on a straight-line basis over the terms of the leases.

Additional operating lease right-of-use assets of $2,946 were recognized as non-cash asset additions that resulted from new operating lease liabilities as of the twelve months ended December 31, 2019. Cash paid for amounts included in the

F-27


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

measurement of operating lease liabilities was $3,872 during the twelve months ended December 31, 2019 and is included in operating cash flows.

The Company often has the option to renew lease terms for buildings and other assets. The exercise of lease renewal options is generally at the Company’s sole discretion. In addition, certain lease arrangements may be terminated prior to their original expiration date at the Company’s discretion. The Company evaluates renewal and termination options at the lease commencement date to determine if it is reasonably certain to exercise the option on the basis of economic factors. The weighted average of the remaining lease term for operating leases as of December 31, 2019 was 6.7 years.

The discount rate implicit within the Company’s leases is generally not determinable and therefore the Company determines the discount rate based on its incremental borrowing rate. The incremental borrowing rate for our leases is determined based on the lease term in which lease payments are made. The weighted average discount rate used to measure operating lease liabilities as of December 31, 2019 was 4.5%.

The following table presents information about the amount and timing of cash flows arising from the Company’s operating leases as of December 31, 2019:

 

 

 

 

 

Maturity of Lease Liabilities

 

Lease Payments

 

2020

 

$

5,901

 

2021

 

 

4,659

 

2022

 

 

4,059

 

2023

 

 

3,398

 

2024

 

 

2,939

 

Thereafter

 

 

8,196

 

   Total undiscounted operating lease payments

 

 

29,152

 

Less: Imputed interest

 

 

4,276

 

   Present value of operating lease liabilities

 

$

24,876

 

8.

Convertible Notes Receivable:

On May 31, 2018, the Company entered into a convertible loan agreement with Simax Precision Technologies Limited (“the borrower”), which allowed them to borrow up to $15,000 in multiple promissory notes with an interest rate of 4.25% per annum payable on a semi-annual basis.  The Company expected to be a supplier of lithography modules to Simax, which is used in the manufacture, sale and service of lithography systems. At December 31, 2019, the Company had $5,000 in outstanding convertible notes receivable with the borrower.  

During the fourth quarter 2019, the Company and the borrower began negotiations to end their relationship as it pertains to this agreement. The Company determined that it is unlikely that a portion of the convertible note receivable will be collectable, and a reserve in the amount of $2,000 was recorded during the period ended December 31, 2019.  In addition, the Company ceased recognizing interest income on these convertible notes receivable as of September 30, 2019.

9.

Balance Sheet Details:

Inventories

Inventories are comprised of the following:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Materials

 

$

108,492

 

 

$

61,025

 

Work-in-process

 

 

42,694

 

 

 

21,910

 

Finished goods

 

 

24,948

 

 

 

13,885

 

Total inventories

 

$

176,134

 

 

$

96,820

 

F-28


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Property, Plant and Equipment

Property, plant and equipment, net, is comprised of the following:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Land and building

 

$

47,222

 

 

$

2,584

 

Machinery and equipment

 

 

56,504

 

 

 

29,097

 

Furniture and fixtures

 

 

3,968

 

 

 

3,226

 

Computer equipment and software

 

 

15,770

 

 

 

7,906

 

Leasehold improvements

 

 

13,069

 

 

 

9,448

 

 

 

 

136,533

 

 

 

52,261

 

Accumulated depreciation

 

 

(38,113

)

 

 

(33,387

)

Total property, plant and equipment, net

 

$

98,420

 

 

$

18,874

 

Depreciation expense amounted to $5,965, $4,848 and $3,990 for the years ended December 31, 2019, 2018 and 2017, respectively.

Other assets

Other assets is comprised of the following:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Convertible notes receivable, net of allowance of $2,000

 

$

3,000

 

 

$

5,000

 

Operating lease right-of-use assets

 

 

23,588

 

 

 

 

Other

 

 

1,351

 

 

 

506

 

Total other assets

 

$

27,939

 

 

$

5,506

 

Accrued liabilities

Accrued liabilities is comprised of the following:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Payroll and related expenses

 

$

19,365

 

 

$

10,648

 

Warranty

 

 

6,348

 

 

 

2,441

 

Other

 

 

491

 

 

 

611

 

Total accrued liabilities

 

$

26,204

 

 

$

13,700

 

Other current liabilities

Other current liabilities is comprised of the following: 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Contingent consideration - acquisitions

 

$

569

 

 

$

1,422

 

Income tax payable

 

 

2,783

 

 

 

 

Current operating lease obligations

 

 

4,906

 

 

 

 

Customer deposits

 

 

1,994

 

 

 

1,135

 

Accrued inventory

 

 

1,614

 

 

 

1,103

 

Accrued professional fees

 

 

1,520

 

 

 

532

 

Other

 

 

5,786

 

 

 

3,351

 

Total other current liabilities

 

$

19,172

 

 

$

7,543

 

 

 

 

59

F-29


NANOMETRICS INCORPORATEDTable of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – STATEMENTS—(Continued)

(In thousands, except per share data)

 

Note 9. Commitments and ContingenciesOther non-current liabilities

Other non-current liabilities is comprised of the following:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Unrecognized tax benefits (including interest)

 

$

6,384

 

 

$

5,409

 

Non-current operating lease obligations

 

 

19,970

 

 

 

 

Contingent consideration - acquisitions

 

 

 

 

 

638

 

Deferred revenue

 

 

2,464

 

 

 

1,314

 

Other

 

 

2,953

 

 

 

3,800

 

Total non-current liabilities

 

$

31,771

 

 

$

11,161

 

10.

Commitments and Contingencies:

Factoring

The Company maintains arrangements under which eligible accounts receivable in Japan are sold without recourse to unrelated third-party financial institutions. These receivables were not included in the consolidated balance sheets as the criteria for sale treatment had been met. The Company sold $9,018 of receivables during the year ended December 31, 2019. There were no material gains or losses on the sale of such receivables. There were 0 amounts due from such third-party financial institutions at December 31, 2019.

Intellectual Property Indemnification Obligations

The Company will, from time to time,has entered into agreements with customers that include limited intellectual property indemnification obligations that are customary in the normal courseindustry. These guarantees generally require the Company to compensate the other party for certain damages and costs incurred as a result of business, agree to indemnify certain customers, vendors or others against third party claims that Nanometrics’ products, when used for their intended purpose(s), or the Company’sthird-party intellectual property infringeclaims arising from these transactions. The nature of the intellectual property rightsindemnification obligations prevents the Company from making a reasonable estimate of such third parties or other claims made against parties with whom it enters into contractual relationships. It is not possible to determine the maximum potential amount of liability under these indemnification obligations dueit could be required to the limited history of prior indemnification claims and the unique facts and circumstances that are likelypay to be involved in each particular claim.its customers. Historically, the Company has not made any indemnification payments under these obligationssuch agreements and believes that the estimated fair value of these agreements is immaterial. Accordingly, no liabilities have0 amount has been recorded for these obligationsaccrued in the accompanying consolidated balance sheets as of December 30, 2017, and December 31, 2016.financial statements with respect to these indemnification guarantees.

Contractual ObligationsWarranty Reserves

The Company maintains certain open inventory purchase agreements withgenerally provides a warranty on its suppliersproducts for a period of 12 to ensure a smooth14 months against defects in material and continuous supply availability for key components. The Company’s liability under these purchase commitments is generally restricted to a forecasted time-horizon as mutually agreed upon between the parties. This forecasted time-horizon can vary among different suppliers.workmanship. The Company estimates the costs that may be incurred during the warranty period and records a liability in the amount of such costs at the time revenue is recognized. The Company’s estimate is based primarily on historical experience. The Company periodically assesses the adequacy of its open inventory purchase commitment as of December 30, 2017, was approximately $50.7 million. Actual expenditures will vary based upon the volume of the transactionsrecorded warranty liabilities and length of contractual service provided. In addition,adjusts the amounts paid under these arrangements may be lessas necessary. Settlements of warranty reserves are generally associated with sales that occurred during the 12 to 14 months prior to the year-end and warranty accruals are related to sales during the same year.

Changes in the event that the arrangements are renegotiated or cancelled.

The Company leases facilities and certain equipment under non-cancelable operating leases. Rent expense, which is recorded on a straight-line basis over the term of the respective lease, for 2017, 2016 and 2015 was approximately $1.8 million, $1.8 million and $1.7 million, respectively. Future minimum lease payments under its operating leasesCompany’s warranty reserves are as follows (in thousands):

follows: 

 

 

Operating

Leases

 

2018

 

 

1,664

 

2019

 

 

935

 

2020

 

 

313

 

2021

 

 

54

 

2022

 

 

2

 

Thereafter

 

 

 

Total

 

$

2,968

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

Balance, beginning of the period

 

$

2,441

 

 

$

2,427

 

Accruals

 

 

4,265

 

 

 

3,486

 

Warranty liability assumed in Merger

 

 

4,227

 

 

 

 

Usage

 

 

(4,585

)

 

 

(3,472

)

Balance, end of the period

 

$

6,348

 

 

$

2,441

 

 


F-30


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Legal ProceedingsMatters

From time to time, the Company is subject to various legal proceedings orand claims arising in the ordinary course of business. The following reflects an overview of the material activities with regard to these matters.

Optical Solutions Inc. v. Nanometrics Incorporated (Case No. 18-cv-00417-BLF): On August 2, 2017, the CompanyNanometrics was named as defendant in a complaint filed in New Hampshire Superior Court (“Complaint”). The Complaint, brought by Optical Solutions, Inc. (“OSI”), alleges claims arising from a purported exclusive purchase contract between OSI and the CompanyNanometrics pertaining to certain product. On September 18, 2017, the CompanyNanometrics removed the action to the United States District Court for the District of New Hampshire. On September 25, 2017, Nanometrics moved to transfer the Company movedComplaint to the District Court for the Northern District of California (the “Court”). On December 20, 2017, Nanometrics filed its complaint against OSI in the California Superior Court for the County of Santa Clara alleging claims arising from OSI’s breach of certain purchase orders. Nanometrics’ complaint was later removed by OSI to the Northern District of California.  On May 29, 2018, the District Court of New Hampshire issued an order granting Nanometrics’ motion to transfer the Complaint to the Northern District of California and denying Nanometrics’ motion to dismiss all claims in the Complaint for lack of personal jurisdiction andwithout prejudice. On June 14, 2018, the Complaint was consolidated with Nanometrics’ complaint against OSI. On August 9, 2018, OSI filed an Amended Complaint.  On September 19, 2018, Nanometrics filed a motion to dismiss OSI’s Amended Complaint for failure to state a claim.  Nanometrics’ motion to dismiss was heard on February 28, 2019.  On September 27, 2017,March 5, 2019, the Court granted Nanometrics’ Motion to Dismiss with leave to amend. OSI filed a Second Amended Complaint on March 29, 2019. Nanometrics filed a motion to remand.dismiss OSI’s Second Amended Complaint on May 31, 2019. In October of 2019, Nanometrics was renamed Onto Innovation Inc. as a result of the Merger.  Thereafter, the Company’s second motion to dismiss was heard on November 14, 2019.  On November 26, 2019 the Court granted the Company’s Motion to dismiss with leave to amend. OSI filed a Third Amended Complaint on January 31, 2018,21, 2020.  Trial has been set for May 16, 2022.  At this time, the Company does not anticipate the outcome of this matter to have a material impact on its financial position, results of operations, or cash flows.

Following the announcement of the proposed merger transaction between Nanometrics Incorporated and  Rudolph Technologies, Inc., two purported class action complaints and three complaints were filed on behalf of Rudolph’s stockholders against Rudolph and its directors; of those five complaints, three were filed in the United States District Court for the District of Delaware, one in the United States District Court for the District of New Hampshire denied OSI’s motionJersey, and one in the United States District Court for the District of Massachusetts. One of those five complaints also named Nanometrics and the subsidiary formed to remand. OSIeffectuate the proposed merger transaction as defendants. A sixth complaint was filed on behalf of a Nanometrics stockholder against Nanometrics and its directors in the United States District Court for the Northern District of California. The complaints are captioned as follows: Stein v. Rudolph Technologies, Inc., et al. (D. Del.); Rosenblatt et al. v. Rudolph Technologies, Inc., et al. (D. Del.); Stein et al. v. Rudolph Technologies, Inc., et al. (D. Del.); Parikh v. Rudolph Technologies, Inc., et al. (D.N.J.); Roy v. Rudolph Technologies, Inc., et al. (D. Mass.); and Bryden-Moore v. Nanometrics Inc., et al. (N.D. Cal.). The Company refers to these actions collectively as the “Shareholder Actions.”  The complaints in the Shareholder Actions generally asserted claims under Sections 14(a) and 20(a) of the Exchange Act challenging the adequacy of certain disclosures made in the version of the joint proxy statement/prospectus filed with the SEC on August 15, 2019, or, solely with respect to the complaint captioned Roy v. Rudolph Technologies, Inc., et al. (D. Mass.), the version of the joint proxy statement/prospectus filed with the SEC on September 10, 2019. The complaints generally sought, among other relief, an injunction preventing Rudolph from holding the Rudolph special meeting or consummating the transaction, an injunction preventing the Company from consummating the transaction, damages in the event that the merger is consummated, and attorneys’ fees.  On October 11, 2019, plaintiffs in each of the Shareholder Actions agreed in principle to dismiss their claims in connection with the issuance of certain supplemental disclosures regarding the transaction and reserved the right to seek attorneys’ fees.  The supplemental disclosures were filed with the Securities and Exchange Commission that same day.  Subsequently, each of the plaintiffs filed a Notice of Voluntary Dismissal and a negotiation regarding the collective plaintiffs’ mootness fee claims was finalized.  The payment for the plaintiffs’ mootness fee claims, which was immaterial, was thereafter made and the Shareholder Actions have been closed.

Royalty Agreements

Under various licensing agreements, the Company is obligated to pay royalties based on net sales of products sold. There are no minimum annual royalty payments. Royalty expense amounted to $1,429, $1,904 and $1,117 for the years ended December 31, 2019, 2018 and 2017, respectively.


F-31


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Open and Committed Purchase Orders

The Company has open and committed purchase orders of $97,877 as of December 31, 2019.

Line of Credit

The Company has a credit agreement with a bank that provides for a line of credit which is secured by the marketable securities the Company has with the bank.  The Company is permitted to borrow up to 70% of the value of eligible securities held at the time the line of credit is accessed.  The available line of credit as of December 31, 2019 was approximately $91,258 with an available interest rate of 3.3%.  The credit agreement is available to the Company until such time that either party terminates the arrangement at their discretion.  The Company has not yet respondedutilized the line of credit to date.

11.

Revenue

The following table represents a disaggregation of revenue by timing of revenue:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

Point-in-time

 

$

286,130

 

 

$

257,124

 

Over-time

 

 

19,766

 

 

 

16,660

 

Total revenue

 

$

305,896

 

 

$

273,784

 

See Note 16 of the Notes to the Consolidated Financial Statements for additional discussion of the Company’s motions to transfer or dismiss, but is scheduled to on February 19, 2018.disaggregated revenue in detail.

Contract Liabilities

The Company records a provision for a losscontract liabilities when it believes that it is both probable that a lossthe customer has been incurred and the amount can be reasonably estimated. Based on current information,billed in advance of the Company believes it does not have any probablecompleting its performance obligations. These amounts are recorded as deferred revenue in the Consolidated Balance Sheets.

Changes in deferred revenue were as follows:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

Balance, beginning of the period

 

$

8,080

 

 

$

7,206

 

Deferred revenue assumed in Merger

 

 

5,931

 

 

 

 

Deferral of revenue

 

 

28,651

 

 

 

19,326

 

Recognition of deferred revenue

 

 

(27,569

)

 

 

(18,452

)

Balance, ending of the period

 

$

15,093

 

 

$

8,080

 

12.

Share-Based Compensation and Employee Benefit Plans:

Share-Based Compensation Plans

The Company’s share-based compensation plans are intended to attract and reasonably estimable losses relatedretain employees and to any current legal proceedings and claims. Although it is difficultprovide an incentive for them to predict the outcome of legal proceedings,assist the Company believes that any liability that may ultimately ariseto achieve long-range performance goals and to enable them to participate in long-term growth of the Company. The Company settles restricted stock unit awards and stock option exercises with newly issued common shares.

Rudolph Technologies, Inc. 2018 Stock Plan (the “2018 Plan”). The 2018 Plan provides for the grant of 2,709 stock awards and stock options to employees, directors and consultants at an exercise price equal to or greater than the fair market value of the common stock on the date of grant. Restricted stock units granted under the 2018 Plan typically vest over a three to five-year period for employees and one year for directors; however, other vesting periods are allowable under the 2018 Plan. Restricted stock units granted to employees have time based or performance based vesting.  If options were to be granted under the 2018 Plan, they would typically grade vest over a five-year period and expire ten years from the resolutiondate of these ordinary course matters will not have a material adverse effect on the business, financial condition and results of operations.

 

60F-32


NANOMETRICS INCORPORATEDTable of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS – STATEMENTS—(Continued)

(In thousands, except per share data)

 

Note 10. Net Income Per Share

The Company presents both basicgrant.  As of December 31, 2019 and diluted net income per share on the face of its consolidated statements of operations. Basic net income per share excludes the effect of potentially dilutive shares and is computed by dividing net income by the weighted-average number of2018, there were shares of common stock outstandingavailable for issuance pursuant to future grants under the 2018 Plan totaling 2,478 and 2,680, respectively.

Rudolph Technologies, Inc. 2009 Stock Plan (the “2009 Plan”). The 2009 Plan provided for the period. Diluted net income per share is computed usinggrant of 4,711 stock options and other stock awards to employees, directors and consultants at an exercise price equal to or greater than the weighted-average numberfair market value of the common stock on the date of grant. Options granted under the 2009 Plan typically grade vested over a five-year period and expired ten years from the date of grant. Restricted stock units granted under the 2009 Plan typically vested over a three to five-year period for employees and one year for directors; however, other vesting periods were allowable under the 2009 Plan. Restricted stock units granted to employees have time based or performance based vesting.  In the second quarter of 2018, the 2009 Plan was terminated and therefore as of December 31, 2019 and 2018, there were 0 shares of common stock outstandingavailable for issuance pursuant to future grants under the 2009 Plan.  

Nanometrics Incorporated 2005 Amended and Restated Equity Incentive Plan (the “2005 Plan”). The 2005 Plan provides for the period plus the effect to all potentially dilutive common shares outstanding during the period, including contingently issuable shares and certaingrant of 4,714 stock options calculated usingand other stock awards to employees, directors and consultants at an exercise price equal to the treasury stock method. A reconciliationfair market value of the common stock on the date of grant. Options granted under the 2005 Plan typically grade vest over a three-year period and expire ten years from the date of grant. Restricted stock units granted under the 2005 Plan typically vest over a three-year period for employees and one year for directors; however, other vesting periods are allowable under the 2005 Plan. Restricted stock units granted to employees have time based or performance based vesting.  As of December 31, 2019, there were 1,253 shares of common stock available for issuance pursuant to future grants under the 2005 Plan.

The following table reflects share-based compensation expense by type of award:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Share-based compensation expense:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units, including all performance and market

    based awards

 

$

10,421

 

 

$

6,062

 

 

$

5,433

 

Stock options and employee stock purchase options

 

 

164

 

 

 

 

 

 

237

 

Total share-based compensation

 

 

10,585

 

 

 

6,062

 

 

 

5,670

 

Tax effect on share-based compensation

 

 

2,283

 

 

 

1,362

 

 

 

2,052

 

Net effect on net income

 

$

8,302

 

 

$

4,700

 

 

$

3,618

 

Effect on earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.28

)

 

$

(0.18

)

 

$

(0.14

)

Diluted

 

$

(0.28

)

 

$

(0.18

)

 

$

(0.14

)


F-33


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share denominatordata)

Restricted Stock Unit Activity

A summary of the basic and diluted net income per share computations is as follows (in thousands):

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Weighted average common shares outstanding used in

   basic net income per share calculation

 

 

25,334

 

 

 

24,655

 

 

 

24,059

 

Potential dilutive common stock equivalents,

   using treasury stock method

 

 

585

 

 

 

498

 

 

 

316

 

Weighted average shares used in diluted net income

   per share calculation

 

 

25,919

 

 

 

25,153

 

 

 

24,375

 

For the year ended December 30, 2017, December 31, 2016, and December 26, 2015, the Company had securities outstanding which could potentially dilute basic earnings per share in the future. ForCompany’s restricted stock unit activity with respect to the years ended December 30,31, 2019, 2018 and 2017 follows:

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

Nonvested at December 31, 2016

 

 

914

 

 

$

15.29

 

Granted

 

 

225

 

 

$

28.23

 

Vested

 

 

(258

)

 

$

14.80

 

Forfeited

 

 

(65

)

 

$

17.14

 

Nonvested at December 31, 2017

 

 

816

 

 

$

18.50

 

Granted

 

 

228

 

 

$

34.80

 

Vested

 

 

(325

)

 

$

17.73

 

Forfeited

 

 

(80

)

 

$

22.12

 

Nonvested at December 31, 2018

 

 

639

 

 

$

24.26

 

Granted

 

 

271

 

 

$

29.58

 

Assumed in Merger

 

 

598

 

 

$

31.43

 

Vested

 

 

(366

)

 

$

25.69

 

Forfeited

 

 

(35

)

 

$

26.44

 

Nonvested at December 31, 2019

 

 

1,107

 

 

$

28.89

 

As of December 31, 2016 and December 26, 2015, the weighted average common share equivalents consisting2019, there was $22,230 of stock options andtotal unrecognized compensation cost related to restricted stock units included ingranted under the calculationplans. That cost is expected to be recognized over a weighted average period of diluted net income1.9 years.


F-34


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share were 0.6 million, 0.5 million and 0.3 million shares, respectively.data)

 

Stock Option Activity

Note 11. Stockholders' EquityA summary of the Company’s stock option activity with respect to the years ended December 31, 2019, 2018 and Stock-Based Compensation2017 follows:

Stockholders' Equity

 

 

Shares

 

 

Weighted

Average

Exercise

Price

Per Share

 

 

Weighted

Average

Remaining

Contractual

Term (years)

 

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2016

 

 

173

 

 

$

12.67

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(114

)

 

 

11.37

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

59

 

 

 

15.20

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(22

)

 

 

15.20

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

37

 

 

$

15.20

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumed in Merger

 

 

12

 

 

 

16.27

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2

)

 

 

14.96

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

47

 

 

$

15.49

 

 

 

2.4

 

 

$

985

 

Vested or expected to vest at December 31, 2019

 

 

47

 

 

$

15.49

 

 

 

2.4

 

 

$

985

 

Exercisable at December 31, 2019

 

 

47

 

 

$

15.49

 

 

 

2.4

 

 

$

985

 

Preferred and Common Stock

The authorized capitaltotal intrinsic value of the stock of Nanometrics consists of 47,000,000 shares of common stock, par value $0.001 per share,options exercised during 2019, 2018 and 3,000,000 shares of preferred stock, par value $0.001 per share.

Stock Repurchase

On May 29, 2012, our Board of Directors authorized the repurchase of up to $20.0 million of our common stock of which $4.4 million remained as2017 was $51, $384 and $853, respectively.  As of December 31, 2016.2019, there was 0 unrecognized compensation cost related to stock options granted under the plans.

On November 15, 2017,The options outstanding and exercisable at December 31, 2019 were in the Company's Board of Directors approved a program to repurchase up to $50.0 million of its common stock which superseded the 2012 repurchase program. This new plan is referred to as the Stock Repurchase Plan with an effective date of November 20, 2017. Stock repurchases under this plan may be made through open market and privately negotiated transactions, at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased is dependent on a variety of factors includingfollowing exercise price corporate and regulatory requirements and other market conditions.

Shares repurchased and retired for fiscal year 2017, 2016 and 2015, with the associated cost of repurchase and amount available for repurchase at the end of the respective periods are as follows (in thousands, except number of shares and weighted average price per share):ranges:

 

 

 

Fiscal Year 2017

 

 

Fiscal Year 2016

 

 

Fiscal Year 2015

 

Number of shares of common stock repurchased

 

 

1,065,848

 

 

 

 

 

111,050

 

Weighted average price per share

 

$

25.33

 

 

 

 

 

$

15.49

 

Total cost of repurchase

 

$

26,999

 

 

 

 

$

1,721

 

Amount available for repurchase at end of period

 

$

23,001

 

 

 

 

 

$

4,397

 

61


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The Stock Repurchase Plan was completed in February 2018, with purchases since December 30, 2017 of 896,187 shares of our common stock at the weighted average price of $25.65 for a cost of $23.0 million.

Stock Option Plans

The Nanometrics option plans are as follows:

Plan Name

Participants

Shares

Authorized

2005 Equity Incentive Plan

Employees, consultants and directors

8,292,594

2000 Employee Stock Option Plan

Employees and consultants

2,450,000

2000 Director Stock Option Plan

Non-employee directors

250,000

Accent Optical Technologies, Inc. Stock Incentive Plan

Employees and consultants

205,003

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Shares

 

 

Weighted

Average

Remaining

Contractual

Life (years)

 

 

Weighted

Average

Exercise Price

 

 

Shares

 

 

Weighted

Average

Exercise Price

 

$14.08 - $14.08

 

 

1

 

 

 

0.7

 

 

$

14.08

 

 

 

1

 

 

$

14.08

 

$15.20 - $15.20

 

 

35

 

 

 

3.0

 

 

$

15.20

 

 

 

35

 

 

$

15.20

 

$15.61 - $18.22

 

 

9

 

 

 

0.5

 

 

$

16.37

 

 

 

9

 

 

$

16.37

 

$18.79 - $18.79

 

 

1

 

 

 

1.2

 

 

$

18.79

 

 

 

1

 

 

$

18.79

 

$14.08 - $18.79

 

 

47

 

 

 

2.4

 

 

$

15.49

 

 

 

47

 

 

$

15.49

 

 

Employee Stock Purchase Plan

Under the 2003Rudolph Technologies, Inc. 2018 Employee Stock Purchase Plan (“(the “2018 ESPP”), eligible employees are allowed to have salary withholdings of up to 10% of their base compensation to purchase shares of common stock at a price equal to 85% of the lower of the market value of the stock at the beginning or end of each six-month offering period, subject to an annual statutory limitation. At the end of the fiscal year ended December 30, 2017, the Company had 0.5 million shares remaining for issuance under the ESPP. Shares purchased under the.  The 2018 ESPP were 122,298 shares, 212,619 shares and 125,504 shares in 2017, 2016 and 2015 at a weighted average price of $21.19, $14.29 and $13.98, respectively.

Stock-based Compensation

The Company measures and recognizes compensation expense for all share-based payment awards made to employees and directors including employee stock options, restricted stock units and employee stock purchases related to the Employee Stock Purchase Plan (collectively “Employee Stock Purchases”) based on estimated fair values. The fair value of share-based payment awards is estimated on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periodswas terminated in the Company's consolidated statementthird quarter of operations.

Valuation and Expense Information

The fair value of stock-based awards to employees is calculated using the Black-Scholes option pricing model, which requires subjective assumptions, including future stock price volatility and expected time to exercise. The expected life was calculated using the simplified method allowed by the SAB 107. The risk-free rates were based on the U.S Treasury rates in effect during the corresponding period. The expected volatility was based on the historical volatility of the Company's stock price. These factors could change in the future, which would affect the stock-based compensation expense in future periods.

The weighted-average fair value of stock-based compensation to employees is based on the single option valuation approach. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized over the vesting period. The weighted-average fair value calculations are based on the following average assumptions:

 

 

Fiscal Year 2017

 

 

Fiscal Year 2016

 

 

Fiscal Year 2015

 

Employee Stock Purchase Plan:

 

 

 

 

 

 

 

 

 

 

 

 

Expected life

 

0.5 years

 

 

0.5 years

 

 

0.5 years

 

Volatility

 

37.2%

 

 

38.7%

 

 

36.9%

 

Risk free interest rate

 

0.91%

 

 

0.44%

 

 

0.12%

 

Dividends

 

 

 

 

 

 

62


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Stock Options and Restricted Stock Units (“RSUs”)

On May 23, 2017, the Company approved further amendments to the 2005 Equity Incentive Plan including: increasing the number of shares of common stock authorized by 1.0 million shares and extending the term of the 2005 Equity Incentive Plan through 2027. All other terms remained the same.

Stock Options

No stock options were granted in fiscal years 2017, 2016 and 2015. A summary of activity of stock options is as follows:

 

 

Number of

Shares

Outstanding

(Options)

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual Term (Years)

 

 

Aggregate Intrinsic Value (in Thousands)

 

Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 26, 2015

 

 

1,059,471

 

 

$

14.61

 

 

 

2.47

 

 

$

1,920

 

Exercised

 

 

(442,339

)

 

 

13.66

 

 

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

(176,587

)

 

 

15.83

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

 

440,545

 

 

 

15.06

 

 

 

2.12

 

 

$

4,405

 

Exercised

 

 

(223,364

)

 

 

13.35

 

 

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

(855

)

 

 

16.63

 

 

 

 

 

 

 

 

 

Outstanding at December 30, 2017

 

 

216,326

 

 

$

16.82

 

 

 

1.76

 

 

$

1,752

 

Exercisable at December 30, 2017

 

 

215,620

 

 

$

16.81

 

 

 

1.76

 

 

$

1,748

 

The aggregate intrinsic value in the above table represents the total pretax intrinsic value, based on the Company’s closing stock price of $24.92 as of December 30, 2017, which would have been received by the option holders had all option holders exercised their options as of that date. The total intrinsic value of options exercised during 2017, 2016 and 2015 was $3.1 million, $2.7 million and $1.6 million, respectively. The fair value of options vested during 2017, 2016 and 2015 was $0.3 million, $0.7 million and $1.5 million, respectively.

The following table summarizes ranges of outstanding and exercisable options as of December 30, 2017.

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Prices

 

Number

Outstanding

 

 

Weighted

Average

Remaining

Contractual Life

(Years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise

Price

 

$12.98-$15.00

 

 

23,383

 

 

 

1.83

 

 

$

14.64

 

 

 

23,383

 

 

$

14.64

 

$15.08-$15.65

 

 

27,697

 

 

 

1.37

 

 

 

15.62

 

 

 

27,697

 

 

 

15.62

 

$15.74-$15.74

 

 

3,333

 

 

 

0.40

 

 

 

15.74

 

 

 

3,333

 

 

 

15.74

 

$15.85-$15.85

 

 

60,000

 

 

 

2.20

 

 

 

15.85

 

 

 

60,000

 

 

 

15.85

 

$16.00-$17.33

 

 

31,700

 

 

 

1.82

 

 

 

17.00

 

 

 

31,700

 

 

 

17.00

 

$17.70-$18.08

 

 

6,613

 

 

 

1.55

 

 

 

17.92

 

 

 

6,588

 

 

 

17.92

 

$18.22-$18.22

 

 

3,600

 

 

 

3.16

 

 

 

18.22

 

 

 

3,449

 

 

 

18.22

 

$18.51-$18.51

 

 

9,000

 

 

 

3.14

 

 

 

18.51

 

 

 

8,583

 

 

 

18.51

 

$18.79-$18.79

 

 

1,000

 

 

 

3.23

 

 

 

18.79

 

 

 

887

 

 

 

18.79

 

$19.03-$19.03

 

 

50,000

 

 

 

1.13

 

 

$

19.03

 

 

 

50,000

 

 

$

19.03

 

$12.98-$19.03

 

 

216,326

 

 

 

 

 

 

 

 

 

 

 

215,620

 

 

 

 

 

As of December 30, 2017, the total unrecognized compensation costs related to unvested stock options was less than $0.1 million and is expected to be recognized as an expense over a weighted average remaining amortization period of 0.10 years.

63


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Restricted Stock Units (“RSUs”)

Each RSU counts against the Company’s “2005 Equity Incentive Plan” at a ratio of one and seven tenths shares for each unit granted but represents an amount equal to the fair value of one share of the Company’s common stock. The Company granted 454,600 and 476,667 RSUs during the years ended December 30, 2017, and December 31, 2016, respectively, to key employees with vesting periods up to three years.

A summary of activity for RSUs is as follows:

Summary of activity for RSUs

 

Number

of RSUs

 

 

Weighted

Average Fair

Value

 

Outstanding RSUs as of December 26, 2015

 

 

713,243

 

 

$

15.99

 

Granted

 

 

476,667

 

 

 

17.45

 

Released

 

 

(315,872

)

 

 

16.05

 

Cancelled

 

 

(54,253

)

 

 

16.29

 

Outstanding RSUs as of December 31, 2016

 

 

819,785

 

 

 

16.79

 

Granted

 

 

454,600

 

 

 

27.12

 

Released

 

 

(387,592

)

 

 

16.81

 

Cancelled

 

 

(96,494

)

 

 

19.01

 

Outstanding RSUs as of December 30, 2017

 

 

790,299

 

 

$

22.46

 

As of December 30, 2017, the total unrecognized compensation costs related to RSU's was $12.5 million and is expected to be recognized as an expense over a weighted average remaining amortization period of 1.75 years.

Market-Based Performance Stock Units (“PSUs”)

In addition to granting RSUs that vest on the passage of time only, the Company granted PSUs to certain executives. The PSUs will vest in tranches over one, two, and three years based on the relative performance of the Company’s stock during those periods, compared to a peer group over the same period. If target stock price performance is achieved, 66.7% of the shares of the Company’s stock subject to the PSUs will vest, and up to a maximum of 100% of the shares subject to the PSUs will vest if the maximum stock price performance is achieved for each tranche. For certain shares granted in fiscal 2017, 62,500 shares are the cumulative maximum number of shares that may vest for all measurement periods.

A summary of activity for PSUs is as follows:

Summary of activity for PSUs

 

Number of PSUs

 

 

Weighted Average Fair Value

 

Outstanding PSUs as of December 26, 2015

 

 

60,000

 

 

$

12.23

 

Granted

 

 

67,500

 

 

 

8.52

 

Released

 

 

(13,333

)

 

 

12.03

 

Cancelled

 

 

(6,667

)

 

 

12.03

 

Outstanding PSUs as of December 31, 2016

 

 

107,500

 

 

 

9.94

 

Granted

 

 

122,050

 

 

 

20.51

 

Released

 

 

(38,500

)

 

 

10.41

 

Cancelled

 

 

(61,100

)

 

 

19.41

 

Outstanding PSUs as of December 30, 2017

 

 

129,950

 

 

$

15.60

 

64


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Valuation of PSUs

On the date of grant, the Company estimated the fair value of PSUs using a Monte Carlo simulation model. The assumptions for the valuation of PSUs are summarized as follows:

 

 

2017 Award

 

2016 Award

 

 

2015 Award

 

Grant Date Fair Values Per Share

 

$14.57-$26.75

 

$

8.52

 

 

$

12.23

 

Weighted-average assumptions/inputs:

 

 

 

 

 

 

 

 

 

 

Expected Dividend

 

 

 

 

 

Range of risk-free interest rates

 

1.74%-1.84%

 

0.92%

 

 

0.25%-1.1%

 

Range of expected volatilities for peer group

 

22%-66%

 

22%-93%

 

 

23%-65%

 

The number of RSUs granted during fiscal year 2017 was 454,600, which counted as 772,820 shares, and PSUs granted during fiscal year 2017 was 122,050, which counted as 207,485 against the 2005 Equity Incentive Plan. The number of RSUs cancelled during fiscal year 2017 was 96,494, which counted as 164,040 shares, and PSUs cancelled during fiscal year 2017 was 61,100, which counted as 103,870, against the 2005 Equity Incentive Plan. Each RSU represents an amount equal to the fair value of one share of the Company's common stock.

A summary of activity under the Company’s stock option plans including options, RSUs and PSUs during fiscal year 2017, 2016 and 2015 and shares available for grant as of the respective period end dates, is as follows:

 

 

Fiscal Year 2017

 

 

Fiscal Year 2016

 

 

Fiscal Year 2015

 

Shares available for grant at beginning of fiscal year

 

 

1,334,581

 

 

 

1,916,589

 

 

 

2,464,082

 

Additional Shares Authorized

 

 

1,000,000

 

 

 

 

 

 

 

Options – cancelled

 

 

855

 

 

 

176,587

 

 

 

94,012

 

Options - expired plan shares

 

 

 

 

 

 

(116,192

)

 

 

(1,800

)

RSUs – granted

 

 

(772,820

)

 

 

(810,334

)

 

 

(860,980

)

RSUs – cancelled

 

 

164,040

 

 

 

92,230

 

 

 

202,356

 

RSUs - shares issued to satisfy tax

   withholding obligations

 

 

251,724

 

 

 

179,117

 

 

 

120,919

 

PSUs – granted

 

 

(207,485

)

 

 

(114,750

)

 

 

(102,000

)

PSUs – cancelled

 

 

103,870

 

 

 

11,334

 

 

 

 

Shares available for grant at end of fiscal year

 

 

1,874,765

 

 

 

1,334,581

 

 

 

1,916,589

 

Stock-based Compensation Expense

Stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Effective January 1, 2017,2019 as a result of the adoptionMerger.  Under the terms of ASU No. 2016-09 “Improvementsthe ESPP, eligible employees may have had up to Employee Share-Based Payment Accounting”,15% of eligible compensation deducted from their pay and applied to the purchase of shares of Company has electedcommon stock. The

F-35


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

price the employee would pay for each share of stock was 95% of the fair market value of Company common stock at the end of the applicable six-month purchase period. The ESPP was intended to account for forfeituresqualify under Section 423 of the Internal Revenue Code and was a non-compensatory plan as they occur. Refer to Note 2. Recent Accounting Pronouncements for further discussion on the adoption. As such, for fiscal year ended December 30, 2017,defined by FASB ASC 718, “Stock Compensation.” NaN stock-based compensation expense is recognized in the consolidated statement of operations, net of actual forfeitures during the period. Priorattributable to the adoption of ASU No. 2016-09, the Company estimated forfeitures at the time of grant, based on historical forfeiture experience, and revised if necessary, in subsequent periods, if actual forfeitures differ from estimates. Stock-based compensation expense recognized in the consolidated statement of operations2018 ESPP was recorded for the years ended December 31, 2016,2019, 2018 and December 26, 2015, has been reduced for estimated forfeitures.2017.

Tax benefits resulting from tax deductions in excessNanometrics Incorporated Amended and Restated 2003 Employee Stock Purchase Plan (the “2003 ESPP”).  Under the terms of the 2003 ESPP, eligible employees may have up to 10% of eligible compensation cost recognizeddeducted from their pay and applied to the purchase of shares of Company common stock. The price the employee pays for those options are requiredeach share of stock is 85% of the lesser of the fair market value of Company common stock at the beginning or the end of the applicable six-month purchase period. The 2003 ESPP is intended to be separately classified inqualify under Section 423 of the consolidated statements of cash flows. The Company recognized $1.0 million of excess tax benefit in fiscal year 2016,Internal Revenue Code and none in both fiscal years 2017 and 2015, respectively.

65


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

is a compensatory plan as defined by FASB ASC 718, “Stock Compensation.” Stock-based compensation expense for all share-based payment awards madeattributable to the Company’s employees and directors pursuant to2003 ESPP was $165 for the employee stock option andyear ended December 31, 2019.  

Through the Company’s employee stock purchase plans, employees purchased 72, 13 and 11 shares during the twelve months ended December 31, 2019, 2018 and 2017, respectively.  As of December 31, 2019 and 2018, there were 236 and 1,206, shares available for issuance under the Company’s employee stock purchase plans, respectively.

401(k) Savings Plan

The Company has a 401(k) savings plan that allows employees to contribute up to 100% of their annual compensation to the Plan on a pre-tax or after-tax basis, limited to a maximum annual amount as set periodically by function were as follows (in thousands):the Internal Revenue Service. The plan provides a 50% match of all employee contributions up to 6 percent of the employee’s salary.  Matching contributions to the plan totaled $1,317, $1,118 and $1,047 for the years ended December 31, 2019, 2018 and 2017, respectively. 

13.

Other Income (Expense), Net:

Other income (expense), net is comprised of the following:

 

 

 

Fiscal Year 2017

 

 

Fiscal Year 2016

 

 

Fiscal Year 2015

 

Cost of products

 

$

842

 

 

$

403

 

 

$

274

 

Cost of service

 

 

616

 

 

 

509

 

 

 

309

 

Research and development

 

 

1,720

 

 

 

1,408

 

 

 

1,036

 

Selling

 

 

2,323

 

 

 

2,046

 

 

 

1,881

 

General and administrative

 

 

3,318

 

 

 

3,300

 

 

 

2,748

 

Total stock-based compensation expense related to employee

   stock options and employee stock purchases

 

$

8,819

 

 

$

7,666

 

 

$

6,248

 

 

Year Ended December 31,

 

 

2019

 

 

2018

 

 

2017

 

Foreign currency exchange gains (losses), net

$

676

 

 

$

(255

)

 

$

(457

)

Gain on casualty insurance claim

 

 

 

 

302

 

 

 

 

Rental income

 

2

 

 

 

 

 

 

 

Other

 

102

 

 

 

9

 

 

 

 

Total other income (expense), net

$

780

 

 

$

56

 

 

$

(457

)

 

 

Note 12. Defined Benefit Pension PlanF-36


Table of Contents

Nanometrics sponsors a statutory government mandated defined benefit pension plan (the “Benefit Plan”) in Taiwan for its local employees.

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

14.

Income Taxes:

The fair valuecomponents of plan assets was $0.3 million for fiscal year ended 2017, and $0.2 million for each of fiscal years 2016 and 2015, respectively; and the net funding deficiencyincome tax expense are as follows:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(27

)

 

$

4,423

 

 

$

6,020

 

State

 

 

88

 

 

 

1,038

 

 

 

507

 

Foreign

 

 

1,548

 

 

 

626

 

 

 

3,159

 

 

 

 

1,609

 

 

 

6,087

 

 

 

9,686

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(4,730

)

 

 

1,961

 

 

 

17,034

 

State

 

 

506

 

 

 

(73

)

 

 

643

 

Foreign

 

 

108

 

 

 

275

 

 

 

(470

)

 

 

 

(4,116

)

 

 

2,163

 

 

 

17,207

 

Total income tax expense (benefit)

 

$

(2,507

)

 

$

8,250

 

 

$

26,893

 

The income before tax is comprised of the Benefit Plan was $0.5 million, $0.4 million, and $0.3 millionfollowing:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Domestic operations

 

$

(7,087

)

 

$

49,089

 

 

$

57,079

 

Foreign operations

 

$

6,490

 

 

$

4,257

 

 

$

2,723

 

The provision for income taxes differs from the fiscalamount of income tax determined by applying the applicable U.S. federal income tax rate of 21% for the years ended December 30, 2017,31, 2019 and 2018, and 35% for years ended December 31, 2016, and December 26, 2015, respectively. Based on the nature and limited extent of the pension plan, we determined this pension plan was not material2017 to income before provision for separate disclosure.income taxes as follows:

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Federal income tax provision at statutory rate

 

$

(125

)

 

$

11,203

 

 

$

20,931

 

State taxes, net of federal effect

 

 

113

 

 

 

747

 

 

 

573

 

Foreign taxes, net of federal effect

 

 

(1,277

)

 

 

17

 

 

 

(238

)

Domestic manufacturing benefit

 

 

 

 

 

 

 

 

(1,569

)

Foreign Derived Intangible Income ("FDII") Deduction

 

 

(2,278

)

 

 

(2,217

)

 

 

 

Global Intangible Low-Taxes Income ("GILTI") inclusion

 

 

1,786

 

 

 

113

 

 

 

 

Non-deductible officer's compensation

 

 

826

 

 

 

526

 

 

 

 

Research & development tax credit

 

 

(2,126

)

 

 

(2,298

)

 

 

(1,559

)

Remeasurement of deferred tax balances, related to the Tax Act

 

 

 

 

 

(33

)

 

 

8,020

 

Transition tax on foreign earnings, related to the Tax Act

 

 

 

 

 

138

 

 

 

(106

)

Other

 

 

574

 

 

 

54

 

 

 

841

 

Provision (benefit) for income taxes

 

$

(2,507

)

 

$

8,250

 

 

$

26,893

 

Effective tax rate

 

 

420

%

 

 

15

%

 

 

45

%

 

 

Note 13. Income TaxesF-37


Table of Contents

Income Tax Assets and Liabilities - The Company accounts for income taxes whereby deferred

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

Deferred tax assets and liabilities are recognized using enacted tax rates forcomprised of the effectfollowing:

 

 

December 31,

 

 

 

2019

 

 

2018

 

Deferred Tax Assets:

 

 

 

 

 

 

 

 

Reserves and accruals

 

$

8,254

 

 

$

4,880

 

Deferred revenue

 

 

1,219

 

 

 

1,201

 

Share-based compensation

 

 

2,955

 

 

 

1,259

 

Tax credit carryforward

 

 

11,307

 

 

 

2,484

 

Net operating losses

 

 

6,008

 

 

 

1,692

 

Depreciation and amortization

 

 

7,151

 

 

 

4,298

 

Operating lease right-of-use assets (1)

 

 

4,965

 

 

 

 

Other

 

 

1,128

 

 

 

777

 

Gross deferred tax assets

 

 

42,987

 

 

 

16,591

 

Less: valuation allowance

 

 

(14,160

)

 

 

(3,172

)

Total deferred tax assets after valuation allowance

 

 

28,827

 

 

 

13,419

 

Deferred Tax Liabilities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

(89,286

)

 

 

(609

)

Operating lease liabilities (1)

 

 

(4,709

)

 

 

 

Other

 

 

(416

)

 

 

 

Gross deferred tax liabilities

 

 

(94,411

)

 

 

(609

)

Net deferred tax assets (liabilities)

 

$

(65,584

)

 

$

12,810

 

(1) As discussed in Note 7 to the Consolidated Financial Statements, in 2019, the Company adopted an updated accounting standard that resulted in the recognition of temporary differences between the book and tax accounting foroperating right-of-use assets and lease liabilities.  Also,The Company adopted this standard using a transition method that does not require application to periods prior to adoption.  

At December 31, 2019 and 2018, the Company had recorded valuation allowances of $14,160 and $3,172, respectively, on a certain portion of the Company’s deferred tax assets are reduced byto reflect the deferred tax assets at the net amount that is more likely than not to be realized.  The Company maintained a full valuation allowance on its remaining foreign tax credits in the amount of $2,366, as well as maintaining a full valuation allowances against its China, Switzerland and United Kingdom deferred tax assets of $478, $3,434 and $443, respectively.  The Company also maintained a valuation allowance toagainst a portion of its California deferred tax assets of $7,439.

In assessing the extentrealizability of deferred tax assets, the Company uses a more likely than not standard. If it is determined that management cannot concludeit is more-likely-than-not that deferred tax assets will not be realized, a valuation allowance must be established against the deferred tax assets. The ultimate realization of the assets is dependent on the generation of future taxable income during the periods in which the associated temporary differences become deductible. Management considers the scheduled reversal of deferred income tax liabilities, projected future taxable income and tax planning strategies when making this assessment.  In making the determination that it is more likely than not that a portion of the Company’s deferred tax assetassets will be realized inas of December 31, 2019, the future. The Company evaluatesrelied primarily on the reversal of deferred tax assets on a continuous basis throughoutliabilities as well as projected future taxable income.

At December 31, 2019, the year to determine whether or not a valuation allowance is appropriate. Factors used in this determination include future expected income and the underlying asset or liability which generated the temporary tax difference. The income tax provision is primarily impacted byCompany had federal, statutory rates, state and foreign income taxes, and changes in the valuation allowance.

Income (loss) before provision for income taxes consists of the following (in thousands):

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Domestic

 

$

34,238

 

 

$

25,372

 

 

$

178

 

Foreign

 

 

9,060

 

 

 

3,763

 

 

 

5,390

 

Income (loss) before income taxes

 

$

43,298

 

 

$

29,135

 

 

$

5,568

 

66


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The provision (benefit) for income taxes consists of the following (in thousands):

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

3,250

 

 

$

697

 

 

$

148

 

State

 

 

9

 

 

 

85

 

 

 

3

 

Foreign

 

 

2,998

 

 

 

2,111

 

 

 

2,266

 

 

 

 

6,257

 

 

 

2,893

 

 

 

2,417

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

6,314

 

 

 

(16,641

)

 

 

190

 

State

 

 

53

 

 

 

(320

)

 

 

3

 

Foreign

 

 

472

 

 

 

(832

)

 

 

53

 

 

 

 

6,839

 

 

 

(17,793

)

 

 

246

 

Provision (benefit) for income taxes

 

$

13,096

 

 

$

(14,900

)

 

$

2,663

 

Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):

 

 

At

 

 

 

December 30, 2017

 

 

December 31, 2016

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Reserves and accruals

 

$

5,797

 

 

$

11,043

 

Deferred revenue

 

 

240

 

 

 

349

 

Shared based compensation

 

 

1,483

 

 

 

2,590

 

Tax credit carry-forwards

 

 

9,669

 

 

 

10,112

 

Net operating losses

 

 

9,755

 

 

 

8,434

 

Depreciation & amortization

 

 

(1,525

)

 

 

(2,898

)

Other

 

 

207

 

 

 

(1,252

)

Total deferred tax assets

 

 

25,626

 

 

 

28,378

 

Less: Valuation allowance

 

 

(13,702

)

 

 

(10,980

)

Total deferred tax assets net of valuation allowance

 

 

11,924

 

 

 

17,398

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation & amortization

 

 

(12

)

 

 

(6

)

Other

 

 

(167

)

 

 

(14

)

Total deferred tax liabilities

 

 

(179

)

 

 

(20

)

Net deferred tax assets

 

$

11,745

 

 

$

17,378

 

As of December 30, 2017, the Company had net operating loss carryforwards of $25.6 million$1,997, $25,630 and $20,986, respectively. The federal, state and foreign net operating loss carryforwards expire on various dates beginning in California, $3.0 million in other states,2020 through 2035.

At December 31, 2019, the Company had federal and $35.0 million instate research & development credits and foreign countries, which begintax credit carryforwards of $6,859, $9,948 and $2,366, respectively.  The state research & development credits are set to expire at various dates beginning in 2018.2025. The foreign tax credit is set to expire at various dates through December 31, 2029.

As of December 30, 2017,31, 2019, the Company had available carryforward Federal and California R&D tax credits of $7.0 million and $8.9 million, respectively. Federal R&D tax credit carryforwards begin to expire in 2032. State R&D tax credits carryforward indefinitely.

During the years ended December 30, 2017, and December 31, 2016, the change in valuation allowances was $1.5 million and $(25.8) million, respectively. The valuation allowance increase in 2017 was primarily related to the increase net benefit of the California deferred tax assets from lower federal rates, offset by a valuation allowance release against a portion of the Company’s foreign deferred tax assets. The realization of deferred tax assets is primarily dependent on the Company generating sufficient U.S. and foreign taxable income in future fiscal years. The Company regularly assesses the need for a valuation allowance against its deferred tax assets. In making that assessment, the Company considers both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more-likely-than-not that some or all of the deferred tax assets will not be realized. For the year ended December 30, 2017, the Company possessed enough positive evidence to determine that is was more-likely-than-not that the Company would utilize a significant portion of its Singapore deferred tax assets.

67


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

Therefore, the Company released $0.3 million of valuation allowance in that jurisdiction. The Company continues to maintain valuation allowances against its California and certain foreign deferred tax assets as a result of uncertainties regarding the realization of the asset due to cumulative losses and uncertainty of future taxable income. The Company will continue to assess the realizability of the deferred tax assets in each of the applicable jurisdictions and maintain the valuation allowances until sufficient positive evidence exists to support a reversal. In the event the Company determines that the deferred tax assets are realizable, an adjustment to the valuation allowances will be reflected in the tax provision for the period such determination is made.

Changes in tax laws and tax rates could affect the Company's recorded deferred tax assets and liabilities in the future. The Company's tax liabilities involve dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. Management will account for any such changes or factors in the period in which such law changes are enacted. On December 22, 2017, H.R.1, formerly known as the Tax Cuts and Jobs Act (“The Act”), was signed into law. Among other items, H.R.1 reduces the federal corporate tax rate from 35% to 21% effective January 1, 2018. As a result, the Company revalued its net deferred tax asset to the lower enacted rate. The Company's net deferred tax asset represents differences between the carrying amounts and tax bases of assets and liabilities carried on the Company's balance sheet.

In addition to the revaluation of deferred tax assets and liabilities in reflecting the lower tax rates, the Act also imposes a deemed repatriation tax on the Company’s total post-1986 deferred foreign income.  During the year ended December 30, 2017, the company recognized $0.6 million as a provisional estimate for income taxes under the U.S. Securities and Exchange Commission Accounting Bulletin No. 118. The provisional estimate is subject to revisions as we complete our analysis of the Act, collect and prepare necessary data, and interpret any additional guidance issued by the U.S. Treasury Department, Internal Revenue Service (“IRS”), FASB, and other standard-setting and regulatory bodies.  Our accounting for the tax effects of the Act will be completed during the measurement period, which should not extend beyond one year from the enactment date.

Differences between income taxes computed by applying the statutory federal income tax rate to income (loss) before income taxes and the provision (benefit) for income taxes consist of the following (in thousands):

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Income taxes computed at U.S. statutory rate

 

$

15,153

 

 

$

10,197

 

 

$

1,949

 

State income taxes

 

 

227

 

 

 

223

 

 

 

28

 

Foreign tax rate differential

 

 

794

 

 

 

3,502

 

 

 

342

 

Change in valuation allowance

 

 

1,490

 

 

 

(25,738

)

 

 

1,648

 

Equity compensation

 

 

(1,803

)

 

 

380

 

 

 

311

 

Tax credits

 

 

(2,336

)

 

 

(3,191

)

 

 

(1,834

)

Domestic production activities deduction

 

 

(608

)

 

 

(354

)

 

 

 

Liabilities for uncertain tax positions

 

 

18

 

 

 

67

 

 

 

74

 

Other, net

 

 

161

 

 

 

14

 

 

 

145

 

Provision (benefit) for income taxes

 

$

13,096

 

 

$

(14,900

)

 

$

2,663

 

As of December 30, 2017, The Company has provided U.SU.S. income taxes on all its foreign earnings.  The Company still continues to permanently reinvest the cash held offshore to support its working capital needs.  Accordingly, no additional

F-38


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

foreign withholding taxes that may be required from certain jurisdictions in the event of a cash distribution have been provided thereon.for.  

The Company recognizes tax liabilities for uncertain tax positions and adjusts these liabilities when its judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the Company's current estimate of the tax liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which they are determined.

The accounting for uncertainty in income taxes recognized in an enterprise's financial statements prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return, and the derecognition of tax benefits, classification on the balance sheet, interest and penalties, accounting in interim periods, disclosure, and transition.

68


NANOMETRICS INCORPORATED

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

A reconciliation of the beginning and endingtotal amount of unrecognized tax benefits isare as follows (in thousands):follows:

 

 

 

Rollforward Table (at Gross): As of

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Unrecognized tax benefits - beginning of the period

 

$

6,477

 

 

$

6,961

 

 

$

6,442

 

Gross increases-tax positions in prior period

 

 

32

 

 

 

23

 

 

 

127

 

Gross decreases-tax positions in prior period

 

 

 

 

 

(1,193

)

 

 

(306

)

Gross increases-current-period tax positions

 

 

723

 

 

 

686

 

 

 

698

 

Lapse of statute of limitations

 

 

(81

)

 

 

 

 

 

 

Unrecognized tax benefits - end of the period

 

$

7,151

 

 

$

6,477

 

 

$

6,961

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Balance, beginning of the period

 

$

5,528

 

 

$

4,880

 

 

$

4,827

 

Gross increases—tax positions in prior period

 

 

9,989

 

 

 

496

 

 

 

171

 

Gross decreases—tax positions in prior period

 

 

(932

)

 

 

(61

)

 

 

(362

)

Gross increases—current-period tax positions

 

 

558

 

 

 

213

 

 

 

244

 

Lapse of statute of limitations

 

 

 

 

 

 

 

 

 

Balance, end of the period

 

$

15,143

 

 

$

5,528

 

 

$

4,880

 

 

The unrecognized tax benefit at December 30, 2017, was $7.2 million,31, 2019 and 2018 were $15,143 and $5,528, respectively, of which $4.0 million$10,649 and $4,995, respectively, would impact the effectivebe reflected as an adjustment to income tax rateexpense if recognized.  The year over year increase from 2018 to 2019 is primarily due to additional unrecognized tax benefits related to federal tax exposures.  It is reasonably possible that certain amounts of unrecognized tax benefits may reverse in the next 12 months; however, the Company accruesdoes not expect such reversals to have a significant impact on its results of operations or financial position.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits in its provision for income taxes. The total amount oftax expense. During the years ended December 31, 2019, 2018 and 2017, the Company recognized approximately $236, $199 and $246, respectively, in interest and penalties and interest were not material asexpense associated with uncertain tax positions. As of December 30, 2017, December 31, 2016,2019 and December 26, 2015. The2018, the Company does not expect a material change in itshad accrued interest and penalties expense related to unrecognized tax benefits within the next 12 months.of $1,681 and $1,445, respectively.

The Company is subject to taxationU.S. federal income tax as well as income tax in the U.S. and various states including California,multiple state and foreign jurisdictions including Korea, Japan, Taiwan,jurisdictions.   The Company is subject to ordinary statute of limitation rules of three and China. Duefour years for federal and state returns, respectively.  However, due to tax attribute carry-forwards,carryforwards, the Company is subject to examination for tax years 2003 forward for U.S. federal tax purposes.  The Company wasis also subject to examination in various states for tax years 2002 forward.  The Company is subject to examination for tax years 20092011 forward for various foreign jurisdictions. The Company believes that adequate amounts have been reserved for any adjustments that may ultimately result from any future examinations of these years.

In the normal course of business, the Company is subject to tax audits in various jurisdictions, and such jurisdictions may assess additional income taxes or other taxes against it. Although the Company believes its tax estimates are reasonable, the final determination of tax audits and any related litigation could be materially different from the Company’ s historical income tax provisions and accruals. The results of an audit or litigation could have a material adverse effect on the Company’ s results of operations or cash flows in the period or periods for which that determination is made.

15.

Accumulated Other Comprehensive Loss:

Comprehensive income includes net income, foreign currency translation adjustments, and net unrealized gains and losses on available-for-sale debt securities.  See the Consolidated Statements of Comprehensive Income for the effect of the components of comprehensive income on the Company’s net income.

 

F-39


Table of Contents

Note 14. Segment, Geographic, Product and Significant Customer Information

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

The Company has one operating segment, which is the sale, design, manufacture, marketing and support of thin film and optical critical dimension systems. The Chief Executive Officer has been identified as the Chief Operating Decision Maker (“CODM”) because he has the final authority over resource allocation decisions and performance assessment. The CODM does not receive discrete financial information about individual components of the Company's business. For the years ended December 30, 2017, December 31, 2016, and December 26, 2015, the Company recorded revenue from customers primarily in the United States, Asia and Europe. The following tables summarize totalaccumulated other comprehensive loss, net revenues and long-lived assets (excluding intangible assets) attributed to significant countries (in thousands):of tax, are as follows:

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Total net revenues (1):

 

 

 

 

 

 

 

 

 

 

 

 

South Korea

 

$

94,082

 

 

$

44,735

 

 

$

30,572

 

China

 

 

29,826

 

 

 

43,460

 

 

 

17,373

 

Singapore

 

 

21,810

 

 

 

37,096

 

 

 

17,395

 

United States

 

 

33,983

 

 

 

29,887

 

 

 

36,720

 

Taiwan

 

 

20,147

 

 

 

27,189

 

 

 

46,715

 

Japan

 

 

41,979

 

 

 

26,604

 

 

 

31,140

 

Other

 

 

16,794

 

 

 

12,158

 

 

 

7,452

 

Total net revenues

 

$

258,621

 

 

$

221,129

 

 

$

187,367

 

 

 

Foreign currency

translation

adjustments

 

 

Net unrealized

(gains) losses on

marketable

securities

 

 

Accumulated

other

comprehensive

loss (income)

 

Balance at December 31, 2017

 

$

1,079

 

 

$

126

 

 

$

1,205

 

Net current period other comprehensive loss

 

 

194

 

 

 

(136

)

 

 

58

 

Reclassifications

 

 

 

 

 

 

 

 

 

Balance at December 31, 2018

 

 

1,273

 

 

 

(10

)

 

 

1,263

 

Net current period other comprehensive income

 

 

(709

)

 

 

44

 

 

 

(665

)

Reclassifications

 

 

 

 

 

 

 

 

 

Balance at December 31, 2019

 

$

564

 

 

$

34

 

 

$

598

 

 

(1)16.

Net revenues are attributed to countries based on the customer's deploymentSegment Reporting and service locations of systems.Geographic Information:

69


NANOMETRICS INCORPORATEDThe Company is engaged in the design, development, manufacture and support of high-performance control metrology, defect inspection, advanced packaging lithography and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment: the design, development, manufacture and support of high-performance process control defect inspection and metrology, advanced packaging lithography and process control software systems used by microelectronics device manufacturers. Therefore, the Company has 1 reportable segment. The Company’s chief operating decision maker is the Chief Executive Officer (the “CEO”). The CEO allocates resources and assesses performance of the business and other activities at the reportable segment level.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

The following table lists the different sources of revenue:

 

 

 

December 30, 2017

 

 

December 31, 2016

 

Long-lived tangible assets:

 

 

 

 

 

 

 

 

United States

 

$

43,427

 

 

$

42,688

 

Taiwan

 

 

510

 

 

 

818

 

South Korea

 

 

576

 

 

 

554

 

Japan

 

 

60

 

 

 

57

 

All Other

 

 

237

 

 

 

109

 

Total long-lived tangible assets

 

$

44,810

 

 

$

44,226

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Systems and software

 

$

255,723

 

 

 

84

%

 

$

234,241

 

 

 

86

%

 

$

216,884

 

 

 

85

%

Parts

 

 

34,892

 

 

 

11

%

 

 

28,658

 

 

 

10

%

 

 

27,143

 

 

 

11

%

Services

 

 

15,281

 

 

 

5

%

 

 

10,885

 

 

 

4

%

 

 

11,071

 

 

 

4

%

Total revenue

 

$

305,896

 

 

 

100

%

 

$

273,784

 

 

 

100

%

 

$

255,098

 

 

 

100

%

 

The Company’s product lines differ primarily based onsignificant operations outside the environmentUnited States include sales, service and application offices in Asia and Europe. For geographical revenue reporting, revenue is attributed to the geographic location to which the systems will be used. Automated systems are used primarily in high-volume production environments. Materials characterization products are primarily used to measure the composition, band gap, structure, and other physical and electrical properties of semiconducting materials for discrete electronic industry, high brightness LED and solar/photovoltaic structures in both development and high-volume environments. Integrated systems are installed inside wafer processing equipment to provide near real-time measurements for improving process control and increasing throughput. Revenuesproduct is shipped. Revenue by product type weregeographic region is as follows (in thousands): follows:

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Automated Systems

 

$

151,401

 

 

$

127,378

 

 

$

102,386

 

Integrated Systems

 

 

42,183

 

 

 

43,846

 

 

 

31,579

 

Materials Characterization Systems

 

 

21,293

 

 

 

13,842

 

 

 

12,980

 

Total product revenues

 

$

214,877

 

 

$

185,066

 

 

$

146,945

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Revenue from third parties:

 

 

 

 

 

 

 

 

 

 

 

 

United States

 

$

46,717

 

 

$

43,944

 

 

$

36,104

 

Taiwan

 

 

66,601

 

 

 

45,312

 

 

 

63,079

 

South Korea

 

 

43,997

 

 

 

51,750

 

 

 

44,180

 

Singapore

 

 

10,699

 

 

 

14,371

 

 

 

12,775

 

Japan

 

 

29,816

 

 

 

22,361

 

 

 

18,943

 

Germany

 

 

4,899

 

 

 

14,913

 

 

 

15,580

 

China

 

 

80,017

 

 

 

63,243

 

 

 

35,925

 

Other Europe

 

 

18,124

 

 

 

12,260

 

 

 

23,768

 

Other Asia

 

 

5,026

 

 

 

5,630

 

 

 

4,744

 

Total revenue

 

$

305,896

 

 

$

273,784

 

 

$

255,098

 

 

The following customers

F-40


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

In 2019, sales to Taiwan Semiconductor Manufacturing Co. Ltd and SK Hynix Inc. accounted for 13.4% and 13.1%, respectively, of the Company’s revenue.  In 2018, sales to SK Hynix Inc. accounted for 12.2% of the Company’s revenue.  No individual end user customer accounted for more than 10% orof the Company’s revenue in 2017.  The Company does not have purchase contracts with any of its customers that obligate them to continue to purchase its products.

At December 31, 2019, 1 customer, Taiwan Semiconductor Manufacturing Co. Ltd., accounted for more than 10% of totalnet accounts receivable, net:receivable.  At December 31, 2018, 0 individual customer accounted for more than 10% of net accounts receivable.

Substantially all of the Company’s long-lived assets are located within the United States of America.

17.

Earnings Per Share:

Basic earnings per share is calculated using the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed in the same manner and also gives effect to all dilutive common stock equivalent shares outstanding during the period.   Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive.  In accordance with U.S. GAAP, these shares were not included in calculating diluted earnings per share.

For the year ended December 31, 2019, the weighted average number of restricted stock units and stock options excluded from the computation of diluted earnings per share were 69 and 0, respectively.  For the year ended December 31, 2018, the weighted average number of restricted stock units and stock options excluded from the computation of diluted earnings per share were 52 and 0, respectively.  For the year ended December 31, 2017, the weighted average number of restricted stock units and stock options excluded from the computation of diluted earnings per share were 8 and 0, respectively.

The Company’s basic and diluted earnings per share amounts are as follows:

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Taiwan Semiconductor Manufacturing Company Limited

 

***

 

 

 

20

%

 

 

26

%

Samsung Electronics Co. Ltd.

 

 

13

%

 

 

14

%

 

***

 

Micron Technology, Inc.

 

 

18

%

 

 

12

%

 

***

 

Intel Corporation

 

***

 

 

 

11

%

 

***

 

Toshiba Corporation

 

 

31

%

 

 

10

%

 

 

27

%

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

1,910

 

 

$

45,096

 

 

$

32,909

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings per share - weighted average shares

   outstanding

 

 

29,729

 

 

 

25,470

 

 

 

25,325

 

Effect of potential dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units and stock options - dilutive

   shares

 

 

278

 

 

 

426

 

 

 

539

 

Warrants - dilutive shares

 

 

 

 

 

 

 

 

1

 

Diluted earnings per share - weighted average shares

   outstanding

 

 

30,007

 

 

 

25,895

 

 

 

25,865

 

Earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.06

 

 

$

1.77

 

 

$

1.30

 

Diluted

 

$

0.06

 

 

$

1.74

 

 

$

1.27

 


F-41


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

 

***18.

The customer accounted for less than 10% of total accounts receivable, net, as of that period end.Shares Repurchase Authorization:

In October 2018, the Rudolph Board of Directors approved a share repurchase authorization, which allowed Rudolph to repurchase up to $40,000 worth of shares of the Rudolph’s common stock.  The authorization provided for repurchases to be made in the open market or through negotiated transactions from time to time.  The share repurchase authorization was terminated on October 25, 2019 due to the closing of the Merger.

The following table summarizes the Company’s stock repurchases: 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Shares of common stock repurchased

 

 

37

 

 

 

1,061

 

 

 

 

Cost of stock repurchased

 

$

744

 

 

$

21,069

 

 

$

-

 

Average price paid per share

 

$

19.85

 

 

$

19.86

 

 

$

-

 

Following the Merger, the Company assumed the share repurchase authorization approved on March 14, 2019, by the former Nanometrics Board of Directors.  This share repurchase authorization allows for the Company to purchase up to $80,000 worth of shares of its common stock. Under the terms of this share repurchase authorization, shares may be repurchased through open market or privately negotiated transactions. NaN shares have been repurchased under this repurchase authorization as of December 31, 2019.


F-42


Table of Contents

ONTO INNOVATION INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

(In thousands, except per share data)

19.

Quarterly Consolidated Financial Data (unaudited):

The following customers accountedtables present certain unaudited consolidated quarterly financial information for 10%the years ended December 31, 2019 and 2018. In the opinion of the Company’s management, this quarterly information has been prepared on the same basis as the consolidated financial statements and includes all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the information for the periods presented. The results of operations for any quarter are not necessarily indicative of results for the full year or morefor any future period.

Year-over-year quarterly comparisons of total net revenue:the Company’s results of operations may not be meaningful, as the sequential quarterly comparisons set forth below tend to reflect the cyclical activity of the semiconductor industry as a whole. Other quarterly fluctuations in expenses are related directly to sales activity and volume and may also reflect the timing of operating expenses incurred throughout the year, and changes in tax rates.

 

 

 

Years Ended

 

 

 

December 30, 2017

 

 

December 31, 2016

 

 

December 26, 2015

 

Samsung Electronics Co. Ltd.

 

 

26

%

 

***

 

 

 

13

%

SK Hynix

 

 

13

%

 

 

15

%

 

 

11

%

Micron Technology, Inc.

 

 

12

%

 

 

20

%

 

 

16

%

Intel Corporation

 

 

11

%

 

 

18

%

 

***

 

Toshiba Corporation

 

 

11

%

 

***

 

 

 

10

%

Taiwan Semiconductor Manufacturing Company Limited

 

***

 

 

 

10

%

 

 

19

%

 

 

Quarters Ended

 

 

 

 

 

 

 

March 31,

2019

 

 

June 30,

2019

 

 

September 30,

2019

 

 

December 31,

2019

 

 

Total

 

Revenue

 

$

60,892

 

 

$

61,511

 

 

$

62,935

 

 

$

120,558

 

 

$

305,896

 

Gross profit

 

 

32,019

 

 

 

31,911

 

 

 

31,511

 

 

 

39,587

 

 

$

135,028

 

Income (loss) before income taxes

 

 

8,795

 

 

 

6,121

 

 

 

6,908

 

 

 

(22,421

)

 

$

(597

)

Net income (loss)

 

 

7,576

 

 

 

5,526

 

 

 

6,560

 

 

 

(17,752

)

 

$

1,910

 

Income (loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.31

 

 

$

0.22

 

 

$

0.26

 

 

$

(0.41

)

 

$

0.06

 

Diluted

 

$

0.30

 

 

$

0.22

 

 

$

0.26

 

 

$

(0.41

)

 

$

0.06

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,863

 

 

 

25,032

 

 

 

25,079

 

 

 

43,609

 

 

 

29,729

 

Diluted

 

 

25,144

 

 

 

25,250

 

 

 

25,305

 

 

 

43,609

 

 

 

30,007

 

 

***

The customer accounted for less than 10% of total net revenue during the period.

 

 

Quarters Ended

 

 

 

 

 

 

 

March 31,

2018

 

 

June 30,

2018

 

 

September 30,

2018

 

 

December 31,

2018

 

 

Total

 

Revenue

 

$

73,096

 

 

$

77,476

 

 

$

60,432

 

 

$

62,780

 

 

$

273,784

 

Gross profit

 

 

42,421

 

 

 

41,736

 

 

 

31,454

 

 

 

32,668

 

 

 

148,279

 

Income before income taxes

 

 

17,674

 

 

 

17,290

 

 

 

8,368

 

 

 

10,014

 

 

 

53,346

 

Net income

 

 

15,130

 

 

 

14,697

 

 

 

7,187

 

 

 

8,082

 

 

 

45,096

 

Income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.59

 

 

$

0.57

 

 

$

0.28

 

 

$

0.32

 

 

$

1.77

 

Diluted

 

$

0.58

 

 

$

0.56

 

 

$

0.28

 

 

$

0.32

 

 

$

1.74

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

25,463

 

 

 

25,621

 

 

 

25,655

 

 

 

25,146

 

 

 

25,470

 

Diluted

 

 

25,989

 

 

 

26,086

 

 

 

26,063

 

 

 

25,449

 

 

 

25,895

 

 

 

 


SUPPLEMENTAL FINANCIAL INFORMATION

F-43


Table of ContentsSelected Quarterly Financial Results (Unaudited)

The following table sets forth selected consolidated quarterly results of operations for the years ended December 30, 2017, and December 31, 2016 (in thousands, except per share amounts):

ONTO INNOVATION INC. AND SUBSIDIARIES

SCHEDULE OF VALUATION AND QUALIFYING ACCOUNTS

(In thousands)

 

 

 

Quarters Ended

 

 

 

December 30, 2017

 

 

September 30, 2017

 

 

July 1, 2017

 

 

 

 

April 1, 2017

 

Total net revenues

 

$

78,205

 

 

$

56,675

 

 

$

64,427

 

 

 

 

$

59,314

 

Gross profit

 

$

43,973

 

 

$

30,660

 

 

$

33,621

 

 

 

 

$

28,447

 

Income from operations

 

$

19,162

 

 

$

7,484

 

 

$

10,652

 

 

 

 

$

5,508

 

Net income(1)

 

$

10,798

 

 

$

5,764

 

 

$

8,288

 

 

 

 

$

5,352

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.43

 

 

$

0.23

 

 

$

0.33

 

 

 

 

$

0.21

 

Diluted

 

$

0.42

 

 

$

0.22

 

 

$

0.32

 

 

 

 

$

0.21

 

Shares used in per share computations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

25,378

 

 

 

25,494

 

 

 

25,307

 

 

 

 

 

25,133

 

Diluted

 

 

25,819

 

 

 

25,932

 

 

 

25,906

 

 

 

 

 

25,833

 

 

 

Quarters Ended

 

 

 

December 31, 2016

 

 

September 24, 2016

 

 

June 25, 2016

 

 

March 26, 2016

 

Total net revenues

 

$

59,159

 

 

$

58,714

 

 

$

55,767

 

 

$

47,489

 

Gross profit

 

$

30,804

 

 

$

30,404

 

 

$

28,425

 

 

$

24,491

 

Income from operations

 

$

8,963

 

 

$

9,066

 

 

$

7,336

 

 

$

3,730

 

Net income(2)

 

$

26,654

 

 

$

7,883

 

 

$

6,031

 

 

$

3,467

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.07

 

 

$

0.32

 

 

$

0.25

 

 

$

0.14

 

Diluted

 

$

1.04

 

 

$

0.31

 

 

$

0.24

 

 

$

0.14

 

Shares used in per share computations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

24,949

 

 

 

24,826

 

 

 

24,524

 

 

 

24,308

 

Diluted

 

 

25,514

 

 

 

25,282

 

 

 

24,927

 

 

 

24,597

 

(1)

Our net income included a $2.9 million additional tax expense from the remeasurement of deferred tax assets relating to the Tax Cuts and Jobs Act that was signed into law on December 22, 2017

(2)

Net Income included a release of non-cash valuation allowance of $27.4 million on the Company’s U.S., and foreign deferred tax assets.

Column A

 

Column B

 

 

Column C

 

 

Column D

 

 

Column E

 

Description

 

Balance at

Beginning of

Period

 

 

Charged to (Recovery

of) Costs and Expense

 

 

Charged to Other

Accounts (net)

 

 

Deductions

 

 

Balance at

End of Period

 

Year 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful

    accounts

 

$

691

 

 

$

363

 

 

$

 

 

$

(193

)

 

$

1,247

 

Deferred tax valuation

    allowance

 

 

3,172

 

 

 

942

 

 

 

10,046

 

 

 

 

 

 

14,160

 

Allowance for convertible

    notes receivable

 

 

 

 

 

2,000

 

 

 

 

 

 

 

 

 

2,000

 

Year 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful

    accounts

 

$

460

 

 

$

293

 

 

$

 

 

$

62

 

 

$

691

 

Deferred tax valuation

    allowance

 

 

2,447

 

 

 

725

 

 

 

 

 

 

 

 

 

3,172

 

Year 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for doubtful

    accounts

 

$

680

 

 

$

(222

)

 

$

 

 

$

(2

)

 

$

460

 

Deferred tax valuation

    allowance

 

 

1,924

 

 

 

626

 

 

 

(103

)

 

 

 

 

 

2,447

 

 

 


ITEM 9.

F-44


Table of ContentsCHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

 

SIGNATURES

ITEM 9A.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and ProceduresPURSUANT TO THE REQUIREMENTS OF SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THEREUNTO DULY AUTHORIZED.

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports that we file or submit under the Securities Exchange Act of 1934 (“Exchange Act”), as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure. Our management, with participation by our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of December 30, 2017, the end of the period covered by this Annual Report on Form 10-K.

Based on the evaluation of our disclosure controls and procedures, our CEO and CFO have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective as of such date.

Remediation of material weakness

As disclosed in Part II. Item 9A. Controls and Procedures in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, we identified a material weakness in internal control over financial reporting related to the existence of inventories subject to our cycle counting program.

During fiscal 2017, we implemented the following remedial actions:

Implemented an additional reporting and monitoring controls over additions or changes to our inventory item master records; and

Designed an automated methodology for determining and assigning the frequency levels each inventory item should be counted

We believe that the remediation steps completed during fiscal 2017 significantly improved our internal control over financial reporting and the material weakness reported as of December 31, 2016, had been fully remediated as of December 30, 2017.

Report of Management on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13(a)-15(f) and 15d-15(f) under the Exchange Act, as amended. Our internal control over financial reporting was designed to provide reasonable, not absolute, assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our CEO and CFO, we assessed the effectiveness of our internal control over financial reporting as of December 30, 2017. In making this assessment, we used the criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).


Based on our assessment, which was conducted based on the COSO criteria, our management, including our CEO and CFO have concluded our internal control over financial reporting was effective, as of December 30, 2017.

The effectiveness of our internal control over financial reporting as of December 30, 2017, has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears under Item 8.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the fourth quarter ended December 30, 2017, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B.

OTHER INFORMATION

None.


PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required by this Item is incorporated by reference to our Proxy Statement for our 2017 Annual Meeting of Stockholders (the “Proxy Statement”) to be filed with the SEC not later than 120 days after the end of our fiscal year ended December 30, 2017, specifically:

Information regarding our directors and any persons nominated to become a director, as well as with respect to some other required board matters, is set forth under Proposal 1 entitled “Election of Directors” and under “Corporate Governance.”

Information regarding our audit committee and our designated “audit committee financial expert” is set forth under the caption “Corporate Governance.”

Information on our code of business conduct and ethics for directors, officers and employees is set forth under the caption “Code of Ethics” under “Corporate Governance.”

Information regarding Section 16(a) beneficial ownership reporting compliance is set forth under the caption “Section 16(a) Beneficial Ownership Reporting Compliance.”

Information regarding procedures by which stockholders may recommend nominees to our board of directors is set forth under the caption “Nominating and Governance Committee” under “Corporate Governance.”

Information regarding our executive officers is set forth at the end of Item I, Part 1 of this Annual Report on Form 10-K under the caption “Executive Officers of the Registrant."

ITEM 11.

EXECUTIVE COMPENSATION

Information regarding compensation of our named executive officers is set forth under the caption “Executive Compensation” in the Proxy Statement, which information is incorporated herein by reference.

Information regarding compensation of our directors is set forth under the caption "Compensation of Directors" in the Proxy Statement, which information is incorporated herein by reference.

Information regarding compensation committee interlocks is set forth under the caption "Compensation Committee Interlocks and Insider Participation" in the Proxy Statement, which information is incorporated herein by reference.

The Compensation Committee Report is set forth under the caption "Compensation Committee Report" in the Proxy Statement, which report is incorporated herein by reference.

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information regarding security ownership of certain beneficial owners, directors and executive officers is set forth under the caption "Security Ownership of Certain Beneficial Owners and Management" in the Proxy Statement, which information is incorporated herein by reference.


Equity Compensation Plan Information

The following table gives information about the common stock that may be issued under all of our existing equity compensation plans as of December 30, 2017.

Plan category

 

Number of securities to be

issued upon exercise of

outstanding options,

warrants and rights

 

 

Weighted-average

exercise price of

outstanding options, warrants and rights (1)

 

 

Number of securities  remaining

available for future issuance

under equity compensation

plans (excluding securities

reflected in first column)

 

Equity compensation plans approved by security holders

 

 

216,326

 

 

$

16.82

 

 

 

1,981,016

 

Equity compensation plans not approved by

   security holders

 

 

 

 

$

 

 

 

 

Total

 

 

216,326

 

 

$

16.82

 

 

 

1,981,016

 

(1)

The weighted-average exercise price does not take into account the shares issuable upon vesting of outstanding awards of restricted stock units and performance-based shares, as they have no exercise price.

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

Information regarding certain relationships and related transactions is set forth under the caption "Related Person Transaction Policy" under the caption "Corporate Governance" in the Proxy Statement, which information is incorporated herein by reference.

Information regarding director independence is set forth under the caption “Board of Directors Meetings and Committees” under “Corporate Governance” in the Proxy Statement, which information is incorporated herein by reference.

ITEM 14.

PRINCIPAL ACCOUNTING FEES AND SERVICES

Information regarding principal auditor fees and services is set forth under the proposal entitled “Ratification of Appointment of Independent Registered Public Accounting Firm” in the Proxy Statement, which information is incorporated herein by reference.


PART IV

ITEM 15.

EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)

The following documents are filed as part of this report on Form 10-K:

(1)

Consolidated Financial Statements.

See Index to Consolidated Financial Statements in Item 8 on page 39 of this Annual Report on Form 10-K.

 

(2)Onto Innovation Inc.

Consolidated Financial Statement Schedule.(Registrant)

The following consolidated financial statement schedule of Nanometrics Incorporated is filed as part of this Annual Report on Form 10-K and should be read in conjunction with the Consolidated Financial Statements:

Schedule

 

 

II - Valuation and Qualifying Accounts as of and for the years ended December 30, 2017, December 31, 2016 and December 26, 2015

Our allowance for doubtful accounts receivable consists of the following (in thousands):

Year Ended

 

Balance at

beginning

of period

 

 

Additions to Allowance

 

 

Charges Utilized/Write-offs

 

 

Balance

at end

of period

 

December 30, 2017

 

$

73

 

 

$

78

 

 

$

(25

)

 

$

126

 

December 31, 2016

 

$

150

 

 

$

 

 

$

(77

)

 

$

73

 

December 26, 2015

 

$

253

 

 

$

10

 

 

$

(113

)

 

$

150

 

Our valuation allowance for deferred tax assets consists of the following (in thousands):

Year Ended

 

Balance at

beginning

of period

 

 

Additions to Allowance

 

 

Charges Utilized/Write-offs

 

 

Balance

at end

of period

 

December 30, 2017

 

$

10,980

 

 

$

2,984

 

 

$

(262

)

 

$

13,702

 

December 31, 2016

 

$

36,786

 

 

$

1,643

 

 

$

(27,449

)

 

$

10,980

 

December 26, 2015

 

$

35,835

 

 

$

951

 

 

$

 

 

$

36,786

 

Schedules not listed above have been omitted because they are not applicable or are not required or the information required to be set forth therein is included in the Consolidated Financial Statements or notes thereto.

(3)

Exhibits.

See Exhibit Index under part (b) below.

(b)

Exhibit Index


Exhibit No.

 

Exhibit Description

 

Form

 

 

File Number

 

 

Date of First Filing

 

 

Exhibit Number/Appendix Reference

 

3.(i)

 

Certificate of Incorporation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.1

 

Certificate of Incorporation of the Registrant

 

8-K

 

 

000-13470

 

 

10/5/2006

 

 

3.1

 

3.(ii)

 

Bylaws

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.2

 

Bylaws of the Registrant

 

8-K

 

 

000-13470

 

 

4/12/2012

 

 

3.1

 

4

 

Instruments Defining the Rights of Security Holders, Including Indentures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.1

 

Form of Common Stock Certificate

 

10-Q

 

 

000-13470

 

 

11/9/2016

 

 

4.1

 

10

 

Material Contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Management Contracts, Compensatory Plans, Contracts or Arrangements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10.1

 

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers

 

8-K

 

 

000-13470

 

 

2/20/2013

 

 

10.1

 

10.2

 

Registrant’s 2000 Employee Stock Option Plan and form of Stock Option Agreement

 

S-8

 

 

333-40866

 

 

7/6/2000

 

 

4.2

 

10.3

 

Registrant’s 2000 Director Stock Option Plan and form of Stock Option Agreement

 

10-K

 

 

000-13470

 

 

3/13/2008

 

 

10.2

 

10.4

 

Registrant’s Amended and Restated 2003 Employee Stock Purchase Plan

 

Schedule 14A

 

 

000-13470

 

 

4/4/2016

 

 

Appendix 1

 

10.5

 

Form of Subscription Agreement Under the Registrant’s Amended and Restated 2003 Employee Stock Purchase Plan

 

S-8

 

 

333-40866

 

 

9/3/2003

 

 

4.1

 

10.6

 

Registrant’s Amended and Restated 2005 Equity Incentive Plan

 

Schedule 14A

 

 

000-13470

 

 

4/4/2017

 

 

Appendix B

 

10.7

 

Registrant’s Amended and Restated 2005 Equity Incentive Plan forms of Stock Option and Restricted Stock Unit Agreements

 

10-K

 

 

000-13470

 

 

3/13/2008

 

 

10.8

 

10.8

 

Transition and Consulting Agreement, dated as of August 9, 2017, between Nanometrics Incorporated and Timothy J. Stultz.

 

8-K

 

 

000-13470

 

 

8/11/2017

 

 

10.1

 

10.9

 

Nanometrics Incorporated 2017 Executive Performance Bonus Plan

 

Schedule 14A

 

 

000-13470

 

 

4/4/2017

 

 

Appendix A

 

10.10

 

Compensation Arrangements with Named Executive Officers

 

8-K

 

 

000-13470

 

 

11/8/2017

 

 

Item 5.02

 

10.11

 

Form of Performance-Based Restricted Stock Unit Agreement

 

8-K

 

 

000-13470

 

 

3/24/2015

 

 

99.1

 

10.12

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and Timothy J. Stultz, Ph.D., dated May 19, 2015

 

8-K

 

 

000-13470

 

 

5/22/2015

 

 

10.1

 

10.13

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and Jeffrey Andreson, dated May 19, 2015

 

8-K

 

 

000-13470

 

 

5/22/2015

 

 

10.2

 

10.14

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and S. Mark Borowicz, dated May 19, 2015

 

8-K

 

 

000-13470

 

 

5/22/2015

 

 

10.3

 

10.15

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and Kevin Heidrich, dated May 19, 2015

 

8-K

 

 

000-13470

 

 

5/22/2015

 

 

10.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


10.16

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and Janet Taylor, dated August 27, 2015

 

10-Q

 

 

000-13470

 

 

10/30/2015

 

 

10.1

 

10.17

 

Compensation Arrangement with Non-Employee Directors

 

10-Q

 

 

000-13470

 

 

7/28/2016

 

 

10.3

 

10.18

 

General Severance Benefits and Change in Control Severance Benefits Agreement between Registrant and Rollin Kocher, dated November 10, 2016

 

10-K

 

 

000-13470

 

 

3/3/2017

 

 

10.22

 

10.19

 

Employment Agreement between the Registrant and Jeffrey Andreson, dated September 22, 2014

 

10-Q

 

 

000-13470

 

 

10/31/2014

 

 

10.1

 

10.20

 

Employment Agreement between the Registrant and Pierre-Yves Lesaicherre, dated November 27, 2017

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

10.21

 

Separation Agreement between Registrant and S. Mark Borowicz, dated January 8, 2018

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

10.22

 

Independent Contractor Agreement between Registrant and S. Mark Borowicz, dated January 8, 2018

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

10.23

 

Retention Bonus Agreement between Registrant and Greg Swyt, dated December 18, 2017

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

10.24

 

Relocation Agreement between Registrant and Rollin Kocher, dated December 16, 2016

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

10.25

 

Form of Offer Letter to Timothy J. Stultz

 

8-K

 

 

000-13470

 

 

8/8/2007

 

 

10.1

 

 

 

All Other Material Contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21

 

Subsidiaries

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21.1

 

Subsidiaries of the Registrant

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

23

 

Consents of Experts and Counsel

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23.1

 

Consent of PricewaterhouseCoopers LLP Independent Registered Public Accounting Firm

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

31

 

Rule 13a-14(a)/15d-14(a) Certifications

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31.1

 

Certification of Pierre-Yves Lesaicherre, principal executive officer of the Registrant, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

31.2

 

Certification of Greg Swyt, principal financial officer and controller of the Registrant, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

32

 

Section 1350 Certifications

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32.1*

 

Certification of Pierre-Yves Lesaicherre, principal executive officer of the Registrant, and Greg Swyt, principal financial officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This Certification accompanies this report and shall, not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed for purposes of §18 of the Securities Exchange Act of 1934, as amended.

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

100.INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Document previously filed in the table above are incorporated by reference.

ITEM 16.

FORM 10-K SUMMARY

None.


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 26, 2018

NANOMETRICS INCORPORATED

By:

/S/ Pierre-Yves Lesaicherres/  Michael P. Plisinski

 

 

Pierre-Yves LesaicherreMichael P. Plisinski

President and Chief Executive Officer

 

Date:

(Duly Authorized Officer and Principal Executive Officer)February 25, 2020

Pursuant to the requirements of the Securities Exchange Act of

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, this Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.THIS REPORT HAS BEEN SIGNED BELOW BY THE FOLLOWING PERSONS ON BEHALF OF THE REGISTRANT AND IN THE CAPACITIES AND ON THE DATES INDICATED.

 

Signature

 

Title

 

Date

 

 

 

 

 

/S/ Pierre-Yves Lesaicherres/ Michael P. Plisinski

 

President, Chief Executive Officer and Director

February 26, 2018

Pierre-Yves Lesaicherre

(Principal(Principal Executive Officer)

 

February 25, 2020

/S/ Greg Swyt

Vice President, Finance

February 26, 2018

Greg Swyt

(Principal Financial Officer and Controller)

/S/ Bruce C. Rhine

Chairman of the Board of Directors

February 26, 2018

Bruce C. RhineMichael P. Plisinski

 

 

 

 

 

 

 

 

 

/S/ J. Thomas Bentleys/  Steven R. Roth

Senior Vice President, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

February 25, 2020

Steven R. Roth

/s/ Jeffrey A. Aukerman

 

Director

 

February 26, 201825, 2020

J. Thomas BentleyJeffrey A. Aukerman

 

 

 

 

 

 

 

 

 

/S/ Edward J. Brown Jr.s/  Leo Berlinghieri

 

Director

 

February 26, 201825, 2020

Leo Berlinghieri

/s/  Edward J. Brown, Jr.

Director

February 25, 2020

Edward J. Brown Jr.

 

 

 

 

 

 

 

 

 

/S/ Robert G. deusters/  Vita A Cassese

 

Director

 

February 26, 201825, 2020

Vita A. Cassese

/s/  Robert G. Deuster

Director

February 25, 2020

Robert G. Deuster

 

 

 

 

 

 

 

 

 

/S/ Christopher A. Seamss/  David B. Miller

 

Director

 

February 26, 201825, 2020

David B. Miller

/s/  Bruce C. Rhine

Director

February 25, 2020

Bruce C. Rhine

/s/  Christopher A. Seams

Director

February 25, 2020

Christopher A. Seams

 

 

 

 

 

 

 

 

 

/S/ s/  Timothy J. Stultz, Ph.D.

 

Director

 

February 26, 201825, 2020

Timothy J. Stultz, Ph.D.

 

 

 

 

 

 

 

 

 

/S/ Christine Tsingos

s/  Christine A. Tsingos

 

Director

 

February 26, 201825, 2020

Christine A. Tsingos

 

 

 

 

 

 

 

 

 

/s/  John R. Whitten

Director

February 25, 2020

John R. Whitten

 

 

 

 

 

 


79Table of Contents